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Insulin prescription errors are a common, costly problem in NHS hospitals in the United Kingdom (UK), and are a 
consistent source of unintentional harm to inpatients with diabetes. Prompted by the lack of large-scale 
quantitative and qualitative research conducted in the UK in this area, this research aimed to investigate inpatient 
insulin prescribing practice and the current use of interventions designed to prevent insulin prescription errors in 
UK hospitals. 
Following the conduct of a systematic review of interventions designed to reduce inpatient insulin prescribing 
errors, a questionnaire was developed, validated, and used as part of a cross-sectional survey of chief/diabetes 
pharmacists representing every NHS acute trust in the UK. Information was captured regarding the use, 
functionality and perceived effectiveness of insulin prescribing systems and interventions. Follow-up qualitative 
interviews were conducted with survey respondents to further analyse their experiences and opinions regarding 
insulin prescribing practice and intervention use. Realist synthesis was then undertaken to further understand 
how insulin self-administration policy interventions worked in different contexts. A participatory health research 
approach was taken throughout the research to maximise relevance and impact of the research for end-users, 
and a combination of middle-range theories were used throughout the research to aid the transferability of 
findings. 
Ninety-five hospital trusts responded to the survey (54%), 18 of whom participated in follow-up interviews. 
Results indicated that a wide range of prescribing systems with varying functionalities were in use, along with a 
diverse range and combination of error-prevention interventions. Intervention use was positively associated with 
the availability of specialist diabetes pharmacists (P=0.002), who worked with diabetes teams to improve insulin 
safety in their organisations. Although mandatory insulin training was used by only 46% of trusts, it was perceived 
to be very effective at preventing errors. This was due to the perceived lack of understanding and confidence 
prescribers have with insulin, but the difficulties associated with accessing staff to deliver training in hospital. The 
insulin passport was perceived to be ineffective and only used by 31% of trusts on account of faults in its design, 
incompatibility with existing systems, and unreliable use by patients. Self-administration policy interventions were 
used by 63% hospitals and were described as salient but complex to implement; The use of realist synthesis 
generated 10 programme theories to further explain how they work, for whom and in what circumstances. Key 
contexts, outcomes and mechanisms were identified, including hierarchical and blame cultures, patient 
empowerment, control, shared decision-making, and clarification of roles. 
As the first study to investigate insulin prescribing practice and intervention use at a multi-organisational level in 
the UK, this research contributes to the literature by describing and explaining how interventions may be used to 
improve the care received by inpatient with diabetes. Actionable findings are included that may help hospitals 
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Foreword from the Author 
 
This thesis presents work that I have carried out during my PhD, whereby I have sought to gain an understanding 
of the strategies used to reduce errors associated with the prescribing of insulin for inpatients with diabetes. 
Undertaking this work has enabled me to develop skills in research design, conduct and dissemination using a 
variety of methods and methodologies and has enabled me to make an original contribution of knowledge for the 
benefit of improving the quality of care that people with diabetes receive in hospital. 
My personal and professional background provides an important context to the work presented in this thesis, so 
I will outline this briefly here. I am currently working as an embedded clinical academic pharmacist at the 
University of Huddersfield and Sheffield Teaching Hospitals NHS Foundation Trust. This post primarily involves 
curriculum design and delivery for undergraduate and postgraduate pharmacy students in the areas of applied 
therapeutics, interprofessional education and prescribing. I am also involved in delivering undergraduate student 
hospital placements at the hospital, undertaking clinical pharmacy activities on ward areas, conducting practice-
based research based at the trust, and supporting other pharmacists in research activities. I have been working in 
hospital pharmacy since I graduated from my undergraduate MPharm programme in 2009, and have been a 
proponent of interprofessional working and quality improvement efforts throughout this time. Prior to the PhD, I 
completed an MSc in clinical pharmacy and an MA in higher education where I developed my skills in quality 
improvement methods and qualitative research in the areas of insulin prescribing and interprofessional 
education. In recent years I have contributed to the national assessment of final-year medical students’ 
prescribing competency as a senior author for the national Prescribing Safety Assessment (PSA). 
As a clinical pharmacist in a hospital setting, my goal is to always patient safety at the heart of my practice. My 
motivation for undertaking the PhD is to be able to further my knowledge and skills to become a more advanced 
pharmacy practitioner for the benefit of the patients that I care for, and to generate and disseminate knowledge 
that aids wider hospital service improvement efforts. Prior to commencing the PhD, I have worked with colleagues 
to lead and disseminate quality improvement research regarding insulin prescribing practice at the point of 
admission and discharge from hospital.  
Moreover, following the identification of this topic as being important to both patients and the hospital 
organisation in which I work. This involved investigating insulin prescribing and administration errors across the 
trust (Bain, Kavanagh, McCarthy, & Babar, 2019), documenting the impact that medicines reconciliation processes 
had on insulin errors (Bain, Moussallati, & Kavanagh, 2017), investigating the quality of insulin discharge 
prescriptions (Bain, Nettleship, Kavanagh, & Babar, 2017), and designing, implementing and evaluating quality 
improvement interventions to reduce insulin errors and improve patient safety (Bain, Silcock, Kavanagh, Quinn, 
& Fonseca, 2019). The positive impact that this activity has had on care provision locally, as well as further afield 
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(e.g. published work being cited by other authors), provided motivation to continue investigating this topic or my 
PhD. 
The research objectives therefore derived from issues I considered important in my own professional practice and 
experience working in hospital pharmacy, and my prior knowledge of the literature, quality improvement 
initiatives, and national drivers. The way I have conducted the research reflects both my comfort discussing this 
topic with members of my own profession, the role I understand pharmacists have in this topic nationally, and 
the importance I place on involving patients in the care they receive and the research that informs it. As I am the 
main instrument of data collection throughout the thesis (Bryman, 2012 p405), I have considered how my values, 
motives and position have influenced how questions are framed, the analysis of the data and the outcomes. I 
have kept a reflective diary throughout to document how my own background, profession, institutional 
affiliations, and opinion about the topic may have shaped the design, data collection and analysis. 
My journey through the PhD represents something of an epistemological migration from my professional 
background and training, which was predominantly of a positivist persuasion, towards a more relativist position. 
To answer the research questions in the most appropriate way, I needed to think more critically about a wider 
variety of methodological approaches; this resulted in an exploration of paradigms and a deeper engagement 
with theoretical frameworks and methodological tools that I had not previously encountered. A particular 
highlight of my journey through this PhD was discovering my methodological ‘home’ of scientific realism and 
participatory health research, and having the opportunity to reflect on how these have furthered my 
understanding of research involving interventions in healthcare settings. 
This thesis presents research that furthers our understanding of insulin prescribing practice in the inpatient 
setting, and the use of interventions that are designed to prevent prescription errors. Chapter 1 introduces the 
area of insulin prescribing for inpatients with diabetes in the UK, including insulin prescription error types and 
proposed improvement strategies to prevent these errors. This chapter incorporates a review of relevant national 
guidance, policy, and peer-reviewed literature to highlight gaps in what we know that are addressed by the 
current research. Theoretical models relevant to the research are also introduced, including Reason’s human error 
theory, Human Factors, and Normalisation Process Theory, along with explanations as to why they are particularly 
suitable to apply to this research. 
The review of the evidence to support the research topic provided in the first chapter is followed by a systematic 
literature review in Chapter 2. This review systematically identifies and evaluates the peer-reviewed literature 
pertaining to the effect of inpatient insulin prescribing interventions on improving insulin prescribing practice. 
The results are synthesised and presented in a narrative form on account of the diverse methodologies used in 
the studies identified, and conclusions are drawn that provide a foundation for the original research that follows. 
Chapter 3 presents the methodology and methods of the research, including ethical and governance 
considerations. The chapter starts by outlining the overall design of the research, followed by a discussion of the 
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chosen methodologies and methods used for each of the studies conducted in the thesis. An explanation as to 
why mixed methods and realist synthesis were chosen to answer the research questions is provided, including a 
discussion regarding the compatibility of the methodological approach with my ontological and epistemological 
position. Details of how the stakeholder groups interacted with the research are also given in this chapter. 
The results of the mixed methods study are included in Chapters 4 and 5. These relate to the investigation of 
insulin prescribing practice in UK hospitals and the interventions used to prevent insulin prescription errors. 
Chapter 4 describes the development, use and validation of a questionnaire tool based on the findings of the 
systematic review. The results obtained from using this tool in a national cross-sectional survey of NHS Hospitals 
in the UK to describe insulin prescribing systems and intervention use are presented. Factors associated with 
intervention use were extracted from the analysis of results, and conclusions informed the design of the next 
study. 
Chapter 5 presents the development and use of a semi-structured qualitative interview guide to investigate the 
use of interventions in hospital organisations further, following the national survey results. The results of the 
qualitative study, which involved interviewing pharmacists who participated in the national survey, are presented 
as a reflexive thematic analysis, and are interpreted with the aid of a Human Factors model. Conclusions from this 
study inform the design of the final study of the thesis, which seeks to further explain how one particular 
intervention works, for whom, in what circumstances and why.  
Chapter 6 presents the results of the final study, which is a realist synthesis of self-administration policy 
interventions. This intervention was chosen as a particularly salient intervention from the results of the mixed 
methods study presented in Chapters 4 and 5, as well as input from the stakeholder groups. 
The key results of the mixed methods study and realist synthesis are discussed in their respective chapters. 
Chapter 7 includes a general discussion of the quality of the research conducted and how this meets the objectives 
of the thesis. The implications for practice are also outlined in this chapter as well as opportunities for further 
work. The thesis concludes with a summary of the research findings and the contribution this work has made to 
the literature. 
I refer to myself as ‘the researcher’ throughout this thesis. Unless otherwise stipulated, reference to ‘the 
research’, ‘the study’ or ‘the present work’ refers to the original research designed and conducted by me, 
presented in this thesis. Where reference to additional researchers, reviewers or team members is made, this is 
accompanied by some description of who this is: either members of the supervisory team, peer researchers or 
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ADA – American Diabetes Association 
BBCI -  Basal bolus correctional insulin 
BG – Blood glucose 
CF – Cystic Fibrosis 
CMG – Clinical management group (hospital-level) 
CMOC – Context-mechanism-outcome configuration 
CPOE – Computer provider order entry, or electronic prescribing (see also EP and EPMA) 
CQC – Care Quality Commission  
CQUIN – Commissioning for Quality and Innovation 
DISN – Diabetes Inpatient Specialist Nurse  
DKA – Diabetic Ketoacidosis  
DSN – Diabetes Specialist Nurse 
DUK – Diabetes UK  
EP – Electronic prescribing 
EPMA – Electronic prescribing and medicines administration 
FRIII – Fixed Rate Intravenous Insulin Infusion  
HbA1c – Glycated Haemoglobin  
HHS – Hyperosmolar Hyperglycaemic State 
HPC – Healthcare professional 
IPT – Initial programme theory 
IV – Intravenous 
JBDS – Joint British Diabetes Societies for In-patient Care group 
LADDER –Lay Advice on Diabetes and Endocrine Research 
MMT – Medicines Management Technician 
NaDIA – National Diabetes Inpatient Audit 
NCEPOD – National Confidential Enquiry in Patient Outcomes and Death  
NHS – National Health Service 
NICE – National Institute for Health and Care Excellence  
NPT – Normalisation Process Theory 
PPI – Patient Public Involvement 
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QI-MQCS - The Quality Intervention Minimum Quality Criteria Set 
RCT – Randomised controlled trial 
SAM – self-administration of medicines 
SEIPS – Systems Engineering Initiative for Patient Safety 
SC – Subcutaneous 
SCR – Summary care record 
SD – Standard Deviation  
SSI - subcutaneous sliding scale insulin. 
TFA – Theoretical Framework of Acceptability 
UBA – Uncontrolled before-after study 
VRIII – Variable Rate Intravenous Insulin Infusion 
 
 
Glossary and Definitions 
 
Blood glucose monitoring – the amount of glucose measured in the blood. 
CMO configurations (CMOC) - Heuristic used to generate causative explanations pertaining to outcomes in the 
observed data. The process draws out and reflects on the relationship of context, mechanism, and outcome of 
interest of aspects of the intervention. 
Context - The ‘backdrop’ of interventions, which may change over time. These include cultural norms and 
environment in which the intervention is implemented, the nature and scope of existing social networks, or 
intervention infrastructure. 
CQUIN - Quality improvement goals that are associated with financial incentives for organisations if achieved. 
DATIX -a patient safety organization that produces web-based incident reporting and risk management software 
for healthcare and social care organisations. 
Foundation Trainee – otherwise referred to as FY1 or FY2 doctor. Recent graduates of medical school in the 
initial training stages (junior doctor). 
General Practitioner – Primary care physician or doctor. 
Hypoglycaemia – low blood glucose levels. 
Hyperglycaemia – high blood glucose levels. 
Insulin – a hormone produced naturally in the pancreas, which regulates blood glucose. 
Inpatient – A person receiving hospital care who requires a bed for an overnight stay. 
LADDER panel – Patient public involvement panel dedicated to diabetes-related research, consisting of people 
with diabetes, based at Sheffield Teaching Hospitals NHS Foundation Trust.  
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Mechanism - The generative force of resources from the intervention that leads to outcomes. This denotes the 
reasoning (cognitive or emotional) and responses of the various actors in relation to the work, challenges, and 
successes of the intervention.  
Middle-range theory – theory that is not so specific as to pertain to one intervention but is abstract enough to 
be connected to the practical workings of interventions.  
National Health Service – UK Government-funded medical and health care services. 
National Institute for Health and Care Excellence –  provides national guidance and advice to improve health and 
social care. NICE is an executive non-departmental public body, sponsored by the Department of Health and 
Social Care. 
Never Event - Serious, largely preventable patient safety incidents that should not occur in the NHS. 
Outcome- Intended or unintended, proximal, intermediate, or final outcomes of the intervention. 
Prescription chart – Electronic or paper-based chart that documents and communicates information about a 
patient’s medication that they receive during the course of their hospital admission. 
Prescribing error  - An error in the prescribing decision-making or prescription writing process. 
Prescription error - errors made in the act of writing a prescription or the prescription itself. 
Prescription fault – errors made in the decision-making process. 
Realist research - Realist research reflects a combination of logical empiricism and constructivism by posing 
questions that seek out the truth of matters. It operates from the view that human knowledge is context-bound 
and contingent. 
Realist synthesis - A theory-driven approach to synthesizing quantitative, qualitative or mixed methods research 
in order to answer questions regarding ‘what worked, for whom and in what circumstances, how and why?’ 
with respect to interventions. 
Retroduction/retroductive theorising - The activity of uncovering hidden mechanisms of action in the deeper 
‘layers’ of reality. 
Summary Care Record  - An electronic record of important patient information, including current repeat 
medication, created from GP medical records. This can be accessed by appropriate healthcare professionals 
working in hospital (e.g. doctors, pharmacists, pharmacy technicians). 
Type 1 diabetes – type of diabetes characterised by absolute insulin deficiency due to autoimmune pancreatic 
beta cell destruction. 
Type 2 diabetes – type of diabetes characterised by insulin resistance due to a progressive loss of adequate 




Chapter 1: Introduction 
 
This chapter introduces the topic of inpatient insulin prescribing practice and situates it within the wider literature 
on inpatient prescribing errors. The importance of the research topic will be outlined, and a rationale for the 
current research will be established. The following areas will be covered: 
• Introduction to insulin use and prescribing practice in the hospital setting. 
• Types of insulin errors and their causes. 
• Interventions designed to improve inpatient insulin prescribing practice. 
• Opportunities for research to improve insulin prescribing practice in UK hospitals. 




The safe use of medicines is an important and topical issue that has been highlighted by both the World Health 
Organisation and the Secretary of State for Health and Social care following research estimating that, each year 
in England, 237 million medication errors are made, costing 1,708 lives and £98 million to the National Health 
System (BBC News, 2018; Elliott et al., 2018; Elliott, Camacho, Jankovic, Sculpher, & Faria, 2020; WHO, 2019).  
One of the top medicines consistently associated with patient harm worldwide is insulin (Amori et al., 2008; 
Budnitz, Lovegrove, Shehab, & Richards, 2012; Dooley et al., 2011; Geller et al., 2014; Santell, Hicks, McMeekin, 
& Cousins, 2003).  Insulin is a high-risk medication, and as such, it has a greater potential to cause harm than other 
medicines, and due to the complexities associated with the insulin prescribing process, people with insulin-treated 
diabetes (of all types) are particularly susceptible to the effects of harmful, avoidable medication errors that occur 
in the prescribing and administration processes (Cousins, Rosario, & Scarpello, 2011; Institute of Safe Medication 
Practitices, 2011). To reduce the occurrence of insulin errors and resultant harm to patients, interventions have 
been designed to improve insulin prescribing practice. These include the use of patient-held medication records 
and electronic prescribing systems with various functions to restrict or guide the prescribing process. 
The work of this thesis focuses on these interventions and their use in the acute hospital setting in the United 
Kingdom (UK). This chapter introduces the research by first providing an overview of insulin prescribing practice 
and errors in the hospital setting, with particular emphasis then being placed on the interventions designed to 
improve the quality of insulin prescriptions. Key terms will be defined, and central theoretical concepts pertaining 
to the research will be discussed throughout. The aim of this chapter is not to present an extensive or exhaustive 
critique of the entire literature related to the topic, but rather to explain the relevance of the research and present 
selected studies that help to explain the rationale for the current work. A thematic funnelling approach will be 
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taken, where topics and key ideas of increasing specificity to the research question will be discussed successively, 
prior to the presentation of the systematic literature review presented in Chapter 2. 
 
1.2 Insulin use in people with diabetes 
 
Diabetes is a chronic, incurable endocrine condition that is an important cause of mortality, morbidity and 
associated healthcare costs worldwide (Danaei et al., 2014). Diabetes is characterised by elevated blood glucose 
(hyperglycaemia) secondary to insufficient insulin production or the presence of insulin resistance. Although there 
are many types of diabetes, the majority of people would be classified as having either type 1 diabetes (absolute 
insulin deficiency due to autoimmune pancreatic beta cell destruction) or type 2 diabetes (insulin resistance due 
to a progressive loss of adequate pancreatic beta cell insulin secretion) (American Diabetes Association, 2020). All 
people with type 1 diabetes need to inject exogenous prescribed insulin, subcutaneously, to control their blood 
glucose. Type 2 diabetes is initially managed with lifestyle modification and oral hypoglycaemic agents but for 
many people, insulin will also be required to control blood glucose levels due to the progressive decrease in insulin 
secretory capacity over time (Home et al., 2014). 
The global prevalence of diabetes is increasing. The International Diabetes Federation (IDF) estimates suggest that 
there were 463 million people with diabetes in 2019, which is set to rise to 700 million by 2045 (International 
Diabetes Federation, 2019). In the UK, numbers of people with diabetes have doubled over the last 20 years, with 
current estimates of around 4.6 million and continue to rise, and associated costs to the NHS are significant; 10% 
of the overall hospital budget per year (around £5.5 billion) is spent on diabetes treatment (Stedman et al., 2020). 
Although the majority of this increase involves people with type 2 diabetes, the number of people being diagnosed 
with type 1 diabetes is also increasing, particularly as a result of COVID-19 (Unsworth et al., 2020).  
People with diabetes are more likely to be admitted to hospital, on a more frequent basis, and have longer lengths 
of stay than people without diabetes (Aro, Kangas, Reunanen, Salinto, & Koivisto, 1994; Comino et al., 2015; De 
Berardis et al., 2012; Sajjad et al., 2018). Given the increase in incidence of diabetes globally, along with the 
significant impact that COVID-19 has had on this demographic, the demand for hospital services is likely to 
increase (Apicella et al., 2020). This increase in incidence of diabetes leads to an increase in demand for prescribed 
insulin, with current conservative estimates suggesting that there are around 150-200 million insulin users 
worldwide (Garg, Rewers, & Akturk, 2018). 
Insulin is undoubtedly a medication of paramount importance, particularly to people with type 1 diabetes who 
require insulin injections to survive. It is, however, also classified as a high-alert medication by the Institute for 
Safe Medication Practices (Institute of Safe Medication Practitices, 2011). High-alert medications confer a 
heightened risk of causing significant harm when used inappropriately, and require particular safeguards to 
minimise the risk associated with their use. It is also categorised as a critical medicine that can cause significant 
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harm to patients if a dose is missed or delayed (e.g. due to a prescribing error). As insulin facilitates glucose 
movement from the bloodstream into cells, patients receiving excessive insulin may experience low blood glucose 
levels (hypoglycaemia). Hypoglycaemia can result in impairment of cognitive function, seizures, hemiparesis and 
even coma. Inpatient mortality rates and length of hospital stay are also higher for people using insulin 
experiencing hypoglycaemia compared to those who do not use insulin (Akirov, Grossman, Shochat, & Shimon, 
2017; Turchin et al., 2009). 
Hyperglycaemia can occur when insulin use is under-utilised, or when the dose prescribed and administered is 
not sufficient to control increased blood glucose levels. Hyperglycaemia, if untreated, may result in diabetic 
ketoacidosis (DKA) or Hyperosmolar Hyperglycaemic State (HHS) for people with type 1 and type 2 diabetes, 
respectively. These conditions can result in serious harm and may be fatal if not managed appropriately. People 
experiencing DKA or HHS during their hospital stay face lengthier admissions, require more intensive nursing input 
and have an increased chance of requiring intensive care (Joint British Diabetes Societies Inpatient Care Group, 
2012; Sinclair-Hammersley et al., 2010).  
Unfortunately, such adverse effects associated with inappropriate insulin use are not uncommon. Between 2003 
and 2009, there were 16,600 reported patient safety incidents involving insulin use in hospitals in England and 
Wales, 24% of which involved patient harm (Cousins et al., 2011). In 2017, an estimated 9,600 people required 
rescue treatment after falling into a coma following a severe hypoglycaemic attack.  During the same year, 2,200 
people (1 in 25 people with type 1 diabetes) suffered from DKA due to under treatment with insulin (NHS England 
and Wales, 2018). More recently, a patient who was administered insulin that had been erroneously prescribed 
at 10 times the correct dose during his hospital admission suffered a tragic fatality as a result (BBC News, 2020). 
The adverse effects described above are often a result of suboptimal or erroneous insulin prescribing and 
administration practices in hospital. These practices are described in the next section, specifically the insulin 
prescribing process and potential errors that can occur therein. 
 
1.3 Insulin prescribing in the hospital setting 
 
Patients interact with hospital care either on an outpatient basis, whereby they attend a hospital clinic 
appointment at a specified time (but do not stay overnight), a day patient (day case) basis, where they occupy a 
hospital bed on a ward for surgery or investigations (but do not stay overnight), or on an inpatient basis, where 
they occupy a hospital bed for one or more nights to receive medical or surgical treatment (either on an elective 
or emergency basis) (NHS, 2019). This thesis covers inpatient care, where people with any type of diabetes who 
use insulin are admitted to hospital for either emergency or elective treatment. The practice of writing insulin 




1.3.1 Prescribing systems 
 
When patients are admitted to hospital as inpatients, they are assigned a prescription chart for the 
purposes of communicating information within and across healthcare teams regarding medications given 
(and to be given) during the course of their hospital stay (Shemilt, Morecroft, Ford, Mackridge, & Green, 
2017). These prescription charts often incorporate medication administration records and may be either 
paper-based or electronic (Z. Ahmed, Garfield, Jani, Jheeta, & Franklin, 2016; Shemilt et al., 2017).  
In Wales, Scotland, and Northern Ireland, hospital organisations have developed standardised paper 
inpatient prescribing charts for use across all hospitals in their respective nations (Healthcare 
Improvement Scotland, 2014; Medicines Governance Northern Ireland, 2016; Routledge, 2012). In 
England, despite previous calls for the introduction of a standard drug chart across NHS hospitals 
(Academy of Medical Royal Colleges, Royal College of Nursing, & Royal Pharmaceutical Society, 2011; 
Dornan et al., 2009), there is no standardised paper-based or electronic prescribing system in use across 
hospitals at the time of writing. Rather, individual hospital organisations have developed their own 
inpatient prescribing systems with varying functionalities and standards (Z. Ahmed, McLeod, Barber, 
Jacklin, & Franklin, 2013; Dixon, 2017; East Kent Hospitals University NHS Foundation Trust, 2019; 
Heatherwood and Wexham Park Hospitals NHS Foundation Trust, 2008; Routledge, 2012; Shemilt et al., 
2017; Sherwood Forest Hospitals NHS Foundation Trust, 2017).  
The incentive to increase the use of electronic prescribing systems in NHS hospitals has been supported 
by government policy to drive technology use within the NHS (Department of Health, 2000; NHS England, 
2019; NHS England et al., 2014). Previous plans for full digitalisation of hospital services by 2020 have not 
been realised, however; the latest target for all hospitals to implement electronic prescribing systems by 
2024 seems equally ambitious considering the substantial work involved in designing and implementing 
these systems in hospital organisations, as well as the slow uptake of electronic prescribing nationally (Z. 
Ahmed et al., 2016; Department of Health and Social Care, 2018; Healthcare Safety Investigation Branch, 
2019; National Information Board, 2014; NHS England, 2019).  
Unlike in Wales, Scotland and Northern Ireland, there seems to be no plan to implement a standardised 
electronic prescribing record, with many hospitals using electronic prescribing systems heterogeneously 
across their organisations, and often in combination with supplementary paper prescription charts for 
complex medicines like insulin (Z. Ahmed et al., 2013; Cresswell, Coleman, Slee, Williams, & Sheikh, 2013; 
Healthcare Safety Investigation Branch, 2019; Shemilt et al., 2017).  
Details regarding how insulin is currently prescribed using available prescribing systems in UK hospitals 
represents an important line of enquiry that has yet to be investigated. This research can therefore 
complement previously published work on prescribing system use by focusing on insulin prescribing 
22 
 
systems as more complex systems and processes compared to other medicines. The consistent selection 
of pharmacists as participants in these studies (on account of their broad and in-depth knowledge of 
prescribing systems in hospitals) informs the consideration of pharmacists as participants in the current 
study. 
 
1.3.2 The prescribing process 
 
Prescribing medicines involves the “identification of the need for a drug and selection of the correct drug, 
together with the route, form, dose, frequency and duration, for the individual patient” (Coombes, 
Stowasser, Reid, & Mitchell, 2009). Most inpatient prescribing is undertaken by junior doctors who are 
undergoing Foundation training during their first two years of graduating from medical school (P. J. Lewis, 
Seston, & Tully, 2018). In the UK, these doctors are referred to as Foundation Trainees, or Foundation 
year one (FY1) or Foundation year two (FY2) doctors, depending on their year of training. Increasingly, 
non-medical prescribers, such as suitably qualified nurses and pharmacists, undertake the task of 
prescribing insulin for inpatients with diabetes (Courtenay, Carey, James, Hills, & Roland, 2007), however, 
the majority of prescribing (around 70-75%) falls on the junior medical staff (Dornan et al., 2010; P. J. 
Lewis et al., 2018).  
In the UK, not all people with diabetes receive insulin as inpatients. This contrasts other countries where 
it is more common to use insulin to treat hyperglycaemia in all hospitalised people with diabetes during 
their stay, irrespective of their pre-admission treatment (e.g. oral hypoglycaemic agents only) (American 
Diabetes Association, 2019). When most people who use insulin to treat their diabetes are admitted to 
hospital, their pre-admission subcutaneous insulin regimen continues to be prescribed and administered 
throughout their stay, alongside regular blood glucose monitoring.  
Unless patients are being treated for DKA or HHS, or are undergoing surgery or require treatment with 
corticosteroids, major changes to their insulin are not usually expected during their inpatient stay (Joint 
British Diabetes Societies for inpatient care, 2019; Joint British Diabetes Societies for Inpatient Care, 2014; 
Joint British Diabetes Societies Inpatient Care Group, 2012; Sinclair-Hammersley et al., 2010). There are 
many factors that impact control of blood glucose, however, meaning that the amount of insulin an 
individual requires each day varies. Many of these factors, including the timing, amount, frequency and 
carbohydrate content of food, as well as concomitant medical conditions (e.g. infection) and stress levels, 
are likely to differ in the hospital setting compared to at home (Corsino, Dhatariya, & Umpierrez, 2020). 
This adds a layer of complexity to the process of prescribing insulin in the hospital setting, and necessitates 
regular review of capillary blood glucose (BG) levels to ensure doses continue to be appropriate for 
individual patients (Joint British Diabetes Societies for inpatient care, 2019).  
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The subcutaneous insulin prescribing process may be delineated as outlined in Figure 1.1. The steps 
included are based on Barker’s model of drug therapy (diagnosis → prescription written → prescription 
received and processed by a pharmacist → drug dispensed → drug administered → patient receives drug 
→ patient is well) (Barker, Mikeal, Pearson, Illig, & Morse, 1982) and represents the product of personal 
professional knowledge and experience gained from working in the hospital setting as a pharmacist 
alongside other members of the healthcare team (doctors and nurses).  
 
 
The process of prescribing insulin on a discharge prescription is distinct from prescribing insulin on an 
inpatient prescription. Often different systems or forms are used and it serves an additional purpose of 
communicating information about the care a patient has received in hospital to the General Practitioner 
(Callen, McIntosh, & Li, 2010; Kripalani et al., 2007). Insulin prescription errors at the point of discharge 
have previously been investigated prior to the start of the PhD and are not considered in this thesis  (Bain, 
Nettleship, et al., 2017; Bain, Silcock, Kavanagh, Quinn, et al., 2019). The prescription of intravenous (IV) 
insulin as part of DKA/HHS/peri-operative/hyperkalaemia treatment pathways are also not included due 
to the clinically distinct situations that these represent. Instead we focus on the process of the routine 
Figure 1.1: Inpatient insulin prescribing process in hospital, based on Barker’s model of drug therapy (Barker 1982). Green boxes represent input 
from pharmacy, orange boxes represent input from nurses. 
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prescription of subcutaneous insulin for inpatients with diabetes, irrespective if these prescriptions are 
new (e.g. as inpatients newly diagnosed with diabetes) or continuations of pre-admission insulin therapy. 
Opportunities for error exist throughout the entire subcutaneous insulin prescribing, dispensing, 
administration and monitoring process, with prescribing errors being one of the most frequently reported 
types of medication error (Cousins et al., 2011). Only one published study has explored the problems 
associated with insulin prescribing processes in the hospital setting with original research. Researchers in 
a Canadian hospital conducted a focus group study with doctors, nurses and pharmacists, which revealed 
that a lack of access to information, high personnel turnover, and the availability of numerous types of 
available insulin led to mistakes with insulin prescriptions (Rousseau et al., 2014). This study was bound 
in the context of a single hospital setting and although thematic analysis was used, the methods for 
generating and refining themes were not mentioned in the report. The findings were suggestive of a 
positivistic approach to thematic analysis and were not interpreted considering any theoretical 
frameworks or models for wider translatability. There have been no qualitative studies that explore 
inpatient subcutaneous insulin prescribing issues in a UK hospital context, or across multiple 
organisations.  
 
1.4 Insulin prescription errors 
 
The prescribing stage of medication use is the source of the highest rates of preventable harm in healthcare 
settings (58%) (Hodkinson et al., 2020), and is the stage at which most medication errors occur, affecting 7% of 
inpatient medication orders and 52 per 100 hospital admissions (D. King et al., 2014; P. J. Lewis et al., 2009; Velo 
& Minuz, 2009). For high risk medicines such as insulin, error rates increase to 107-218 errors per 100 admissions 
(Alanazi, Tully, & Lewis, 2016). Medication errors occurring at the prescribing stage are often referred to as 
‘prescribing errors’. 
The term ‘prescribing error’ has been defined as:  
“A clinically meaningful prescribing error occurs when, as a result of a prescribing decision or prescription 
writing process, there is an unintentional significant (1) reduction in the probability of treatment being 
timely and effective or (2) increase in the risk of harm when compared with generally accepted practice” 
(Dean, Barber, & Schachter, 2000) 
 
The above definition focusses on outcomes of the error rather than the process, and in so doing, may exclude 
errors that do not result in harm or those resulting from problems in the wider context (Aronson, 2009; Ferner & 
Aronson, 2006). It also somewhat ambiguously encompasses the whole process of prescribing (as outlined in 
Figure 1.1), from decision-making to prescription writing, and is less helpful in terms of prevention due to its focus 
on outcomes rather than causes. When considering prescribing errors, the consensus is that the overall 
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prescribing process should be categorised into a) the decision-making process, followed by b) the act of writing 
the prescription. As such, ‘prescribing faults’ – errors made in the decision-making process (e.g. irrational or 
inappropriate prescribing) are distinguished from ‘prescription errors’ – errors made in the act of writing a 
prescription or the prescription itself (e.g. writing illegibly or omitting information) (Aronson, 2009; Dean et al., 
2000; Velo & Minuz, 2009).  
With respect to insulin prescribing, much of the literature, practice guidance and national audit metrics for 
diabetes makes the distinction between an ‘insulin prescription error’ and an ‘ insulin-related glucose 
management error’ (Al-Yassin et al., 2013; Hamilton, Nation, Penfold, Kerr, & Richardson, 2013; Joint British 
Diabetes Societies for inpatient care, 2019; NHS Digital, 2020). Failing to increase the insulin dose following 
persistently high blood glucose results (e.g. over 11mmol/L) would be classed as an insulin-related glucose 
management error, in contrast to the doctor erroneously writing “300 units” instead of “30 units” on a 
prescription (this would be classed as an insulin prescription error). This work focusses on insulin prescribing 
errors (specifically the act of writing a prescription and the prescription itself) rather than insulin-related glucose 
management errors, along with the interventions designed to prevent them being made. For the purposes of this 
thesis, the definition of a prescription error offered by Aronson will be adopted: 
“A prescription error is ‘a failure in the prescription writing process that results in a wrong instruction 
about one or more of the normal features of a prescription’. The ‘normal features’ include the identity of 
the recipient, the identity of the drug, the formulation, dose, route, timing, frequency, and duration of 
administration.” (Aronson, 2009) 
 
Insulin prescription errors therefore involve wrong or missing information including the normal features described 
above. For insulin prescriptions, in order to correctly identify the drug, a product name (e.g. as well as or instead 
of a generic drug name), device and concentration need to be included. As any of these elements may be missing 
or wrong (resulting in a prescription error) they may be considered separately. In the inpatient insulin prescribing 
context, prescription errors relating to unintentional omission of insulin from the drug card altogether are 
described in the National Diabetes Inpatient Audit (NaDIA) and related literature. This is not obviously included in 
the above definition, which seems to assume that at least one element of the prescription is written. For the 
purposes of being inclusive and meaningful for the research topic, process-related errors such as omission from 
the drug chart are included in the definition of a prescription error. Table 1.1 presents examples of insulin 
prescription errors that may occur in practice. It is the prevention of these errors occurring that the work of this 






* Errors that are not currently included in the National Diabetes Inpatient Audit tool for measuring insulin errors 
 
All the insulin prescription errors included in Table 1.1 have the potential to cause harm to patients due to the 
high-risk nature of the drug, with consequences ranging from being classified as mild/moderate to severe/fatal 
(Cousins et al., 2011; Cox & Ferner, 2009). Prescription errors that result in excessive insulin doses being 
administered may lead to hypoglycaemia, which can result in confusion, seizures, coma or even death (Cohen, 
2010). Examples of this include insulin being prescribed twice daily instead of once daily, insulin being prescribed 
in the wrong device, or the abbreviation of ‘units’ to ‘u’, which may be mistaken by the administering nurse as a 
‘0’, resulting in in a 10-fold overdose (Lamont, Cousins, Hillson, Bischler, & Terblanche, 2010; Prescrire Editorial 
Staff, 2014). Prescribing insulin at the wrong time of day may also result in hypoglycaemia due to the need for 
some insulins to be administered alongside meals (on account of their release profiles). For example, prescribing 
mixed (biphasic) insulins at night may result in significant nocturnal hypoglycaemia.   
Errors that result in a failure to provide an adequate amount of insulin may result in hyperglycaemia, DKA, HHS 
or even death. This may include not including insulin on the prescription altogether (e.g. following incomplete 
drug history taking on admission), or failing to provide the insulin concentration on a prescription, which could 
cause delay in administration or result in a patient who usually receives insulin at a higher concentration of 200 
or 300units/ml being given the more commonly available 100units/ml product. Similarly, failure to stipulate the 
type of insulin device can be a cause of significant confusion, and patients prescribed the wrong device may be 
unable to receive their insulin dose when needed. The most commonly reported insulin prescription errors 
Prescription error Example Reference 
Wrong number of units (dosage) 40 units prescribed instead of 4 units  (Dooley et al., 2011) 
Wrong insulin product name Humulin prescribed instead of Humulin I (Bain, Kavanagh, McCarthy, & 
Babar, 2019) 
Wrong frequency*  Once daily insulin prescribed instead of twice daily (Bain, Moussallati, et al., 2017) 
Wrong concentration of insulin* Humalog Kwikpen 100units/ml prescribed instead of 
Humalog Kwikpen 200units/ml 
(Segal, Brunner, Burch, & 
Jackson, 2010) 
Wrong insulin device* Humalog vial prescribed instead of Humalog KwikPen 
(disposable pen) 
(Boparai & Kavanagh, 2015) 
Wrong time of day Biphasic insulin prescribed at night instead of with 
evening meal 
(Bain, Kavanagh, McCarthy, & 
Babar, 2019) 
Incomplete prescription*  Missing name of product, device, time of 
administration, concentration, signature of prescriber, 
patient details 
(Leech, Johnson, Nayar, Nunez, 
& Macleod, 2013) 
Unclear prescription Abbreviating ‘units’ to ‘u’, which may be misinterpreted 
for ‘0’  
(Hamid et al., 2016) 
Omission of therapy  Patient who usually uses insulin not prescribed insulin (Cousins et al., 2011) 
Table 1.1: Types of inpatient insulin prescription error with examples 
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reported include errors of omission, incorrect doses, devices and inaccurate insulin types (Bain, Moussallati, et 
al., 2017; Boparai & Kavanagh, 2015; James, 2005; Lane & Hunter, 2020; Santell, Cousins, Hicks, & Protzel, 2003).  
In the UK, 33 medical negligence claims during 2013-2018 were related to insulin prescription or administration 
errors (Rayman & Kar, 2020), and between April 2018-19 there were 14 insulin-related NHS Never Events recorded 
(NHS England & NHS Improvement, 2019). The National Diabetes Inpatient Audit (NaDIA) records insulin 
prescription error rates each year, along with other insulin errors such as insulin management errors (collectively 
grouped together in the wider category of ‘insulin errors’). On the day of the audit in 2019, 18.2% of inpatient 
prescriptions for insulin-treated inpatients had one or more insulin error (NHS Digital, 2020). This value has not 
changed significantly (i.e. P value < 0.05) since 2011, when 20.7% prescriptions were found to contain an insulin 
error (NHS Digital, 2020). It should be noted, however, that the NaDIA does not include certain types of 
prescription errors included in Table 1.1, such as wrong device or concentration prescribed, and groups “insulin 
given/prescribed at the wrong time” as one error type, despite these two processes being temporally and 
technically distinct in practice. As such, despite the published NaDIA data providing useful information about 
overall insulin errors, it may not provide a true estimate of the prevalence or incidence of insulin prescription 
errors in UK hospitals. 
As we have found that insulin prescription errors are common, potentially harmful and comprise a significant 
proportion of medication-related patient safety incidents, our attention must now turn to the causes of such 
errors, and how these errors may be reduced. 
 
1.4.1 Causes of insulin prescription errors 
 
Identifying and understanding the causes of insulin prescription errors, and the factors associated with 
them, is important to help develop ways to reduce their occurrence. A systematic review conducted by 
Tully et al concluded that inpatient prescribing errors were associated with multiple, complex, error-
provoking conditions and causes, which often acted together (M. P. Tully et al., 2009).  The findings of the 
review were organised according to Reason’s causation of error theory, which is one of the most 
commonly used theoretical modules when considering medication error (J. T. Reason, 1990).  
According to Reason’s theory, causal factors are present in a system before an error sequence occurs. 
These causal factors can include fallible decisions made and implemented by decision-makers and 
management, and conditions that permit efficient and safe operations (error-provoking conditions). 
These causal factors are otherwise known as ‘latent failures’ and can be precursors for unsafe acts.  Unsafe 
acts, otherwise known as ‘active failures’, can be unintentional or intentional. Unintended active failures 
include slips (e.g. attentional failures on account of being tired or busy) or lapses (e.g. memory failures). 
Intentional unsafe acts are classified as either mistakes (e.g. lack of knowledge) or violations (e.g. 
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conscious decision to ignore procedure, or application of an inappropriate rule). The application to this 
theory to insulin prescription errors is exemplified in Table 1.2. 
 
Table 1.2: Examples of causes of insulin prescription errors categorised according to Reason's human error framework 




• Lack of training in diabetes or insulin use 
• Insufficient numbers of ward pharmacists  
• Lack of insulin prescribing guideline (e.g. to specify 
brand name prescribing) 
(Cox & Ferner, 2009) 





• New electronic prescribing system introduced 
• Numerous available insulin mixtures 
• Look-alike-sound-alike insulin products (e.g. Humalog 
and Humulin) in proximity on electronic prescribing 
system 
• Numerous descriptors for insulin (e.g. short-acting, 
basal, mixed, cloudy, clear) 
• No set dose-range (maximum/minimum) as dosing is 
highly individual to patient 
(Bain, Silcock, Kavanagh, Quinn, et al., 
2019) 
(Cox & Ferner, 2009) 
(Cornish, 2014) 
(Ratanawongsa, Chan, Fouts, & Murphy, 
2017) 
(Leech et al., 2013) 
(Cornish, 2014) 
Active failure 
Slip • Prescriber interrupted when writing prescription 
• Prescriber writes “Novorapid” instead of “Novomix” 
• Prescriber mishears dose and writes 15 instead of 50 
(Sutherland, Ashcroft, & Phipps, 2019) 
(Cousins et al., 2011) 
(Cox & Ferner, 2009) 
Lapse • Prescriber tired and forgets to sign the prescription 
• Prescriber forgets to prescribe insulin on admission 
(Hamid et al., 2016) 
(Cousins et al., 2011) 
Mistake • Lack of knowledge about what insulins are available (N. A. A. Kelly, Brandom, & Mattick, 2015) 
Violation • Prescriber does not include details of insulin device on 
prescription 
• Adjusting insulin dose not prioritised by doctor 
• Prescriber incorrectly omits insulin from prescription 
of person with type 1 diabetes and hypoglycaemia 
• Prescriber applies outdated guidance/discouraged 
practice to insulin prescribing  
(Boparai & Kavanagh, 2015) 
(Weiss, 2006) 
(C. King, Hackett, McKenchie, Higgins, & 
Gallagher, 2015) 
(Newsom et al., 2018) 
 
According to Reason, there are two approaches to the problem of human fallibility: the person approach, 
which focusses on the errors of individuals (e.g. inattention, forgetfulness, carelessness, negligence) and 
the system approach, which focuses on optimising the working conditions and building defences to avert 
errors (J. Reason, 2000). The former approach begets strategies, or measures of preventing errors 
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(otherwise known as interventions), that are targeted at reducing unwanted variability in undesirable 
individual prescriber behaviour, or making them less fallible, such as poster campaigns, retraining, and 
policy-writing.  
Interventions targeted at modifying human behaviour are often underpinned by behaviour change 
theories and frameworks such as the Theory of Planned Behaviour (Ajzen, 1991) or more recently, the 
Theoretical Domains Framework and Behaviour Change Wheel (S. Michie et al., 2005; Susan Michie, van 
Stralen, & West, 2011). The Behaviour Change Wheel, for example, links intervention functions 
(restrictions, education, persuasion, incentivisation, coercion, training, enablement) to sources of human 
behaviour (capability, motivation, and opportunity) to characterise interventions. Previous studies have 
identified lack of prescriber knowledge and confidence regarding insulin use (Bain, Kavanagh, McCarthy, 
& Babar, 2019; Derr, Sivanandy, Bronich-Hall, & Rodriguez, 2007; Lee, Liu, Quek, & Chew, 2013). If lack of 
knowledge is considered to be a causative factor for insulin prescription errors, it follows that 
interventions designed to remediate this– such as education, training or memory aids – are often 
implemented (Al-Yassin et al., 2013; N. A. A. Kelly et al., 2015; A. S. Lewis, Mallon, & Cooke, 2018). 
The system approach, by contrast, assumes that humans are fallible and that errors are to be expected, 
and instead focusses on organisational processes that give rise to ‘error traps’ in the workplace (J. Reason, 
2000). As people of all levels of experience and skill can make errors, attention is drawn instead to 
identifying and changing the error-prone conditions under which humans work. For example, the 
technologies that prescribers use to write a prescription (either a paper chart or an electronic system) can 




Reason’s Swiss Cheese model depicts this as elements of a system (e.g. a hospital, ward) having layers of 
barriers, defences, or safeguards to avoid error. These layers may include people (e.g. pharmacists 
identifying and correcting prescription errors), technologies (e.g. electronic prescribing system alerts 
when high doses of insulin are prescribed), physical barriers (e.g. pre-printed forms for prescribing insulin 
that include the word ‘units’ to avoid abbreviations), and procedures (e.g. nurses checking the 
prescription prior to administering insulin). The model implies that all of these layers have ‘weaknesses’ 
(depicted as holes in the swiss cheese) through which a trajectory of opportunity for error may travel (see 
Figure 1.2). These holes comprise the active failures and latent conditions described above.  
 
This model presents a useful and powerful heuristic for understanding a system approach to error 
causation, however the systems within healthcare are complex and adaptive. Various features of the work 
setting (e.g. people, circumstances, activities) combine in multiple ways to bring about (or prevent) an 
error from occurring, and staff adjust their work according to circumstantial changes as well as their own 
expertise (Sutherland & Phipps, 2020). As such, the linear and simplistic representation of error causation 
may not account for the system as a whole, nor provide an understanding of the links between different 
causal, organisational, local and individual factors (Larouzee & Le Coze, 2020). For example, the systems 
in which insulin is prescribed in an inpatient setting are ‘open’, such that interactions with other 
settings/systems with their own priorities and procedures (e.g. primary care services, community 
pharmacy services) have an impact on the task at hand (Sterman, 2006). An example of how different 
Figure 1.2: The Swiss Cheese Model by James Reason (2000) adapted to exemplify an insulin prescription error trajectory. 
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systems interconnect in the process of writing an inpatient insulin prescription, drawn from personal 
experience and knowledge, is shown in Figure 1.3. 
  
The combination of human and system approaches is known as Human Factors. Specifically, it is the study 
of the relationship between the people within a work system and the system itself and its impact on 
Figure 1.3: Example of systems involved in the safe prescribing of insulin in secondary care.  
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safety, performance and wellbeing  (Hignett et al., 2015; Karsh, Holden, Alper, & Or, 2006). The application 
of Human Factors to healthcare systems and medication safety research has increased in popularity over 
recent years and is particularly useful for studying the inherently complex and open systems of healthcare 
(Weir, Newham, & Bennie, 2020).  
The Systems Engineering Initiative for Patient Safety (SEIPS) model, for example, incorporates human 
factors with Donabedian’s widely-used structure-process-outcome model (Donabedian, 1978) to help 
improve its applicability to healthcare (Pascale Carayon et al., 2014). Donabedian considered quality of 
healthcare services (e.g. the prescribing of insulin) in terms of structure, process, and outcome. For quality 
insulin prescribing to occur, for example, assessment of outcomes (e.g. number of prescribing errors) 
should be considered alongside elements of organisational structure (e.g. availability of staff, presence of 
insulin prescribing policy) and process (e.g. medicines reconciliation process timely, insulin prescription 
verification by pharmacist). The SEIPS model (outlined in Table 1.3) has the benefits of accounting for the 
entire work system and how it interacts to impact on patient safety  (P Carayon et al., 2006; Pascale 
Carayon et al., 2014; Pascale Carayon, Wooldridge, Hoonakker, Hundt, & Kelly, 2020). The benefits of this 
approach are recognised with respect to investigating inpatient insulin prescription errors within the 
context of multiple organisations. The application of the SEIPS model will therefore be useful in helping 
to interpret results for the benefit of various hospitals across the UK and further afield.  
 
Table 1.3: Systems Engineering Initiative for Patient Safety (SEIPS) model. Adapted from Carayon (2014) 
Component Elements 
Structure Person Education, skills, knowledge, motivation, needs 
Organization Teamwork, communication, culture, management 
Technologies or tools Electronic prescribing and medicines administration, human factors 
characteristics of tools 
Tasks Job content, challenge, workload, control 
Environment Regulatory, stakeholders 
Process Care processes and other processes Information follow, improvement activities 
Outcome Employee and organisational 
outcomes 
Burnout, job satisfaction 
Patient outcomes Patient safety, quality of care 
 
We have recognised that there is a variety of complex and related causes of insulin prescription errors 
within the open system that is a hospital organisation. Consideration of the underlying psychological 
mechanisms leading to prescription errors can lead us towards consideration of strategies that help to 
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reduce their occurrence. The next section discusses the interventions that are designed to prevent insulin 
prescription errors in the inpatient setting. The section also summarises the current guidance and policy 
to help improve insulin prescribing practice.  
 
1.5 Preventing insulin prescription errors 
 
Preventing insulin prescription errors from occurring is important to minimise preventable harm to patients. In 
the hospital setting, pharmacists have an important role in supporting safe prescribing by providing education 
and training, designing and implementing systems, protocols and guidance to minimise prescription errors and 
providing accurate drug histories for patients on admission to hospital (Cohen, 2010; Joint British Diabetes 
Societies for inpatient care, 2019; J. . Kelly, 2010; Patel, Pevnick, & Kennelty, 2019; Szumita, 2009; Ward & Wasson, 
2017). Interventions such as these may be targeted at addressing specific causes of insulin prescription errors as 
described above, using Reason’s human error framework. For example, latent failures such as lack of training in 
insulin use can be addressed with educational interventions, and active failures such as lapses may be addressed 
with re-design of prescription forms to encourage completion of all necessary aspects of the prescription.  
Interventions designed to reduce insulin prescription errors may be categorised according to the Cochrane 
Effective Practice and Organisation of Care (EPOC) Taxonomy (Effective Practice and Organisation of Care, 2015). 
Examples include education, clinical practice guidelines, protocols, and the use of information technology. These 
interventions are the most frequently mentioned in the literature regarding reducing prescribing errors (De 
Araújo, De Melo, De Bortoli, De Alcântara Bonfim, & Toma, 2019; Manias, Kusljic, & Wu, 2020; The Health 
Foundation, 2012). Therefore, they will be described further below along with relevant policy and national 
guidance. The systematic review presented in Chapter 2 documents and discusses all published interventions 
designed to reduce inpatient insulin prescription errors. 
 
1.5.1 Educational interventions 
 
Interventions to deliver education and training to prescribers in the hospital setting are designed to 
reduce insulin prescription errors by addressing prescribers’ theoretical and practical knowledge deficits 
and unfamiliarity with insulin treatment, that contribute to these errors (Hellman, 2004; R. Hansen, 
Bradley, & Sahm, 2016; Ryan et al., 2014). Various studies indicate that prescribers lack both knowledge 
and confidence to prescribe insulin in the hospital setting (Al-Yassin et al., 2013; Bain, Kavanagh, 
McCarthy, & Babar, 2019; Derr et al., 2007; George et al., 2011; Lee et al., 2013; C. G. Taylor, Morris, & 
Rayman, 2012), although the measures and tools used to assess knowledge and confidence in these 
studies varied. These knowledge deficits are thought to, in part, be attributed to insufficient 
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undergraduate medical training on prescribing, particularly with respect to insulin (Brinkman et al., 2018; 
Hansen, Walsh, Bradley, & Sahm, 2017; N. A. A. Kelly et al., 2015).  
Delivering postgraduate education and training to prescribers regarding the safe prescribing of insulin in 
the hospital setting is currently recommended by the Joint Diabetes Societies for Inpatient Care, who 
state that hospitals should implement mandatory “1 hour diabetes prescribing training as part of the 
induction programme for new doctors and pharmacists joining the Trust” and “mandatory insulin safety 
e-learning annually” (Joint British Diabetes Societies for inpatient care, 2019). Diabetes UK recommends 
“basic training on the safe use of insulin…should be mandatory for all healthcare professionals caring for 
people with diabetes” (E. Watts & Rayman, 2018), and the recent Getting it Right First Time National 
report for Diabetes recommends that “training should be provided for every  healthcare professional who 
dispenses, prescribes and/or administers insulin, appropriate to their level of responsibility, including an 
assessment of competency” (Rayman & Kar, 2020). These recommendations do not stipulate how insulin 
education and training should be designed or delivered, only that it should be mandatory, and include 
assessment of competency. 
Educational interventions can take a variety of forms and their design may be informed by pedagogical 
theory, for example Kolb’s experiential learning theory informing simulated educational sessions that 
incorporate reflection and conclusion-drawing (Kolb, 1984; O’connor et al., 2009; Stocker, Burmester, & 
Allen, 2014). Intervention delivery may include face-to-face teaching (C. G. Taylor et al., 2012), structured 
educational outreach, for example by pharmacists on ward areas (Hart, Lloyd, Furlong, & Hardy, 2017), 
and online e-learning modules,  which are the most common digital learning resource shown to be 
effective in teaching prescribers the required knowledge and skills (Bakkum, Tichelaar, Wellink, Richir, & 
Agtmael, 2019). Other methods include short educational videos (Field, Woodier, Clayton, Plichta, & Teo, 
2018) and educational games (Quail et al., 2018). 
Studies involving educational interventions to improve prescribing practice more generally have used 
different outcome measures to demonstrate their effectiveness (Kamarudin, Penm, Chaar, & Moles, 
2013). This is the same for studies concerning inpatient insulin prescribing practice. Some have used test 
performance (e.g. insulin-related knowledge) (Conn, Dodds, & Colman, 2003), self-reported confidence 
levels (N. A. A. Kelly et al., 2015), or prescribing competence, where prescribers are assessed on their 
prescription writing skills for theoretical cases (Celebi, Weyrich, Riessen, Kirchhoff, & Lammerding-Köppel, 
2009). Others have used prescribing performance, where prescribers are assessed on their ‘real world’ 
prescription-writing abilities (Al-Yassin et al., 2013; Clarke & Narendran, 2005). This makes it difficult to 
make comparisons between interventions, particularly as these studies do not often explicitly relate the 




1.5.2 Insulin prescribing guidance, protocols, and policy 
 
Prescriber decision-support tools such as guidelines, protocols and policies are designed to reduce insulin 
prescription errors by providing prompts to prescribers when writing or entering prescriptions. 
Prescribing guidelines usually include concise instructions on how to prescribe insulin for inpatients in 
certain circumstances (e.g. peri-operative period, hypoglycaemia), and in so doing, minimise the need for 
prescribers to rely on their knowledge and memory to write appropriate, complete, and accurate 
prescriptions for patients using insulin. Guidelines may reassure prescribers about the appropriateness of 
their practice, and when followed appropriately, improve the consistency of care for patients more widely 
(Woolf, Grol, Hutchinson, Eccles, & Grimshaw, 1999).  
The Joint British Diabetes Societies for Inpatient Care (JBDS) have published a suite of guidelines that 
address how insulin should be prescribed in a range of clinical conditions (for example in adults 
undergoing surgery, hypoglycaemia, diabetic ketoacidosis), the latest of which summarises best practice 
in adult inpatient diabetes care. This is based on all previously published guidance (Joint British Diabetes 
Societies for inpatient care, 2019) and it also outlines how to write a safe insulin prescription (see Box 1.1) 
Box 1.1: Guidance pertaining to writing a safe insulin prescription, taken from the Joint British Societies for Inpatient Care guideline on the 
Safe Use of Insulin (2019).  
Patients self-administering insulins should be assessed daily and this should be documented accordingly 
Never use abbreviations e.g. ‘U’ or ‘IU’. Include administration method (e.g. Flexpen, Solostar, cartridges, vials) in 
‘Device’ box. IV insulin should be prescribed on the separate IV insulin medication order and administration chart 
Always use full correct name and proprietary name of the insulin 
Always give rapid acting analogues (Humalog, Apidra, Novorapid), short acting human insulin (Humulin S, Human 
Actrapid) and human biphasic (Humulin M3) and analogue biphasic (Novomix 30, Humalog Mix 25 or Humalog Mix 50) 
with meals 
Always give Insulin Glargine (Lantus), Insulin Detemir (Levemir), Insulin Degludec (Tresiba) or insulin Toujeo or other 
BASAL and intermediate acting insulin at the same time each day, irrespective of meals and even if the patient is 
receiving intravenous insulin 
Confirm any single dose of intermediate/long acting insulin over 50 units and any dose over 25 units of short acting 
insulin and document 
Insulin doses must never be omitted or delayed unless clearly outlined on the prescription and documented in the 
medical notes by the prescriber 
Prescribe ‘Insulin as per chart’ on the patient’s main inpatient prescription chart 
Prescribe and review insulin doses on a regular basis according to clinical need 
Cross off and re-write the prescription if changes are required 
If changes in the patient’s insulin regimen are required, as a general rule, alter one insulin prescription at a time by 
roughly 10% of the dose 
Further dose adjustments should be made no less than 48 hourly 
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The National Institute for Health and Care Excellence (NICE) published a Key Therapeutic Topic called 
‘safer insulin prescribing’ in 2017, which was updated in 2019 (National Institute for Health and Care 
Excellence, 2017). Unlike the above, this is not a formal clinical guideline, but rather advice that claims to 
summarise the evidence base on safer insulin prescribing. The advice contained in this document, 
however, mainly includes what information to give patients being prescribed insulin (e.g. around 
hypoglycaemia and fitness to drive) rather than the prescription-writing process itself and cites national 
patient safety alerts rather than peer-reviewed publications on the topic. Where the prescription writing 
process is mentioned, advice given is included in Box 1.2. 
Box 1.2:  Advice from the National Institute for Health and Care Excellence Key Therapeutic Topic [KTT20] on Safer Insulin Prescribing 
(2019) 
 
In addition to this, NICE also charge hospitals are charged with putting in place systems to allow self-
administration of insulin by inpatients to reduce the harmful impact of insulin errors (National Institute 
for Health and Care Excellence, 2019). Insulin self-administration is where a person who is prescribed 
insulin and is staying in hospital as an inpatient, administers their own dose of insulin. This occurs with 
varying degrees of independence depending on the circumstances. Policies to facilitate this practice in 
the inpatient setting are required because it represents a deviation in the standard practice of nurses 
administering medicines to patients (Richardson, Brooks, Bramley, & Coleman, 2014). 
Hospital organisations often produce bespoke insulin prescribing guidelines, protocols, and policies that 
take into account their local organisational context, systems, and service provision (Dixon, 2017; Helmle 
et al., 2017; Jenkins-Liu et al., 2018; Rushmer & Voigt, 2008).  These interventions have been shown to 
demonstrate improvements in error rates and patient harm events when implemented in practice 
(Donihi, DiNardo, DeVita, & Korytkowski, 2006; Dooley et al., 2011; Noschese et al., 2008; Singh et al., 
2018). They are, however, often introduced as part of multifaceted error-prevention strategies or as part 
of electronic prescribing systems, making it difficult to attribute outcomes to an individual intervention. 
In addition to guidelines, policies, and procedures regarding the prescription-writing process, both the 
Joint British Diabetes Societies for Inpatient Care (JBDS) and the National Institute for Health and Care 
Excellence (NICE) recommend that hospitals implement insulin self-administration policies to reduce 
insulin prescribing errors and the consequential impact on patients (Joint British Diabetes Societies for 
inpatient care, 2019; Joint British Diabetes Societies for Inpatient Care Group, 2012; National Institute for 
Health and Care Excellence, 2019). This has also been reinforced by the Getting It Right First Time report, 
[Prescribe] insulin doses in units ensuring that the word ‘units’ is spelled out in lower case. 
Healthcare professionals cross-reference available information to confirm the correct identity of insulin products. 




Diabetes UK and the NaDIA results (Rayman & Kar, 2020; E. Watts & Rayman, 2018). There are currently 
no published studies relating self-administration policy use to insulin error reduction, or that explore their 
impact, acceptability, or implementation in-depth. 
 
1.5.3 Technologies and tools 
 
The Human Factors approach to error prevention described in section 1.4 concerns the interface between 
systems, tools and the people interacting with them (i.e. prescribers). With respect to reducing 
prescribing errors, tools and technologies that can simplify, standardise and ‘force’ processes, such as 
electronic prescribing or standardised prescription charts, may be useful (Etchells, Juurlink, & Levinson, 
2008). The introduction of electronic prescribing and standardised prescription charts with respect to 
insulin prescriptions will be outlined briefly, along with the Insulin Passport, which is a patient-held record 
containing insulin prescription information designed to help reduce insulin prescription errors on 
admission to hospital. 
 
Electronic prescribing  
 
Most studies regarding the redesign of technologies and tools to reduce prescription errors address the 
implementation and outcomes of electronic prescribing systems and computerised decision-support tools 
(also known as computerised provider order entry (CPOE) systems). The introduction of electronic 
prescribing systems for inpatient prescribing provides the opportunity to reduce certain types of 
prescription error, for example abbreviations, missing prescription elements or ambiguities on account of 
poor handwriting (Prgomet, Li, Niazkhani, Georgiou, & Westbrook, 2017). However, their use is not 
without its problems, with sociotechnical difficulties, the introduction of new types of prescription error 
and increased workload also being reported (Brown et al., 2017). A recent overview of systematic reviews 
concluded that although the use of electronic prescribing resulted in a statistically significant decrease in 
medication errors, there was considerable variation in the magnitude of their relative risk reduction 
(Abraham et al., 2020). 
With respect to inpatient prescriptions for subcutaneous insulin, the introduction of electronic prescribing 
has been shown to reduce insulin errors concerning the wrong name or the use of ‘u’ for units, or insulin 
not being prescribed (Leech et al., 2016). The latest national audit data suggests that hospitals with 
electronic prescribing systems have lower insulin error rates than those not using electronic prescribing 
(17.1% vs 19.5% inpatients with errors, P<0.05 (exact p value not stated)), or only partially using electronic 
prescribing (17.9%, p>0.05). (NHS Digital, 2020). It is unclear what impact this has on insulin prescription 
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errors, however, as the definition of ‘insulin error’ in the audit also includes glucose management errors 
with insulin (e.g. when insulin is not reduced if unexplained blood glucose results are <4 mmol/L). 
Individual studies have demonstrated improvement in insulin prescription errors following the 
introduction of electronic prescribing integrated with electronic blood glucose results (24% to 7.7% after 
14 months (p=0.017) (Leech, Cook, Cook, & Heed, 2017; Leech et al., 2016). Some insulin prescription 
error types seem to persist, however, including errors in device, time, and where insulin is omitted 
altogether (Goble, Sayar, & Pang, 2010; Leech et al., 2017, 2016). Other benefits for insulin prescribing 
have been demonstrated with electronic prescribing system introduction, including their ability to be 
manipulated for the purposes of audit and quality improvement more readily than paper systems (Grant, 
Mustafa, & Malik, 2012; C. King et al., 2015). This benefit has been recognised by a recent report by 
Diabetes UK, which recommends that “effective electronic prescribing system for detecting, recording, 
and avoiding insulin errors should be used across hospitals” (E. Watts & Rayman, 2018). 
Most studies focus on outcomes following the implementation of electronic prescribing systems, rather 
than the interaction between them and the prescribers. One study, however, explored the impact of the 
implementation of a new electronic insulin prescribing order set with doctors and nurses across three 
hospital sites in Canada (Helmle, Edwards, Kushniruk, & Borycki, 2018). Results indicated that although 
the intervention was perceived to positively impact patient outcomes, there were several barriers to its 
use, including a lack of initial and ongoing education, lack of availability of information at the time of 
prescribing, impaired workflow, and lack of communication between care teams. The authors used a 
chiefly positivistic approach to thematic analysis and did not refer to or use a theoretical framework or 
model to present their results. The impact of the intervention on insulin prescription errors was also not 
explicitly mentioned in the study.  
The latest national audit figures suggest that around 45% hospitals in England are using electronic 
prescribing systems for their inpatients (NHS Digital, 2020). It is currently unknown how insulin is 
prescribed using electronic prescribing in these hospitals. For example, we do not know what controls or 
functions are in place to restrict, simplify or standardise the prescribing process electronically, how these 
systems are used and perceived, or how many of these systems are linked to electronic blood glucose 
results to facilitate workflow. 
As there have been no UK based studies regarding inpatient prescribing systems being used for insulin, 
there is an opportunity to contribute to the existing literature by investigating the use and perception of 
electronic prescribing on insulin prescription errors at an organisational level. The use of mixed methods 
and the application of a theoretical framework or model, such as the SEIPS, can further aid transferability 




Insulin prescribing charts 
 
Hospitals prescribing insulin using paper systems (around 55% according to the latest national audit data) 
may be doing so using standard hospital prescription charts, or bespoke, dedicated insulin prescription 
charts. The use of these charts aims to help prescribers to write accurate and complete insulin 
prescriptions by providing decision-support (e.g. summary clinical guidance/protocols/policies) and 
instructions on how to prescribe insulin safely for people with diabetes. They are also recommended to 
be designed ergonomically (with human factors in mind) to facilitate workflow and reduce the 
opportunity for errors by placing critical information and guidance close to the place of prescription (U. 
Dashora, Castro, Sampson, Stanisstreet, & Hillson, 2015).  
The introduction of inpatient subcutaneous insulin prescribing charts has resulted in improvements in 
insulin prescription errors during audit from 65% to 14% over a period of 3 years in one study (Hamilton 
et al., 2013) and in another had eliminated them altogether (Wijetilleka, Ahmed, & Patel, 2015), although 
re-audit was only 4 months after the intervention, and further re-audit would be recommended to 
demonstrate sustained benefit. A study by Rushmer and colleagues found that although insulin 
prescription charts improved the accurate recording of insulin device (from 11% to 100% correct), there 
were no significant reductions in errors concerning dosing, name or time of administration (84% to 87% 
correct) (Rushmer & Voigt, 2008). There is a distinct lack of qualitative research that explores the impact 
and acceptability of insulin prescribing chart use, or relates their implementation to human factors 
approaches to preventing prescription errors. Such research would be timely to conduct considering the 
sustained insulin prescription errors being reported nationally, despite previous evidence supporting 
insulin chart use.  
The use of insulin prescription charts is not formally recommended, although the Joint British Diabetes 
Societies for Inpatient Care (JBDS) guidelines stated above recommend that insulin is cross-referenced on 
the main drug chart, implying that a separate insulin/diabetes chart is preferable. In 2014, the Joint British 
Diabetes Societies for Inpatient Care launched a national competition to demonstrate the best insulin 
prescription chart for inpatient use, the results of which were published in 2015 and included 
recommendations for insulin charts to be practical, appealing, user-friendly, informative, educational, and 
colour-coded (U. Dashora et al., 2015). It is not currently known how many organisations use insulin 
prescription charts, or what elements they contain to restrict, standardise, or simplify the process of 
insulin prescribing. Research that elucidates current practice in this area may help to direct national 





Patient-held insulin prescription information 
 
A National Patient Safety Alert in 2011 instructed organisations to issue patients with a document 
containing contemporaneous information about their insulin prescriptions (known as the insulin 
passport), with the objective of reducing insulin prescription errors due to the unavailability of this 
information provided to prescribers by patients (National Patient Safety Agency, 2011).  
The introduction of the insulin passport was not explicitly based on any evidence of effectiveness, but 
rather on expert panel consultation and discussions amongst the National Patient Safety Agency (National 
Patient Safety Agency, 2011). Studies conducted since the instruction for organisations to issue the insulin 
passports have failed to demonstrate successful use or outcomes. One report demonstrated that out of 
50 patients using insulin identified in hospital, only 4% had a completed insulin passport on their person 
(Walkers & Wilcock, 2014). Concerns have also been raised over uncertainties of who is responsible for 
ongoing documentation and initial issuing of the passports, as well as time and work constraints and 
clinical risk being introduced with multiple information sources containing insulin prescription 
information (Hodgkinson, McFarlane, & Leong, 2013). These findings, however, were presented as 
conference abstracts relatively recently after the national implementation of the intervention and relate 
to experiences within a single hospital. The finer details relating to the study methods and findings were 
unable to be appraised. 
Nevertheless, even recent studies have indicated that problems persist with the insulin passport, as they 
attract little support from patients. An evaluation study conducted in one UK hospital trust found that 
only 15% of patients issued passports carried them, 30% of whom found it useful and 92% specialist staff 
surveyed had concerns over its use (Gulati, Oborne, & Babri, 2019). A qualitative study exploring 
pharmacy staff views on patient handheld medication tools at another UK hospital trust concluded that 
the insulin passport was not widely implemented across the organisation, was not useful for patients with 
carers, had design flaws and was not integrated into current systems and workflow (Waly, Garfield, & 
Franklin, 2018). The wider uptake and regard for this intervention across hospital organisations in the UK 
is unknown. 
Despite the lack of evidence supporting the use of insulin passports, the recently updated NICE key 
therapeutic topic on Safer Insulin Prescribing reinforces the instructions given by the NPSA in 2011, and 
advises to “give adults who are using insulin therapy a patient information booklet and an Insulin 
Passport” (National Institute for Health and Care Excellence, 2019).  Contemporaneous information about 
the uptake of the insulin passport and its perceived effectiveness across a range of organisations would 
be useful to help direct national recommendations regarding its use. This is particularly important in the 
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context where medication errors on transfer of care are prevalent and resources are scarce (Breuker et 
al., 2017; Riordan, Delaney, & Grimes, 2016). 
 
1.6 Implementing Interventions 
 
All interventions described above require some sort of change in a behaviour, process or a practice related to 
insulin prescribing in the inpatient setting. As discussed in section 1.4, the insulin prescribing process is part of a 
wider, interconnected system within (and beyond) the hospital organisation. With respect to implementing insulin 
prescribing interventions, previous studies have suggested that barriers to uptake are ‘complex’ and require a 
multidisciplinary, systems-based approach (Helmle et al., 2018).Johnson and May argue that all interventions that 
are targeted at healthcare professionals and systems are all complex because they are operationalised in complex 
organisational and policy contexts, where their implementation depends on collective rather than individual 
action (M. J. Johnson & May, 2015).  
The implementation of interventions is important to consider alongside their design because of the impact of this 
on intended outcomes. Implementation research is concerned with studying the uptake of the intervention into 
regular use by practitioners, and has been defined as:  
"the scientific inquiry into questions concerning implementation — the act of carrying an intention into 
effect, which in health research can be policies, programmes, or individual practices (collectively called 
interventions).” (Peters, Adam, Alonge, Agyepong, & Tran, 2014) 
 
As this thesis is concerned with investigating the use of interventions to reduce insulin prescribing errors, methods 
and tools that can help us to understand how and why interventions work in the real-world setting need to be 
considered. For example, context is of rudimentary importance in implementation research  in healthcare 
settings, as complex organisational and social factors can significantly influence the implementation of an 
intervention, and indeed interact with each other as part of adaptive systems such as hospital organisations 
(Peters et al., 2014). As such, methods should be chosen that allow for a practical way to understand multiple 
perspectives, causal pathways and multiple types of outcomes, such as the use of both quantitative and 
qualitative methods as part of a mixed methods study (Peters et al., 2014). 
The application of theories that help us to understand how and why things become routine and normal 
components of everyday work can also aid implementation research (Kislov, Pope, Martin, & Wilson, 2019; Nilsen, 
2015). Relevant theories chosen to aid research should match the level of measurement to avoid erroneous 
interpretations. For example, in this research, interventions are studied as a unit of analysis at an organisational 
level (i.e. how well do interventions ‘work’ to prevent insulin errors in a hospital setting). As such, theories that 
are concerned with individual level behaviour change, or a seek to explain how individuals interact with 
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interventions on an inter- or intra-personal level (such as social-cognitive theory and the Theoretical Domains 
Framework) are less relevant for this work than those that seek to explain how interventions work at an 
institutional level. The Theoretical Domains Framework, for example, although well-validated and commonly used 
in studies concerning prescribing practice, does not consider the interactions between diverse domains 
influencing prescribing practice in the same way as the SEIPs model (R. Hansen et al., 2016). 
A systems approach viewed through a human factors lens calls for the application of more systems-level theories. 
There are several theories that seek to explain how interventions work at an institutional level, including the 
theoretical framework of acceptability (Sekhon, Cartwright, & Francis, 2017), organisational readiness for change 
(Weiner, 2009), and normalisation process theory (E. Murray et al., 2010). Normalisation Process Theory (NPT) 
may be particularly beneficial for understanding implementation processes for insulin prescription interventions. 
This is because NPT focuses on the collective work and action in a specific context, rather than an individual’s 
beliefs, attitudes, and intentions (as is the case with the Theoretical Domains Framework, or Theory of Planned 
Behaviour) (E. Murray et al., 2010).  
Normalisation Process Theory characterises implementation processes as the product of four social mechanisms 
(coherence, cognitive participation, collective action, and reflexive monitoring), and in so doing, facilitates and 
understanding of the contexts, social structure and processes through which interventions are enacted (M. J. 
Johnson & May, 2015; C. May & Finch, 2009). The application of this theory to the results may therefore facilitate 
a deeper understanding of insulin prescription interventions and enhance the transferability of findings. 
A key principal of implementation research is that researchers work with populations that will use and be affected 
by an intervention (Peters et al., 2014). Although pharmacists are targeted as participants in this research on 
account of their role in prescribing system and intervention design and implementation in UK hospitals, insulin 
prescribing interventions will also impact doctors, nurses, policymakers, and importantly, patients. This research 
adopts a participatory health research-informed approach that involves co-originating the input of people living 
with diabetes and members of the multidisciplinary diabetes inpatient care team (doctors, nurses, pharmacy 
technicians) as well as policy-makers, as members of the wider research team, on account of the importance of 
co-creating knowledge with stakeholders to improve the relevance, accessibility and impact of the research 
(Baxter et al., 2016; Gray-Burrows et al., 2018; Ocloo & Matthews, 2016; Tomlinson, Medlinskiene, Cheong, Khan, 
& Fylan, 2019; Wilson et al., 2015). These stakeholders have been involved in the identification, design and 
conduct of the research rather than just being targets for dissemination of study results (Peters et al., 2014). 





1.7 Summary and rationale for the research 
 
Insulin is considered as one of the top medicines associated with serious patient harm worldwide. Errors in the 
prescription of insulin for inpatients with diabetes are an important cause of poor outcomes and patient injury 
globally. Despite advances in our understanding of medication error causation in recent years, insulin prescription 
errors remain a significant and clinically important problem in hospitals, and patients continue to suffer from 
preventable harm as a result. The consistently unacceptably high insulin error rates identified from national audit 
data from hospitals in the UK have prompted calls from national bodies for hospitals to further increase efforts 
from inpatient teams to reduce potentially life-threatening inpatient insulin errors (Joint British Diabetes Societies 
for inpatient care, 2019; NHS Digital, 2020; Rayman & Kar, 2020; E. Watts & Rayman, 2018).  
To make progress in reducing avoidable insulin prescription errors and related harms and costs, it is important to 
understand the current factors that contribute to these errors in a UK hospital context. This is also vital to  critically 
examine the systems used to prescribe insulin and interventions that are designed to prevent errors. The current 
thesis seeks to respond to the call for increased efforts to reduce inpatient insulin prescription errors by 
investigating the use of interventions that are designed to reduce insulin prescription errors in UK hospitals. 
Although the problem of insulin prescribing safety concerns all healthcare settings (e.g. including primary care 
and nursing homes), the current thesis bounds the enquiry to the inpatient setting in acute hospitals. This is to 
allow the requisite depth of enquiry to occur by investigating similar processes and contexts. The process of 
prescribing in primary care, for example, is markedly different to that occurring in an inpatient setting, and 
although also prescribing involves risks, these are of a different nature to that of the inpatient setting. Although 
there would be merit in investigating insulin prescribing errors across care contexts, by bounding the enquiry to 
the inpatient setting this research can also build on previous work that has focussed on prescribing in the inpatient 
setting. 
There is a paucity of original research investigating the systems used to prescribe insulin for inpatients in UK 
hospitals. There is also a lack of research that extends our understanding of the factors that contribute to inpatient 
insulin prescription errors in a UK context, and how interventions may or may not aid the effort to reduce them. 
The current use of interventions to reduce insulin prescription errors across UK hospitals, including those 
recommended by national bodies, is also unknown. The existing literature is currently largely limited to UK-based 
conference abstracts, or published studies in North America, where the healthcare delivery context differs 
markedly from that of the UK. The absence of theoretical model application in these studies limits the application 
of results to a UK context. There is, therefore, a significant opportunity to contribute to the literature on this topic 
by conducting theoretically informed original research that investigates the systems and interventions used to 




1.8 Aims and objectives of the thesis 
 
The aim of this research is to investigate inpatient insulin prescribing practice and the current use of interventions 
designed to prevent insulin prescription errors in UK hospitals. This will be achieved by meeting the following 
objectives, and answering the associated research questions: 
1. To undertake a systematic review of the evidence regarding the impact of interventions on insulin 
prescription errors in the hospital setting. 
o What types of interventions are designed to improve inpatient insulin prescribing practice in the 
hospital setting? 
o Which interventions are effective in reducing insulin prescription errors? 
2. To investigate the current use and perceived effectiveness of interventions designed to improve 
inpatient insulin prescribing practice across hospitals in the UK using a national cross-sectional survey. 
o What systems are currently used to prescribe subcutaneous insulin for inpatients in UK 
hospitals? 
o What interventions are currently being used in UK hospitals to improve insulin prescribing 
practice? 
o Is there an association between hospital characteristics and intervention use? 
o What interventions are perceived to be most effective for improving insulin prescribing practice 
by those who have a role in designing, implementing and evaluating them? 
o Is there an association between hospital characteristics and perceived effectiveness of 
interventions? 
3. To analyse the experiences and opinions of UK-based hospital pharmacists involved in the design, 
implementation and evaluation of inpatient insulin prescribing practice interventions using qualitative 
interviews. 
o What are the current challenges and solutions with respect to improving insulin prescribing 
practice in the UK hospital setting? 
o What are the contextual factors that may influence the success of insulin prescribing practice 
interventions in the UK hospital setting? 
4. To use realist synthesis methodology to generate evidence-informed theory that explains how a chosen 
intervention works, for whom, and in what circumstances. 
o What are the mechanisms by which self-administration policy interventions are believed to 
result in their intended outcomes? 
o What are the important contexts that determine whether or not the identified mechanisms 
produce either positive or negative outcomes? 
o What are the circumstances in which self-administration policies are most likely to be effective? 
45 
 
1.9 Overview of the research  
 
The overall outline of the PhD project is shown in Figure 1.4.  
Figure 1.4: Overview of the research 
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To meet objective 1, a systematic literature review of interventions designed to improve inpatient insulin 
prescribing quality was conducted. This review is presented in Chapter 2, and has also been published in Diabetic 
Medicine (Bain, Hasan, & Babar, 2019).  The results of this review were considered and incorporated into the 
design of a mixed methods study which meets objectives 2 and 3. The underlying methodology and technical 
details of the methods used for this study are presented in Chapter 3. This study incorporates a quantitative cross-
sectional survey and follow-up qualitative interviews. The survey results are presented in Chapter 4, and have 
been published across two papers in Diabetic Medicine (Bain, Hasan, Kavanagh, & Babar, 2020, 2019). The findings 
from the qualitative study are presented in Chapter 5 and have also been submitted for publication. The results 
of the mixed methods study, and their interpretation with the stakeholder groups, informed the design of the 
final study. This study meets objective 4 by using realist research methods, and is presented in Chapter 6. A 
discussion of the research relating to the overall objectives and quality is presented in Chapter 7, including the 




Chapter 2: Systematic review of insulin prescribing interventions in hospital 
 
 
This chapter builds on the previous chapter by presenting a systematic review of the literature regarding the 
effectiveness of insulin prescribing safety interventions in the hospital setting. The review will be reported in its 
entirety in this chapter, including a discussion of the results and implications for the original doctoral research 




Interventions to improve prescribing practice more generally have been the subject of much study, and are often 
targeted according to the type of error (Aronson, 2009; Velo & Minuz, 2009). A variety of interventions to improve 
insulin prescribing practice in the inpatient setting has been recommended by consensus expert panels, including 
the use of dedicated insulin prescription forms, electronic prescribing, insulin order sets, education, and readily 
available insulin prescribing guidance/protocols (American Diabetes Association, 2019; Cobaugh et al., 2013; 
Cornish, 2014). Despite these recommendations to improve the safe use of insulin in hospital, insulin errors 
persist. In recent years there have been a number of insulin prescribing safety interventions described in the 
literature, however, there have not yet been any reviews conducted that summarise the available evidence with 
respect to the success of these interventions. 
The aim of this review was to identify and document interventions designed to reduce insulin prescription errors 
for hospital inpatients with diabetes. To account for the different definitions of ‘prescription errors’ or ‘prescribing 
errors’ in use, all studies that reported on prescription accuracy and completeness were included, as well studies 
that reported as adherence to national or local insulin prescription guidelines. Insulin-related glucose 





The Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines (Moher, Liberati, 
Tetzlaff, Altman, & PRISMA Group, 2009) were used to guide and report the systematic review (see Appendix 1). 
The study protocol was published in advance of the review conduct on the PROSPERO register (CRD42018107133) 
(Bain, Babar, & Hasan, 2018). The systematic literature review did not require ethical approval as no personal, 





2.2.1 Identification of studies 
 
A literature search was undertaken between 16th August and 12th November 2018 to identify full-text, original 
research articles published in English. There were no geographical or date restrictions to maximise the capture 
of relevant articles. The search strategy used a combination of free-text words and medical subject heading 
(MeSH) terms targeting ‘insulin’, ‘prescribing’, ‘interventions’, ‘medication error’, ‘quality improvement’ and 
‘hospital’ and was tailored to accommodate varying databases (see Table 2.1). 
 
Table 2.1: Example search strategy for the systematic review 
Medline EMBASE 
# Database Search term Results 
1 Medline (insulin).ti,ab 327220 
2 Medline (prescri*).ti,ab 174621 
3 Medline (48ypogly*).ti,ab 2017563 
34 Medline (hospital).ti,ab 866517 
4 Medline (1 AND 2 AND 3) 823 
5 Medline (error).ti,ab 167012 
6 Medline (4 AND 5) 12 
7 Medline exp INSULIN/ 176510 
8 Medline exp PRESCRIPTIONS/ 33632 
33 Medline exp INPATIENTS/ 18443 
9 Medline (7 AND 8) 148 
10 Medline exp “MEDICATION ERRORS”/ 
15009 
11 Medline (7 AND 10) 179 
12 Medline “QUALITY IMPROVEMENT”/ 
17576 
13 Medline (7 AND 12) 36 
35 Medline (1 AND 2 AND 34) 305 
42 Medline (1 AND 2 AND 34 AND 5 AND 
35) 13 
# Database Search term Results 
14 EMBASE (insulin).ti,ab 426331 
15 EMBASE (prescri*).ti,ab 297893 
16 EMBASE (48ypogly*).ti,ab 2864344 
37 EMBASE (error).ti,ab 200390 
36 EMBASE (hospital).ti,ab 1292072 
18 EMBASE exp “INAPPROPRIATE PRESCRIBING”/ 3933 
19 EMBASE exp “QUALITY CONTROL”/ 344052 
21 EMBASE exp INSULIN/ 302730 
22 EMBASE exp PRESCRIPTION/ 166546 
24 EMBASE exp “TOTAL QUALITY MANAGEMENT”/ 50965 
27 EMBASE exp “PATIENT SAFETY”/ 101625 
29 EMBASE exp “MEDICATION ERROR”/ 17198 
31 EMBASE exp “HOSPITAL PATIENT”/ 145163 
38 EMBASE (14 AND 15 AND 16 AND 37) 55 
39 EMBASE (14 AND 15 AND 37 AND 36) 50 
40 EMBASE (14 AND 15 AND 37) 118 
41 EMBASE (18 AND 21) 67 
42 EMBASE (21 AND 22 AND 24) 32 
43 EMBASE (21 AND 22 AND 27) 121 
44 EMBASE (21 AND 29 AND 31) 99 
45 EMBASE (21 AND 22 AND 31) 251 
 
Computerised scientific databases, including CENTRAL (Cochrane Central Register of Controlled Trials), 
PubMed, Medline, EMBASE (Excerpta Medica dataBASE), TRIP (Turning Research Into Practice), and IPA 
(International Pharmaceutical Abstracts) were searched, as well as hand searches of journals considered 
to have topic relevance (e.g. Diabetic Medicine, Diabetes Care). Grey literature searches using e-theses 
online service (EThOS), National Institute for Health and Clinical Excellence (NICE), and Google Scholar 
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were performed to reduce publication bias. The reference lists of relevant studies were also hand 
searched to capture studies that may not have been previously identified. 
 
2.2.2 Study Selection 
 
Both randomised and non-randomised studies were included, with no restrictions on research design, 
sample size, age or follow-up time period. Due to the specific area of interest and the diverse methods 
and measures included in quality improvement literature, it was felt that a broad and inclusive approach 
was required. 
 
Inclusion and exclusion criteria 
 
Only studies that examined the effect of inpatient insulin prescribing practice interventions with 
quantifiable data were included. Interventions targeting any group of healthcare professional or patient 
were included. The studies reporting the effects of any system-orientated or practitioner-orientated 
intervention on prescribing compared with no intervention/standard practice were also included (see 
Table 2.2 for definitions).  
 
Table 2.2. Classification and definition of interventions, adapted from Nuckols et al. (Nuckols et al., 2018) 
Classification  Definition 
System-orientated Strategies 
Team changes Changes to the structure or organisation of the clinical health care team, including: 
adding a team member or “shared care” e.g. routine visits with personnel other than 
which would be provided as part of ‘standard care’ like a new diabetes specialist 
nurse or pharmacist; expansion or revision of professional roles (e.g. non-medical 
prescribing or increased glycaemic monitoring role) 
Continuous Quality 
Improvement 
Interventions explicitly identified as using the techniques of continuous quality 
improvement, such as plan-do-study-act (PDSA) or any iterative process for 
assessing quality issues, developing solutions, testing their impact and then 





The use of a dedicated form specifically designed for the ordering/prescribing of 
insulin, either as a template to be completed by adding handwritten prescriptions, 
or typed and printed.  
Electronic insulin 
order set 
Electronic prescribing of insulin whereby a prescription requirements are pre-
populated in some capacity, enabling a more standardised, consistent approach. 
Restrictive changes Introduction of a policy or protocol that requires additional validation prior to 




Audit and feedback Summary of clinical performance of healthcare delivery by an individual or group of 
individuals over a specified period, which is relayed back to the clinician. 
Provider education Interventions designed to promote increased understanding of principles guiding 
clinical care are awareness of specific recommendations regarding insulin 
prescribing. Interventions may include face-to-face lectures, seminars or workshops, 
e-learning packages or educational outreach visits. This does not include training on 




Tools designed to help prescribers make decisions on how to prescribe insulin. May 
include guidelines or algorithms, flowcharts or pocket-guides, reminders to perform 
certain tasks or include certain information. May be included as part of electronic 
prescribing software or paper-based. 
 
 
Studies relating to insulin use in nursing homes, outpatient facilities, community care or long-term care 
facilities were excluded. Studies focusing on the prescription for intravenous insulin were excluded due 
to the distinct clinical circumstances in which it is used. Studies focusing on errors in insulin use (e.g. 
insulin administration errors or not increasing/decreasing insulin doses in response to blood glucose 
results) were also excluded. Pilot studies for which the complete results were published later were not 
included. 
  
2.2.3 Data extraction 
 
Titles and abstracts were independently screened to identify potentially relevant articles. Full text review 
was performed by the researcher using a pilot data extraction form to determine eligibility for inclusion. 
Uncertainties were resolved by discussion with a second reviewer to achieve consensus. 
The researcher extracted all data, which were checked by a member of the supervisory team. 
Discrepancies were resolved by discussion and where necessary after discussing with a second member 
of the supervisory team. Attempts were made to contact article authors via email where outcome data 
were unclear with respect to prescribing practice or insulin errors. Articles were excluded if the data were 
not obtained.  
For each study, the following variables were extracted using a bespoke data extraction form adapted from 
the Cochrane Handbook (J. Higgins, 2011): study details (authors, date, citation), patient population 
(numbers of patients, type of diabetes, age, length of stay), number of hospital sites and location (and if 
stated, institution type and size), intervention characteristics (type of intervention and implementation) 




2.2.4 Assessment of quality and risk of bias in included studies 
 
The quality of the eligible studies was assessed using the Cochrane Risk of Bias Tool (J. P. Higgins, Altman, 
& Sterne, 2011) for randomised trials and the Newcastle-Ottowa Scale for nonrandomised studies (Wells 
GA et al., 2012). The Quality Intervention Minimum Quality Criteria Set (QI-MQCS) (Hempel et al., 2015) 
was used to assess key reported information for all included studies. Studies were not excluded on the 
basis of risk of bias or quality assessment in order to be as inclusive as possible for the purposes of 
achieving the aims of the review. 
 
2.2.5 Data analysis 
 
The primary analysis was based on the change in outcomes, for example the difference in insulin 
prescribing error numbers (%). For studies reporting multiple outcomes, only the outcome of interest was 
included where the extractable data were available. When studies used controlled designs, the change in 
numbers of prescribing errors represented absolute differences between the control and intervention 
groups after the implementation of the intervention.  With studies using uncontrolled designs, the change 
reported represented changes from baseline to follow-up for the intervention group. 
As the studies were heterogeneous in terms of methods of analysis, the results are presented in the same 
manner as in the articles. Statistical meta-analysis was only considered for studies that were similar in 




Searches of the main electronic databases led to identification of 32,333 titles (see Table 2.3).  
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After examination of titles and abstracts, 429 studies were retrieved for more detailed evaluation. Hand searching 
of reference lists produced 21 new articles. After exclusion of conference abstracts and non-relevant studies, a 
total of 65 articles were selected for full-text review. After the application of inclusion/exclusion criteria, 35 
studies were included in the final review (Figure 2.1). Details of the excluded studies at the final stage are listed 
in Appendix 2. 
 
Figure 2.1: Study selection flowchart.  
 
2.3.1 Characteristics of included studies 
 
In total, 35 studies were included: 2 cluster randomised controlled trials (RCTs), 2 cohort studies, and 31 
uncontrolled before-after (UBA) studies. The 2 RCTs were at high risk of bias due to lack of blinding and 
optional use of the intervention. Observational studies were also at high risk of bias due to 
representativeness of the exposed cohorts and study controls for confounders (see Appendix 3).  
The reporting quality of the studies was critically appraised using the Quality Improvement Minimum 
Quality Criteria Set (QI-MQCS). Many included studies did not include details to satisfy the minimum 
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reporting requirements according to this tool. For example, more than half of the studies failed to 
describe the members’ shared resolve and belief in their collective ability to implement change (otherwise 
known as organisational readiness). Descriptions of organisational motivation and the comparator (e.g. 
practice before the intervention) were also lacking in many studies (see Appendix 3). 
All included studies were conducted in hospitals, 6 of which involved multiple sites. The included studies 
originated from Australia (n=4), Austria (n=1), Canada (n=3), Spain (n=2), the United Kingdom (n=6) and 
United States of America (n=19). The number of participants ranged from 18 to 4,239 in each individual 
study.  Table 2.4 includes details of the characteristics of included studies. 
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Tully 2018 (V. 
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Helmle 2017 
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2017) 
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Four acute care 
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Canada 
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Hospital Marina 
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Spain 
Inpatients with 
type 2 diabetes or 
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unit. A trend 
toward more 
appropriate 
orders (91% vs 
80%) was 
observed on the 
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Note: NaDIA = National Diabetes Inpatient Audit (United Kingdom). SSI = subcutaneous sliding scale insulin. BBCI = basal bolus correctional 
insulin. BG = blood glucose 
 
Studies described a median of 2 interventions as part of their quality improvement strategy (maximum 7, 
minimum 1). Twenty-two studies involved the introduction or optimisation of provider decision support 
tools (such as guidelines and algorithms), 14 studies described the introduction or optimisation of a 
dedicated insulin order form/prescribing chart, 15 studies involved education of healthcare professionals 
and 12 involved electronic prescribing interventions such as insulin order sets (involving the automatic 
population of additional required or supplementary information on electronic prescriptions (e.g. type of 
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insulin, meal association etc.). Seven studies took a continuous quality improvement approach. Other 
interventions were used less frequently (see Table 2.5).  















































































































































Achtmeyer 2002    x x    
Al-Yassin 2013       x  
Courtneay 2007 x      x  
Donihi 2006   x     x 
Dooley 2011     x    
Donsa 2016    x    x 
Doyle 2014  x x    x x 
Ena 2009       x x 
Gomez-Huelgas 2014   x     x 
Guerra 2010    x x   x 
Hamilton 2013   x      
Harbin 2015   x     x 
Helme 2017  x x x x x x x 
Horton 2015       x  
Kowiatek 2001  x   x  x x 
Lehnbom 2009   x     x 
Mamillapalli 2012        x 
Maynard 2009  x  x    x 
McIver 2009  x x     x 
Mulla 2015    x   x x 
Newsom 2018 x   x   x x 
Noschese 2008   x     x 
Rushmer 2008  x x     x 
Schnipper 2009    x   x x 
Schnipper 2010    x     
Taylor 2012       x  
Thompson 2009 x  x     x 
Trujillo 2008       x x 
Tully 2018  x    x  x 
Vaida 2012       x  
Valgardson 2015   x x     
Wesorick 2010   x    x  
Wexler 2010    x     
Wong 2016   x    x  




Although a few studies described a team approach to the design of interventions, there was a lack of 
explicit mention of patient or public involvement. Only 2 studies looked at economic or financial 
sustainability/impact of interventions (Courtenay et al., 2007; V. Tully et al., 2018) and there was a general 
lack of consideration of the theoretical basis or justification for interventions. Well-reported studies 
included details of usual care in the control/before group, as well as the organisational characteristics and 
readiness for change (Helmle et al., 2017; Kowiatek et al., 2001; Newsom et al., 2018; Noschese et al., 
2008; V. Tully et al., 2018; V. W. Wong, Ho, Fiakos, Lau, & Russell, 2016). 
Compliance with insulin prescribing guidance was measured either by prescription accuracy, 
completeness, the number of insulin errors on inpatient prescriptions, or the use of basal bolus 
correctional insulin compared to subcutaneous ‘sliding scale’ insulin monotherapy. This is the strongly 
discouraged practice (mainly in North America) of controlling blood glucose in the inpatient setting with 
correctional doses of short-acting insulin (American Diabetes Association, 2019). As these two measures 
represent apparent distinct priorities for practitioners based on geographical location, the results are 
presented based on the aim of each intervention.  
 
2.3.2 Interventions to improve insulin prescribing accuracy and completeness 
 
Eleven studies reported interventions to improve insulin prescription completeness, accuracy or 
reduction in insulin prescribing errors defined by the individual authors. 
There were 6 studies performed in the United Kingdom, 2 in Australia, 1 in Austria and 2 in the United 
States. All were uncontrolled before-after studies. Four studies were multisite (Al-Yassin et al., 2013; 
Dooley et al., 2011; McIver et al., 2009; C. G. Taylor et al., 2012), 7 studies involved teaching or tertiary 
hospitals (Donihi et al., 2006; Donsa et al., 2016; Dooley et al., 2011; Kowiatek et al., 2001; McIver et al., 
2009; Rushmer & Voigt, 2008; V. Tully et al., 2018) and 3 involved district general hospitals (Al-Yassin et 
al., 2013; Courtenay et al., 2007; Hamilton et al., 2013). 
Interventions described in the study included the following: structured education sessions (Al-Yassin et 
al., 2013; C. G. Taylor et al., 2012), insulin prescribing charts (McIver et al., 2009), insulin charts that 
incorporate prescribing guidance (Donihi et al., 2006; Hamilton et al., 2013; Rushmer & Voigt, 2008), a 
diabetes specialist nurse prescriber service (Courtenay et al., 2007), a high-dose insulin validation 
guideline (Dooley et al., 2011), a medicines reconciliation sticker (V. Tully et al., 2018), and the use of 
electronic software to calculate required total daily and bolus insulin doses (Donsa et al., 2016). None of 
the studies studied the impact of introducing electronic prescribing software or insulin order sets. 
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There was a lack of consistency with respect to the methodology and outcome measures used in the 
studies. Seven studies measured the reduction in insulin prescribing errors (Al-Yassin et al., 2013; 
Courtenay et al., 2007; Donihi et al., 2006; Donsa et al., 2016; Dooley et al., 2011; Hamilton et al., 2013; 
C. G. Taylor et al., 2012), 3 studies measured the accuracy, clarity and completeness of prescriptions 
(Kowiatek et al., 2001; Rushmer & Voigt, 2008; V. Tully et al., 2018), and one measured opportunity for 
error as a result of unclear prescribing (McIver et al., 2009). The types of intervention varied, as well as 
the implementation strategies, and measures of improvement between studies (see Appendix 5). 
Although 3 studies used the United Kingdom’s National Inpatient Diabetes Audit (NaDIA) methodology 
and data collection tool, the follow-up period, interventions, implementation, and the data reported were 
varied, hence it was difficult  to pool data or make meaningful comparisons (Al-Yassin et al., 2013; 
Hamilton et al., 2013; C. G. Taylor et al., 2012).  
The introduction of simple, small focused interventions led to an improvement in the completeness and 
accuracy of insulin prescribing, particularly when they involved ‘hard stops’ (such as pre-printing ‘units’ 
on dedicated insulin prescription charts to avoid misinterpretation of ‘u’) (Hamilton et al., 2013; McIver 
et al., 2009; Rushmer & Voigt, 2008). McIver et al. implemented a standardised insulin prescribing form 
incorporating pre-printed ‘units’ and mealtime associations (McIver et al., 2009). As a result, they 
reported a reduction in the opportunity for error as a result of non-standard abbreviations from 41.8% to 
12.2% and unclear frequency from 65.9% to 6.5%. Hamilton et al. saw a reduction in NaDIA-reported 
insulin prescribing errors from 65% to 14% and later 2%, after making the same changes to their dedicated 
insulin chart, as well as including practice guidance and using root cause analysis (Hamilton et al., 2013).  
Rushmer et al. created a subcutaneous insulin ‘care cluster’ and used a Plan-Do-Study-Act (PDSA) 
approach to design and implement changes to their dedicated insulin prescribing chart, involving both a 
multi-disciplinary team and patients in the process (Rushmer & Voigt, 2008). Prescription accuracy did 
not increase significantly as a result (84% to 87%); however, by simply dedicating space for insulin device 
to be documented on the chart, prescriptions improved in their ‘completeness’ from 11 to 100%. A 
smaller quality improvement project undertaken by Tully et al. focused on the medicines reconciliation 
process of insulin on admission to hospital (V. Tully et al., 2018). Using continuous improvement 
methodology, the design and introduction of a sticker to prompt accurate and complete prescribing of 
insulin on admission resulted in an increase in insulin medicines reconciliation from 64% to 91%.  
Both Taylor et al. and Al-Yassin et al. describe the impact of a single educational intervention involving 
junior doctors (Al-Yassin et al., 2013; C. G. Taylor et al., 2012). The amount of NaDIA-reported errors 
reduced from 15.4 to 7.8% (p<0.05) and 32% to 17% (p>0.05), respectively. Studies more commonly 
involved a multimodal interventional strategy including a variety of healthcare professionals, which 
seemed to result in a more substantial improvement in insulin prescribing.  
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All studies discussed above were non-randomised, hence making it difficult to attribute any quality 
improvement measures to the impact of interventions alone. 
 
2.3.3 Adherence to national guidelines 
 
None of the studies reported on interventions designed to increase adherence to the UK national 
recommendations on insulin prescribing safety, for example the implementation of the insulin passport. 
Twenty-four studies described interventions to improve the adherence to American Diabetes Association 
guidance, specifically the recommendation that basal bolus correctional insulin regimens are used in non-
critically ill inpatients with diabetes instead of subcutaneous sliding scale insulin monotherapy. Two of 
these studies were cluster randomised controlled trials (Schnipper et al., 2010; Wexler et al., 2010), 2 
were cohort studies (Noschese et al., 2008; Wesorick et al., 2010) and 20 were uncontrolled before-after 
studies. Most studies were conducted in the United States (n=17). Three studies were conducted in 
Canada (Doyle et al., 2014; Harbin et al., 2015; Helmle et al., 2017), 2 in Australia (Lehnbom et al., 2009; 
V. W. Wong et al., 2016) and 2 in Spain (Ena et al., 2009; Gomez-Huelgas et al., 2014). 
Most studies measured outcomes as the difference in prescribing patterns (change in percentage of 
subcutaneous ‘sliding scale’ insulin or basal bolus correctional insulin regimens prescribed); others 
measured this as percentage patient-days on subcutaneous ‘sliding scale’ insulin or basal bolus 
correctional insulin (Wesorick et al., 2010) or percentage of orders for different combinations of insulins 
(Lehnbom et al., 2009). Results from studies reporting the same outcome measure are shown in Figure 
2.2.  
Studies mainly described small-scale local change at a microsystem (e.g. ward) level, or single institution 
level. Three studies described large scale, resource-heavy initiatives involving more than one hospital site 
(Helmle et al., 2017; Mulla et al., 2015; V. W. Wong et al., 2016). 
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Most interventions involved the introduction of insulin order sets using computer physician order entry 
(CPOE) or a dedicated insulin order form, often including decision support tools such as guidelines or 
dosing algorithms. Eleven studies described the implementation of electronic insulin order sets 
(Achtmeyer et al., 2002; Donsa et al., 2016; Guerra et al., 2010; Helmle et al., 2017; Maynard et al., 2009; 
Newsom et al., 2018; Schnipper et al., 2010, 2009; Valgardson et al., 2015; Wexler et al., 2010; Yeung et 
al., 2018). Most significant improvements were seen when prescribers were required to use insulin order 
sets to prescribe insulin (i.e. there was no other option). 
























Absolute change in sliding scale insulin prescribing (%)
Absolute change in basal bolus correctional insulin prescribing (%)
Figure 2.2: Absolute change in prescribing patterns (reduction in subcutaneous ‘sliding scale’ insulin or increase in basal bolus correctional 
insulin) reported in studies after implementation of intervention (vs before the intervention), or in the intervention group (vs control group) (%). 
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Yeung et al. reported only a small, non-significant reduction in subcutaneous ‘sliding scale’ insulin use 
from 52% to 47% with the optional use of a new computerised insulin order set containing basal bolus 
correctional insulin ordering options, where there were previously only subcutaneous ‘sliding scale’ 
insulin monotherapy order sets (Yeung et al., 2018). The main limitation was the failure to study 
uptake/use of the order set, which would have helped to examine the intervention’s effect more 
completely. Wexler et al. implemented a similar insulin order set and also found only a very slight 
reduction in subcutaneous ‘sliding scale’ insulin use (35% vs 38%). Authors suggested that this was likely 
to be due to the optional use of the order set along with minimal support for its implementation (Wexler 
et al., 2010). Where multiprofessional provider education campaigns supported the implementation of 
order sets, such as reported by Mulla et al. (Mulla et al., 2015), success of the intervention was greater 
(e.g. up to 66% absolute increase in use of basal bolus correctional insulin prescribing). 
Newsom et al. described the large-scale transition of an entire organisation to the use of an electronic 
glucose management system integrated with the hospital’s electronic health record. The ordering of 
insulin became simpler and more standardised, and the use of subcutaneous ‘sliding scale’ insulin 
monotherapy dramatically reduced from 95% to 4% (Newsom et al., 2018). Wong et al. described the 
reduction in subcutaneous ‘sliding scale’ insulin monotherapy use from 16.7% to 3.2% (p=0.014) after the 
introduction of a mandatory insulin prescribing chart necessitating a doctor’s prescription for every single 
insulin dose in each patient (V. W. Wong et al., 2016). 
Educational initiatives mostly complemented the introduction of other interventions and were only 
described as the sole intervention in 2 studies. Horton et al. reported that face-to-face education of 
medical residents on the 2009 American Diabetes Association Guidelines for inpatient insulin use alone 
saw a reduction in subcutaneous ‘sliding scale’ insulin prescribing from 62% to 52% (p=0.289) (Horton et 
al., 2015). Details of the session content and delivery were not reported in the sufficient detail to allow 
for further analysis and conclusion. Vaidya et al. similarly reported statistically non-significant reductions 
in subcutaneous ‘sliding scale’ insulin use (25 to 15%) following the introduction of a computerised 
educational module across the endocrinology department (Vaidya et al., 2012). 
Despite the outcome measures being similar across several studies, the difference in characteristics of 
the organisation, comparators, interventions, their combination, and implementation did not allow for a 
statistical comparison between studies. Meta-analysis, subgroup analyses and meta-regression were 








Although several studies reported on the effectiveness of interventions to increase adherence to insulin 
prescribing guidelines, the range of heterogeneous study designs, differences in implementation and outcome 
measures limits the validity and generalisability of conclusions. Despite this, a number of key findings are of 
interest.  
First, the introduction of mandatory, dedicated insulin prescribing documentation can lead to significant 
improvements in insulin prescribing accuracy and completeness. The introduction of pre-printed ‘units’ on a 
dedicated prescription form designed to increase insulin prescribing safety is an excellent example of how a simple 
intervention reduces the opportunity for a knowledge-based error or writing error. In the United Kingdom, insulin 
prescription form design to promote insulin safety has been encouraged nationally with the Rowan Hillson Insulin 
Safety Awards, which enables the sharing of good practice in this area (60, 61). 
Second, educational interventions comprise an important part of quality improvement strategies but tend to be 
less effective when used in isolation. Similar results were found in a review by Kamarudin et al. concerning 
educational interventions to improve prescribing performance, concluding that multifaceted interventions where 
education was incorporated into a system-based approach produced more positive results (Kamarudin et al., 
2013). Educational interventions targeted at non-medical prescribers and involving feedback to prescribers was 
missing from the studies included in the review. With increasing numbers of non-medical prescribers being active 
in the inpatient setting, research into the impact of non-medical prescribers on insulin errors should be 
encouraged (Cope, Abuzour, & Tully, 2016). 
The implementation of electronic insulin order sets had a positive impact on insulin prescribing quality, although 
the extent of the impact varied. These results echo a previous systematic review that concluded that the 
implementation of computerised physician order entry (CPOE) reduced medication errors in the hospital setting 
by around half, although the studies were highly heterogeneous and seldom reported the desired contextual and 
implementation variables (Nuckols et al., 2014). In the present review, all studies reporting on the implementation 
of electronic insulin order sets concerned the use of subcutaneous ‘sliding scale’ insulin versus basal bolus 
correctional insulin or the calculation of total daily insulin doses. Although the NaDIA has shown that insulin errors 
are slightly less likely to occur with the use of electronic prescribing compared to paper prescriptions (17.1% vs 
19.5%), this is not specific to insulin prescription errors, as NaDIA defines insulin errors as those including insulin 
management errors (NHS Digital, 2020). There were no included studies showing the impact of electronic 
prescribing on insulin prescribing errors, accuracy and completeness that could be applicable in the context of 
hospitals in the United Kingdom. 
Applying the results to Reason’s error theory (J. T. Reason, 1990), we find that most published interventions are 
targeted at addressing errors deriving from organisational processes (e.g. education addressing lack of training in 
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diabetes or insulin use), lapses (e.g. pre-printed prescription proformas prompting prescribers to include all 
elements of the insulin prescription), mistakes (e.g. validation policies addressing unintentional dosing errors) and 
violations (electronic order sets addressing prescribers’ non-application of insulin prescribing guidance). The 
results indicate that interventions designed to reduce active errors (such as lapses, mistakes and violations) may 
be more effective, particularly when they are mandatory.  Due to the number of studies reporting on the impact 
of more than 1 type of intervention (e.g. education plus order set), it is difficult to draw conclusions about which 
types of error are best to address when attempting to prevent insulin prescription errors.  
Improvement strategies involving system change that engage multiple stakeholders at various levels were more 
likely to be effective and sustainable, which is consistent with principles of total quality management (Pereira & 
Aspinwall, 1997). None of the studies identified reported taking a whole systems, human factors approach to 
intervention design and there was a lack of use of models such as the SEIPS that facilitated consideration of the 
wider organisational factors that can impact on the sustainability of intervention use. Due to the variety of 
organisational, process and systems contexts described, there is scope to further explore how and why certain 
interventions work in these different contexts and settings. This level of analysis was missing from included 
studies, which focussed more on the impact of the intervention rather than exploring issues of design and 
implementation.  
Notably, there was a lack of reported patient involvement in the design, evaluation and reporting of interventions 
being implemented. The current drive for people with diabetes to self-administer and/or self-manage their insulin 
in hospital would be further supported by evidence linking this practice to reductions in prescribing errors 
(Flanagan, Dhatariya, Kilvert, & group, 2018). Although arguably resource-intensive (and not without other 
limitations described in Chapter 1), routine use of the National Diabetes Inpatient Audit (NaDIA) in the United 
Kingdom can provide organisations with valuable data with which to monitor and benchmark their performance 
with respect to insulin prescribing errors and patients’ experience. Along with other national insulin safety 
initiatives such as the Rowan Hillson award, these tools can facilitate individuals and organisations to further 
direct and drive improvement in this area (U. Dashora et al., 2015). 
 
Challenges and limitations 
 
This review aimed to be exhaustive by including all study designs and reporting any outcome of interest. However, 
only English-language studies were included, which may have excluded studies published in different languages. 
This review was also conducted prior to the very recently published JBDS guidelines that outlines how insulin 
should be prescribed in the inpatient setting (see section 1.5.2). It may be anticipated that future studies 
conducted in the UK may use these guidelines to measure the impact of interventions on insulin prescription 
quality (absence of errors, accuracy, completeness).  
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Differences in operational definitions across geographical locations presented difficulties in the initial searching 
and selection of articles. For example, the use of the term ‘sliding scale insulin’ in the United Kingdom is mostly 
reserved for the use of variable rate intravenous insulin infusions due to the non-routine use of ‘sliding scale’ 
subcutaneous insulin regimens as described in the American literature. Articles were therefore identified in hand-
searches that were not identified or retrieved in the initial stages of searching. A uniformity of terminology would 
therefore aid future reviews of this nature.  
Studies also varied in how they defined an insulin prescribing error. The use of the NaDIA methodology may offer 
a way of standardising this somewhat, although this is not without its limitations. Documentation of insulin device 
and concentration, for example, are not included as insulin prescription errors, which may limit the 
representativeness of the entire range of insulin errors encountered in practice. Standardisation of definitions of 
insulin prescribing error, along with a theoretical justification for interventions would facilitate evidence 
interpretation. 
Overall, the conclusions drawn are somewhat limited by the quality and heterogeneity of the included studies. 
The overall risk of bias across studies was high due to the majority of studies adopting uncontrolled before-after 
study designs. It is appreciated that the design and implementation of interventions will depend on many 
institution-specific factors such as current practice, structures, culture, staff education, and workflow processes. 
The difference in organisational behaviour and practice between settings within and between hospitals often 
means that large randomised studies with effective blinding and controlling for confounding factors is often not 
possible when it comes to studying prescribing interventions involving inpatients. Nevertheless, studies with more 
rigorous designs that are powered to detect changes in insulin prescribing errors are needed and should be 
reported in sufficient detail to facilitate evidence interpretation and uptake.  Inclusion of discussions of local 
context, organisational motivation and readiness, barriers and facilitators, and sustainability issues, including 
economic evaluations would facilitate assessment of the feasibility, spread potential, sustainability and 
effectiveness of insulin prescribing interventions.  
 
2.5 Stakeholder group discussions 
 
The results of the systematic review were presented at the Lay Advice for Diabetes and Endocrine Research at 
Sheffield Teaching Hospitals NHS Foundation trust. A lay summary of the results of the review and the proposed 
research (mixed methods study) were circulated to the panel prior to the meeting. A number of questions were 




Box 2.1: Example questions asked in the first LADDER panel PPI meeting 
• Do you think insulin use in hospital is a problem, and/or one worth investigating? 
• Is the research question clear? 
• Do you think the project is worthwhile and would you support it in principle? 
• Is the reason for the research clear? 
• Do you think there is anything that could be done to make the project more acceptable to patients? 
• Are incentives are acceptable and adequate? 
• Can you think of any ways to improve the research? 
 
The questions were adapted from Patient Public Involvement (PPI) resources available online produced by the 
National Institute for Health Research (NIHR) INVOLVE group and Diabetes UK. During the meeting, I presented 
the results and research proposal to the panel, and the above questions were discussed further. Discussions 
suggested that the topic was important to people with diabetes, and supported the investigation of insulin 
prescribing practice in the hospital setting. Box 2.2 contains a summary of the verbatim written feedback as 
circulated by the panel secretary following the meeting: 
Box 2.2: Feedback from the LADDER panel regarding the systematic review and proposed original research 
• Yes – it is worth investigating a) to see if it is a problem, b) to find better ways of prescribing/delivering 
insulin in hospital.  
• Definitely worthwhile.  
• Very interesting. 
• From a personal point of view, I’ve never been admitted hospital since having diabetes. However, the 
thought of someone else determining how much and when I get my insulin frightens the life out me, as 
it takes control away from me (unless that someone is a member of MY diabetic team, e.g. Consultant, 
Registrar or DSN).  So definitely worth investigating. 
• Yes [the research question is clear] but it needs to be specific that this is about prescribing insulin for 
in-patients. 
• Yes [the project is worthwhile and we would support it in principle]  
• Yes [the reason for the research is clear] – to improve how much/when insulin should be prescribed 
and reduce errors (which will result in hypo/hyperglycaemia) 
• Involving patients in all aspects of the project, not just interviewing them for their opinions, but letting 
them know what issues staff members have, and how staff think these issues can be resolved.   
• Yes – the biggest potential benefit (and thus incentive) if the project is successful is patients retaining 






2.6 Implications for original research 
 
In general, there is a dearth of literature on the topic of insulin inpatient prescribing practice intervention use and 
effectiveness in a UK context, particularly at a multi-organisational level. Reflections on the results in relation to 
the researcher’s professional experience lead to the conclusion that many interventions that have been designed 
and used to reduce insulin prescription errors are not widely reported in the literature. This suggests that the 
development of a tool that can capture information about the use of interventions across UK hospitals would be 
useful to help describe current practice and identify areas for future development.  
Although there were many studies reporting intervention impact on adherence to American Diabetes Association 
(ADA) guidance, there were no studies reporting on adherence to UK national guidance. The design of the original 
research of this thesis should therefore incorporate questions around the use of interventions supported 
nationally in the UK by NICE – namely the insulin passport, non-abbreviation of ‘units’ on prescriptions, and the 
implementation of insulin self-administration policies. Although the practices reported in North American studies 
are less applicable to a UK context (e.g. interventions to discourage the use of subcutaneous sliding scale insulin 
monotherapy), the interventions used to do this, for example electronic insulin order sets, may be used in a UK 
context. No interventions to improve insulin prescribing practice were targeted at inpatients with diabetes. This 
is perhaps unsurprising considering the types of intervention identified, and would support the design of research 
that aims to elicit healthcare professionals’ opinions on intervention design, use and evaluation. 
Studies identified in the review reported effectiveness of insulin prescribing safety interventions by measuring 
reduction in insulin errors or increased prescription accuracy/completeness. Comparing intervention 
effectiveness is, however, restricted by differences in implementation and use in different contexts, organisational 
factors (such as available staffing and resources), and data collection methods. Measuring perceived effectiveness 
of interventions is also a way of circumventing the above limitations for the purposes of identifying salient 
strategies nationally (Blendon et al., 2002). Perceived effectiveness - “the extent to which the intervention is 
perceived as likely to achieve its purpose” (Sekhon et al., 2017), can indicate levels of support, acceptability and 
scepticism towards adopting recommended interventions irrespective of current intervention use (Rosen et al., 
2005). Insights of perceived effectiveness from healthcare professionals can be used to garner support for the 
wider implementation of interventions and focus national insulin improvement efforts.  
There is currently no tool to assess the perceived effectiveness of inpatient insulin prescribing safety 
interventions. An opportunity therefore exists to conduct research that helps us to understand healthcare 
professionals’ perceptions of effectiveness regarding a range of inpatient insulin prescribing practice 
interventions.  This review has enabled the identification of a range of interventions used globally to help improve 
inpatient insulin prescribing practice, providing a good foundation on which to base the design of original research 





Evidence-based interventions are required to help tackle the problem of insulin prescription errors that have the 
potential to cause serious harm. Interventions that are sensitive to the local context and designed to increase 
adherence to insulin prescribing guidelines are associated with a reduction in insulin prescribing errors. The use 
of multiple interventions involving various stakeholders at different institutional levels may help to reduce insulin 
prescription errors. The lack of UK-based studies on insulin prescription error reduction and intervention use 
prompts the design of original research to investigate insulin prescribing practice and intervention use further in 




Chapter 3: Methodology and Methods 
 
 
This chapter discusses and justifies the approach, study design, and methods used to address the research 
questions outlined in Chapter 2. This chapter includes the following: 
• Methodology and research design. 
• Patient public involvement and participatory health research approach. 
• Study methods, including research ethics and governance. 
 
3.1 Methodology and design 
 
The processes involved in insulin prescribing, and the use of interventions that aim to make these safer, were 
shown in Chapter 1 to be inherently complex. The best way of understanding how to make insulin prescribing 
safer should therefore seek to consider multiple perspectives as well as to explore the context in which they are 
situated. As the need for this research has arisen in response to a current, real-world problem impacting patient 
safety, and concerns practical solutions to be implemented, it sits within a pragmatic paradigm. This is where the 
choice of methodologies is directed by their ability and appropriateness to answer the research questions 
(Creswell & Clark, 2017, p41). 
The methodology chosen also reflects the philosophical, ontological, and epistemological positionality of the 
researcher. This positionality aligns with that of critical realism, as described by Bhaskar and Sayer  (Bhaskar, 1997; 
R. A. Sayer, 2000), which is grounded in way of understanding society that proposes the existence of a reality that 
exists independent of our thoughts about it, or our observations of it. This reality exists in layers. Only the surface 
layer of reality comprises observable events; underneath there are additional layers that are not directly 
perceivable, and we are unable to empirically capture their essence. These deeper layers contain mechanisms, or 
causal forces (such as motives and interests) that produce reality at the empirical (observable) level (Bhaskar, 
1997; Jagosh, 2019). 
Critical realists argue that while interpretative understanding is an important and necessary feature of any social 
science, there is also scope for causal explanation (Bhaskar, 1997). Critical realism thus sits between positivism 
and constructivism as it searches for the alignment between reality and our constructions of reality, and therefore 
lends itself to a relativist epistemology. This is particularly characteristic of the scientific realism described by 
Pawson and Tilley (1997), Sayer (2000), and Miles and Huberman (1994), who argue that:  
“social phenomena exist not only in the mind but also in the objective world, and that some lawful and 




Although a universal truth is assumed, our knowledge of this truth is only partial. Therefore, although we may 
seek to uncover this objective reality using a variety of methods and techniques, our interpretations should always 
be tentative and cautious.  
Critical realists are interested in generative causation, but cannot escape from their particular positions in the 
world through the rigorous use of methods (N. King, Horrocks, & Brooks, 2019).  This is especially true in the 
context of this study, where the researcher is studying the use of complex, socially contingent interventions in 
open and naturalistic systems that they are somewhat ‘embedded’ in. This is a disparate position to that of 
positivists, where the study of phenomena must exist in a controlled environment, free from external influences 
or ‘bias’ from the researcher and study conditions.  
The combination of phenomena being studied that are both ‘real’ (e.g. insulin errors, intervention use, the act of 
prescribing) and ‘constructed’ (e.g. confidence, perceptions of effectiveness, clinical inertia) lends itself to a 
methodology that can accommodate both inductive and deductive approaches to provide a more complete and 
corroborated understanding of the research problem.  This study conforms to the view of scientific realism, which 
seeks to combine scientific rigour comparable to positivist approaches with the relativist emphasis on 
understanding the worldview of the participants. 
A methodological approach that can expansively explore contextual factors and engage in complexities of open 
systems in healthcare is congruent with this ontological and epistemological position. The use of mixed methods 
approaches facilitates both the quantification and description of insulin prescribing processes and interventions, 
as well as the exploration of perceptions and insights into the experiences of those for whom this has immediate 
currency. The additional use of realist synthesis allows a single intervention of interest to be explored in-depth, 











Using a funnelling approach to the research design enables the investigation of the broader topic of insulin 
prescribing safety interventions, followed by a more in-depth study of interventions identified as salient by the 
research and stakeholder team following discussion of results. This has benefits for both transferability and 
importance of the research findings within a national and local context, both of which are needed to enable impact 
and change for the benefit of patient safety. 
The next section will describe the approaches used and will provide an overview of the study design, which 





Figure 3.1: Overview of research design. 
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3.1.1 Mixed methods research 
 
Mixed methods research design is an approach that involves the collection, analysis and integration of 
both quantitative and qualitative data in such a way as to provide a better understanding of a research 
problem than either approach would achieve in isolation (Creswell & Clark, 2017). Originating as a 
“distinct and self-conscious strategy” in the 1980s-1990s (J. A. Maxwell, Chmiel, & Rogers, 2015), mixed 
methods research is an evolving methodology that has gained traction in healthcare services and clinical 
pharmacy research in recent years due to its advantages over mono-method approaches, particularly 
relating to the study of complex systems and patient-centred care  (Hadi & Closs, 2016; Mertens, 2018). 
There are multiple definitions of mixed methods research, along with variations in underpinning 
paradigms, ranging from that which is essentially constructivist in nature to that which is positivist 
(Teddlie & Tashakkori, 2009). In keeping with the critical realist position of the researcher, it is assumed 
that both types of data can be integrated in a single paradigmatic position, as proposed by Hall (in Lê & 
Lê, 2013). This position is important for both the design and the criteria on which the quality of the study 
is judged. The mixed methods research study design is described below. 
 
Mixed methods study design 
 
The types of mixed methods studies may be categorised based on the timing, interaction and dominance 
of each component of the study (Creswell & Clark, 2017). These include designs whereby qualitative and 
quantitative components are conducted simultaneously (convergent parallel design), separately 
(explanatory sequential or exploratory sequential designs) or where one component is subsidiary to 
another (embedded design).  
This study follows an explanatory sequential design, where the quantitative data is collected and analysed 
prior to the qualitative data collection and analysis. The quantitative phase provides a general 
understanding of the research problem and helps to answer descriptive questions about insulin 
prescribing processes and interventions. The qualitative data and their analysis help to refine and explain 
the findings of the quantitative component by exploring participants’ views in more depth (Ivankova, 
Creswell, & Stick, 2006).  Notwithstanding the strength of this approach, this design is time-intensive and 
requires the researcher to be familiar in the use of both quantitative and qualitative techniques. A visual 




Figure 3.2: Mixed methods study design 
  
Although often in this design, the initial quantitative component is given priority in answering the research 
question (Hadi & Closs, 2016), this study gives an equal value and weighting to both the quantitative and 
qualitative phases, which has previously been described by Ivankova et. al. (2006). This decision was 
influenced by the research questions, which involve in-depth exploration of the factors that impede on 
the success of insulin prescribing interventions, as well as being contingent with the epistemological 
position of the researcher. 
Integration of the quantitative and qualitative components occurs at the beginning of the study in the 
formulation of the research questions, as well as at the intermediate stage, where the results from the 
Integration of quantitative and qualitative findings
Interpretation and explanation of the findings from both phases of the study
Qualitative data analysis
Coding and thematic analysis using Braun and Clarke's reflexive thematic analysis.
Qualitative data collection
Individual in-depth telephone interviews with a sample of participants generating textual data
Connecting of quantitative and qualitative phases
Development of interview questions and selection of participants
Quantitative Data analysis
Descriptive statistical analysis, reliability, face, and content validity
Quantitative Data Collection
Cross-sectional postal and online survey generating numeric data
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quantitative study inform the data collection in the qualitative study. The results from the survey inform 
the development of the interview guide for the qualitative study, such that the results of interest can be 
explored in greater depth with participants. A variety of participants were included to represent a variety 
of hospitals, based on organisational characteristics included in the quantitative phase (e.g. presence of 
diabetes pharmacist at the trust). Data integration at the interpretation level in this study involves a 
narrative approach that reports both types of data in a staged way, where quantitative results were 
reported first, followed by qualitative results (Fetters, Curry, & Creswell, 2013). If any conflicting findings 
were found between the quantitative and qualitative studies, these would be discussed in the respective 
chapters. The results from both phases were then discussed together in Chapter 7, enabling a robust and 
meaningful treatment of the research questions. The use of alternative data integration approaches that 
employ quantification of qualitative data, or use qualitative data to verify, dispute or corroborate 
quantitative data was rejected for this study on the basis that they would not have been epistemologically 
consistent and would not serve to answer the research questions. 
Critical reflections on the findings from the mixed methods directed the design of the subsequent realist 
synthesis. The focus on a single intervention of significant importance for patients, staff, and 
policymakers, as well as the study participants, facilitates a greater in-depth exploration and examination 
of detailed organisational and contextual factors that impact the outcomes of the intervention. This 
enables the generation of meaningful knowledge regarding a complex and socially contingent 
intervention that operates in an open system where multiple, diverse healthcare professionals and 
patients are involved. 
 
3.1.2 Realist Synthesis 
 
“Interventions are theories incarnate.” – Pawson and Tilley (1997) 
Realist synthesis (otherwise known as realist review) is a theory-driven methodology grounded in the 
principals of scientific realism, that is concerned with generating an in-depth understanding of an 
intervention’s architecture and the context in which it produces certain outcomes. A realist perspective 
would argue that an intervention does not simply produce an outcome with an effect size. Instead, it 
alerts context1 (e.g. making resources available) that triggers mechanisms that exist in the deeper layers 
of reality (e.g. trust between patients and pharmacists) which produce both intended and unintended 
 
1 It should be noted that in realist terms, context refers to specific elements in the backdrop of an intervention, such as 




outcomes. As such, an intervention may work well in one context but not in another (G. Wong, 
Greenhalgh, Westhorp, Buckingham, & Pawson, 2013).  
The results of the systematic review in Chapter 2 suggest that an array of factors influence the success of 
any given insulin prescribing intervention. Particularly in complex organisational settings (such as that of 
a hospital), intervention outcomes will be somewhat determined by the interplay with organisational 
factors and socio-cultural influences. These elements of context cannot be ‘controlled’, particularly in a 
dynamic environment such as a hospital ward. This makes the use of traditional evaluative methods (using 
positivistic approaches) limited in their ability to generate transferable knowledge about the design, 
implementation, and effectiveness of interventions. Indeed, the dynamic interactions and contextual 
factors often seen as ‘confounding factors’ in experimental designs should be studied in and of themselves 
as vital ingredients in relation to attributing causation and facilitating sustainability to any complex 
intervention (Craig et al., 2008; Greenhalgh & Papoutsi, 2018).  
Realist approaches are underpinned by an understanding that there is more to reality than we can 
perceive (often referred to as ‘ontological depth’) but we are able to ‘unearth’ the hidden mechanisms 
that underpin causal forces (known as ‘retroduction’ or ‘retroductive theorising’). Realist approaches 
assert that intervention outcomes are the product of particular responses by people (mechanisms), within 
given circumstances (context) and therefore allow for the exploration of how and why the intervention 
works, for whom, and in what circumstances (Pawson & Tilley, 1997).  This is distinct from the traditional 
systematic review approach described in Chapter 2, which seeks to answer the question ‘does the 
intervention work?’ and quantify ‘how well?’.  
Realist synthesis involves the secondary analysis of multiple primary analyses in an iterative, non-linear 
process to develop a conceptual model that aims to make explicit (and configure) elements of context, 
mechanism and outcomes relating to an intervention, and thus create an empirical theory of how and 
why the intervention works. An illustrative example of how these are defined and presented is given in 







Figure 3.3: Illustrative interaction between context, mechanism, and outcome in realist research. Adapted and expanded from Pawson and 
Tilley, 1997, p58  
 
The development and refinement of these context, mechanism outcome configurations (CMOCs) into a 
testable ‘programme theory’ combined with evidence, are the product of realist synthesis (Pawson, 
2002). Programme theories seek to identify the intended outcomes of an intervention and the 
mechanisms and contexts that affect its success, or lack thereof (Pawson, 2006b). The identified 
programme theories may then be tested and further refined through the process of realist evaluation, 
which involves the primary collection and analysis of evidence from intervention users and providers. 
Realist evaluation is outside of the scope of this thesis but is described briefly in Chapter 7 (section 7.5). 
A key feature of realist synthesis is the systematic involvement of stakeholders throughout the process; 
their expert insider understanding of policy use is documented, formalised, tested, and sometimes 
arbitrated to produce theories that account for different ways in which the policy is framed across 







Pawson and Tilley conceptualise interventions as ‘theories incarnate’ that are based on hypotheses about 
how they work (irrespective of if these hypotheses are realised by the intervention designers). Realist 
synthesis lends itself well to the study of interventions that are inherently complex, which is defined as 
having ‘social contingency’, that is, being ‘imbedded in social systems’ (Pawson, Haley, Greenhalgh 2005). 
Complex interventions have multiple elements with different aims, or occur within complex adaptive 
systems consisting of people who adapt behaviour to improve outcomes from their perspective 
(Greenwood-Lee, Hawe, Nettel-Aguirre, Shiell, & Marshall, 2016; Moore et al., 2015). 
The intervention chosen for further investigation in this study is one which is both complex, and has social 
contingency, because its use and success may depend on trust, relationships, culture, leadership, 
understanding, perceptions and motivation of both a variety of staff and patients, as well as the 
characteristics of the intervention itself (what are its components and how is it meant to work?) (G. Wong 
et al., 2015).  
With the use of realist synthesis, some of these contexts and mechanisms pertinent to the success of the 
intervention under study may be uncovered, which enables knowledge generated to be customisable to 
different contexts. Knowing how the intervention works within a context also builds capacity to 
understand why policies might fail in one setting and work in another. This knowledge will be useful in 
informing, directing, and implementing this intervention and can help develop a more complexity-
sensitive process or outcome measures that may be used in future implementation or evaluation studies.  
The Medical Research Council’s framework for the design and evaluation of complex interventions (Craig 
et al., 2008) promotes the use of randomised experimental methods but recognises that this is not 
feasible in situations where the researcher has no influence on the implementation of the intervention. 
They stipulate the need to evaluate the process of why an intervention works in order to assess fidelity 
and implementation alongside outcomes, which includes identifying causal mechanisms and contexts that 
lead to different outcomes. This is the essence and product of realist research. 
 
Critique of realist synthesis 
 
Realist synthesis aims to explain (rather than judge) intervention use and learns from real-world 
phenomena rather than controlling it. This is a flexible, theory-based approach that can maximise learning 
across organisational, policy and disciplinary boundaries (Pawson et al., 2005). The critique of realist 
synthesis is, however, important to consider, in order to anticipate any issues that may occur during the 
research process, and to critically consider other perspectives on the approach taken.  
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Realist synthesis aims to understand the mechanisms and contexts behind how interventions produce 
positive and negative outcomes. Much of this information arises from analysis of narrative information or 
qualitative data. Pawson advocates inclusion of a wide range of evidence sources with which to conduct 
realist synthesis (Pawson 2006). These include opinion, unpublished service evaluation and stakeholder 
views. This has been met with criticism by Dixon-Woods et. al. who posit that treating all types of evidence 
equally can challenge the robustness of the theory generated (Dixon-Woods, Agarwal, Jones, Young, & 
Sutton, 2005).  The quality of the data included are, however, assessed as part of the process of realist 
synthesis, albeit using different criteria than in systematic reviews. This will be discussed further in 
Chapter 6. 
Another criticism of realist synthesis is the operational challenge that is posed, both intellectually and 
practically, with identifying and differentiating between contexts and mechanisms and thus developing 
context-mechanism-outcome configurations (CMOCs). Porter (2015) suggests that the confusion 
between contexts and mechanisms can undermine the explanatory clarity of realist research.  
Finally, the way realist synthesis is conducted does not lend itself to reproducibility in the same way as 
traditional systematic reviews and is not conductive to rigid protocol-driven approaches. The dependence 
on the individual researcher’s ability to be reflective and explicit may also be problematic for some critics. 
However, conducting a realist synthesis felt like a natural progression for the trajectory of the research. 
It also  fits well with the participatory health research approach that has been adopted throughout this 
work. This approach is explained in more detail below. 
 
3.2 Participatory approach 
 
The involvement of patients and the public in the design, conduct and dissemination of research is strongly 
encouraged as best practice in clinical and health services research (Gray-Burrows et al., 2018).  Patient and public 
involvement (PPI) in research helps to improve the quality, relevance and impact of research, particularly when it 
involves interventions or services that are designed to improve patient outcomes (Tomlinson et al., 2019). Patient 
public involvement enables research to focus on issues that matter most to patients (and hence more likely to 
have beneficial impacts), helps to widen accessibility of study materials, and broadens the sphere of dissemination 
(Baxter et al., 2016; Gray-Burrows et al., 2018; Ocloo & Matthews, 2016). Patients involved in PPI have reported 
to feel more empowered to share their experiences whilst directly influencing change, and to contribute to society 
in a positive way (Wilson et al., 2015).  
The involvement of PPI in the research in this study seeks to a embody participatory health research approach, 
whereby the knowledge and action gap is bridged by undertaking the enquiry with those affected by the issues 
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being studied (Macaulay et al., 1999). This means that stakeholders such as patients and healthcare professionals 
are involved in setting research goals, objectives, interpreting results and dissemination of findings, and 
contextualising the results from their unique positions. This facilitates a ‘culture of partnership’ between 
academia and practice, and allows the co-production of knowledge that is more context-specific, and therefore 
more easily incorporated into changes in practice (Vindrola-Padros, Pape, Utley, & Fulop, 2017).   
This research therefore tries to ensure that those for whom the benefit is intended (i.e. patients and healthcare 
professionals) are at the heart of the research decision-making. This ownership and awareness of the research by 
the stakeholders helps to improve uptake and sustainability of recommendations resulting from the output, and 
increases the relevance of the research even throughout the project. In this project, integrated knowledge 
transition is sought, whereby the audience is found first and then the research is done (rather than traditional 
research to practice knowledge-transition), making ‘practice-based evidence’ (L. W. Green, 2009). 
Despite some of the logistical and financial drawbacks of establishing and maintaining PPI during doctoral studies, 
the benefits of PPI to positively contribute to the development of doctoral pharmacy and health research studies 
has been documented (Tomlinson et al., 2019). As a healthcare professional researcher situated within a hospital 
trust, the researcher draws on an established PPI group that is experienced in reviewing and being involved in 
diabetes research. In this project, the Sheffield Teaching Hospitals NHS Foundation Trust Lay Advice on Diabetes 
and Endocrine Research (LADDER) panel was consulted throughout. This panel consists of 8 patients with diabetes 
(including type 1 and type 2 diabetes) from the Sheffield area, one of whom is also a health economist. The panel 
have inputted their views and feedback from the conceptualisation of the study and have been consulted at each 
stage of the project (e.g. the systematic review, cross-sectional survey, qualitative interviews, and realist 
synthesis). Outcomes from the discussions are presented throughout the thesis and are also discussed in Chapter 
7. 
The research has also had input from the multidisciplinary diabetes inpatient service improvement team based at 
Sheffield Teaching Hospitals NHS Foundation Trust throughout the project. This team consists of consultant 
diabetologists, registrars, diabetes specialist nurses, diabetes link nurses, healthcare assistants, service managers, 
diabetes pharmacists and pharmacy technicians. The team was involved in direction-setting, tool design and 
sense-checking and interpretation of the results at each stage of the project. This helped to incorporate valuable 
insights and alternative perspectives from other members of the multidisciplinary team throughout. This is 
important for this research topic which involves multidisciplinary efforts to implement research 
recommendations. 
In addition to the two panels mentioned above, additional stakeholders were recruited for the purpose of undertaking 
the  realist synthesis. These included people with diabetes who had had a hospital admission within the past 5 years, 
and healthcare professionals working in an inpatient setting from across the UK. The composition of this additional 
group is outlined in Chapter 6, along with the nature of the input and discussions for the realist synthesis. Throughout 
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the research, patients and healthcare professionals involved in the research process (not as participants) are referred 
to collectively as ‘stakeholders’. 
The above section has outlined the overall design, methodology and approach of the research, which is presented 
as two distinct but related studies. Details of the study methods employed in both the mixed methods study and 
the realist synthesis are explained below. 
 
3.3 Study methods 
 
This section describes the study methods of the two studies, including a brief justification of the methods used, 
how participants were sampled and recruited, and the processes for data collection and analysis.  
 
3.3.1 Mixed methods study 
 
The mixed methods study comprises a national cross-sectional postal and online survey and semi-structed 
follow-up telephone interviews with hospital pharmacist participants.  The details of the research conduct 
for the mixed methods study are outlined below: 
 
Quantitative component: Cross-sectional survey 
 
The purpose of the quantitative component to the mixed methods study was to describe current insulin 
prescribing processes and systems in UK hospitals, along with the range and uptake of interventions 
currently used to improve prescribing practice. This study was also designed to capture current opinion 
on intervention effectiveness from those who design, implement and evaluate interventions in practice.  
 
Justification of methods 
 
Cross-sectional studies are one of several observational approaches to investigate events or phenomena 
in a set population or time-period.  As inpatient prescribing processes are undergoing mandatory system-
level change across hospitals in the UK with the introduction of electronic prescribing and administration 
systems (see Chapter 1), a description and analysis of the current landscape of practice (and potential 
factors that may be associated with intervention implementation) would enable us to draw conclusions 
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related to the research questions. As such, a cross-sectional approach was taken as opposed to alternative 
observational methods such as retrospective cohort or prospective case control studies. 
A cross-sectional approach allows the study of a large population in a convenient way within a reasonable 
time-frame and with limited resources (Von Elm et al., 2007). The main limitation with a cross-sectional 
research design is that it is not possible to establish causality of exposure with an outcome. This is not an 
issue for the current study, however, as the research pertains to complex systems and interventions that 
are not suited well to studies reporting successive causation of factors with outcomes. 
Furthermore, due to the results of the systematic review suggesting that no one intervention is 
outstanding in reducing insulin errors, it was decided that capturing information on a breath of 
intervention use was most appropriate at this stage. Other observational methods, such as cohort studies 
and case control studies would, therefore, not have been as appropriate to capture the information 
required to answer the research questions.  A broad dataset was required to capture information about 
a wide range of hospital trusts to provide currency for national policymakers and individual organisations 
alike.  
For convenience and accessibility, a postal and online survey was identified as the most suitable method 
to employ for the cross-sectional study. Cross-sectional studies often employ survey methods to generate 
measurable data regarding phenomena, events, behaviour, or attitudes in a specific population (Calnan, 
2013).  Surveys are usually disseminated to participants via email or post, or alternatively, administered 
by researchers themselves in person or over the telephone  (Calnan, 2013). Surveys enable the collection 
of high-level data across a large sample (Bowling, 2009) but are limited by low response rates and 
obtainable information. As respondents are all registered, practicing pharmacists in this study, 
recruitment bias due to linguistic problems was not thought to be problematic. Careful attention to the 
questionnaire design can limit non-response, for example limiting the length and complexity of the 
questionnaire and allowing participants the flexibility to write responses via open question boxes. The 
development of the tool to enable accessibility and maximise response rate is described in Chapter 4.  
 
Sampling and recruitment 
 
The aim of sampling in cross-sectional surveys is to draw a representative group of participants from the 
population of interest (Bowling, 2009).  As the topic of interest is insulin prescribing practice and 
intervention use across a national health system, the entire population of UK National Health Service 
(NHS) hospital organisations was chosen as the sample to maximise representativeness. Probability or 
random sampling were thus not employed. This was to ensure external validity of the study and to reduce 
the chance of random error variation in the sample and bias in the study’s estimates.  
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In order to include all NHS hospitals in the UK in our sample, we chose to direct the survey to the main 
acute hospital within a single hospital trust, on the presumption that prescribing systems are very likely 
to be homogenous across the organisation (McLeod, Ahmed, Barber, & Franklin, 2014).  
A list of all UK NHS hospital trusts and health boards was obtained from NHS webpages (Health and Social 
Care Online; Health in Wales; NHS; Scotland’s Health on the Web) resulting in a total of 175 trusts/health 
boards at the time of study. A single representative of each hospital trust was asked to complete the 
questionnaire. Chief hospital pharmacists, lead diabetes specialist pharmacists or medicines safety 
officers (MSOs) were chosen as the organisation representative due to their broad knowledge of the 
prescribing systems used in their trust, particularly with respect to subcutaneous insulin and current 
prescribing safety interventions in place.   
An online version of the postal survey was created using Qualtrics© (Qualtrics, Provo, UT) to help improve 
response rate (T. Taylor & Scott, 2019). Follow-up emails with a link to an online version of the survey 
were sent to non-respondents after 4 weeks (where email addresses were publicly available via the 
hospital webpages), as well as promotion via social media, the UK Clinical Pharmacist Association online 




Postal questionnaires were sent during January 2019 to the chief pharmacist (or specialist diabetes 
pharmacist/MSO if known) at each hospital trust (see Appendix 4). A cover letter was sent in the postal 
questionnaire as well as a business-franked return envelope to help increase response rate (see Appendix 
5).  
The respondents were asked to complete the questions with respect to their main acute hospital. As only 
one response from each hospital trust was required, and concerned the main acute hospital within the 
trust, duplicate online responses were excluded if received. Any online responses from non-NHS/private 
hospitals were excluded upon receipt. 
All completed postal and online questionnaires returned by May 10th, 2019 were eligible for inclusion. 
Data from paper questionnaires were manually inputted into Microsoft Excel 2016. Online data were 
retrieved from the Qualtrics © platform, incorporated into the dataset and exported to SPSS (IBM V24) 
for descriptive analysis. Data input was checked by a peer-researcher and a joint decision was made 




Research ethics and governance 
 
Ethical approval for the cross-sectional survey was required and granted by the university research ethics 
committee (SAS-SREIC 4.1.19-3). The project was deemed to be exempt from requiring Health Research 
Authority (HRA) and NHS Research Ethics Committee (REC) approvals according to the online HRA tool 
(http://www.hra-decisiontools.org.uk/ethics/). Exemption was granted on account of answering ‘no’ to 
all 4 sets of questions for all UK-member countries using the online tool (England, Wales, Scotland and 
Northern Ireland). Respondents were informed that all data would be anonymised, and their responses 
would remain confidential. 
Informed voluntary consent was assumed by participation and outlined in the cover letter sent with the 
postal surveys, or on the front page of the online survey. No sensitive or evocative data were collected, 
and participants were not financially remunerated for responding.  The envelopes were coded to maintain 
anonymity on receipt of paper responses as well as to keep a record of respondent organisation names.  
The back page of the survey, where respondents could volunteer their names and email addresses to 
register their interest in participating in the follow-up interviews, was separated from the rest of the 
survey prior to data entry. This was done to maintain anonymity in response. All parts of returned paper 
surveys were securely locked in a cupboard in the researcher’s university office for confidentiality. All data 
were kept on a password-protected Microsoft Excel files on a university-networked computer. Email 




The main outcome for analysis of sections A-D was a binary variable (yes/no) indicating the use of 
interventions and system functions relating to inpatient subcutaneous insulin prescribing (see Appendix 
4). The main unit of analysis for section E was the average score of effectiveness (out of 5) for each 
intervention. Missing and ‘unsure’ responses to individual items were classed as ‘unknown’. Individual 
item non-response was not compensated for with imputation methods or weighted adjustment methods. 
The analysis was restricted to the recorded responses for each item in accordance with the descriptive 
univariate analysis performed (Brick & Kalton, 1996). 
Descriptive statistics were performed by calculating the frequencies of binary variables (and unknown 
responses) for each item in section A-D, and the mean scores of items in section E. Subgroup analysis was 
conducted according to the prescribing system used by hospitals (electronic/paper).  Any ‘unsure’ 
responses regarding categorial data (e.g. the current use of an intervention) were excluded from the 
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subgroup analysis. Open question data regarding local interventions were grouped according to 
intervention categories described in the systematic review and were not subject to quantitative analysis.  
The null hypothesis was that there was no association between organisational characteristics (e.g. type 
or location of hospital) and intervention use or perceived effectiveness. Chi-squared and Fishers Exact 
tests were used to determine associations between two sets of categorical data. The 2-tailed independent 
t-test for equality of means was used to determine differences between categorical and continuous data. 
One-sided Fisher’s Exact was used when comparing intervention use between hospital types, based on 
the assumption that teaching hospitals with more resource will use more interventions than smaller 
district general hospitals. One-way ANOVA with Tukey’s HSD was used to compare means between groups 
of >2, such as hospital type, size, and country (England, Wales, Scotland, and Northern Ireland). A P value 
below 0.05 was considered significant.  
Content validity was performed using the responses from four specialist diabetes pharmacists and Fleiss 
Kappa (for level of agreement between raters) was calculated. Internal consistency or reliability was 
analysed using Cronbach’s alpha. Criterion validity was not appropriate for this survey as there was an 
absence of a measure and criterion with which to find any relationship (Rubio, Berg-Weger, Tebb, Lee, & 
Rauch, 2003). Construct validity testing was initially conducted, but was ultimately deemed unnecessary 
for this questionnaire. This was because the tool was not specifically designed to be a psychometric scale 
that described all of the possible dimensions of the latent concept of ‘perceived effectiveness’ (DeVellis, 
2016). Due to the nature of items (which represented interventions rather than constructs of a 
phenomenon) it was noted that both exploratory factor analysis and confirmatory factor analysis were 
not suited to this study. Instead, a priori categorisations (based on the systematic review) were used to 
examine score distributions across the questionnaire. 
 
Qualitative component: Semi-structured telephone interviews 
 
The purpose of the qualitative component was to explain the results of the quantitative component, and 
to analyse the experiences and opinions of hospital pharmacists regarding the use of inpatient insulin 
prescribing safety interventions. In line with the epistemology of the research, the various perceptions of 
intervention effectiveness can be elucidated and explored with the generation and analysis of in-depth 
qualitative data. The next section justifies and outlines the use of semi-structured telephone interviews 






Justification of method 
 
Qualitative research aims to study people in their natural social settings and focuses on the meanings the 
participants attach to their world. Qualitative research seeks answers to questions about the ‘what’, ‘how’ 
or’ why’ of phenomena, as opposed to questions about ‘how much’ or ‘how many’? (J. Green & 
Thorogood, 2004). For example, qualitative research is well-suited to answer questions regarding why 
healthcare professionals may perceive certain interventions to be ineffective at improving insulin 
prescribing practice, and the perceived problems and potential solutions regarding insulin prescribing. 
The chosen methodology and methods for data collection and analysis in qualitative research should be 
congruent with the purpose of the qualitative study. If the purpose of the study is to generate an all-
encompassing theory of insulin prescribing intervention use, then approaches such as grounded theory 
may be considered, along with its associated methods of data collection and analysis (Corbin & Strauss, 
2012). Despite being a common methodology used by those with a relativist epistemology, a grounded 
theory approach was not chosen for this study. This is because we do not seek to generate theory about 
insulin prescribing interventions in general, as multiple overarching theories exist that may be relevant 
for prescribing interventions (see Chapter 1). Furthermore, as an embedded researcher with recent 
experience researching and working in the topic area, it would not be possible to approach the research 
completely free from any prior assumptions or knowledge of the literature, which is indeed a requirement 
of the grounded researcher (Corbin & Strauss, 2012).  
Those with more interpretivist, constructivist ontological and epistemological persuasions lend 
themselves to the use of qualitative approaches such as phenomenology, and their associated methods 
(open interviews, interpretive phenomenological analysis, and discourse analysis) to generate detailed 
explanations of personal lived experiences and meaning according to their own ideas and frames of 
reference. Due to the disagreement with a completely constructivist position of epistemology and its 
integration within a mixed methods approach, interpretivist approaches were not considered as an 
appropriate overarching methodology for this study. 
Positivist approaches tend to adopt very structured data collection techniques with forced-choice 
answers imposed on the participants and apply quantitative techniques to sampling and analysis. This was 
not considered to be a suitable approach due to its limited ability to generate in-depth data of interest to 
answer the research questions.  
Methods that facilitate data integration and triangulation, such as follow-up semi-structured interviews 
with a sample of respondents from the quantitative component, are more congruent with the overall 
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research design of a sequential, explanatory mixed methods study.  The use of interviews for this study is 
explained below. 
Interviews in Qualitative research 
 
Interviews aim to help the researcher discover the participant’s own framework of meanings while 
avoiding imposing their structures and assumptions as far as possible. By using open-ended, neutral, 
sensitive, and clear questions, they allow the researcher to help uncover contextually contingent 
mechanisms by which the causes of specific social phenomena might be plausibly be understood (J. 
Maxwell, 2012). 
Interviews may be either structured, semi-structured or open. Within a relativist epistemology, a semi-
structured approach is most appropriate to allow flexibility within a given agenda. Open interviews are 
more congruent with constructivist methodologies, and structured interviews with more positivistic 
approaches, both of which would be limited in their ability to answer the research questions of this study. 
In this study, a semi-structured interview guide was used to help direct the course of the interviews. The 
development of this tool is outlined in Chapter 5. 
Due to the geographic diversity of the sample of survey respondents across the UK, face-to-face 
interviews or focus groups with participants would be logistically, environmentally, and financially 
problematic. Remote interviewing instead allows participants that otherwise would have been excluded 
on practical grounds to be interviewed. The general inaccessibility and unavailability of high-quality 
videoconference equipment and fast internet connection speeds across many NHS hospital sites excluded 
the use of videoconference interviews, therefore one-to-one telephone interviews were chosen as the 
method of data collection based on increased flexibility and accessibility for participants. 
The use of telephone interviews is not without its limitations. The style of interaction may differ from face 
to face conversation due to the absence of visual and nuance , although this may allow more focus on the 
research topic and does not necessarily affect the type or quality of data collected (N. King et al., 2019). 
Conducting the dialogue in the participant’s practice site can also provide a more meaningful context 
(Deakin & Wakefield, 2014) even if this is done remotely, and would allow participants to access any 
relevant materials for discussion more easily should they need to.  
 
Sampling and recruitment 
 
In qualitative research, the function of sampling is rarely to represent a given population with large 
numbers, and is usually strategic and purposive, based on who might most effectively and meaningfully 
answer the research questions according to specific attributes relating to the phenomena of interest 
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(Yardley, 2000). Smaller samples are often appropriate for qualitative research (Marshall, 1996) because 
the aim is to describe information-rich accounts of phenomena rather than to generate generalizable 
knowledge relating to successive causation.  
As this was a mixed methods sequential explanatory study, the primary intention was to acquire a sample 
of pharmacists from a variety of hospital organisations with a range of experience and specific roles 
relating to insulin prescribing safety, who had completed the survey such that they could comment further 
on the topic. The sample was therefore conceptualised around the parameters of breadth of experience 
and knowledge with insulin prescribing errors and interventions across the trusts they were employed in 
and was drawn from those who responded to the survey who expressed interest in participating in follow-
up interviews.  
To account for potential non-recruitment, all survey respondents who had agreed to be contacted for 
interview (n=53) were contacted directly by the researcher and invited to participate in the study via 
email. Email invitations detailed the purpose, subject, process, and voluntary nature of the study and 
included a participant information sheet (see Appendix 6). No remuneration for participation was 
advertised or offered. Survey respondents were asked to reply to the email if they would like to 
participate, to arrange a mutually convenient time to undertake the interview directly with the 
researcher. Twenty pharmacists were initially recruited, and interviews were arranged with 18 of them (2 
did not respond to follow-up emails). 
The eighteen interviewees represented the maximum practically achievable interview sample from the 
survey respondents and is consistent with recommendations for interview-based studies (Crouch & 
McKenzie, 2006; Vasileiou, Barnett, Thorpe, & Young, 2018). This enabled an information-rich 
complement of cases that represented a variety of organisations across the survey sample (according to 
type, size, and location across the UK). There was no further process of selection from the sample of 20 
respondents. This also helped to avoid any unnecessary selection bias. 
Data saturation was not regarded as an appropriate strategy to justify the sample size in this project 
because it is a concept that is coherent with neo-positivist, grounded theory approaches. Braun and 
Clarke’s reflexive thematic analysis was used in this study (see “data analysis” section below), which has 
distinct values and assumptions that are not consistent with the concept of data saturation (Braun & 
Clarke, 2019). Instead, consistent with the theoretical approach and nature of phenomenon under 
investigation, a practical, information-rich sample that could be analysed interpretatively and provided 








All interviews were conducted via telephone at the researcher’s university or remote office at the pre-
arranged time and date of convenience to both parties. Participants were encouraged to arrange a time 
to interview that would not impede on their work schedule, in a location that was suitable to them with 
respect to convivence and confidentiality. Interviewees were informed that the usual length of interviews 
was around 30 minutes, but this could be flexible depending on their needs/preference. 
Interviews were audio recorded using a recording device with an adaptor allowing connection through 
the researcher’s office or mobile telephone. Audio files were uploaded to the researcher’s university-
networked drive immediately after recording. Interviews followed a flexible structure, which was adapted 
for individual participants depending on the topics of interest and flow of the conversation. Interviews 
started with introductory descriptive questions about the participant’s occupation and accounts of 
experiences, followed by questions about concepts/interventions mentioned in the survey and their 
evaluation of these interventions.  
Explanatory questions were thoughtfully asked as well as probing questions throughout the interview, 
which helped to demonstrate engagement and emphasise interest in what participants were saying (for 
example linking to earlier comments directly). The interviewer took field notes during each interview 
including key points, phrases or topics raised during the interview, which facilitated linking back to earlier 
comments. The interview concluded with reflections and expectations/ hopes for the future to end the 
interview positively, along with a thorough debrief, which allowed participants to ask any questions and 
informed them about how their contribution will help study the topic. 
The interviews were conducted in a conversational style in keeping with the interviewer’s positionality 
(as a fellow pharmacist working in the context of a hospital), and ability to respond to the participant’s 
questions regarding the topic and research. In order to be transparent in acknowledging the axiology of 
the researcher, a reflective diary was kept in order to document ideas, opinions and progression 
throughout both the collection, transcription and coding of the data.  
 
Research ethics and governance 
 
Ethical approval for the qualitative interviews was required and granted by the university research ethics 
committee (SAS-SREIC 12.7.19-1). It was deemed to be Health Research Authority (HRA) and NHS 
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Research Ethics Committee (REC) exempt following use of the online HRA tool (described above) and 
further discussion with the host NHS trust’s research co-ordinator. Careful consideration was given to 
issues of confidentiality, anonymity, and informed consent.  
Participant contact information was self-volunteered by interested survey respondents as described 
above. Only interested survey respondents were invited to participate over email from the researcher, 
which included a participant information sheet containing a topic guide and research aims as well as 
information about the study conduct (see Appendix 7). Fully informed, voluntary consent was implied by 
pharmacists replying to the email and arranging a date for interview.  
Once the phone call was arranged, the researcher checked if participants read and understood the 
information in the participant information sheet, and consent was verbally obtained again at the start of 
the phone call. Participants were given an indication of what questions would be asked prior to interview 
and reminded of the subject area (inpatient subcutaneous insulin prescribing practice and intervention 
use). All participants were reminded of their right to withdraw at any point, and their permission to be 
recorded sought, at the start of the telephone conversation. Participants were debriefed about how their 
data would be used and invited to ask any questions before ending the interview. 
Any identifiable data (names of people and organisations) contained in the audio files were anonymised 
at the point of transcription and were not presented in the results. Audio and text files were stored on 




Thematic analysis was used to identify themes and patterns of meaning across the dataset in relation to 
the research questions.  Thematic analysis aims to generate an analysis from the data upwards. Although 
this may be shaped by the researcher’s standpoint and disciplinary knowledge, it is not specifically guided 
by pre-existing theory or theoretical concepts. Thematic analysis is flexible in that it is not paradigm-
specific or prescriptive for use within certain epistemological frameworks (Braun & Clarke, 2013). It is 
therefore a method of analysis that is compatible with a mixed methods explanatory study within a critical 
realist and relativist epistemology. Other approaches to qualitative data analysis, such as interpretative 
phenomenological analysis (Smith & Osborn, 2008), constant comparison analysis (with grounded theory) 
(Henwood & Pidgeon, 2004) and variations of discourse analysis (Potter & Wetherell, 2010) are more 
specific to particular epistemological positions that are different from the researcher’s approach.  
The particular approach to thematic analysis taken in this study is the reflexive thematic analysis described 
by Braun and Clarke (2006). This approach uses a six-stage sequential but recursive process is used to 
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guide analysis that facilitates a rigorous process of data interrogation and engagement. These steps 
include data familiarisation, coding, generating initial themes, reviewing themes, defining and naming 
themes, and writing up. The positionality and reflexivity of the researcher is important to be considered 
in this approach as the researcher is considered an essential tool that influences the generation of themes. 
The use of template analysis with soft a priori themes (e.g. those derived from current theory/ideas) was 
considered to incorporate both deductive and inductive coding in the analysis. However, it was decided 
that in order to be as consistent as possible throughout the coding process, the analysis remained 
completely inductive and close to the data in order to stay as true to the participants’ accounts as possible 
(S. Watts, 2014). The incorporation of existing literature and theory may then be incorporated into the 
discussion of the analysis (rather than the analysis itself), with a view to ensure that the findings of the 
study are as transferable as possible. This allowed scope for the researcher to actively engage with the 
analysed data in a way that would not confuse or impose their position on or with the expressed views of 
the participants. 
More details about the stages involved in the reflexive thematic analytical process are given below: 
 
Transcription and data familiarisation 
 
All interview recordings were listened to by the researcher before being fully transcribed via intelligent 
verbatim, omitting any insignificant non-semantic sounds (such as ‘er’, ‘mm’ or ‘uhuh’) or pauses from 
the transcript, but including significant paralinguistic features (e.g. laughter, intonation, strong emphasis) 
in order to not compromise on data quality (N. King et al., 2019). If discourse analysis techniques were to 
be employed, non-verbal details (e.g. length of pauses, overlapping speakers) would have formed an 
important part of the paralinguistic transcription due to the need to convey meaning in the spoken word. 
For the purposes of this study, which seeks to identify broad patterns of common themes in the data, an 
in-depth level of transcription was not necessary.  
The researcher personally transcribed and repeatedly read every transcript to familiarise and immerse 
themselves in the data, with the aim of understanding the data from the perspective of the participant. 
Interviews were transcribed using Microsoft Word as soon after the interview as practicable and were 
aided by the field notes taken where necessary. A bespoke orthographic transcription notation system 
was constructed to help readers interpret the transcriptions (see Appendix 8). This was based on the 
system exemplified by Braun and Clarke (Braun & Clarke, 2013). All transcriptions were checked by two 
independent student researchers for errors of omission, mistaken words/phrases or sentence structure 
and punctuation errors. A pseudo-anonymised table of participant and organisational characteristics was 
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constructed, to enhance the potential for transferability of the research. Any identifying information 




Transcript documents were imported into NVivo version 12 (QSR International Pty Ltd, 2018) for coding. 
Coding the data involved assigning a succinct label to sections of text in the transcript to identify important 
features of the data that might be relevant to answering the research question. In order to thoroughly 
and systematically identify the key themes, issues and meanings within the data, the entire dataset 
underwent complete and consistent, open, two-level, inductive, descriptive coding by the researcher, 
whereby anything of interest of relevance to the research questions were coded. This followed a ‘what-
how’ approach (what is the participant talking about and how is it being described?) as described by Watts 
(2014). Codes included positive and negative aspects of insulin prescribing interventions (e.g. “electronic 
prescribing as effective” and “the insulin passport as useless”) and the perceived risks and benefits of 
environmental and systems contexts described (e.g. “staff turnover as a threat to sustainability”). The aim 
with the coding process was to be as inclusive and close to the data as possible.  
To prioritise the participant’s words and viewpoints, the researcher attempted to be empathetic to the 
participants, and set aside their viewpoint and values as much as possible during the coding process. This 
was applied thoroughly and consistently. Being mindful of the positionality of the researcher, a reflective 
diary was used throughout the process. This was used to reflect on the researcher’s thoughts and feelings 
following each interview and make explicit any persuasions that may influence data analysis. This process 
helped to contribute to transparency in the data analysis process. 
Throughout the coding process, codes were modified slightly in an iterative and organic way to 
incorporate the new material. Slightly overlapping codes were merged and similar codes were grouped 
into superordinate codes where appropriate to answer the research question. The aim was to achieve a 
comprehensive set of codes that differentiates between different concepts and ideas in the data but 
captures the patterning within (Braun & Clarke, 2013).   
 
Generating and reviewing initial themes 
 
After coding the data, transcripts were then re-read and the codes, along with their corresponding data 
segments, were re-examined to identify significant broader patterns of meaning (themes) in the data. For 
example, codes that related to insulin self-administration intervention design, use, evaluation and 
implementation were collated under an initial broader theme of ‘insulin self-administration’. The 
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frequency with which patterns occur is not the chief measure of significance here, but rather the 
identification of meaningful patterns that represent central organising concepts, which are relevant and 
important in relation to the research question.  
These broader patterns in the data (candidate themes), along with their corresponding data, were then 
reviewed with respect to their viability. This included reviewing themes to decide how they relate to each 
other, if they have coherence and enough evidence in the data to support them.  The candidate themes 
were then checked against the entire dataset to determine if they “capture something important about 
the data in relation to the research question, and represent some level of patterned response or meaning 
within the dataset” (Braun & Clarke, 2006). This is an active process, whereby the researcher makes 
choices about how the data is shaped and crafted, hence the importance of reflexivity and transparency 
on the part of the researcher. The resulting themes should remain faithful to the data and tell a story that 
‘rings true’ with the data from an objective point of view (Braun & Clarke, 2013). 
A member of the supervisory team with a similar background (a practicing clinical pharmacist working 
across hospital and academia with a background in diabetes) reviewed the generated themes to ‘sense 
check’ the analytical structure and provided critical insight into their relevance and contribution. This 
included asking the following questions:  
1. Do you think the codes represent the chunks of interview data they are filed under? 
2. Do you think the themes represent the codes within them? 
3. Do you think the themes capture something meaningful and interesting about the topic that can 
add to the literature? 
The purpose of this process was not to examine inter-researcher reliability as per positivist approaches, 
but to enable a greater degree of reflective discussion and reflexivity during the analysis. 
 
Defining themes and write-up 
 
The candidate themes were further developed through detailed analysis, involving working out their 
scope, boundaries, focus and assigning them informative names. Possible definitions of the themes were 
explored and evaluated, and then the most plausible explanations were chosen. 
A critical realist framework was used to make sense of the accounts given by the respondents. This means 
that the participant’s accounts were considered as ‘real’ and ‘true’, yet inextricably shaped by the social 
and cultural context that may come with their experiences, characteristics, and environment. As such, a 
chiefly data-driven, semantic approach to analysis was taken to remain close to the data whilst adding 
value to it. The data were treated illustratively to help tell a story about the interpreted data patterns. 
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This involved articulating, unpacking and amplifying implicit meanings in the data (S. Watts, 2014). This is 
in keeping with the relativist positionality, as opposed to constructionist, or interpretivist, whereby data 
are used more analytically to highlight latent meanings. 
Data extracts were used to “illustrate/support an analysis that goes beyond their specific content, to make 
sense of the data, and tell the reader what it does or might mean” (Braun & Clarke 2006, p. 94). In choosing 
extracts to include, a purposive sample was drawn relative to the identified themes to illustrate the 
analytic point made about the data. To try and maintain closeness to the data during extract selection, 
each participant’s data was re-read and extracts that were felt to be most representative of the 
participant’s view were selected.  
Data extracts were chosen from across the data to demonstrate the breadth of a theme and to avoid too 
much selectivity (for example over-selecting extracts from more articulate participants). They were also 
selected based on their capacity to illustrate something distinct and interesting about a theme and make 
a discernible contribution to the literature. Themes and corresponding data were presented in a logical 
order respective to the research questions.  
After inductive coding and theme generation, additional analyses were conducted whereby codes 
pertaining to the SEIPS framework were deductively mapped to the model to provide additional findings 
that have further translatable relevance for hospital teams and policymakers. Data was also re-examined 
by categorisation according to the participant’s current use of the intervention to help further explain 
salient results from the survey. This is explained further in Chapter 5.  
The analytic narrative was then woven together with the quantitative findings and contextualised relating 
to the existing literature in the short discussion section in Chapter 5. Key underpinning themes are further 
discussed in Chapter 7. These summarise the evidence from the whole dataset as it relates to the research 
questions and objectives. 
The next section describes the methods involved in undertaking the realist synthesis. This study was 
conceptualised and undertaken following reflection on the integrated findings of the mixed methods 





3.3.2 Realist synthesis 
 
Justification of method 
 
The primary reason for conducting a realist synthesis of self-administration policies was its ability to 
explain how interventions work and in what context. Realist synthesis is explanatory and is sensitive 
enough to account for the complexity of the social world in which the intervention operates (Boaz 2002). 
The conclusions from the systematic review presented in Chapter 2, as well as the findings of the mixed 
methods study presented in Chapters 4-5, pointed to the need to consider these important contextual 
factors in the investigation of complex interventions. Realist synthesis provides an opportunity to analyse 
the effects of contextual influences on the function and outcomes of the intervention by extracting and 
evaluating theories that underpin the intervention (Pawson 2006). 
Realist synthesis compares how the intervention was supposed to function in relation to the empirical 
evidence regarding what happens in different situations along the lines of context-mechanism-outcomes. 
An analysis of the different contingencies that impact the intervention’s ability to produce the intended 
outcome then provides guidance to policymakers or practitioners with respect to resources or contexts 
required to trigger the mechanisms for the intervention to produce the intended outcomes. The result of 
a realist synthesis is not a simple answer (e.g. the intervention works) but instead, provides: 
“a rich, detailed and highly practical understanding of complex social interventions which is likely 
to be of much more use to them when planning and implementing programmes at a national, 
regional or local level.” (Pawson et al., 2005). 
 
The decision to focus the review on a single intervention was prompted by the need to carefully define 
and describe the intervention in-depth to review and theorise the way it functions to produce outcomes. 
A wider review of all insulin prescribing practice would not be practical or achievable due to the 
heterogenicity in the types of interventions and the degree to which they are socially contingent. The 
choice to focus on insulin self-administration policy interventions was directed by careful and collective 
reflection on the results of the mixed methods study with the stakeholder groups. The process of 
undertaking the realist synthesis is described below: 
 
Overview of process 
 
Realist synthesis is a non-linear, iterative process due to the nature of identifying, defining, and refining 
theory from the literature available about the intervention under study. The general process of 





The above process was followed to conduct the realist synthesis, which is reported in its entirety in 
Chapter 6. This was aided by the use of the Realist And Meta-narrative Evidence Syntheses: Evolving 
Standards (RAMESES) training materials for realist synthesis (G. Wong, Westhorp, Pawson, & Greenhalgh, 
2013). A modified diagram explaining the iterative literature searches performed is provided in Chapter 
6 (Figure 6.1), along with details of how each step was performed.  
 
Research ethics and governance 
 
The realist synthesis did not require ethical approval as no original, personal, sensitive, or confidential 
information was collected. It was considerate of the reporting and quality standards produced by the 
RAMESES I project (G. Wong, Greenhalgh, et al., 2013; G. Wong, Greenhalgh, Westhorp, & Pawson, 
Present the research output
Draft and test recommendations with key stakeholders
Synthesise evidence and draw conculsions
Organise and analyse data according to initial theories
Extract data
Extract different data from different studies to populate evaluative framework with evidence
Quality appraisal of evidence
Assess the relevance and rigour of data
Search for evidence
Exploratory background search, progressive focusing and refining of inclusion criteria in light of emerging data 
Define and focus the scope
Identify the review question, refine the purpose and articulate key theories to be explored
Figure 3.4: Key stages in the realist synthesis process according to Pawson (2005). 
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2014b) and the study protocol was published in the PROSPERO registry prior to undertaking 
(CRD42020193351) (Bain, Jeffries, Kavanagh, & Babar, 2020). 
 
3.4 Summary  
 
This chapter discussed the approach, methodology and methods used for the original research in the thesis. A 
participatory health research approach is taken in this thesis to help increase the relevance of the research output 
for those whom it is intended and to help generate practice-informed evidence about the research topic.  
A mixed methods research methodology is used to enable us to gain a thorough  understanding of the research 
problem, and to enable the initial quantitative results to be explained by more in-depth qualitative data. Methods 
that are consistent with mixed methods within a critical realist paradigm are used to allow collection of data that 
can be meaningfully integrated together. Finally, a realist synthesis is conducted to further explain how an 
intervention works, for whom and in what circumstances. A single intervention is chosen for this purpose to allow 
a more meaningful and in-depth enquiry within the scope of the thesis. The selected intervention was chosen as 
a result of careful and collective reflection of the results of the mixed methods study with stakeholder groups. 
This allowed the research to follow a line of enquiry that was deemed most relevant to both patients and 
practitioners, in line with following a participatory health research approach. 
The next chapter presents the findings of the first phase of the mixed methods study, which is the national cross-




Chapter 4: Cross-sectional survey of insulin prescribing practice and 
interventions in UK hospitals 
 
 
This chapter presents the findings of the quantitative phase of the mixed methods study. This is the first phase of 
the explanatory sequential mixed methods study and precedes the qualitative stage (Chapter 5). This chapter 
includes the following: 
• Development of the questionnaire tool that describes inpatient insulin prescribing systems and 
intervention use in hospitals and measures their perceived effectiveness. 
• Findings from the national cross-sectional survey in which the tool was used. 
• Validation of the questionnaire tool. 
• Discussion of key findings. 




The safe and appropriate prescribing of subcutaneous insulin in the hospital setting is an important and common 
goal, with various studies reporting on the implementation and effectiveness of interventions to help achieve this 
aim. It was evident from the systematic review in Chapter 2 that although some inpatient teams and researchers 
have documented the process and outcomes of improvement efforts, particularly in the US and Canada, reporting 
intervention use and effectiveness in the published literature is not commonplace in the UK. The use of the annual 
National Diabetes Inpatient Audit (NaDIA) in the UK is useful for tracking the self-reported use of a selection of 
nationally recommended initiatives (e.g. the insulin passport and combined glucose monitoring/diabetes drug 
charts), but information about how hospitals are prescribing insulin, and the extent of current interventions in 
use, is lacking. A detailed examination of insulin prescribing systems and error reduction strategies in current use 
is therefore needed to make recommendations about the implementation of interventions to reduce insulin 
prescription errors. 
The systematic review also demonstrated that comparing intervention effectiveness is restricted by several 
important factors that differ between organisations. These include how the intervention was implemented and 
used in different contexts, organisational factors (such as available staffing and resources), and methods used to 
collect data and evaluate interventions. Scientific methods seeking to establish intervention effectiveness with 
any certainty (such as randomised controlled trials) across organisations may also be unsuitable for evaluating 
complex interventions in the hospital setting due to the inability to control the significant number of ‘confounders’ 
existing in open and complex hospital systems. 
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In the absence of a viable method to measure and compare actual effectiveness of interventions across NHS 
hospitals, it may be  useful to use a measure that is universal to all respondents. Measuring perceived effectiveness 
of interventions is a way of circumventing the above limitations for the purposes of identifying salient strategies 
nationally (Blendon et al., 2002). Perceived effectiveness, as a theoretical construct of intervention acceptability, 
is defined as “the extent to which the intervention is perceived as likely to achieve its purpose” (Sekhon et al., 
2017). Measuring perceived effectiveness can indicate levels of support, acceptability and scepticism towards 
adopting recommended interventions (Rosen et al., 2005). Using this notion also allows responses from hospitals 
irrespective of current intervention use. Insights of perceived effectiveness from healthcare professionals can be 
used to garner support for the wider implementation of interventions and focus national insulin improvement 
efforts.  
The objective of this study was to investigate the current use and perceived effectiveness of interventions 
designed to improve inpatient insulin prescribing practice across hospitals in the UK using a national cross-
sectional survey. Research questions included: 
• What systems are currently used to prescribe subcutaneous insulin for inpatients in UK 
hospitals? 
• What interventions are currently being used in UK hospitals to improve insulin prescribing 
practice? 
• Is there an association between hospital characteristics and intervention use? 
• What interventions are perceived to be most effective for improving insulin prescribing practice 
by those who have a role in designing, implementing and evaluating them? 
• Is there an association between hospital characteristics and perceived effectiveness of 
interventions? 
To answer these questions, a tool was developed and validated to elicit the current practice and opinion of 
hospital pharmacists and medicines safety officers regarding insulin prescribing safety interventions and their 
perceived effectiveness. This tool was used as part of a cross-sectional survey of NHS hospitals to determine the 
systems currently used to prescribe subcutaneous insulin for inpatients with diabetes. The tool also described the 
range, uptake and perceived effectiveness of interventions currently used to reduce insulin prescription errors 
and improve insulin prescribing safety. Further details of the methods used to collect and analyse the data 
presented here are included in Chapter 3. The survey has been reported with consideration of the Strengthening 
the Reporting of Observational Studies in Epidemiology (STROBE) guidelines for observational studies (Von Elm et 





4.2 Questionnaire development 
 
Validated survey tools to measure patient perceptions of insulin use are reported in the literature (Anderson et 
al., 2004; Moock, Hessel, Ziegeler, Kubiak, & Kohlmann, 2010; Snoek, Skovlund, & Pouwer, 2007). However, no 
such tool exists to measure the service-provider use or perception of effectiveness of insulin prescribing 
interventions in the hospital setting. Therefore, it was necessary to develop, use and validate a tool to understand 
healthcare professionals’ perceived effectiveness of a range of insulin prescribing safety strategies.  
The results of the systematic review of the literature regarding insulin intervention effectiveness (presented in 
Chapter 2) provided the basis for many of the items included in the questionnaire. This was supplemented by the 
researcher’s and supervisor’s knowledge of current practice and potential influencing factors (e.g. the presence 
of a diabetes pharmacist, or specialist diabetes service provision at the trust). The questionnaire included both 
system-level interventions and prescriber-orientated interventions, including prescribing system functions, 
guidelines, policy, restrictive measures (such as hard limits on electronic prescribing programs), provider 
education, and decision support tools. 
The Lay Advice for Diabetes and Endocrine Research (LADDER) panel were consulted throughout the 
conceptualisation and design of the questionnaire, and items regarded as very important for people with diabetes 
were included in the tool (e.g. self-administration and self-management policies). Additional input from the multi-
disciplinary diabetes inpatient group at the host trust (including consultant diabetologists, registrars, diabetes 
specialist nurses and pharmacists) enabled representation of the views of a range of professions involved in insulin 
safety. 
The questionnaire was developed according to good practice guidance, paying attention to elements of design 
such as layout, brevity, use of language, clarity of questions and the appropriateness of response formats  (Burns 
et al., 2008; Dillman, Smyth, & Christian, 2014; Kelley, Clark, Brown, & Sitzia, 2003). A cover letter was sent with 
the postal questionnaires, which were printed on good quality stationary including departmental headers and the 
researcher’s signature to help increase credibility (see Appendix 4 and 5). These stated the objective of the survey 
an explanation as to why they were selected as potential respondents. Cover letters were personalised with the 
recipient’s name to help increase response rate. Estimates of time taken to complete the survey were included in 
the cover letter, along with an affirmation that the recipient’s participation is imperative to the success of the 
survey (Kelley et al., 2003). 
The questionnaire had five sections: hospital demographics (section A), functionality of electronic prescribing 
systems with respect to subcutaneous insulin (section B), paper prescribing of insulin (section C), strategies for 
insulin error reduction (section D) and respondent’s opinions on the effectiveness of error reduction strategies 
(section E). In sections A to D, respondents selected ‘yes’, ‘no’ or ‘unsure’ to the use of system functions and 
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strategies identified from the systematic review and experience of current practice. An open question allowed 
respondents to describe any additional initiatives in use that were not included in the list.  
In section E, a 5-point Likert scale was used to determine how effective each intervention was perceived to be (or 
could be, in the case where it was not currently used in their organisation) on a scale of 1 (not effective) to 5 (very 
effective). Respondents were not asked to explicitly to base their answers on objective local data due to the 
expected heterogeneity in practice and available measures across hospitals. If respondents used insulin 
prescribing interventions that were not included on the list, they could describe these in an open-ended question 
and indicate how effective they were perceived to be on the Likert scale. This enabled the description of a broader 
range of currently used interventions that could be used in future iterations of the questionnaire.  
 
4.2.1 Pre-testing, sensibility testing, and piloting  
 
The purpose of pre-testing and piloting is to review and revise questions according to whether 
respondents interpreted questions in a consistent manner as intended by the researcher (Collins, 2003). 
The tool was pre-tested with four very experienced specialist diabetes pharmacists from four separate 
acute NHS hospital trusts in England, as well as three members of the research supervisory team and a 
peer-doctoral researcher at the university. The pharmacists were recruited via the researcher’s 
professional network and were thought to be representative of the target population. The respondents’ 
comprehension of the items may impact the quality of the questionnaire data, therefore these 
pharmacists and academics were asked to judge the appropriateness of each included question, as well 
as their salience and relevance.  
The pharmacists were also asked to comment on how comprehensive the tool was, and well they thought 
it addressed the research objective. This was done through individual verbal interviews and written 
feedback via email. Decisions were made to either accept the original question and meaning, change the 
question or eliminate it altogether.  
Following this process, the tool was re-presented and piloted with the four pharmacists who were 
representative of the sample population, as well as two additional student-researchers. They were asked 
to examine the tool with respect to its relevance, flow, arrangement, and administrative ease. Any 
redundant or unclear question stems, items or responses were identified. They were also asked to time 
how long it took to complete the questionnaire, such that a realistic timeframe could be stated on the 
cover sheet for participants. A summary of the changes made following pre-testing, sensibility testing and 




Table 4.1: Summary of changes resulting from pre-testing, sensibility testing and piloting the survey 
Prior to pre-test Following pre-test 
 “Are there local hypoglycaemia 
and hyperglycaemia guidelines in 
use?” (Y/N/U) 
One question split into two: “Are there local hypoglycaemia guidelines in 
use?” and “Are there local hyperglycaemia guidelines in use?” 
“Remote blood glucose 
monitoring.” (Y/N/U) 
Wording amended to “Electronic system linked to results from remote 
blood glucose testing” for clarity. 
Blood glucose was abbreviated to 
BG in section C. 
Blood glucose written in full. 
Prior to sensibility test Following sensibility test 
“Is there currently a specialist 
diabetes pharmacist in post?” 
(Y/N/U) 
Addition of an open question immediately following this to capture input 
of non-specialist pharmacists in diabetes: “Please describe the grade/role 
and full-time equivalent (FTE) of the pharmacist(s) overseeing diabetes 
care.” 
“Dropdown menu selection for 
insulin product(s)” 
Amended to “Dropdown or auto fill menu selection for insulin product(s)” 
to account for different systems and terminology. 
 “Ability to signpost for self-administration and/or self-management with 
insulin” and “Alerts to notify prescriber when a concentrated insulin 
product is selected” items added to section B. 
Prior to piloting  Following piloting  
“Mandatory annual insulin safety 
education for clinical staff.” 
“Mandatory repeat/booster insulin safety education for clinical staff” to 
account for repeated education that occurs at a different frequency to 
yearly (e.g. 3-yearly). 
“Please go to Section D” written 
after section B. 
This was deleted, as respondents who should be completing both section 
B and C may see this and skip section C. 
“Specific requirements for 
medicines reconciliation of 
insulin.” 
One question split into two for : “Additional requirements for medicines 
reconciliation of insulin on admission” and “Specific requirements for 
medicines reconciliation of insulin on discharge” and a footnote was 
added to give examples of what this means on the survey. 
 
These processes of pre-testing, sensibility testing and piloting helped to improve the questionnaire by 
minimising the chance that questions will be misinterpreted, or that respondents will fail to recall what is 
requested or that the researcher will misinterpret their true response. Factor analysis was not performed 
following pilot testing due to the nature of the items (which represented interventions rather than 
constructs of a phenomenon) and purpose of the survey (to describe current use of interventions and 




4.3 Questionnaire use 
 
This section describes the use of the questionnaire tool as part of a national cross-sectional survey of NHS 
hospitals. The whole population of 175 NHS hospitals across the UK were sent a paper copy of the survey, which 
was addressed to the chief pharmacist, (or diabetes pharmacist/medicines safety officer if known). Follow-up 
electronic surveys were sent out via professional networks to increase response rate. The following results pertain 
to both the paper and online responses received from participants. 
 
4.3.1 Respondent demographics 
 
After excluding duplicate or incomplete responses, 95 NHS hospital trusts (54% of 175 organisations) were 
Included in the final analysis; 55 (58%) from initial postal responses and an additional 40 (42%) after online 
follow-up. These included 82 out of 150 hospital Trusts in England (55%), 5 out of 6 hospital health boards 
Figure 4.1: map representing geographical locations of survey respondents' hospital organisations across 
England, Wales, Scotland, and Northern Ireland (n=95) 
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in Wales (83%), 3 out of 14 health boards from Scotland (21%) and 5 out of 5 health and social care trusts 
from Northern Ireland (100%) (see Figure 4.1).  
 
Section A of the questionnaire pertained to self-reported demographic information. Most of the 95 
respondents represented teaching hospitals (42%) or district general hospitals (40%), with between 200-
500 (35%) or 501-1000 (40%) inpatient beds. Eighty-one (85%) organisations provided a specialist diabetes 
service, but only 28 (29%) employed a specialist diabetes pharmacist. An additional 27 (28%) organisations 
were able to describe a pharmacist who was overseeing diabetes care, but there was a wide range in their 
availability and experience (ranging from a part-time newly qualified junior pharmacist to a full-time 
consultant pharmacist).  
 
4.3.2 Prescribing system use 
 
The systems used to prescribe subcutaneous insulin were described by respondents’ answers to sections 
B and C, which pertained to electronic and paper prescribing systems, respectively. A summary of the 
findings with respect to systems use is outlined in Figure 4.2. The results pertaining to electronic and 







Forty-six (48%) organisations used inpatient electronic prescribing, all of which were in England. Of these, 
38 (83%) used electronic prescribing systems to prescribe subcutaneous insulin. The 8 hospitals (17%) 
that did not prescribe insulin electronically (e.g. where insulin use was documented electronically but 
required cross-reference to a paper prescription where further details were given) were excluded from 
electronic prescribing subset analysis. 
The null hypothesis was that there was no association between hospital characteristics (e.g. hospital type, 
size) and the use of electronic prescribing systems at the organisation. A statistically significant association 
was found between hospital type and the use of electronic prescribing, with a greater proportion of 
teaching hospitals using electronic prescribing than district general hospitals (63% vs 39%, p = 0.035), and 
a significantly greater proportion of teaching hospitals prescribing insulin electronically (96% vs 67%, p = 
0.003). Only 1 out of 5 community hospitals used electronic prescribing, but insulin was excluded from 
electronic prescribing and was prescribed separately on a paper chart. No significant correlation was 
Figure 4.2: Summary of systems used to prescribe insulin in NHS Hospitals as reported by survey respondents. The use of insulin prescribing charts 
for hospitals not prescribing insulin on paper was unknown in 2 cases.  
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observed between hospital size (number of inpatient beds) and the use of either electronic prescribing 
systems, or the electronic prescribing of insulin electronic prescribing (p = 0.174). 
Figure 4.3 provides an overview of the reported functions of electronic prescribing for subcutaneous 
insulin at the respondent organ. Although all electronic prescribing systems were linked to the medicines 
administration record, only 14 (37%) were linked with the patient’s electronic medical record, and even 
fewer were linked to electronic blood glucose results (n=8, 21%). Most electronic prescribing systems 
included basic forcing functions, such as the mandatory selection of ‘units’ as the unit of dose measure 
(n= 34, 89%) and dropdown/autofill selection of available insulin products (n= 32, 84%). The use of other 
safety features varied, such as the ability to prescribe variable doses for patients who are carbohydrate 
counting (n=26, 68%) alerts when prescribers selected high doses (n=10, 26%), or concentrated insulin 
(n=18, 47%), and prescribing support features such as the ability to check doses are within a reasonable 
range (n=5, 13%).  
Some electronic prescribing systems were limited in their functionality with respect to insulin prescribing. 
Three systems (8%) could not specify the insulin device used, and only 24 (63%) could associate mealtimes 
with a prescribed insulin dose. Only 18 (47%) of electronic prescribing systems incorporated the use of 
insulin order sets (i.e. pre-populated prescription information). Twenty trusts out of 46 (43%) using 
electronic prescribing systems had electronic systems that could accommodate the prescribing of 




Some respondents described why certain features were included in their electronic prescribing systems 
using space on the survey (or the open question section - see below), such as removing insulin device 
from the prescription to reduce mis-selection error from a drop-down list or the ability to regularly 
interrogate the system to retrospectively review free-text prescribing activity.  Others described the use 
of the electronic prescribing system by pharmacists to identify patients on insulin for priority clinical 
review, or by other staff to allow referral to the ward pharmacist for verification of one-off or high dose 
insulin prescriptions. One respondent described the use of an integrated electronic prescription and 
medical record system that alerts the diabetes team when a high-risk patient is admitted (e.g. where a 
patient uses insulin and is at risk of DKA/has been a previous DKA risk). 
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Figure 4.3:  Functionality of electronic prescribing systems reported by NHS hospitals using electronic prescribing (EP) systems to prescribe 





A total of 57 (60%) hospitals did not use electronic prescribing for prescribing subcutaneous insulin, and 
instead prescribed insulin using handwritten paper prescription charts. Thirty-eight (67%) of these used 
dedicated insulin prescribing charts, or chart sections, for this purpose. Examples of dedicated insulin 
prescribing charts submitted voluntarily by respondents with their returned surveys are shown in Figure 




All participating organisations from Scotland and Northern Ireland used dedicated insulin prescribing 
charts, as did 4 out of 5 (80%) in Wales, and 48 (59%) in England. Thirteen out of 16 teaching hospitals 
that did not prescribe insulin electronically used dedicated insulin prescribing charts (81%), compared to 
Figure 4.4: Examples of dedicated insulin prescribing charts sent in by respondents. The chart on the left is from an English 
hospital trust and shows features such as association with mealtimes and pre-printing of ‘units’. The chart on the right is from a 
Northern Irish hospital trust and shows the inclusion of organisation-specific insulin prescribing and management guidelines. 
110 
 
19 out of 28 (68%) district general hospitals. Only 1 out of 5 (20%) community hospitals used a dedicated 
insulin prescribing chart. The remainder prescribed insulin on the normal paper medication chart. 
Most charts were designed to reduce prescribing errors by pre-printing ‘units’ on the chart (n = 30, 79%) 
and associated insulin doses with mealtimes (n=27, 71%). Many charts also included a STAT dose section 
(n=21, 55%) and the ability to prescribe a dose range for those who were carbohydrate counting (n=22, 
58%). Other features were less common, such as the inclusion of pre-printed devices (n=11, 29%) to 
prompt consideration of this often-neglected element of the inpatient insulin prescription. Most charts 
contained a blood glucose monitoring section to aid management (n=29, 76%) but fewer contained both 
a monitoring section along with organisation-specific management guidelines (n=17, 5%). Fourteen trusts 
(25%) had dedicated paper charts for prescribing continuous subcutaneous insulin pumps. 
 
4.3.3 Use of insulin prescribing practice interventions 
 
Section D of the survey pertained to the use of insulin prescribing practice interventions that were 
designed to reduce insulin prescription errors. An average of 9.0 (SD = 3.1) interventions were used in 
hospitals to improve insulin prescribing safety, ranging from 2 (one medium-sized mental health teaching 
hospital in England) to 16 (one large teaching hospital in England). The null hypothesis was that there was 
no association between hospital characteristics (e.g. hospital type, size) and the number of insulin 
prescribing practice interventions used at the organisation. The type of hospital did not show a statistically 
significant association with the mean number of interventions used (9.5 (SD = 3.4) for teaching hospitals 
vs. 8.9 (SD = 2.6) for district general hospitals (p = 0.42)), but the presence of a specialist diabetes 
pharmacist did (10.6 (SD = 3.1) with a pharmacist vs. 8.3 (SD = 3.0) without (p = 0.002)). Interventions 
used by respondents were categorised into intervention types a priori as per the systematic review results 
in Chapter 2, and are presented in Figure 4.5. Table 4.2 presents data further categorised by hospital type 
and includes data on prescribing system use. 
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 Mandatory insulin education on 
induction 
48 42 20 67 46 0.431 


















Specialist diabetes pharmacist 35 37 0 0 29 0.594 
Local hypoglycaemia guidelines 98 92 100 92 95 0.234 
Local hyperglycaemia guidelines 83 79 80 67 79 0.564 
Correctional dose algorithm 13 21 40 8 17 0.387 
Pocket—sized guideline cards 25 13 0 0 16 0.098 
Insulin discharge checklist 13 11 60 0 13 0.443 








Outreach review for patients using 
insulin 
63 50 20 17 51 0.344 
Medicines reconciliation requirements 
for insulin on admission (e.g. details 
about self-administration) 
40 37 60 42 40 0.404 
Medicines reconciliation requirements 
for insulin on discharge 
23 26 40 25 25 0.500 
Nursing double check of insulin on 
discharge 





Use of patient’s own insulin (from 
home) during hospital 
90 95 100 92 10 0.510 
Insulin self-administration policy 63 63 60 67 63 0.434 
Insulin self-management policy 33 26 60 42 31 0.301 
Insulin biosimilar policy 38 37 40 0 33 0.256 












Hospital formulary limitations 48 63 80 42 55 0.246 
Restrictions on concentrated insulin 33 26 0 25 27 0.225 
High dose validation before supply 8 11 20 8 9 0.583 
Insulin-specific requisition/order form 
for supply 
5 5 0 0 4 0.672 
Limitations of stock/devices on ward 
areas 












Electronic prescribing for inpatients 63 39 20 42 48 0.035 
Electronic prescribing of insulin (for 
those responding ‘yes’ to electronic 
prescribing use) 
96 67 0 33 40 0.003 
Insulin prescribing chart (paper-based 
prescribing) 
55 58 20 42 53 0.383 
Insulin pump chart 15 18 0 8 15 0.553 
P values have been calculated using Chi squared with Fishers Exact (1-sided) to show differences between teaching hospitals and district 
general hospitals only, due to heterogeneous group sizes of other hospital types. 
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The most common interventions in use include hypoglycaemia and hyperglycaemia guidelines to support 
appropriate insulin prescribing (n=90, 95% and n=75, 79%, respectively) and the use of the patient’s own 
insulin on admission to minimise product selection error (n=88, 93%). No intervention was used 
universally by all hospitals, and only 6 interventions were used by more than 50% of organisations 
surveyed.  
The use of policies to encourage self-administration of insulin were reported by 61 (63%) trusts, with self-
management policies being less common (n=29, 31%). Hospitals not included in this number were those 
describing the use of general medicines self-administration policies that were not insulin-specific (n=3, 
3%) or who were currently developing insulin self-administration and self-management policies (n= 2, 
2%).  Insulin self-administration policies were used in hospitals in all countries (70% of respondents in 
England, 40% in Wales and Northern Ireland and 33% in Scotland) and all types of hospital (68% teaching 































































































































































































































































































































































































% yes % no % unknown
Figure 4.5: Use of insulin prescribing interventions in UK NHS hospitals (n=95). Unknown’ comprises responses for ‘unsure’, ‘not 
applicable’, and missing data. 
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management policies were in place in hospitals in England (34%), Wales (20%) and Northern Ireland (20%) 
and in all types of hospital (35% teaching hospitals, 26% district general hospitals, 60% community 
hospitals and 25% of other hospitals). 
Only 31 (33%) organisations had policies in place to aid the safe and appropriate prescribing of biosimilar 
insulins, and just 29 (33%) organisations used the insulin passport. The use of other prescriber support 
interventions was more uncommon. Insulin pocket-guideline cards were used by only 15 organisations 
(16%) and insulin discharge checklists were only used by 12 (13%) organisations. An example of these 
interventions submitted by a respondent is shown in Figure 4.6. 
  
 
Other insulin prescribing practice interventions that were not included in the list of items in the 
questionnaire, but were described by respondents are included in Table 4.3. These interventions were 
not quantified because non-response bias could not be ruled out and may result in unrepresentative 
results (e.g. there is a possibility that not all trusts using educational outreach would have put this in the 
free type/open question response section). Table 4.3 therefore serves an illustrative purpose of the range 
of bespoke and innovative interventions used across the respondent sample, and can be used to 
supplement the pre-printed list of interventions provided in future iterations of the questionnaire. 
Figure 4.6: Insulin pocket-guideline card voluntarily submitted by one of the survey 
respondents. The card aids prescribers by categorising insulin into different types and 
offers advice on confirming doses. 
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Educational outreach to ward staff (e.g. on request or when required) 
Individual insulin prescribing feedback delivered by ward pharmacist and monthly group feedback 
sessions 
Dedicated "Making Insulin Treatment safer (MITS)" funded project 
Participation in the national insulin safety week 
Lunchtime teaching sessions given to foundation doctors annually 
Non-mandatory completion of insulin-specific e-learning packages 
Core training for medical/nursing staff at key points (e.g. progression between foundation year training 


















Insulin resource folder (e.g. containing relevant guidelines and policies) 
Posters on wards (e.g. Think Glucose©, details of insulin devices, profile, dosing and administration) 
"Insulin equipment on discharge" sticker 
Additional discharge form for patients receiving insulin from district nurses or care home 
Diabetes team use the same electronic patient record system as the local primary care teams 
Diabetes guideline mobile software application (mobile app) 








Use of 'in-reach' by community diabetic liaison nurses to support management of patients 
Generalist pharmacist review of those prescribed insulin as priority using prioritisation software 
Specialist diabetes nurses – some of whom are independent prescribers. 
Diabetes link nurses and diabetes champions to upskill clinical areas. 
Pharmacy-led insulin self-administration assessment 
Identifying patients prescribed insulin at nursing handover 




y Insulin prescribing by brand name only 












Removal of insulin cartridges from use; default use of pre-filled pens unless cartridges specified. 
Use of Apidra [insulin glulisine] for correction doses to reduce mix-ups between Novorapid [insulin 
aspart] and Novomix 30 [insulin aspart/insulin aspart protamine]. 














Think Glucose monthly audits reported to ward 
Insulin-related adverse incident report forms reviewed, and trends identified (e.g. monthly) 
Monthly safety /lessons learned meetings to review diabetes related incidents 
Weekly lunchtime meeting involving answering insulin queries 
Wireless monitoring of blood glucose levels - provides alerts to acute inpatient diabetes team when 




4.3.4 Perceived effectiveness of interventions 
 
Section E was designed to assess perceived effectiveness of interventions to improve insulin prescribing 
safety. To do this, respondents were asked to rate the interventions included as questionnaire items in 
section D using a 5-point Likert scale, with 5 being extremely effective and 1 being not effective. As 3 
respondents who completed sections A-D did not complete section E, this section starts by describing the 
demographics of respondents who completed this section. This is followed by presentation of the 




After excluding missing responses from 3 hospitals for section E, data from a total of 92 organisations 
were eligible for analysis. Responses were received from 79 out of 150 (53%) English hospital trusts, 5 out 
of 6 (83%) health boards in Wales, 3 out of 14 (21%) health boards in Scotland, and all 5 trusts in Northern 
Ireland (100%). Most of the 92 respondents were from teaching hospitals (n=39, 42%) or district general 




The highest overall mean score for perceived effectiveness was achieved for outreach team review (4.26 
out of 5), followed by mandatory education on insulin safety for clinical staff (4.15), and local guidelines 
on managing hypoglycaemia (4.09). Modest scores were reported for electronic prescribing (3.87) and 
dedicated insulin prescribing charts (3.76). The lowest scoring strategies included the insulin passport 
(2.80) and the use of dedicated insulin order forms for dispensing (2.65). The mean scores for perceived 
effectiveness of all insulin prescribing safety interventions included in the questionnaire are presented in 






Table 4.4: Respondents’ opinions on how effective insulin prescribing safety interventions are for promoting insulin safety in their 
organisations, based on a 5-point Likert scale. N = the total number of respondents answering the item. 
 Overall Respondents that 
use intervention 
Respondents that do 
not use intervention 
 
Intervention Average (SD) n Average (SD) n Average (SD) n P value 
Outreach team review 4.26 (0.88) 86 4.38 (0.86) 48 4.18 (0.89) 22 0.396 
Mandatory insulin safety 
education for clinical staff 
4.15 (0.89) 87 4.26 (0.75) 43 3.83 (1.08) 29 0.076 
Local hypoglycaemia 
guidelines 
4.09 (0.88) 90 4.07 (0.89) 86 5.00 (0.00) 2 0.146 
Local hyperglycaemia 
guidelines 
4.06 (0.87) 90 4.04 (0.90) 71 4.00 (0.82) 15 0.868 
Insulin self-administration 
policy 
4.06 (0.80) 88 4.03 (0.87) 58 4.11 (0.67) 28 0.701 
Use of patient's own insulin on 
admission to hospital 
4.02 (0.86) 89 4.03 (0.84) 86 3.67 (1.25) 3 0.472 
Insulin self-management 
policy 
3.99 (0.82) 87 4.11 (0.98) 28 3.98 (0.70) 47 0.552 
Requirements for medicines 
reconciliation of insulin on 
admission 
3.97 (0.88) 86 3.97 (1.00) 37 4.02 (0.80) 42 0.805 
Requirements for medicines 
reconciliation of insulin on 
discharge 
3.96 (0.82) 84 4.04 (0.95) 23 3.93 (0.77) 57 0.584 
Algorithm for calculating 
correctional insulin doses for 
hyperglycaemia 
3.94 (0.89) 85 4.07 (0.77) 15 3.93 (0.94) 54 0.602 
Electronic prescribing 3.87 (0.99) 71 3.83 (1.07) 30 3.90 (0.93) 41 0.776 
Insulin discharge checklists 3.78 (1.06) 85 4.08 (1.32) 12 3.73 (0.99) 67 0.292 
Dedicated insulin prescription 
chart 
3.76 (1.14) 88 4.00 (0.90) 49 3.85 (0.99) 26 0.505 
Restrictions on ordering of 
concentrated insulin                                       
3.71 (1.00) 86 4.08 (0.74) 25 3.51 (1.05) 57 0.007* 
Nursing double-check of 
insulin prescriptions on 
discharge 
3.67 (0.98) 86 4.24 (0.77) 29 3.31 (0.92) 51 0.437 
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Limitations on variety of ward 
stock          
3.65 (1.13) 89 3.75 (1.10) 72 3.36 (1.11) 14 0.232 
Additional validation of 'high 
doses' of prescribed insulin 
3.59 (1.07) 85 4.00 (0.50) 8 3.50 (1.05) 70 0.516 
Formulary limitations 3.40 (1.07) 89 3.55 (0.98) 51 3.29 (1.11) 31 0.279 
Pocket-sized guideline cards 3.37 (1.23) 84 3.87 (1.20) 15 3.29 (1.21) 62 0.106 
Tallman lettering on insulin 
prescriptions (e.g HumaLOG, 
HumuLIN) 
3.33 (1.09) 85 4.06 (0.80) 17 3.18 (1.07) 65 0.001* 
Insulin passport 2.80 (1.31) 87 2.73 (1.35) 26 2.83 (1.25) 53 0.751 
Dedicated insulin order form 
(e.g. for dispensing)  
2.65 (1.24) 85 2.67 (1.25) 3 2.65 (1.25) 81 0.987 
 
The factor that best predicted a higher average score of perceived effectiveness of an intervention was 
its current use by organisations. This was observed for most interventions but was significant for Tallman 
lettering on prescriptions (p=0.001) and restricting the use of concentrated insulin (p = 0.007). Self-
administration policies, extra requirements for medicines reconciliation of insulin on admission, 
electronic prescribing and the insulin passport were regarded as less effective by organisations currently 
using them compared to those who were not. 
Scores did not vary significantly between hospital types (e.g. teaching hospital, district general, 
community, mental health), country, or those with a specialist diabetes pharmacist (compared to those 
without). The only intervention that produced a significantly different score between hospitals of 
different sizes was outreach team review (4.69 for >1000-bed hospitals, 3.57 for <200-bed hospitals, 
p=0.034). All interventions returned a minimum score of 1 and a maximum score of 5 amongst 
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respondents. Figure 4.7 shows the percentage of organisations who classed each intervention as “very 
effective” (4 or 5 on the Likert scale). 
 
Respondents were given the opportunity to rate the perceived effectiveness of any additional 
interventions they had described (i.e. in Table 4.3) using a 5-point Likert scale. Highly rated additional self-
reported interventions included pharmacist-delivered insulin prescribing feedback, pharmacy-led self-
administration assessment, the use of prioritisation software to enable pharmacist review of insulin 
prescriptions and brand name only prescribing of insulin (all scored 5 out of 5). The lowest rated additional 
interventions included non-mandatory insulin e-learning and insulin resource folders (both scored 2 out 
of 5). 
 
4.4 Questionnaire validation 
 
The questionnaire underwent face validity and content validity testing, as well internal consistency reliability 
testing. Score distributions across a priori intervention categories (depicted in Figure 4.5) were also examined. 
These are described below and discussed further as part of the research quality assessment in Chapter 7. 
 
Figure 4.7: Percentage of respondents who consider interventions to be “very effective” for promoting insulin prescribing safety in hospital 
(score 4 or 5 on the 5-point Likert scale). Blue bars represent overall %. Green bars represent % of respondents who use that intervention in 
their organisations; Grey bars represent the % of respondents who do not use that intervention in their organisation. 
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4.4.1 Face validity and content validity 
 
Face validity addresses the issue of whether the questionnaire apparently has validity for survey 
participants and helps to ensure that the tool measures what it intends to measure (Rubio et al., 2003). 
In this study, face validity was determined qualitatively using respondents and experts’ viewpoints during 
pre-testing, sensibility testing and piloting of the tool. This process was described in section 4.2. As a 
result of face validity testing some items were changed and added but no items were completely 
discarded.  
Content validity seeks to determine whether questionnaire content accurately assesses all fundamental 
aspects of the topic, and is best performed with at least 3 content experts  (Burns et al., 2008; Rubio et 
al., 2003). Qualitative content validity was incorporated into the tool development process outlined in 
section 4.2. In this process the recommendations of the four experts (who were also target respondents) 
were adopted on use of item wording and using explanations where needed.  
In addition, the panel of 4 very experienced specialist diabetes pharmacists that represented the target 
population was asked to score individual items on the questionnaire to specify if it is necessary with a 
three-degree range of either “essential”, “useful, but not essential”, or “not useful”. All 22 items included 
in the questionnaire were regarded as “essential” or “useful, but not essential” by panellists (see Table 
4.5).  
Their opinions on the relevancy of items used in the tool were also quantified using the calculated level 
of inter-rater agreement using Fleiss Kappa (as there were more than 2 raters). This allowed quantification 
of agreement using a method that adjusts for chance agreement (Wynd, Schmidt, & Schaefer, 2003). As 
all items were either fair or excellent, it was considered appropriate that all 22 items could be retained in 









Table 4.5:  Content validity of the questionnaire. NE = number of experts who rated the item as essential. NU = number of experts who rated 
the item as useful but not essential. NNU = number of experts who rated the item as ‘not useful’. Agreement (%) = Pi value calculated using 
Fleiss Kappa. 
Category and item NE NU NNU Agreement 
(%) 
Provider education 
Mandatory insulin safety education for clinical staff 4 0 0 100 
Provider decision support 
Local hypoglycaemia guidelines 4 0 0 100 
Local hyperglycaemia guidelines 4 0 0 100 
Insulin passport 2 2 0 40 
Insulin discharge checklists 2 2 0 40 
Pocket-sized guideline cards 0 4 0 100 
Algorithm for calculating correctional insulin doses for 
hyperglycaemia 
1 3 0 50 
Team changes 
Specific requirements for medicines reconciliation of insulin on 
admission 
3 1 0 50 
Specific requirements for medicines reconciliation of insulin on 
discharge 
2 2 0 40 
Nursing double-check of insulin prescriptions on discharge 0 4 0 100 
Outreach team review of patients with hypo/hyperglycaemia (e.g. 
who have been flagged by an electronic system linked to remote 
blood glucose monitoring) 
2 2 0 40 
Prescribing and dispensing system 
Dedicated subcutaneous insulin prescription chart 3 1 0 50 
Electronic prescribing of subcutaneous insulin 3 1 0 50 
Dedicated insulin order form (i.e. if transcription required to 
dispense insulin)                                     
0 4 0 100 
Tallman lettering on insulin prescriptions 0 4 0 100 
Policy 
Use of patient's own insulin on admission to hospital 0 4 0 100 
Insulin self-administration policy 4 0 0 100 
Insulin self-management policy 2 2 0 40 
Restrictive measures 
Formulary limitations on numbers of insulins able to be prescribed 1 3 0 50 
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Limitations on number of insulins/devices available to order as 
ward stock          
2 2 0 40 
Restrictions on ordering of concentrated (200-500 units/ml) insulin                                       2 2 0 40 
Additional validation of 'high doses' of prescribed insulin before 
dispensing (e.g. over 50 units) 




Reliability testing was undertaken with assessment of the internal consistency of the questionnaire. This 
was estimated using Cronbach’s alpha (α), and examination of score distributions across a priori 
intervention categories. The Cronbach’s alpha value of the overall questionnaire tool (n = 58 items) was 
0.92 indicating very good reliability. Individual item analysis showed respondents tended to answer all 
items, and the median response rate per item was 99% (range 84%-100%).   
As sections A-D pertained to demographic and binary responses, reliability testing was limited. Section E 
contained the Likert scale responses (n = 22 items), allowing additional reliability testing to be undertaken. 
For this section, the Cronbach’s alpha value was 0.87, indicating good reliability (see Table 4.6). The Fleiss 
Kappa value for this section was also calculated using the data retrieved from the content validity test in 
Table 4.5 (0.35) indicating that there was fair inter-rater agreement (Landis & Koch, 1977). 













Score, Mean (SD) 82 (10.7) 
Score, Median 83 
25th Percentile Score 74 
50th Percentile (Median Score) 83 
75th Percentile Score 89 
Possible Score Range 22-110 
Actual Score Range 52-109 
Alpha Reliability Coefficient (22 items) 0.87 
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An analysis of the individual items in section E showed that the respondents tended to answer all items 
and items were well correlated. The number of items, possible range, and number of respondents for 
each category is presented in Table 4.7. 
 



















n (%)  
Provider 
education 
1 1-5 4.15 
(0.90) 
87 1 (1.1) 38 (44) 
Provider 
decision support 
6 6-30 22.1 
(4.53) 
80 1 (1.2) 6 (7.3) 
Team changes 4 4-20 15.8 
(2.89) 




4 4-20 13.2 
(2.62) 
63 1 (1.6) 4 (6.3) 
Policy 3 3-15 12.1 
(2.16) 
87 1 (1.1) 20 (23) 
Restrictive 
measures 
4 4-20 14.4 
(3.45) 
85 1 (1.2) 9 (11) 
 
There was no bunching of scores at either extreme. There was a modest ceiling effect for the provider 
education category (44% respondents selected the highest possible score on the questionnaire), and a 
slight ceiling effect for the policy category (23% respondents selecting the highest possible score). 
Negligible floor effects were observed across all categories. This indicated that there was enough variation 






4.5 Discussion of key findings 
 
This is the first survey to focus on subcutaneous insulin prescribing system functionality and safety interventions 
in NHS hospitals. The results describe the current use of a range of interventions to improve insulin prescribing 
safety in hospitals, and highlight potential opportunities for safety features to be incorporated in both electronic 
and non-electronic prescribing systems. In describing the current practice, an important context is provided for 
those seeking to design, develop or improve interventions to increase insulin safety. 
The use of inpatient electronic prescribing systems in English hospitals (particularly teaching hospitals) seems to 
be increasing in line with recommendations from the NHS Long Term Plan (NHS England, 2019). The results show 
greater uptake of electronic prescribing in the UK than in previous studies (McLeod et al., 2014; NHS Digital, 2019), 
but progress remains slow, with more than half of organisations using a combination of both electronic prescribing 
and paper-based systems, potentially threatening patient safety (Z. Ahmed et al., 2016).  
Where electronic prescribing is used to prescribe insulin, the variation in system functionality reflects the wide 
range of different systems in current use (Mozaffar et al., 2014). This may impact the extent to which electronic 
prescribing can contribute to insulin prescription error reduction. For example, results show that many electronic 
prescribing systems do not incorporate various error-prevention features that were identified in the systematic 
review (such as clinical support tools, order sets, and high-dose alerts). In light of the current drive to implement 
electronic prescribing across all hospitals, results emphasise the need to carefully design and implement these 
systems in such a way that the potential benefits on insulin prescribing safety can be maximised, and the 
shortcomings, such as any negative impacts on healthcare professional working practices, can be minimised 
(Mohsin-Shaikh et al., 2019).  
The modest rating respondents gave for the perceived effectiveness of electronic prescribing would benefit from 
further explanation, particularly considering the impetus for increased uptake of electronic prescribing system 
use in NHS hospitals. The lack of evidence for electronic prescribing systems in terms of insulin prescription error 
reduction, and the higher perceived effectiveness score given by respondents who are using paper-based systems, 
further contributes to the need to explore this intervention further in future studies. 
Results also show a variation in paper-based insulin prescribing, with around one third of hospitals not using a 
dedicated inpatient subcutaneous insulin chart, and some charts not including some of the beneficial safety 
features identified in the systematic review (e.g. pre-printing of units). Although insulin prescription charts has 
been nationally promoted on account of their ability to reduce insulin errors (U. Dashora et al., 2015), respondents 
only gave this intervention a modest rating for perceived effectiveness. This may also be due to the lack of use of 
beneficial features of the charts; further exploration of the use of this intervention may help to explain this result. 
There was a wide variation in the use of interventions to improve insulin prescribing practice across UK hospitals; 
a much greater number of interventions were found to be in use than had been identified in the systematic review. 
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For example, interventions such as outreach team review, prescriber feedback and therapeutic substitution 
guidelines had not previously been reported in the literature. This may reflect differences in the organisational 
and departmental support available to design, develop, implement, and indeed publish/report these 
interventions. The availability of specialist diabetes pharmacists that typically design, implement, and evaluate 
these interventions, for example, was low (29%), and at comparable levels to those reported in the 2019 NaDIA 
Hospital Characteristics report (26%). As results show an association between specialist pharmacist employment 
and number of interventions used, further creation of these posts should be encouraged nationally. This is now 
being reflected in recent guidance from the JBDS and the GIRFT groups (Joint British Diabetes Societies for 
inpatient care, 2019; Rayman & Kar, 2020). 
Although not widely implemented, respondents regarded mandatory insulin prescribing safety education for 
healthcare professionals as a very effective intervention. Mandatory education of healthcare professionals is 
currently recommended for all staff who care for people with diabetes in the hospital setting (E. Watts & Rayman, 
2018); results indicate that although this is a welcome recommendation, it is not currently widely followed.  
The insulin passport, which has been recommended by NHS Improvement (formally the NPSA) since 2012, and is 
currently recommended by NICE, had one of the lowest uptake (around 1/3 hospitals) and perceived effectiveness 
scores. The cross-sectional nature of the survey means that we are unable to determine if perception of 
effectiveness preceded use, or vice versa. This may be explored further in the qualitative study to help explain 
why the passport is not used and is thought to be ineffective. 
The use of guidelines for prescriber support were, however, perceived by most respondents to be very effective 
for promoting insulin prescribing safety. Although it is acknowledged that guidelines are not always adhered to, 
they represent a measurable standard of quality and are often prescriptive in nature, which can modulate 
prescriber uncertainty. These factors may contribute to their perceived effectiveness in promoting safe insulin 
prescribing.  
Results show national variation in the availability of insulin self-administration and self-management policies 
despite this being recommended back in 2011 (National Patient Safety Agency, 2011). Further explanation of the 
result that self-administration policies were regarded as less effective by organizations currently using them 
(compared to those that were not) would be beneficial to help understand potential issues with its use and 
implementation. Renewed calls for all trusts to have these policies in use also prompts further investigation of the 
experiences and opinions of respondents at this time (National Patient Safety Agency, 2011; NHS Digital, 2020; 
Rayman & Kar, 2020).  
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Despite results allowing us to identify interventions that are perceived to be more effective than others in general, 
both the standard deviations and the max/min scores for individual items indicate that opinion varied 
considerably amongst respondents. This provides support to the conclusions of the systematic review presented 
in Chapter 2, suggesting that several factors may influence intervention effectiveness across different 
organisations. In order to identify and explain factors that may influence perceived effectiveness of interventions, 
which may include various social, behavioural and organisational mechanisms, methods that look beyond 
establishing linear causality should be used (Greenhalgh & Papoutsi, 2018).  The use of semi-structured interviews 
with survey participants would be an appropriate method to help explain the salient results of the survey outlined 
above. 
 
4.6 Stakeholder group discussions 
 
The above results were presented to the Lay Advice on Diabetes and Endocrine Research (LADDER) panel and 
multidisciplinary inpatient diabetes team for discussion. Prior to the LADDER panel meeting, a lay summary of the 
survey results was circulated and a number of questions were asked of the panel regarding the results. During the 
meeting, the results were verbally and visually presented and the questions were discussed amongst the group. 
This allowed the researcher to interpret the results from a different point of view and to direct the focus of the 
next study in such a way that would be most beneficial for people with diabetes. These questions, along with the 
written responses from the circulated minutes following the meeting, are included in Box 4.1. 
Box 4.1: Questions asked of the LADDER panel after presenting the survey results, and a summary of answers. 
How do you think the results might impact people with diabetes?  
• Panel found the results frightening. Members felt that they would not want to give over their insulin 
when staying in hospital as they would not trust the correct management of their own insulin levels. 
Group agrees self-administration is the way forward .The panel noted security for medications is also 
a big issue. They would want a policy allowing them to manage their own insulin but also a security 
box at the bed side to ensure insulin was not stolen.  
Are there any results you find particularly interesting or feel should be emphasised? 
• Panel agreed self-administration should be emphasised as a solution to minimise errors. 
 
Are there any ways you might interpret the results that haven’t been mentioned? 
• None noted. 
Where do you think the research should go from here? 
• The panel agrees that the next stage would be to look at self-management policies. With alternatives 




Discussion of the survey results with the multidisciplinary inpatient diabetes team – incorporating consultant 
diabetologists, registrars, diabetes inpatient specialist nurses and pharmacists – centred more around provision 
of evidence for implementing interventions in the inpatient setting. Members prioritised the generation of data 
to prove intervention effectiveness in practice, such as a reduction in insulin errors or improvement in the number 
of ‘good diabetes days’ with self-administration policies, for example in hospitals that use the policy compared to 
those that do not. They were also interested in various process and patient-orientated outcomes of organisations 
using electronic prescribing systems for insulin compared with those that used paper prescriptions. 
As a result of the discussions with the LADDER panel and the inpatient diabetes group, it was decided that semi-
structured interviews with participants should include questions on self-administration policies and insulin 
prescribing systems, as these were of particular interest to patients with diabetes and multidisciplinary inpatient 
teams, respectively. The qualitative study should also seek to provide evidence for generative mechanisms that 
lead to intervention success/failure in such a way that can help to discriminate between hospitals that use the 
intervention and those that do not. These reflections were taken forward and helped to design the conduct of the 





Effective strategies to improve insulin prescribing quality are needed to reduce harmful and costly insulin 
prescription errors for people with diabetes in hospital. With the use of a validated, cross-sectional survey tool, 
we have described the current systems in use to prescribe insulin in NHS hospitals, as well as the uptake and 
perceived effectiveness of interventions to help improve insulin prescribing safety across a wide range of hospitals 
throughout the UK.  
Inpatient electronic prescribing is increasing, but there are significant differences in the functionality of systems 
to optimise insulin prescribing safety. The use of insulin prescribing charts is also variable, as are the features 
included in their design to help prevent insulin prescription errors. There is a wide variation in the uptake of 
interventions to help improve insulin prescribing quality, including those that are promoted by national bodies 
such as NICE and the JBDS. 
Interventions that are regarded as effective by a large sample of hospitals were identified, such as outreach team 
review, mandatory insulin education, local guidelines and specific insulin self-administration policies. The insulin 
passport was not perceived to be effective and is not used by most hospitals. The range of scores received from 
respondents indicate that perception of intervention effectiveness is likely to be dependent on organisational 
context. Perceived effectiveness was positively associated with current use for many interventions, except for the 
insulin passport, electronic prescribing, or self-administration policies.  It is recognised that intervention design 
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and implementation costs time, resource, and effort. The increased use of specialist diabetes pharmacists may 
facilitate efforts to reduce insulin prescription errors by supporting intervention use to promote safe insulin 
prescribing.  
The salient results from this survey are further explained in the next chapter, which presents the findings of the 




Chapter 5: A qualitative study exploring insulin prescribing safety 
interventions in the hospital setting 
 
 
This chapter presents the findings of the qualitative phase of the mixed methods study, and includes the 
following: 
• The development of a semi-structured interview guide to analyse the experiences and opinions of 
hospital pharmacists involved in the design, implementation and evaluation of insulin prescribing 
practice interventions in the UK hospital setting. 
• Presentation of the themes identified from the reflexive thematic analysis of qualitative data. 
• The application of the Systems Engineering Initiative for Patient Safety (SEIPS) human factors work 
systems model to the findings. 
• The additional categorisation and analysis of coded data according to intervention use for selected 
interventions. 
• Discussion of key findings. 





We have seen from the previous chapter that there are a wide variety of insulin prescribing systems and 
interventions being used across NHS hospital organisations in the United Kingdom, including those currently 
recommended by NICE. Despite this, it is clear that some interventions were perceived to be more effective than 
others; for example the use of outreach team review, mandatory insulin safety training, and guidelines scored 
much higher than the insulin passport and dedicated insulin order forms for dispensing. Some interventions were 
perceived to be more effective by participants from organisations where that intervention was not in use, for 
example insulin self-administration policies, the insulin passport and electronic prescribing systems.  
Results in the previous chapter indicated that perceived effectiveness of insulin prescribing practice interventions 
is likely to depend on various contextual factors. These may include social, behavioural and organisation factors 
such as prior exposure, experience, and implementation success of the intervention. Exposing and exploring these 
contextual factors, barriers, and facilitators to intervention success or failure would help to explain and expand 
on these results, and provide recommendations for the benefit of improving insulin safety in the hospital setting.  
In Chapter 1 we were introduced to the whole systems nature of insulin prescribing practice interventions, and 
the idea that complex organisational and social factors can significantly influence the success of their 
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implementation. Few studies have used qualitative methods to explore some of these contextual factors that can 
hinder or facilitate insulin prescribing intervention success, or the general barriers and facilitators to insulin 
prescribing safety in the hospital setting (see Chapter 1, section 1.3). Findings have suggested that a lack of access 
to useful information for optimal management of insulin therapy and a lack of communication among personnel 
on different work shifts are problematic, and that barriers to intervention use are complex and require a systems-
based approach (Helmle et al., 2018; Rousseau et al., 2014). Previous studies have been limited to single 
organizations or interventions, a lack of theoretical underpinning, or limited reporting on the techniques used to 
generate the findings, and none have been conducted in the UK.  The paucity of qualitative research in this area, 
particularly at an organisation-level of analysis, and the persisting nature of inpatient insulin prescription errors 
provides a convincing need for transferable qualitative evidence that deepens our understanding of inpatient 
insulin prescribing errors and interventions, particularly in a UK context. 
This study seeks to explore insulin prescribing problems, solutions, and interventions at an organisational level, 
and in doing so, will explain some of the salient findings from the cross-sectional survey discussed in Chapter 4. 
To do this, pharmacists who had completed the survey were invited to participate in follow-up qualitative 
interviews. These pharmacists occupied a variety of roles depending on the organisational structure of the 
hospital, such as clinical pharmacy service managers, specialist diabetes pharmacists, and medicines safety 
officers (typically pharmacists who have a particular role in medicines governance at their organisations). All were 
involved at some level in the investigation of insulin prescribing errors, insulin prescribing practice intervention 
design, implementation, or evaluation, and were therefore ideally placed to provide in-depth insights on the topic 
of study. 
The objective of this study was to analyse the experiences and opinions of UK-based hospital pharmacists involved 
in the design, implementation and evaluation of inpatient insulin prescribing practice interventions using 
qualitative interviews. Research questions included: 
• What are the current challenges and solutions with respect to improving insulin prescribing practice in 
the UK hospital setting? 
• What are the contextual factors that may influence the success of insulin prescribing practice 
interventions in the UK hospital setting? 
 
First, the development of the interview guides will be discussed, including the contribution of the two pilot 





5.2 Interview guide development and pilot interviews 
 
The interview guide was developed to include a series of questions to guide conversations with the participant 
(see Appendix 10). It was designed around the research questions and was developed around good practice 
guidance (Braun & Clarke, 2013; Grbich, 1998; N. King et al., 2019; Ogden & Cornwell, 2010). The content was 
informed by critical and collective reflections on the systematic review and survey findings with the patient public 
involvement groups, and included specific topics of particular interest, such as insulin self-administration policies 
and electronic prescribing.  
Questions were designed to be mostly open, positive and framed in the present tense. This was to generate rich 
data and prompt a fluid discussion of the salient results of the survey, whilst allowing participants sufficient room 
to discuss areas of particular interest or priority for them. The interview guide aimed to allow the generation of 
detailed and contextually rich data from a variety of individuals representing a range of hospital organisations. To 
do this is needed to facilitate a flexible approach to interviewing, such that the researcher could respond 
appropriately to in-depth personal accounts with unplanned or spontaneous questions (Braun & Clarke, 2013, 
p79). 
Asking directly about insight and causation is said to produce especially rich data on these aspects, particularly 
later on in the interview (Ogden & Cornwell, 2010). A combination of descriptive and probing questions was 
therefore included in a logical and funnelling order, starting with more general, descriptive questions, and 
progressing to more in-depth issues. Descriptive questions enable the participant to talk about something they 
are familiar with and interested in, such as their life experience or expertise in a particular field (Grbich, 1998, 
p104). Starting the interviews with these types of questions helped to gain rapport and trust with the participant, 
which is a key component in interactive data collection (Braun & Clarke, 2013, p81). Subsequent questions 
explored participants’ perceptions and experiences with insulin prescribing practice interventions in the context 
of their organisations. Closing questions focused on the future hopes and concluding thoughts and allowed 
participants to raise relevant topics they feel may have been missing from the interview and add any final 
comments. 
Brief prompts were included in the interview guide for reference if the interviewee did not understand the 
question or required prompting to answer questions. Prompts were not extensively documented in the interview 
guide to keep the guide brief enough to use with ease during the interviews. The researcher conducting the 
interviews had prior experiential knowledge of the professional and organisational setting (pharmacy practice in 
secondary care) as well as the research topic, and the participants were all hospital pharmacists who had a 
working knowledge and the use of subject and profession-specific terminology. This facilitated a natural 




Two pilot interviews were conducted prior to the start of the study to help refine the interview guide and critically 
examine question wording, sequence, and usefulness. The pilot interviews also helped the researcher to practice 
the interview delivery and gauge the timescale of the interviews prior to recruitment. One pilot interview was 
conducted with a diabetes specialist pharmacist and another was conducted with a medicines safety officer. These 
two interviewees were both female, very experienced in their roles and were colleagues of the researcher working 
at the same hospital trust. As neither were survey respondents they were not included in the final sample of 
participants, but they were felt to be representative of the potential participants. The pilot interviews were 
conducted with fully informed consent in the same manner as the study interviews. They were audio-recorded 
and transcribed verbatim to help the researcher familiarise themselves with the practicalities of using the 
recording equipment. The first pilot interview with the specialist diabetes pharmacist lasted just 15 minutes, and 
the second pilot interview lasted around 45 minutes. 
The researcher reflected on each interview successively to review and develop the interview guide. This included 
assessing if the questions contained in the interview guide helped to generate the required information and help 
to answer the research questions, and if any questions contained problematic assumptions or ambiguous 
meanings. The researcher’s interview style and input were also reflected on to help identify any areas for 
improvement. For example, it was noticed that the researcher used some words or phrases to demonstrate 
engagement with the interviewee that could be leading (e.g. “that’s interesting”). Awareness of this allowed the 
researcher to be more careful to choose more neutral phrases or words to demonstrate listening (e.g. “I see, yes”).  
As a result of the pilot interviews, some question wordings in the interview guide were changed to be more 
neutral. For example, asking interviewees if patients at their hospital have a “lack of ability to self-administer” 
could lead them to the negative connotations of not having a policy and may reveal a particular viewpoint of the 
researcher. This was thus changed to the more neutral wording of “does your trust have a self-administration 
policy at the moment?” following which, expanding questions may be asked.  
Other minor amendments were made to the guide to make it easier to use, such as colour coding for prompts, 
and amending question wording for clarity. Additional prompts were also included following pilot interviews, for 
example with respect to insulin self-administration policies: “Ideas and assumptions about how it works” and 
“What is necessary to support success?” The researcher’s field note-taking practice during interviews was also 
reflected on and amended to be more comprehensive. This process allowed the interview guide and the 
researcher’s interview practice to be further optimised to provide a more useful tool with which to obtain more 
meaningful qualitative data. 
Once the interview guide was optimised a total of 18 telephone interviews with survey participants was 
conducted. Further details regarding the methods employed in this study are outlined in Chapter 3. The section 
below presents the findings of the reflexive thematic analysis of the semi-structured qualitative interviews. The 
study has been reported with consideration of the COREQ (COnsolidated criteria for REporting Qualitative 
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research) Checklist for qualitative studies (Tong, Sainsbury, & Craig, 2007). These guidelines are included in 
Appendix 11 and are discussed further in Chapter 7. 
 
5.3 Findings  
 
Individuals were interviewed remotely over the telephone between 12th September and 16th October 2019 using 
a conversational, semi-structured approach by the researcher, who introduced herself as a hospital pharmacist 
who has occupied a clinical academic role for the past few years and has an active interest in insulin safety. 
Interviews lasted between 24-46 minutes (average 35 minutes), with a total of 10.5 hours of interview data being 
obtained. Interviewees were made aware of the researcher’s occupation and gender prior to the interview from 
the email signature, and the reason for undertaking the research was outlined in the participant information 
leaflet prior to undertaking the interview.  
Further details about the researcher’s occupation were disclosed to some participants during the start of the 
interview on request to help build trust and rapport (e.g. one participant expressed interest in mix of research, 
practice and teaching involved in the researcher’s role at the start of the interview). All participants had previously 
completed the survey presented in Chapter 4; three participants were known to the researcher prior to the 
interview through professional networks or previous working relationships. There were no obvious power 
imbalances that was felt to impact the data collection, such as employee-employer or line-manager relationships, 
positions that were significantly more or less senior than the researcher. 
Pharmacists from a variety of backgrounds and representative organisations (see Table 5.1) expressed a clear and 
patterned set of ideas about insulin prescribing safety risks and interventions in the hospital setting. All 
participants were able to talk confidently and insightfully about the problems and potential solutions to insulin 
prescribing practice issues in their organisations, and were able to talk in-depth about the use and effectiveness 









Table 5.1: Demographics of participants (n=18). Some occupations have been abridged slightly for consistency and/or anonymity. 
Gender Female 12 
Male 6 
Country England 15 
Northern Ireland 2 
Wales 1 
Type of Hospital Teaching Hospital 10 
District General Hospital (DGH) 7 
Other (Mental Health Hospital) 1 
Role Specialist Diabetes Pharmacist 8 
Medicines Safety Officer (MSO) 4 
Clinical pharmacist (managerial) 3 
Clinical Pharmacist (other) 3 
Years in post 1-5 years 8 
6-10 years 5 
> 10 years 5 
Prescribing system Paper insulin chart 9 
Electronic insulin prescribing 4 
Electronic prescribing but excluded insulin 3 
Paper chart but no insulin chart 2 
 
The analytic process resulted in the identification of 7 major themes:  improving insulin prescribing practice is an 
important but ‘wicked’ problem, prescribing insulin is regarded as scary and complex, insulin prescribing safety 
should be everyone’s responsibility, it is an important but uphill battle to educate staff on insulin prescribing 
safety, a balance must be found between prescribing system control and flexibility to prescribe insulin, 
interventions to improve insulin prescribing are hard to evaluate in practice, and inpatient insulin self-
administration is a problem worth solving. An overview of the main thematic structure is shown in Table 5.2. 
Example quotes are given to exemplify themes, and are identified by basic demographic information from the 
participants, along with the participant number in parentheses. The coding tree, which includes the codes 










Table 5.2: Overall thematic structure derived from inductive reflexive thematic analysis of the interview data, along with theme 
descriptions and example quotes. DGH = District General Hospital, MHH = Mental Health Hospital MSO = Medicines Safety Officer 













personal drivers for the 
improvement of insulin 
prescribing quality 
locally, and the 
challenges to making 
desired changes 
amongst individuals, 
teams and organisations. 
 
Insulin prescribing safety is 
important 
 
Improvement is challenging 
 
Drivers for improvement 
 
Pharmacists as a safety net 
 




“Although we, you know, 
they've tried. And they 
will have, they will have, 
you know, bursts of 
intervention, if I can call it 
that where there is 
increased training, but 
then it lapses until 
something else bad 
happens.” –Male clinical 
pharmacist (managerial), 







The nature of insulin 
errors in hospital, and 
the various drug-related 
and socio-cultural factors 
that precipitate them. 
Particular issues and 
risks around prescribing 
at the point of care 
transfer, including access 
to information, and the 
perception of 
interventions that can 
facilitate this. 
 
Errors are there to be made 
 
Insulin prescribing is not easy 
 
Prescribers are scared of insulin 
 
A ‘shot in the dark’ on admission 
 




“In terms of prescribing it 
but they're scared of it. 
It’s two-pronged, they’re 
scared of it because they 
don’t know what to do 
with it. But then they 
don't do anything about 
it.” – Female diabetes 








The input of diabetes 
teams, the need for an 
increased collective 
responsibility for insulin 
prescribing safety and 
the perception of 
interventions that can 
facilitate this. 
 
Diabetes teams as a victim of 
their own success 
 
Guidelines for prescriber support 
 
 
“And I think part of that is 
because for so long when 
the diabetes team has 
been embedded as 
“they’re the experts” and 
so a lot of staff on the 
ward don't take 
responsibility because 
they think, “oh, well, you 
get the diabetes nurse to 
sort it out”, or refer to 
them.” – Female diabetes 
pharmacist, Teaching 




It is an 
important but 





The perceived need for 
educational 
interventions, and the 
importance of how these 
are designed and 
delivered, as well as the 
factors that make 
educating the workforce 





There is a lack of knowledge and 
experience with insulin 
 
Education is desirable 
 
Education alone is insufficient 
 
Staff as peer-educators 
 
Challenges with educating the 
workforce 
 
The trouble with mandatory 
training 
 
Pedagogy is important 
 
“So the idea of providing, 
like, training, and making 
sure everybody's up to 
speed with that is a very, 
very difficult thing to do. 
And when you line it up 
with all the other training 
that sits for a trust to 
have to undertake, 
unless, unless you can get 
these sorts of things into 
the mandatory category, 
you generally don't have 
much success with them.” 
– Male diabetes 
pharmacist (managerial), 
Teaching Hospital, 
Northern Ireland (P8) 
 









the way in which insulin 
is prescribed in hospital 
and how this may 
promote or risk insulin 




beneficial for the sake of 
insulin prescribing 
quality on both paper 
and electronic systems, 
however flexibility is 
needed. 
 




Blood glucose monitoring is tied 
up with prescribing 
 
Opportunities and drawbacks 
with current prescribing systems 
 
“And obviously, we've got 
electronic prescribing, 
and we've got the ability 
to put some limits in 
there. But the regimes are 
so variable, it's very 
difficult to put hard limits 











The desire to measure 
the effectiveness of 
interventions is not met 
with the ability to 
reliably do so using audit 
or error reporting 
systems, and the use of 
feedback and anecdotes 





Audit as a measure for 
improvement 
 
Error reporting  
 
Insulin safety achievements as 
varied 
 
Measuring intervention success is 
desirable but difficult 
“Now can I turn round 
and tell you that they 
definitely reduced our 
error rates? Well I 
actually couldn't. Because 
it's very difficult to 
measure your error 
rates.” – Male diabetes 
pharmacist (managerial), 
Teaching Hospital, 






of insulin in 
the inpatient 




policies to promote the 
independence of people 
with diabetes in hospital 
are laudable and 
encouraged but are 
often difficult to 
implement. 
Assessment processes  
 










Self-administration is a risk 
 




Storage and disposal 
 
Suitability of patients 
 
Writing the policy 
“And for a whole 
multitude of those 
reasons, we're doing it 
very, very badly. So that if 
anyone's got - cracked it 
and got a really good way 
of doing it, then those are 
the kind of shared 
learning we would love to 
hear from.” – Male 
clinical pharmacist 
(managerial), Teaching 
Hospital, England (P9) 
 
The findings from each of the themes outlined in Table 5.2 are presented in detail below, on a theme-by-theme 
basis. Subthemes are incorporated into each theme but are not presented as section headings, to facilitate the 
overall flow of the narrative. 
 
5.3.1 Improving insulin prescribing practice is an important but ‘wicked’ problem 
 
Problems with insulin prescribing were described by all participants, and were mainly perceived as 
common, widespread, challenging, and recurrent: 
“Absolutely, it’s the number one drug in our hospital for harm-related incidents.” Female MSO 
and diabetes pharmacist, Teaching Hospital, England (P11) 
“So I think when we when we look at our incident reporting, we kind of seeing a whole load of 
trends coming through, but only sporadic ones for each and, and it's totally so across the board.” 
Male clinical pharmacist (managerial), Teaching Hospital, England (P9) 
“I don’t know. I mean, you know, there is no one fix. Otherwise we’d have done it.” – Female 
MSO, Teaching Hospital, England (P13) 
“Although we, you know, they've tried. And they will have, they will have, you know, bursts of 
intervention, if I can call it that where there is increased training, but then it lapses until 
something else bad happens.” –Male clinical pharmacist (managerial), DGH, Wales (P12) 
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“And that’s what we’re trying to figure out at the moment is kind of the ways the ways to help 
prevent these issues from happening, it does tend to be the same sort of issues that happen 
again, and again.” – Female clinical pharmacist, DGH, England (P1) 
 
A need for greater insulin prescribing practice improvement efforts in the hospital setting was expressed, 
and participants felt this was reflected in their organisations by being high on the local safety agenda: 
“I think there's such a lot of improvements to be made in every hospital, because of these errors 
and issues that happen everywhere... And, you know, is, is quite high on the on the agenda at 
the hospital, and the medicines safety team as well.” - Female clinical pharmacist, DGH, England 
(P1) 
“All trusts care about insulin safety” - Female clinical pharmacist, Teaching Hospital, England 
(P2) 
 
This perceived need for improvement was often described alongside the difficulties in designing and 
executing improvement strategies: 
“We've been going around in circles for a couple years going, “not entirely sure where to go 
next”.” – Male clinical pharmacist (managerial), Teaching Hospital, England (P9) 
“And the thing that she says about insulin safety is that “we've tried everything, and nothing 
seems to work”.” - Male clinical pharmacist (managerial), DGH, Wales (P12) 
 
When these difficulties were explored further with participants, several factors were felt to impede on 
the success of interventions in general. These mainly included local workforce and organisational factors, 
including a lack of time, money and staff: 
“But it's just obviously dedicating the time and focusing really on how best to improve what is 
going wrong.” Female clinical pharmacist, DGH, England (P1) 
“But again, it comes down to staffing and money etcetera.” - Female diabetes pharmacist, 
Teaching hospital, England (P10) 
“And we don't have many pharmacists in the department, so we all tend to have several wards a 
day so you don't necessarily have the time to do that.” Female clinical pharmacist, Teaching 
Hospital, England (P4) 
 
For staffing issues in particular, the high turnover of staff through ward areas was thought to be 
particularly problematic, creating issues related to sustainability of interventions. This resulted in a need 
for continued momentum for improvement efforts, and a loss of ‘organisational memory’ with respect to 
insulin prescription errors and their consequences: 
“I think the main problem we have, and must be in all hospitals, is the turnaround of staff... But 
it’s having the momentum to keep - you have to keep that up all the time, or are the new 
students, the new doctors coming through, the new pharmacists coming through, are they going 
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to have a better idea now of branding of insulin and, and the importance of - I don't know.” 
Female diabetes pharmacist, Teaching hospital, England (P10) 
“But in terms of overall reflection, the problem is we're set in a workforce that's constantly 
revolving. And as you've been, you're getting somewhere, people move. And you know, even if 
it's the case of nurses moving on to other things, and you get another batch of nurses in and it 
used to feel it in work that the sort of the nurse contingent was the steady thing, as well as 
pharmacists on wards, and now that’s not the case anymore. They nearly turn over as quickly as 
the docs. So it's a real sort of nightmare when it comes what you're trying to do, and instil sort of 
good practice and get keeping people up to speed.” – Male diabetes pharmacist (managerial), 
Teaching Hospital, Northern Ireland (P8) 
“Because the NHS, does have a memory, but unfortunately, it tends to be concentrated in people 
that have been around for a long time. And, as people turn over, then we get more and more 
worried about how is that memory being passed down to stop us making the same mistakes?” - 
Male managerial pharmacist, DGH, Wales (P12) 
 
Drivers for intervention use were described by participants. These included both internal (personal) 
drivers, such as previous experience and professional motivation, as well as external drivers such as 
national alerts (e.g. from the NPSA), national inpatient diabetes audit (NaDIA) data and recommendations, 
local quality indicators, audits, and incident reports: 
“And then, and then, of course, the alerts came out saying you need to do you know, this, this 
and this. And on the back of that, well, I'd come from a trust with a separate insulin drug chart, 
so I devised an insulin drug chart.” - Female MSO, Teaching hospital, England (P13)  
“I think the driver was at the time it was set up we had a consultant nurse for diabetes that was 
very keen on progressing those sort of things, and linked in with pharmacy – it was in response 
to, you know, the number of incidents that were occurring” - Male clinical pharmacist 
(managerial), Teaching Hospital, England (P7) 
“And we've had, unfortunately well I suppose linked to the NPSA and stuff, once you have 
fatalities associated with administration of insulin and coroners are involved and they get on to 
the training bodies and get on to the trusts themselves. And once coroners says well all junior 
doctors should have a mandatory training around the use of insulin it sorts of tends to focus 
people’s minds.” - Male diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland 
(P8) 
 
With respect to personal and organisational drivers, it was acknowledged that change was chiefly 
dependent on individuals embedded within diabetes or pharmacy teams who were enthusiastic about 
improvement. However, it was necessary to engage senior staff who had the power to implement 
interventions: 
“You need to find one or two people who are dead passionate about it. It’s simple, you know, 
leadership stuff ain’t it. If you’ve got somebody really enthusiastic and picks up on it and you 
know, pushes it at different fora, then, you know, you’ll have more success I think.” - Male 
clinical pharmacist (managerial), Teaching Hospital, England (P7)  
“I suppose it’s getting buy in from the great and the good, high up the food chain, is excellent as 
well if you can somehow manage it, sort of aligning it with priorities. Be it with governance 
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groups and saying that we have a problem with our, you know, our diabetes care or insulin 
prescribing or NCEPOD you know, using stuff that’s out there nationally to say that this needs to 
improve.” - Male diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
 
Relationships with the necessary players for action and change were chiefly dependent on individuals, 
and so were subject to change when staff left or moved on: 
“But once the key lead for that stops doing it, it falls.” -  Male diabetes pharmacist (managerial), 
Teaching Hospital, Northern Ireland (P8) 
 
All participants, who were pharmacists themselves, described the significant input of pharmacists working 
alongside or as part of inpatient diabetes teams, in the area of insulin prescribing safety.  
“I’m employed to pick up on that error, so I am the safety net” - Female clinical pharmacist, DGH, 
England (P1) 
“The pharmacist who was in that role before me, she worked quite closely with the diabetes 
nurses to sort of develop our current insulin chart and do things around insulin safety” - Female 
clinical pharmacist, Teaching Hospital, England (P4) 
“So I do all of their insulin safety work and their diabetes work basically” - Female clinical 
pharmacist, Teaching Hospital, England (P2) 
 
Pharmacy teams having a consistent presence advocating for safe insulin prescribing on the ward areas 
was described as an important element of ongoing improvement efforts, particularly in the context of a 
high turnover of staff through organisations: 
“And again, just obviously increase – we are looking at models of one pharmacist per ward. And 
again with having that bit more time dedicated to a ward again, we can offer extra, and then 
extra teaching, etcetera. So that would help also with the doctors coming through, etcetera, you 
could have a bit more of a role of ensuring that they, you know, you could assess their, you 
know, insulin knowledge, etcetera, and obviously make sure they do the e-learning and just have 
these type things.” – Female diabetes pharmacist, Teaching hospital, England (P10) 
“And that's where pharmacists can make things better because we're on the ward every day. 
We're consistently there. We should be highlighting when someone isn't having a good diabetes 
day, and trying to talk to people about why is that happening? Can we do something about it? 
You don't have to be the person who makes the decision about fixing it.” – Female diabetes 
pharmacist, Teaching Hospital, Northern Ireland (P16) 
 
Although insulin prescribing safety was considered as an important element of the pharmacist’s role, 
participants recognised the multidisciplinary nature of improvement strategies, which was considered to 
add to the complexities around intervention design, implementation and ongoing sustainability: 
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“And does that collaboratively work at the minute? No, it doesn't. And so actually, you're moving 
the responsibility from prescribers to our nurses. And is that appropriate? I'm not entirely sure. 
But that’s something we're discussing at this level (interviewer: yes) at the minute. So I guess the 
chart is a challenge, now, at the minute.” - Female diabetes pharmacist, DGH, England (P18) 
“So for the past two years, I've been trying to introduce a specific guideline and drug chart. But I 
need the assistance of the pump teams like specialist nurses and stuff. Getting everyone to sit 
down together has been a bit of a problem. Because everyone is so busy. - Female diabetes 
pharmacist, Teaching Hospital, England (P5) 
 
One method of bringing the necessary stakeholders together to discuss insulin prescribing safety was 
described by participants as involvement in insulin safety groups. These groups existed either within or 
across organisations locally and were thought to be beneficial for facilitating the consideration of the 
multiplicity of systems, cultures and strategies needed to promote the safe use of insulin in hospitals: 
“There's a local MSOs group that's just been set up in the CCG area. And they're going to try and 
look at insulin safety across the patch… So we’re starting to look at it in a better than one trust 
organization kind of perspective.” – Male clinical pharmacist (managerial), Teaching Hospital, 
England (P9) 
“Obviously creating the insulin safety committee has sort of allowed us to focus more on it.” - 
Male diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
“We also have as an offshoot of our medicines safety team we have an insulin safety group as 
well…. I think it meets monthly or bimonthly, but it focusses solely on insulin. Safe prescribing, 
administration, monitoring, diabetes issues in general... So the work with that group and 
medicines safety group and EPMA team sort of all pull together to try and make it as safe as 
possible, but still incidents that happen… But I think the output from that group in particular, 
tied in with the other stuff that’s gone on, we try to tighten it up as best we can.” – Male clinical 
pharmacist (managerial), Teaching Hospital, England (P7) 
 
The complex nature of insulin prescribing problems and improvement efforts outlined in this theme link 
to the next theme, which concerns the nature of insulin errors in hospital and the various factors that 
precipitate them. 
 
5.3.2 Prescribing insulin is regarded as scary and complex 
 
Insulin was often described by participants as a unique risk with respect to prescribing, with reference to 
complex drug-related, human, socio-cultural and system factors that threatened the safe prescribing of 
insulin: 
“And with insulin, it's probably, it's never one thing. It's never just the knowledge. Sometimes it's 
the environment or the circumstance at the time. And also sometimes it's, it's because there are 
competing demands maybe, which, which is a little bit different. So not necessarily the physical 
environment.” – Male managerial pharmacist, DGH, Wales (P12) 
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“All it takes is one three AM night shift and an inexperienced F1 and an inexperienced nurse and 
you get an error.” - Female clinical pharmacist, DGH, England (P1) 
“You know, those sort of errors that you think why on earth would anybody make that mistake? 
Well, people make it because it's there to be made.” - Male clinical pharmacist (managerial), 
Teaching Hospital, England (P7) 
 
For example, participants cited the complexity, dose-variability, variety, and high-risk nature of insulin as 
confounders in the prescribing process, making it more error-prone than with most other medicines: 
“Like, I suppose, like most medicines, they're a bit you know, there's, there's the same stages 
where there’s the prescribing, the dispensing, the administration, and that's the same for an awful 
lot of medicines. But I think the difference that insulin is the variability of the dose, and also simply 
the number of preparations with the fact that so much can go wrong.” - Male managerial 
pharmacist, DGH, Wales (P12) 
“I think there’s a lot of problems in terms of so many different brand names there’s so many 
different insulin types as well and when you, when ordinarily we encourage prescribing by drug 
name, but then with insulins say actually “no, it has to be brand name” and then there being so 
many varieties.” - Female diabetes pharmacist, DGH, England (P17) 
“Once you take a decision to make a prescription for insulin there are a lot of external factors 
that will impact on the outcome of your prescription. And that can be things like the nurse 
forgetting to give the insulin, not giving it at the right time, the patient not eating what they’d 
usually eat, the surgeon coming and saying “I want the patient to fast” you know the 
grandchildren coming and bringing an ice cream when granny doesn't usually have an ice cream. 
All of those things will affect the outcome of your prescribing.” – Female diabetes pharmacist, 
Teaching Hospital, Northern Ireland (P16) 
 
Participants described the resulting fear of insulin and clinical inertia not just from prescribers, but also 
from nursing and pharmacy staff. This was thought to result in negative consequences for people using 
insulin in hospital. This is because decisions about prescribing are delayed and hypo- or hyperglycaemia 
ensues: 
“They don't regard that as a critical medicine I don't think, in terms of prescribing it. But they're 
scared of it. It’s two-pronged, they’re scared of it because they don’t know what to do with it. 
But then they don't do anything about it.” – Female diabetes pharmacist, DGH, England (P18) 
“The core trainee was totally frightened to prescribe insulin because they’d never had the 
opportunity as an F1 do prescribe insulin that often.” - Female diabetes pharmacist, Teaching 
Hospital, Northern Ireland (P16) 
“It’s interesting is that sometimes, there’s a real, I tend to find that it's never in the middle - people 
either treat insulin as if it's poison and sometimes you have errors of omission because people are 
so worried about it.” - Male managerial pharmacist, DGH, Wales (P12) 
“And I think it's because people are scared of insulin, they don’t understand it.” - Female diabetes 




A particular area of risk related to insulin prescribing practice was considered to be the process of 
prescribing insulin on admission to hospital. Participants described their experiences of this in terms of 
the difficulties associated with the lack availability of requisite information about insulin from primary 
care, as well as inadequate drug history taking practices during medical clerking: 
“So then insulin on admission, quite often not prescribing it is probably one of the most common 
things. So people have missed doses.” - Female MSO and diabetes pharmacist, Teaching 
Hospital, England (P11) 
“I think the difficulty there is that they don't know what the patient takes.” - Female MSO, 
Teaching hospital, England (P13) 
“So just the sort of thing of, what dose is the patient on? Primary care sometimes know but are a 
bit vague, depends who’s giving the dose and who is writing it down. Secondary care only knows 
what primary care know or the patient could tell them.” – Female clinical pharmacist, Teaching 
Hospital, England (P2) 
“I guess, just generally, with doctors clerking patients in and I think there's a bit of a lack of 
awareness about how to take a good drug history. They maybe just look at the maybe the GP 
record, or ask patients, they might do both, but they didn't always marry them up.” – Female 
clinical pharmacist, Teaching Hospital, England (P4) 
 
With respect to existing interventions to improve insulin prescribing at the point of care transfer, 
particular disregard was given to the insulin passport. The pervading perception was that this intervention 
was of little value because it contained insufficient information for prescribing, a lack of clarity on who 
was responsible for their upkeep, and their redundancy for the few people that would engage with their 
use: 
“And you know even the insulin passport doesn’t even have the doses on it because they change. 
Like it’s so silly.”- Female diabetes pharmacist, Teaching Hospital, England (P5) 
“You’re relying on people updating it and it actually being a contemporaneous record, which, 
unless somebody takes ownership it never will be.” - Male clinical pharmacist (managerial), 
Teaching Hospital, England (P7) 
“When I started in the role I said “do we use these?” ‘cause we’ve got a huge big store of them 
over in pharmacy store and they were like, “no we don’t use them because people forget to bring 
them in or the insulin changes so much or the doses change so much that they don’t keep them 
updated.” - Female clinical pharmacist, DGH, England (P1) 
“It’s been, you know, a stone around everyone’s foot and we’ve all drowning because no one 
updates it, it can’t be updated and the only people who use it well are the people who don’t 
need them i.e. the highly invested diabetics. So the passport would never work and everyone 
kind of made a sort of sighing effort towards having something available and then chose to 
ignore it because it was never going to happen basically.” – Female clinical pharmacist, Teaching 
Hospital, England (P2) 
 
Despite the lack of support for the insulin passport, some participants indicated that it remained in their 
organisations, either physically or through discussions about their potential use: 
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“It doesn’t help anyone. It just creates a lot of work. And everyone keeps chasing it. Everyone 
keeps saying “we should do more about those passports, do we use those passports? We should 
definitely use those passports” and everyone else is going “We don’t need passports. The 
passports aren’t helpful. Ignore the passports. Do something else.” – Female clinical pharmacist, 
Teaching Hospital, England (P2) 
And probably when they first come, they may get sort of an insulin passport, but that doesn't 
really give any doses. It’s never given the doses anyway.” - Female diabetes pharmacist, 
Teaching hospital, England (P10) 
 
Regarding availability of insulin prescription information on admission, participants described how 
summary care records have superseded the insulin passport as a source of information: 
“But to be honest, now we've got the summary care records and they're in fairly routine use. I 
think that's becoming utilized a lot more frequently than the insulin passport as a source of 
information” - Female MSO, Teaching Hospital, England (P3) 
 
Despite the positive impact of the summary care record on information availability, participants described 
the improvements required in the general transfer and communication of information between primary 
and secondary care. For example, including insulin doses on the SCR was one of the potential solutions 
raised by participants: 
“Exactly, it’s just ‘inject as directed’. So I’d really love to do something along the lines of 
improving that, you know, I wondered about, do we try and get on SCR, you know, such and such 
date the dose was this. And I know that there’s problems of people’s requirements can change 
massively, but at least there’s a ballpark.” – Female diabetes pharmacist, Teaching Hospital, 
England (P5) 
“We wanted to start with at least GPs with something around the, and I know putting a dose on 
is difficult if your carb counting, but even a dose range would be nice. And a frequency would be 
really nice. So that's, we’ve tried to push that for a while at least get the quality of information 
coming from the GP a bit better.” - Male clinical pharmacist (managerial), Teaching Hospital, 
England (P9) 
“It’s just stupid like when you speak to primary care people you say “why don’t you write the 
dose on your prescribing system?” Their response is that because it always changes… and when 
you ask them who changes the dose ninety percent of the time its them so they can write it 
down.” - Female clinical pharmacist, Teaching Hospital, England (P2) 
 
Related to this was the connectedness described between primary and secondary care, and the impact 
that good prescribing practice in primary care had on patients and process outcomes in hospital: 
“So if you’ve got a brilliant insulin prescribing in community policy, you’re likely to see far less 
errors coming Into secondary care, which then means all secondary care are then doing is 




Participants also described the difficulties that junior doctors face when the majority of the inpatient 
prescribing burden falls on them, combined with the seemingly inherent hierarchical and blame-culture 
that may pervade ward micro-cultures: 
“And the really frustrating thing is that if that foundation doctor doesn't do the job right, then 
everyone feels that they can tear strips off them because you know, “what do you mean you 
caused a hypo there? Do you not know what you're doing?” It's not like it “actually I don't know 
what you were doing either. But I’m senior enough to be able to not have to ask you, tell me, you 
know ask me that question”.” - Female diabetes pharmacist, Teaching Hospital, Northern Ireland 
(P16) 
“So it’s very much a negative attitude from the top I would say as well from seniors. It's a very 
much like “oh I haven’t done that for years, I don’t know anything about it”.” - Female diabetes 
pharmacist, DGH, England (P18) 
 
Prescribing errors were described as more consequential for junior staff, who are more likely to regard 
insulin prescribing errors as ‘critical incidents’ compared to their more senior colleagues: 
“So those things just sort of brush off them and they go “yeah, I didn't get it right that time. 
Yeah. You know what, in the grand scheme of things the patient is well and they haven't come to 
any harm.” Whereas the foundation doctor the first time they have the caused a hypo, and they 
see that as a big disaster. Which it is in their life.” - Female diabetes pharmacist, Teaching 
Hospital, Northern Ireland (P16) 
 
Considering the above socio-cultural issues with prescribing insulin described, participants highlighted the 
importance of reflective insulin prescribing practice of foundation doctors before they specialised in their 
medical training: 
“And I think people should, if you don't get the opportunity in F1, to start talking and discussing 
that, then by the time you get to maybe core trainee or registrar, you've totally – it’s too late 
then to say “actually I’m unsure about insulin” because that's totally not acceptable. So, you can 
then just say, just get the junior doctor to do that, and maybe deep down, you don’t actually 
know the answer to it yourself.” – Female diabetes pharmacist, Teaching Hospital, Northern 
Ireland (P16) 
 
The pressure on the foundation doctors to bear the burden of insulin prescribing was also said to be 
relieved by the appointment of the increase in independent (non-medical) pharmacist and nurse 
prescribers: 
“We're quite good here in like the DSNs and myself and others in terms of we can act as 
prescribers so the pressure is not always on juniors in terms of prescribing. Its supporting them 
and in that in that role, you know?” - Male diabetes pharmacist (managerial), Teaching Hospital, 




The support that specialist diabetes teams and increased numbers of prescribers can give junior doctors 
described by participants is included in more detail in the next theme.  
 
5.3.3 Insulin prescribing safety should be everyone's responsibility 
 
The increase in multidisciplinary specialist diabetes teams providing outreach support to clinical teams 
was regarded as a very positive intervention, and participants described the ‘strong presence’ of diabetes 
inpatient specialist nurses (DISNs, or DSNs) as impacting positively on patient care. 
“Exactly, so, that’s been quite useful actually to try and prevent errors in terms of hypos and 
hypers and as part of that as well sometimes we pick up on inappropriate insulin prescribing and 
that gets feedback to the team at that time as well” - Female clinical pharmacist, DGH, England 
(P1) 
Diabetes teams were also perceived as ‘victims of their own success’, overburdened, and overly relied 
upon to complete routine tasks: 
“So we have we obviously have a DSN team we have an in-reach team etcetera. but they can't 
see every single patient.” - Female diabetes pharmacist, Teaching hospital, England (P10) 
“Erm, you know, sort of, I think one of the things that diabetes nurses find very frustrating is the 
fact that they get called to do titrations of doses. When actually we have a policy online, which is 
really straightforward, it goes, it goes through step by step, is it basal bolus, is it mixed, you 
know, which one is out, which one do you want to change and it tells them exactly what to do. 
You know if it is this then change this dose by whatever percentage.  And yet it's just not done." - 
Female diabetes pharmacist, Teaching Hospital, England (P5) 
“Maybe the diabetes teams that are there realize now that in a way they're a victim of their own 
success, in that because they used to treat or work with the people with diabetes, everybody else 
left them alone. And then when you don't have them, things go really pear-shaped.” - Male 
diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
 
Many participants felt that this over-reliance on specialist input was reflective of a general lack of 
responsibility for insulin management felt by non-specialist teams, which was described as something 
that risked patient safety: 
“And, you know, us as pharmacists, “oh we’ll leave it to the doctors, or we’ll leave it to the 
diabetes team, because we don't know any better ourselves”. Or, and the nursing staff they just 
follow the prescription and whatever is said and. You know, we've seen insulins being given at 
the wrong time for a week, and they've been having hypos and they still haven't responded and 
recognised that actually the reason they’ve been having hypos is because you’ve been giving it 
at night.” – Female MSO, Teaching hospital, England (P13) 
“And I think part of that is because for so long when the diabetes team has been embedded as 
“they’re the experts” and so a lot of staff on the ward don't take responsibility because they 
think, “oh, well, you get the diabetes nurse to sort it out”, or refer to them. So yeah, I think I 
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want to improve, improve the knowledge of insulin and diabetes for your average staff group.” - 
Female diabetes pharmacist, Teaching Hospital, England (P5) 
 
The participants felt that empowering non-diabetes staff to take collective responsibility for insulin safety 
was key to improvement efforts. Diabetes link nurses – registered general nurses from diverse clinical 
areas who routinely linked-in with the diabetes team - were also mentioned as a particularly impactful 
resource to help achieve this goal: 
“So if you highlight people, keep them in different areas to take on the responsibility of diabetes 
in their care area and continue to update people. I think it's important for different areas to have 
more ownership of their patients with diabetes, given that it’s so rife and so common and 
numbers are going to increase as the years go on.” – Male diabetes pharmacist, Teaching 
Hospital, England (P14) 
“So, I think it's important for the sort of diabetes team when they're there to be very inclusive 
and to be encouraging as many staff to sort of be getting involved and seeing what their 
thinking is and helping to come up with sort of solutions for the patients. And opposed to DSNs 
you know flicking onto the ward, sorting patients out then going off again you know?” - Male 
diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
“The diabetes link nurses were brilliant and really did sort of promote an ownership of diabetes 
on every ward. So their experience of that was very good and that’s why they were really keen to 
re-implement that.” – Female diabetes pharmacist, DGH, England (P17) 
 
Some participants described the careful design and dissemination of clinical guidelines to be beneficial 
for empowering non-specialist teams to manage insulin, but only if these were made easily accessible and 
were not too cumbersome: 
“Then obviously, we have all the other guidelines that are out there and then trying to sort of put 
them together in one place around our, you know, our trust SharePoint and stuff in our own 
intranet... Better concise sort of guidelines and documentation is designed with error reduction 
in mind. They’ve all sort of helped.” - Male diabetes pharmacist (managerial), Teaching Hospital, 
Northern Ireland (P8) 
“Obviously it is all in our guidelines but then guidelines are long and people don’t have time to 
read them, and you know that’s one of the things that we come across a lot.” - Female clinical 
pharmacist, DGH, England (P1) 
“Like, and is there, so we’ve got a policy that they didn’t know about, advice for junior doctors 
on the ward for hyperglycaemic patients. So it’s a flow chart to say, ‘is the patient well or is your 
patient unwell?’” - Female diabetes pharmacist, DGH, England (P18) 
 
Participants described the involvement of non-diabetes specialist staff in the intervention design and 
implementation processes as beneficial for increasing their accessibility and collective ownership: 
“So, anything you're thinking about doing you got to be thinking about the person who's least 
qualified or least knowledgeable in that area. And making sure they're part of that program. You 
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know, and if you can get a few people like that in it, and you generally tend to find that it 
actually works a lot better. Because it’s so straightforward then (laughs) you know?”– Male 
diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
 
The idea of engagement and empowerment of non-specialist staff is also linked to the next theme, which 
involves the education and training of staff regarding the safe use of insulin and its importance in the 
management of diabetes. 
 
5.3.4 It is an important but uphill battle to educate staff on insulin prescribing safety 
 
A prominent shared opinion amongst participants was that, in general, prescribers lacked knowledge, 
understanding, confidence and experience with insulin, which participants described as a key risk factor 
with respect to insulin errors and suboptimal management: 
“And to be honest, the lack of knowledge and education is a massive gap for them… I just think 
education. Making them more confident. I think if we had confident prescribers, then there 
wouldn't be problems because they would be confident to prescribe the insulin which would be 
available for the patient.” – Female diabetes pharmacist, DGH, England (P18) 
“So yes, you can get the wrong drug prescribed. And we still see that. Because I think primarily, 
there's a lack of understanding in what they're prescribing.” - Female MSO, Teaching hospital, 
England (P13) 
“They luckily gave an underdose otherwise it would have been a ‘never event’. So, it’s that kind 
of thing, they just don't know what they're doing with it a little bit. Just that complete lack of 
experience in knowing what they should be doing, which is very worrying.” – Male MSO, MH 
Hospital, England (P15) 
 
Participants often cited the foundational, basic knowledge of diabetes management and insulin 
pharmacology as insufficient, which when coupled with the inherent risks associated with insulin 
prescribing described in the theme above, can easily result in patient harm: 
“Erm, yeah, I think the issue with diabetes, is that often the simple – its the basics which is going 
wrong.” - Female diabetes pharmacist, Teaching Hospital, England (P5) 
“But I think obviously my biggest concern is certainly no awareness of what insulin, not 
necessarily about what Insulin does. But it is why patients shouldn’t miss it.” - Female diabetes 
pharmacist, DGH, England (P6) 
“And he had about four hypos on the Saturday. And that was slowly picked up on the Sunday 
and the Monday and the fact that we weren't allowing the patient to self-administer their own 
insulin I think was probably the factor in that because he was perfectly fine. He knew exactly 
what he's doing. What his dose is and he comes into us and we mess it up. And that is about the 
junior doctor training. They didn't have a clue between short and long-acting treatments. Didn’t 
really know what the basal bolus regime was all about.” - Male clinical pharmacist (managerial), 




A few participants signalled that insufficient undergraduate education may be partially responsible for 
this, although they appreciated the difficulties in teaching insulin safety as part of the undergraduate 
curricula: 
“I just get the feeling that they’re coming out of med school with less pharmacology knowledge 
than they ever used to. But because as you say, things are so complex these days, how do you 
cover everything?”– Male clinical pharmacist (managerial), Teaching Hospital, England (P9) 
“I don't see that it can be occupying the place that it should do in all undergraduate courses for 
people to be coming out with a level of knowledge that they seem to. And so if it is a priority, it 
needs to be a priority.” – Male managerial pharmacist, DGH, Wales (P12) 
 
Not all participants felt that there was a lack of prescriber knowledge and education, however. The two 
participants from Northern Ireland regarded junior doctors as knowledgeable and well-trained with 
respect to insulin. They perceived that their attitudes towards insulin reflected the experience and 
appreciation of its risks and importance: 
“So obviously, there’re undergraduates’ portfolios and courses and stuff that they're doing are 
more geared towards what they're actually doing when they get out to practice. So over the last 
few years we have found them to be a bit more sensible in terms of insulin prescribing.” – Male 
diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
“I think probably you've, you've probably recognized from your work that people - junior doctors 
are well educated, they're well trained. And there's lots of training in place, and we’re doing a lot 
of good education, but we're still not making any change to good insulin prescribing.” - Female 
diabetes pharmacist, Teaching Hospital, Northern Ireland (P16) 
 
Participants were unanimous in their perception that educational interventions were necessary and 
important, both at undergraduate and postgraduate level: 
“But I think the biggest one is just around education.” - Male diabetes pharmacist, Teaching 
Hospital, England (P14)  
 
“I think we definitely need more education for junior doctors about the types of product and also 
the dangers of someone having the wrong product at the wrong dose.” - Female MSO, Teaching 
Hospital, England (P3) 
“But it’s also about having that repeated training. I don’t think its repeated. I think you’d need to 
have it every three years, like refreshers, for example.” - Male diabetes pharmacist, Teaching 
Hospital, England (P14) 
 




“I do quite a lot of teaching with the junior doctors and that’s something that they identified as, 
you know, they didn't know how to find what doses people were on.” - Female MSO and 
diabetes pharmacist, Teaching Hospital, England (P11)  
“So I’ve experience at providing FY0 and FY1 supervision and training in relation to insulin 
prescribing.” - Male diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
“We sort of have diabetes Awareness Week, as well. So where the diabetic nurses will do a lot of 
on the spot training with doctors and nurses.” - Female clinical pharmacist, Teaching Hospital, 
England (P4) 
 
Despite the perceived need for educational interventions, they were described as a ‘weak barrier’ by 
participants: 
“Although education is a weak barrier, I think, fundamentally it’s a lack of knowledge.” Female 
MSO, Teaching hospital, England (P13) 
 
When the reasons for this were explored further, participants described the restricted access to staff and 
insufficient time allocated to insulin training as significant limitations to delivering educational 
interventions: 
 
“And, and you know, when you are teaching, if you get ten junior doctors turn up, then that's 
probably quite a good number out of the total of them, but I mean, ten, in the scheme of things 
is a drop in the ocean. So yes, we often do do some teaching. But it's obviously. What, you know, 
what can you get across in forty-five minutes to an hour to a small number of junior doctors 
once a year or whatever it may be?” - Female MSO, Teaching hospital, England (P13) 
 
Participants expressed that recipients of education would be quick to forget the messages, and as such 
repeated training would be beneficial: 
“That’s because people, you know, can only remember two or three things, and then might only 
remember that for that week.” - Female MSO, Teaching hospital, England (P13) 
 
“But it’s also about having that repeated training. I don’t think its repeated. I think you’d need to 
have it every three years, like refreshers, for example.” - Male diabetes pharmacist, Teaching 
Hospital, England (P14) 
 
“I mean, I guess probably you’ve got to come back to it, at some point after their first induction.” 




Participants were united in their description of delivering education and training as challenging; 
obstructed by limitations imposed by lack of time, access to various staff groups, suboptimal 
communication channels throughout the organisation: 
“We tried to do some Junior F1 training, but we can't really get more than about ten minutes.” - 
Male clinical pharmacist (managerial), Teaching Hospital, England (P9) 
“So we can reach those sort of staff groups but then we’ve identified that there are others that 
are much harder to reach - the staff grade doctors, your registrars; consultants get no training..” 
- Female diabetes pharmacist, Teaching Hospital, England (P5) 
“It’s a very large teaching hospital. But there are three different sites and we have different 
specialities at each hospital. So that’s a challenge in itself.” - Female diabetes pharmacist, 
Teaching hospital, England (P10) 
“But then again it is getting that cascaded down, which I’m not sure how effectively that 
happens. When people are on night shifts or day shifts or annual leave or you know, so it is 
trying to get everybody consistently taught about it that’s always going to be the issue I think.” - 
Female clinical pharmacist, DGH, England (P1) 
 
In terms of educational interventions, organisational mandatory training for a range of staff was described 
as important, but was not without significant challenges. These included the design and delivery of the 
training whereby staff can share answers, and some pervading negative attitudes to mandatory training 
that it is a ‘tick box exercise’: 
“Some people might share the answers, but at least it will put it on the agenda that insulin is 
important, especially for people who are actually going to come across it in the day to day. So, 
you don't always come across a fire where you work but yet you do the annual fire safety 
training. For insulin its regularly seen so, it will always be on the agenda.” – Male diabetes 
pharmacist, Teaching Hospital, England (P14) 
“But you can see that they’re attending, thinking, “I've read that policy, I know that policy. I've 
got twenty scripts to do when I go back to the ward”, or you know, and they're on their phones. 
They're not looking at the screen. They're not interacting in the teaching… They're just there 
because they sign their name and they get their lunch.” - Female diabetes pharmacist, Teaching 
Hospital, Northern Ireland (P16) 
 
Other challenges with mandatory training included competing priorities obstructing the prioritisation of 
insulin training for all clinical staff:   
“I haven't made it part of the Essential Training because there's so many different things that are 
on the hospital’s agenda that people want as part of the essential training so I think one of our 
consultants asked a couple of years ago and they were declined to have it as part of the essential 




The ‘battle’ for including insulin safety in mandatory or induction training was also described as politicised, 
with topics that attract funding (e.g. attached to a CQUIN) or high on the hospital’s agenda for other 
reasons being prioritised over insulin safety: 
“At the moment there’s not a lot of support for mandatory training… So when there was a 
CQUIN linked to it, it was funded for - everyone had to do a bit of e-learning. But that got pulled 
the moment the CQUIN went.” - Female diabetes pharmacist, Teaching Hospital, England (P5) 
“I think we rely on, what happens is we get a potentially serious error and everyone says ‘you 
must put it in the junior doctor’s training’.  But we have to keep bumping things down. You 
know, you can't do everything in twenty minutes on their first day.”- Female MSO, Teaching 
Hospital, England (P3) 
 
Induction training was frequently described as restricted and insufficient for training staff on insulin 
safety, which did not facilitate engagement or a meaningful learning experience: 
“There’s a slide on a fifteen-minute induction on insulin saying “don't forget units” more or less. 
Shows them what a prescription looks like, that's about as much as we can get on the induction 
training.” – Male clinical pharmacist (managerial), Teaching Hospital, England (P9) 
“Um, but I think at that point, they're getting absolutely bombarded with everything on their 
first day. They’re not really in a position to take it in.” - Female MSO, Teaching Hospital, England 
(P3) 
 
The pedagogy of insulin education was also discussed with the participants. Experiences with more 
participant-focused and engaging training were shared, which involved non-judgemental, supportive and 
reflective discussions with prescribers. These were thought to encourage more meaningful improvements 
in practice: 
“We still need to train and we need all those. I think we need to have some way of allowing 
people to take a space or step back and think about the job that they've done. And how well did 
it or if they could do it better and not dwell so much on their errors per se.”- Female diabetes 
pharmacist, Teaching Hospital, Northern Ireland (P16) 
“So it's about how do you develop the skill of prescribing insulin well, and it's not about having 
the knowledge on its own, it's about having the knowledge and being able to put that into 
practice in a safe way and a secure way, you know, you're, you're sort of supported to put that 
into practice and given the space to, to reflect.” – Female diabetes pharmacist, Teaching 
Hospital, Northern Ireland (P16) 
“But sits around the whole real-world things like, what sort of situation did you find yourself in? 
What other staff are involved in what other pressures are on you in that particular sort of 
moment in time? And then, you know, what is your experience in this area of prescribing? Who 
can you go to? Who is there for advice? It's not about textbook right and wrong answers it's 
more about the real nitty gritty. Everything else going on in the world at that time when you're 
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asked to do it.” - Male diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland 
(P8) 
 
Active learning pedagogies were also described as beneficial, which included gamification, experiential 
learning, and peer-feedback from pharmacy colleagues to help prescribers reflect on their prescribing: 
“Someone will pretend they were an insulin. And they had to ask questions about it to try and 
get to the one they were…So I mean I guess it got people looking in the BNF. You know, try and 
working out in their own heads what the differences between the insulin were.” - Female MSO, 
Teaching Hospital, England (P3) 
“Not in a sort of a purely sort of didactic teaching type session but more sort of hands on. 
Bringing, you know, bringing examples of patients in and case studies and getting them to 
complete the various cardexes and whatever and getting them to review made-up blood sugar 
levels. Getting them to tell us what's wrong with those sugar levels? What are we aiming for 
here, what’s the problems and identifying solutions to the problems, you know? So practical 
things like that have tended to be sort of very beneficial.” - Male diabetes pharmacist 
(managerial), Teaching Hospital, Northern Ireland (P8) 
 
The use active and experiential learning also relates to the next section, which concerns prescribing 
system use to support insulin prescribing safety in the hospital setting. 
 
 
5.3.5 A balance must be found between prescribing system control and flexibility to prescribe 
insulin 
 
One of the major themes of participant’s accounts was the unique challenge of maintaining safe 
prescribing systems for insulin within hospital, with restrictive actions being expressed as particularly 
beneficial for prescribing safety: 
“It just stops you making errors. Stops you doing something.” - Female MSO, Teaching hospital, 
England (P13) 
You know, the timings are fixed so that if you’re prescribing a short acting insulin you can’t 
prescribe it at bedtime, for example, and things like that. - Female clinical pharmacist, Teaching 
Hospital, England (P2) 
“So when that sort of process happened, and those sort of weird errors crop up, we try to build 
systems to take away that risk. And force – well, take the options away from the doctors so they 
can’t just pick the wrong thing from the list.” - Male clinical pharmacist (managerial), Teaching 




Participants represented hospitals that used paper-based, electronic and hybrid systems, and described 
a range of different processes currently in place – for example daily insulin prescribing and rolling insulin 
prescriptions: 
“I mean, we do daily prescribing of it. So our prescriptions are not like a rolling prescription, they 
are a daily prescription so they have to prescribe insulin each day.” - Female diabetes 
pharmacist, DGH, England (P18) 
 
 
All participants using electronic inpatient prescribing that excluded insulin (requiring concomitant paper 
prescriptions) described the risks associated with using multiple systems and handwritten prescriptions: 
“I can’t wait for us to incorporate into the system and see how we can reduce the sort of errors 
and disparity. It’s probably the discrepancies between the written information and the electronic 
system.” - Female diabetes pharmacist, DGH, England (P6) 
“But then again there’s issues with that were people don’t add that on, or they add it accidently 
onto JAC rather than onto the paper chart so there are pitfalls in the way that we do it.” - 
Female clinical pharmacist, DGH, England (P1) 
 
Participants explained that, unlike other medicines, the prescribing system used for insulin was 
inextricably linked to that used for recording blood glucose monitoring; challenges to moving insulin onto 
to electronic prescribing were presented where these were not synchronous or proximal: 
“And do we put it on EP was another discussion that I had yesterday, and move away from a 
chart completely? And [junior doctors] were very much against that, because they very much like 
the chart, because it's all in one place. They like because our charts have the blood glucose next 
to the prescription, and so they can see what the blood glucose is doing and then prescribe, 
whereas they don't want a separate blood glucose chart to then go and look for that and then 
prescribe and they just said that if it goes on to electronic prescribing you don't have that nice 
view to be able to do it straight away.” – Female diabetes pharmacist, DGH, England (P18) 
 
For participants working in hospitals using exclusively paper-based prescribing, specific paper insulin 
charts were heralded as a very effective and sustainable strategy for improving insulin safety by those 
who had implemented them, particularly when they were conspicuous (e.g. with colour), designed to 
support prescribers (e.g. incorporating guidance and blood glucose results), and minimised the input 
required to generate a safe prescription (e.g. multiple pre-printed elements): 
“So they said that our charts are white. So they're not very, like obvious. So they’d quite like 
them to be a brighter colour. Like, the warfarin charts are yellow. So, it's like, “look at me” I need 
to be doing something about it. So having a white chart it isn't helpful, is what they said.” - 
Female diabetes pharmacist, DGH, England (P18) 
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“So I sort of split it into sort of, you know, morning, lunch time, teatime, night-time. And the 
units were pre-printed. And there was a lot of information as well on that drug chart, although it 
was only an A4, you know, folded in half, there was a lot of information on there to support 
them.” - Female MSO, Teaching hospital, England (P13) 
“So it has units pre-printed, the times of insulin prescribing specified, it says ‘brand’ at the top so 
they know they’ve got to write in brand, you know there’s lots of things they’ve got towards its 
insulin prescribing. So that was really successful in terms of how insulin was prescribed…the 
reason it was good was because we did most it for them. The doctor literally just had to write 
the brand name and the number in the right timed box like it’s all they had to do!” - Female 
clinical pharmacist, Teaching Hospital, England (P2) 
 
Despite this, participants described issues with prescribers circumventing the safety measures designed 
into the paper charts: 
“But saying that, you know, we still managed to have two weeks ago, a doctor write ‘units’ on 
an insulin chart where the word ‘units’ was pre-printed which resulted in a you know, a not 
unserious overdose.” – Male managerial pharmacist, DGH, Wales (P12) 
 
Opinion from participants who did not use insulin paper charts felt they were redundant in their context 
and may increase the potential for administration errors: 
“No, no. I have to say, I'm reluctant to introduce a separate chart for insulin because, I feel like 
it’s not, if it’s not on the main chart then there’s the potential for missed doses…I don't, looking 
at the kind of errors that we've had, I’m not convinced that having a separate insulin chart 
would make a difference.” – Female MSO and diabetes pharmacist, Teaching Hospital, England 
(P11) 
 
The experience of participants using electronic prescribing for insulin was described as beneficial overall, 
but that benefits were limited by the absence of certain safety features or the introduction of new types 
of insulin prescription errors: 
“Electronic prescribing, I think has helped overall. Because yeah, you might have seen some of 
those terrible prescriptions where they had no idea the names, the doses, the timings were 
awful. Yeah, I think it’s marginally better.” - Female MSO, Teaching hospital, England (P13) 
“I mean, it’s had some impact on some of the errors that we would get, particularly around units 
and getting the full details of the prescription specified. But what we're getting now is an 
increased I would say error rate from mis-selection from drop down menus.” - Female MSO, 
Teaching Hospital, England (P3) 
“So we’ve still had you know, ridiculous doses. It doesn’t stop you from doing ridiculous things. It 





Although there was a variety in the functionalities of systems that participants described the use of, 
common patterns in responses concerned the importance of simplicity, clarity and support for prescribers 
with electronic prescribing, due to the experience of prescribers circumventing safety features. Electronic 
insulin order sets, for example, were described as particularly beneficial: 
“So it’s just as dangerous, just a different system creates new errors. So when that sort of 
process happened, and those sort of weird errors crop up, we try to build systems to take away 
that risk. And force, well, take the options away from the doctors so they can’t just pick the 
wrong thing from the list... So they pick a regimen, not necessarily pick an individual product, 
because there is too much choice and they just pick the wrong one basically.” – Male clinical 
pharmacist (managerial), Teaching Hospital, England (P7) 
“And that’s why I think we need to go back to that insulin prescribing bundle idea from the 
health foundation. And put the word “insulin” in front of all of these so it is blindingly obvious 
that some of the new, as you say, things that don't even sound like insulin -.” - Male clinical 
pharmacist (managerial), Teaching Hospital, England (P9) 
“So now on EPMA, all insulins are prescribed by protocol. So they’ve all been assigned…you pick 
Novomix twice day protocol and it auto populates with the right admin times and then the dose 
has to be added on basically by the doc.”  – Male clinical pharmacist (managerial), Teaching 
Hospital, England (P7) 
 
Despite the benefits of restrictive functions for insulin prescribing, an appreciation that flexibility, or 
‘scope for patient individuality’ was needed with whatever system was used due to the variety and 
variability of doses and regimens seen in practice. Rule-based hard limits on prescribing (such as dose 
ceilings or frequency restrictions), for example, were difficult to apply to insulin compared with most 
other medicines, which complicated the design of systems to build-in safety for insulin: 
“And obviously, we've got electronic prescribing, and we've got the ability to put some limits in 
there. But the regimes are so variable, it's very difficult to put hard limits on them.” - Female 
MSO, Teaching Hospital, England (P3) 
 
The inclusion and selection of insulin device on electronic prescriptions was an issue of interest for some 
participants due to the frequent errors associated with mis-selection of device by prescribers. This was 
particularly associated with electronic prescribing because on paper prescribing, the pharmacist would 
typically add in the particular device used by the patient onto the prescription form. The consequential 
challenges pharmacists faced with amending electronic prescriptions and the impact this had on patient 
care was described:  
“So have so we did have an instance where the doctor wrote the wrong formulation. The nurse 
asked, I think they wrote up a pen. And we supplied a pen. And the nurse said, “I don’t want a 
pen.” We said, well, that's what's prescribed and then you will have to change the prescription, 
and then that took almost a whole day for it to change, which resulted in a delay to them 
156 
 
receiving it. Whereas before, that wouldn't have been an issue.” – Female MSO, Teaching 
hospital, England (P13) 
 
One participant explained that pharmacists annotate the prescription with the insulin device to avoid 
device-related prescription errors: 
“The device isn’t part of the prescribing. That is added later, usually by the pharmacist, once 
they’ve clarified the device and that kind of thing we add something onto EMPA to clarify that.” - 
Male clinical pharmacist (managerial), Teaching Hospital, England (P7) 
  
With respect to prescribing by brand for insulin, participants perceived this to be beneficial but difficult 
for prescribers who may be unfamiliar with insulin branding, the large number of products that often 
sound alike, and the usual convention of prescribing generically for most other medicines:  
“And also, there’s a number of insulins on the market, which, which a lot of people are simply 
unfamiliar with, and they don't, a lot of them, the naming is weighted towards the brand as 
opposed to the different type of insulin or the different effect it would have.” - Male managerial 
pharmacist, DGH, Wales (P12) 
“We’ve noticed they’re not prescribing by brand. So we had an incident with glargine because 
you’ve got Toujeo, and you’ve got Lantus haven’t you, and you’ve got Abasaglar and you’ve got 
Semglee. So you’ve got multiple products now with the biosimilars coming on the market. So if 
you prescribe it as glargine, what are you actually giving?” – Female diabetes pharmacist, DGH, 
England (P18) 
“The manufacturers want a strong brand name where all their product sounds similar. Which is 
great for establishing a brand, but it's awful for mis-selection.” - Female MSO, Teaching Hospital, 
England (P3) 
 
Participants in Wales and Northern Ireland described the situation and benefits with respect to 
standardising prescribing systems and guidance regionally and nationally, and expectations that using a 
single system would facilitate safer prescribing by allowing prescribers to be familiar with the system 
when rotating through organisations.  
“We have adopted that as well in Northern Ireland in that we have the same paper based - we 
have the same medicines cardex and they can prescribe it across Northern Ireland. And as I said 
earlier, that has been born out and evolved and sort of helped reduce errors through design and 
documentation and stuff that helps to really, you know, reduce errors and stuff. So that's 
regional.” – Male diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
 
Although there was an appreciation that operational variations amongst hospitals may complicate 
standardisation, facilitating enhanced familiarity with systems prior to practice (e.g. in undergraduate 
education) was described: 
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“I would personally like to see a standardization of insulin charts. And that's somebody that I'm 
not a big fan of standardisation in general…So you know, if we're only teaching people one way 
within schools, then you’d hope that, you know, if the message is “you’re never going to have to 
write units down. So don't write units down.” And that might not necessarily be all-Wales, but 
that might be a UK-wide thing, I don’t see why it wouldn’t be.” – Male managerial pharmacist, 
DGH, Wales (P12) 
 
Often, the prescribing systems described above are interrogated for audit purposes that aid the 
evaluation of interventions. This links to the next theme, below, which concerns the evaluation of insulin 
prescribing practice interventions. 
 
5.3.6 Interventions to improve insulin prescribing are hard to evaluate in practice 
 
Participants commonly expressed a desire to be able to evaluate the impact of insulin prescribing 
interventions that had been designed and implemented, but described their inability to do so due to the 
difficulties in measuring outcomes: 
“Now can I turn round and tell you that they definitely reduced our error rates? Well I actually 
couldn't. Because it's very difficult to measure your error rates.” - Male diabetes pharmacist 
(managerial), Teaching Hospital, Northern Ireland (P8) 
 
Many participants described the routine interrogation of clinical incident reporting software (e.g. DATIX) 
in order to observe and review trends in locally reported insulin errors. The experience of using these 
systems to that end was described mainly as challenging and inadequate for measuring the impact on any 
given intervention, particularly with prescribing errors and incidents, which are often under-reported: 
“Our incident reporting system is really difficult to interrogate. It comes down to individual 
drugs. And I can't pull a report very easily at all even just by looking at insulins. So I sort of 
sometimes have to manually trawl it.” - Female MSO, Teaching hospital, England (P13) 
“We have DATIX but then you know, not everybody then actually reports the errors.” - Female 
diabetes pharmacist, Teaching hospital, England (P10) 
 
Participants reflected on the reasons why incident reporting systems were under-used, which mainly 
featured issues with reporting culture, time, and blurred boundaries with respect to professional 
responsibility: 
“I think that one of the biggest things is having a proper handle on the true degree of incidents. 
So it’s changing the culture to make sure that say everything was reported. But also it would be 
about trying to make the reporting systems easier to use, and more intuitive in terms of being 
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able to sort of get information from them. So that that would be one big area because we, we 
genuinely, don't always have a really good handle on what our error rates are for different types 
of insulin problems and things. And even when we have them, we know they're not a true 
reflection.” – Male diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
“But because the DATIXing is so underdone and that’s because it’s a, such a long process to 
DATIX something but also you know people just don’t have time to sit there and DATIX and 
sometimes the role becomes a bit blurred because as a pharmacist you think well actually it is 
my role to pick up on these errors and to resolve them.” – Female clinical pharmacist, DGH, 
England (P1) 
 
The use of audit was also described as a commonly used method to evaluate intervention effectiveness 
and track improvements or changes in insulin prescribing errors. This included the National Inpatient 
Diabetes Audit (NaDIA) but also bespoke insulin prescribing and administration audits that were locally 
designed and implemented: 
“What we did is we just looked, out of the normal NaDIA we just took out the prescribing and 
management for subcut insulin and orals. And so every three months, we did that for the whole 
of the hospital, and reported to back CMGs etc.” – Female diabetes pharmacist, Teaching 
hospital, England (P10) 
 
Limitations with respect to time and labour-intensive data collection, particularly with paper-based 
systems, along with the unreliability of insulin dose administration documentation, were cited as barriers 
to the use of audit for evaluative purposes: 
“And then the other thing that we’re slightly limited about is the fact that we’re so paper based. 
So it's not as if we can pull reports off, you know… But at the moment, that's very hard to do. It's 
very labour intensive. So we're not really able to do it.” - Female diabetes pharmacist, Teaching 
Hospital, England (P5) 
“That's something, I think that actually isn't recorded very well, because no-one documents the 
time they have their lunch and the time that the insulin was administered, as a pharmacist, 
you're just checking the dose and that there's a signature next to the lunchtime prescription.” - 
Female MSO and diabetes pharmacist, Teaching Hospital, England (P11) 
 
Participants also described the use of anecdotal evidence and user feedback for attempting to sustain, 
modify or cease interventions altogether: 
“…learn from somebody being able to say to you “you know what, you've written that policy and 
it's all very good, but practically at two o'clock in the morning, it's not really useful to me. Could 
you make it a bit easier in this way?” And we need to be able to listen.” – Female diabetes 
pharmacist, Teaching Hospital, Northern Ireland (P16)  
“We had a real, real push into teaching the juniors about not repeating Actrapid, because a few 
years ago, we did have quite a lot of instances where people getting hypo because we're getting 
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repeat doses of Actrapid for hyperglycaemia so regularly. And we've just noticed, that that’s not 
happened so much. So your diabetes nurses who go in and see patients, they're just not seeing it. 
So we are aware that’s worked just because it's stopped. But we’ve not measured it directly.” – 
Female diabetes pharmacist, Teaching Hospital, England (P5) 
 
Despite the limitations of tools to measure certain outcomes of interventions in hospital (for example on 
insulin prescribing errors), participants were able to articulate the improvements, or lack thereof, with 
respect to insulin prescribing safety over time: 
“So whatever we've done, it's definitely improved.” - Female diabetes pharmacist, Teaching 
hospital, England (P10) 
 
The next theme was a substantial theme identified in the dataset that pertained to the design, 
implementation and use of a particular intervention. The use of self-administration policies in the hospital 
setting to allow patients to inject their own insulin when required was a salient and timely topic for both 
participants and our patient representative group. As such, particular emphasis is given to the reporting 
of findings relative to this intervention below. 
 
5.3.7 Inpatient insulin self-administration is a problem worth solving 
 
Insulin self-administration policies were discussed with all participants due to the saliency of the 
intervention highlighted by stakeholder group discussions (see Chapter 4, section 4.6). Self-
administration policies were in varying degrees of use across the organisations represented by the sample 
of participants. Some organisations had insulin-specific self-administration policies, whereas others 
worked with a more general self-administration of medicines policy. Eight organisations represented had 
a self-adminstration policy that was described as currently in use, nine described policies as written but 
not actively in use (including where policies are being piloted) and one did not have a self-administration 
policy.  
Some participants described insulin self-administration as something that was “ingrained in the culture” 
of the organisation at ward level. Participants attributed this to satisfying the interests of the patient 
demographic (e.g. long-term patients) as well as the diabetes team: 
“I guess, we’ve got use of patients own medicines on all wards. And we've got, we've got quite a 
good self-administration policy that's been in use for a number of years (Interviewer: okay.) and 
because we've got a number of long-term patients, I guess, who are returning to us. We've got, 
we've got a vested interest in encouraging them to manage their own conditions.” – Female MSO, 
Teaching Hospital, England (P3) 
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“I think for insulin probably, because it's quite well established and understood and the insulin 
team have banged on about it quite a lot and we’ve used it in our sort of CQC inspection, so we 
have got evidence of self-administration and appropriate documentation.” – Male clinical 
pharmacist (managerial), Teaching Hospital, England (P7) 
 
Others described self-administration as having not been implemented well or not utilised to its fullest 
potential, or even adhered to at all: 
“It was really a matter of the sort of implementation by the nursing staff. And I just think, oh, it 
was it was, I guess it was too difficult for whatever reason to implement. But yeah, we’d 
definitely like to look at it again, because it's been a been a while, been a few years.” – Female 
MSO, Teaching hospital, England (P13) 
“But its just the timing as I didn’t actually manage to do any kind of roll out with it. So it was 
completed but we didn’t do any training or any…  yeah. And we've not found it used at all - so 
people just ignore those pages. Erm, so yeah, I'm trying to do a project around it, because we 
know that as much as we say, oh it would be great people if people do it, its jut not happening.” 
– Female diabetes pharmacist, Teaching Hospital, England (P5) 
 
Self-administration of insulin was described by almost all participants as something important that should 
be encouraged, with many participants describing their involvement with helping to facilitate this in their 
organisations, either as part of the diabetes team, or the medicines management team: 
“So, yes, we want to do self-administration. And we'd like to pick it up. And we would hope to sort 
of start thinking “oh, yeah, we should pick this up again and review it”. But we haven't got there 
yet.” – Female MSO, Teaching hospital, England (P13) 
“So we haven't moved to total one hundred percent self-administration, but we know we have 
to, and we know we should do, because that's what patients are demanding.” – Female diabetes 
pharmacist, Teaching Hospital, Northern Ireland (P16) 
 
One of the key benefits to self-administration described by participants was its potential to prevent harm 
from insulin prescription errors, thereby acting as a safety net against administration errors and the 
consequences of prescribing errors: 
“So I personally do feel that most of our errors would be reduced if the patient is competent and 
able to self-administer. A lot of the errors I think would come down.” – Male diabetes 
pharmacist, Teaching Hospital, England (P14) 
“Because actually probably most of those errors were when the insulin wasn’t prescribed and the 
patient has given it themselves, quite rightly so because (laughs) they’re not going to not give 
themselves insulin when they would always at home just because a prescription isn’t there.” – 
Female diabetes pharmacist, DGH, England (P18) 
“And actually, when the prescription, when we've had incidents where the prescription has been 
wrong, fortunately, on most of those occasions, the prescription was wrong, but the patient 




This was often related to the idea that patients were best placed to manage their own insulin whilst in 
hospital. This is due to their greater knowledge and understanding of how their diabetes should be 
managed, compared to non-diabetes specialist healthcare professionals: 
“That patients are best at managing their own insulin to be honest! That’s it. They’re more 
familiar with what their medication is, what they should be giving at what times and when we 
start to get involved in it there is always a risk we will get it wrong.” – Male MSO, MH Hospital, 
England (P15) 
“With diabetes, patients are very well educated. And they usually they know a lot more about 
their condition than a non-diabetes specialist would.” – Male diabetes pharmacist, Teaching 
Hospital, England (P14) 
 
Self-administration was described as empowering for patients, that enabled them to be more involved in 
their care and promote independence during their hospital stay. This was reinforced by stories of patient 
complaints regarding the lack of ability to self-administer: 
“I think just to empower patients to sort of do their own insulin a bit more.” - Female clinical 
pharmacist, Teaching Hospital, England (P4) 
“And I don't think we've ever really looked at that other than we know from time to time we 
would get patients maybe writing to our complaints department to say, “I feel I should be able to 
control my diabetes myself and administer my own insulin.” “ – Female diabetes pharmacist, 
Teaching Hospital, Northern Ireland (P16) 
 
Nurse administration of insulin, on the other hand, was thought to de-skill the patient, which could result 
in additional unintended negative consequences: 
“Because at the end of the day, a patient should be self-administering where they can. They've 
got to go home and do that. And we, you know, we de-skill them, we take that away whilst 
they're in hospital.” – Female MSO, Teaching hospital, England (P13) 
“I think the other thing is that it keeps the patients skilled and doesn’t deskill them whilst in 
hospital. They keep their responsibility for that. Which certainly with our long-stay patients, that 
can become an issue.” – Male MSO, MH Hospital, England (P15) 
 
The extent to which self-administration was suitable for patients was discussed widely, with perceptions 
varying on the currency of the intervention considering the patient demographic and perception of 
‘capacity’ or ‘competency’. For example, participants described a limited application for self-
administration policies where patients are acutely unwell or elderly, and cited elective surgical patients 




“And the wards I'm often involved in are quite often more acute and therefore, medical, and it's 
not necessarily appropriate for the nurse when the patients come in to be doing their insulin 
because they are too acutely unwell. However, the elective ones. We probably do need to get it 
on board.” – Female diabetes pharmacist, Teaching hospital, England (P10) 
“Unfortunately, I've been around for too long than I care to remember, and so having done a 
self-administration policy, you know, twenty years ago in a previous hospital. Things are 
completely different now than what they used to be. Patients are far sicker, because actually if 
they’re not very sick, actually we need the bed for the person who is very sick and waiting in A 
and E, so you have less well patients who could self-administer if you know what I mean.” – 
Female MSO and diabetes pharmacist, Teaching Hospital, England (P11) 
 
The extent to which the policy was used on account of patient suitability also varied widely across 
participant’s accounts, with one participant representing a mental health trust describing the majority of 
their inpatients as self-administering, and another representing a district general hospital explaining that 
very few patients self-administered during a pilot. Of participants who had evaluated the uptake of the 
policy (e.g. via audit), some cited audit figures of up to 95% of their patients self-administering, and others 
describing uptake as “not a high number”, or numbers as “few and far between”. Some participants 
reflected on why uptake was low and postulated that the criteria for self-administration was too strict: 
“And the sort of feedback that we had was the “Oh, the criteria, perhaps was a bit too strict”. 
Because we say obviously, we don't want anybody that’s comatose or going for surgery, x, y, z. 
So the numbers were small.”- Female MSO, Teaching hospital, England (P13) 
 
Some participants described experiences of where self-administration with insulin had resulted in 
unintended harm to patients, often because of communication breakdown between healthcare 
professionals and patients, or changes in clinical condition not being reflected contemporaneously in the 
assessment and documentation, or processes not being followed; These past experiences often resulted 
in reluctance from healthcare professionals to move forward with the policy implementation: 
“I think the problem is that as a trust we have been burnt I suppose in the fact that patients 
refuse to give up their insulin. And we then found that they were probably more confused than 
they thought they were and they've had crashing hypos because they’ve given themselves too 
much insulin. So what’s really difficult here, I think, is the fact that people are wary... So that's 
why, so we were sort of starting it and then ended up being pulled back because of an error, well 
to be fair it wasn’t just one it was a couple of errors from the patient self-medding. But there, 
they hadn't been through a proper process. They hadn't been assessed properly.” – Female 
diabetes pharmacist, Teaching hospital, England (P10) 
“I also think that there have been cases where people have self-admined and it's gone wrong. So 
like, we had a lady who was on a pump. So she was allowed to continue her pump because we 
generally say if they’re well and able to they can continue it. Yes. But their capacity massively 
fluctuated in the day. So she ended up having problems.” - Female diabetes pharmacist, 
Teaching Hospital, England (P5) 
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“So quite often, it wouldn't necessarily be prescribed timely or correctly because they just 
assumed the patients are self-administering. The patient isn't self-administering and there’s 
nobody monitoring the patient… And yet they've been assessed as self-administering. So, you 
know.” – Female MSO and diabetes pharmacist, Teaching Hospital, England (P11) 
 
One of the challenges associated with the implementation of insulin self-administration policies was the 
ambiguity of who oversees and drives the self-administration agenda across the organisation, and who is 
responsible for ensuring its implementation and success: 
“And I really didn't want to lead on it. It’s like “this is not for me to do” this is, I've provided you 
with the framework because you know, I'm happy to put something down on paper. But you 
know, this is for you.” – Female MSO, Teaching hospital, England (P13) 
 
The appetite for driving self-administration of insulin is something that was perceived to be heterogenous, 
and Influenced by healthcare professionals’ personal attitudes, experience, workload, and perception of 
their role: 
“Or if you've got a consultant who is keen for it to happen or it’s in their head because they’ve of 
heard of it or read something, then they're more proactive. Whereas if you've got, say, a bit like 
you talk to a cardiologist, if you're in a cardiology ward, they're never going to even consider it. 
They're going they're going to say, “well, I'm not going to assess the patient”. So it's not just 
having the policy and the staff being aware, it's who's pushing, who's driving it, is probably also 
the thing.” – Female diabetes pharmacist, Teaching Hospital, Northern Ireland (P16) 
“And sometimes it's a bit like, even in our own work, sometimes other things take priority and 
some days you might be focused on thinking, “actually, I'm going to try and get the patients on 
this ward, anybody who can, to self-administer and we'll try and adopt that for this week”. You 
know, that will be this week.’. But then other things get in the way.” – Female diabetes 
pharmacist, Teaching Hospital, Northern Ireland (P16) 
 
Another factor cited was the lack of awareness about self-administration policies in the hospital setting 
from both patients and healthcare professionals: 
“And I just think that a lot of people might not even know that they are able to offer that so were 
currently also putting together a leaflet for diabetes patients when they come into hospital and 
within that leaflet it talks about self-administration” – Male diabetes pharmacist, Teaching 
Hospital, England (P14) 
 
Solutions to this included the education and comprehensive ‘launch’ of the policy to staff, and 
empowering patients themselves to enquire about the ability to self-administer their insulin whilst in 




“So we’re starting (pauses) the wards, so again, we have an e-learning, and then when the 
wards are up to eighty percent of staff, at least in the E learning.” – Female diabetes pharmacist, 
Teaching hospital, England (P10) 
“So maybe it is. It is, you know, the patient trying to, you know, the patient driving it or, I don’t 
know who drives this. And then you get maybe patients who, who aren't aware that it’s 
something they can do so don’t ask the question.” – Female diabetes pharmacist, Teaching 
Hospital, Northern Ireland (P16) 
 
With respect to undertaking the work involved in the intervention, most participants described nurses as 
the professional group who were responsible for initiating and assessing patient suitability for self-
administration at ward-level, although mention was made of pharmacy technicians adopting this role to 
support the intervention. Diabetes specialist nurse involvement was also discussed, but contextualised by 
the unsustainability of this group undertaking assessments across an organisation: 
“It’s the nurse. There really isn’t much time and I know and other hospitals their MMTs, their 
techs do some of that. And we just haven't got the staff to do that unfortunately. But yeah. So in 
my inpatient  safety group they say well can’t pharmacy do, and I say “we'd love to, but we just 
haven't got the technicians base to be able to free up their time to be able to do that, 
unfortunately.”” - Female diabetes pharmacist, Teaching hospital, England (P10)  
“So a fair chunk of patients self-administer. But there’s an assessment process that the nurse has 
to do, and a proforma that they have to complete and put in the notes, that kind of thing.” – 
Male clinical pharmacist (managerial), Teaching Hospital, England (P7) 
“So what’s happened in [trust B] is diabetes nurses have started filling it in and I keep saying to 
them “this is not sustainable. You can’t fill this in for every patient in the trust.” – Female clinical 
pharmacist, Teaching Hospital, England (P2) 
 
Some of the reasons participants gave for not using their self-administration policies included lack of time, 
motivation and confidence from nurses in undertaking the required tasks. For example completing the 
pre-requisite patient capacity or risk assessments: 
“So we have a self-administration policy. It relies on assessing your patient to make sure that 
they’re competent.  But then our nurses don't feel they can make that assessment because they 
don't normally do that kind of capacity assessment. And it makes it a bit long-winded, so that we 
generally don't do it. But then we got the patients on inhalers and insulins who they recognize 
that actually would be sensible if they do self-administer so we kind of tacitly allow patients to 
self-administer their insulins without following our policy. So we kind of shoot ourselves in the 
foot by trying to be safe for the patients to allow them to do it.” – Male clinical pharmacist 
(managerial), Teaching Hospital, England (P9) 
 
Risk assessments that were too comprehensive or complex especially disincentivised nurses from using 
the policy: 
“I’ve been brought into [trust B] to have a look at it and they have gone down this classic road 
and I’ve seen this so many times, and I’ve spoken to so many people about it, where the diabetes 
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nurses have designed this super complex assessment. “does the patient have lipohypertrophy? 
Are they doing an air shot? Are they mixing them in?” And requires a huge amount of diabetes 
knowledge to fill it in. And it’s like an A4 side of paper. And of course what happens is the nurses 
go “I’m not” and they just ignore it. So their self-admin is going nowhere.” – Female clinical 
pharmacist, Teaching Hospital, England (P2) 
 
The participants acknowledged the fact that clinical conditions can change rapidly in hospital, 
necessitating repeated assessments to be undertaken by the nurse to ensure the patient is safeguarded. 
This can add to the time-burden of the intervention, but if the assessment process is made simple and 
easy, to ensure safety rather than complete ‘competence’, this may be integrated more naturally into the 
ongoing clinical review of the patient: 
“So yeah, I think we need to make sure that within the policy we think of doing the capacity 
assessments daily and actually if something goes wrong staff will be supported about it.” – 
Female diabetes pharmacist, Teaching Hospital, England (P5) 
“It’s the classic thing, they fall into this trap of trying to prove perfect diabetes-ness and I keep 
trying to say to them “patients weren’t perfect before they came in but they were safe, and 
that’s all were doing with self-admin”. And as long as that patient doesn’t give themselves a 
hypo or DKA, I don’t actually care what they are doing. And they don’t like it. They don’t like it at 
all. And I’m like “it’s up to the primary care team to look after this patient and their ability to 
inject. Not you. You’re here to keep everyone safe.””- Female clinical pharmacist, Teaching 
Hospital, England (P2) 
 
Attitudes to self-administration interventions were described disparately across the dataset. There were 
several participants describing nursing staff as wary, resistant, or nervous about self-administration, 
which was often attributed to a fear of repercussions and led to disengagement with the policy: 
“Another bit is that the nurses are sort of a little bit tentative in the context of “well if I let the 
patient do this and they forget to do it or they're not as competent as they originally thought 
and they miss their insulin doses and the sugars are sky high. And something happens they’ll 
come back to me on it”. You know “why did you let that patient do that?” you know? So there's a 
little bit of, I would assume, fear. And sort of wanting to protect yourself. So the best way to 
protect yourself is just to blast on and you know, know that it's done.” – Female diabetes 
pharmacist, DGH, England (P18) 
 
 Others described staff as being familiar with the policies which were used frequently on certain wards:  
“I think the nurses on there [the endocrinology ward] are much more aware of it anyway 
because we do get so many younger patients compared with other general medical wards. So 
we do get an awful lot of diabetics on there who routinely self-administer, so yeah, the nursing 
staff are more familiar with it and more used to the patients doing it themselves anyway.”- 
Female diabetes pharmacist, DGH, England (P17) 
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“So I think it's very hit and miss as to where they are doing it well. So I know the CF unit. They are 
using self-admin quite a lot. But then yeah, they self admin all their meds. That's the sort of part 
of the culture of the ward.” – Female diabetes pharmacist, Teaching Hospital, England (P5) 
 
Linked to this was the perception of burden that self-administration placed on staff nursing time, and the 
influence this had on uptake of the policy:   
“And that's one of the things from the nursing staff is that, it's just too time-consuming. Maybe 
the number – you know, you've got to assess the patient. You've got to get their consent, you've 
got to ensure this, that and the other, and it's just easier, you know, for them to, to give it to the 
patient. That’s not to say that it’s right.” – Female MSO, Teaching hospital, England (P13) 
“And I think that's, that's probably a challenge for, you know, a busy ward. When the nurses are 
thinking, “oh, god, and I’m going to have to take that patient off self-administration”, or “I have 
to try and put them on it”. And sometimes maybe they just think you know what, it's just easier 
to just do it all yourself.” – Female diabetes pharmacist, Teaching Hospital, Northern Ireland 
(P16) 
 
Despite this perceived burden, the need for a shift in paternalistic perspectives to facilitate the 
implementation and use of insulin self-administration policies in the hospital was also highlighted: 
“And I think in the past, the sort of de facto position was, we look after everything for you. 
Whereas, we nearly need to flip that. We really need to say that we expect you to be giving your 
own insulin unless you can’t, providing you do it at home and providing it’s safe to do so…” – 
Male diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
 
Widely discussed with respect to self-administration policies was the difficulty in navigating the 
complexities around maintaining adequate storage of insulin at ward level and the safe disposal of sharps. 
The need to satisfy the Care Quality Commission (CQC) requirements for the safe but accessible storage 
of insulin for people self-administering their insulin was a common theme, with many participants 
expressing this as a significant barrier to implementation: 
“The thing that makes us, erm, twitchy, if that's a word, about self-administration of insulin is 
potentially around how you have to store it to make it available. Actually saying it out loud, it 
sounds pathetic. But we, I think we, I think we struggle with the infrastructure to allow it in 
terms of around the keys, you’ve got to give the patient the keys to the locker in order that they 
can they can have access as well. And I, I'm not sure we’re there yet with that. – Male 
managerial pharmacist, DGH, Wales (P12) 
“And also, some of our wards wouldn't have the facility to allow patients to store their own 
insulin at the bedside. The newer wards will have that facility but it's hard it's hard actually.” – 
Female diabetes pharmacist, Teaching Hospital, Northern Ireland (P16) 
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“And the other side of it, we’re never quite sure what the CQC would make of it because their 
stance is, everything needs to be secured and locked away.” – Male clinical pharmacist 
(managerial), Teaching Hospital, England (P9) 
 
Shared learning across hospital trusts was described with respect to evidencing safe storage requirements 
for the benefit of ensuring insulin governance and the CQC. This was described as desirable and beneficial, 
but required the CQC inspectors to have a united stance on how insulin is stored for self-administration: 
“So [pharmacist A] did all the work with the CQC to prove you didn’t have to lock insulin away so 
I took that part of it and [pharmacist B] did the risk assessment that the CQC asked for so I took 
her one and then just [trust A]’d it, submitted it to our medicines governance and they were 
happy to agree to it not being locked away because we had approval from the CQC so they were 
happy with that.” – Female clinical pharmacist, Teaching Hospital, England (P2) 
“And then it was about where do you store the insulin, so if they are able to administer then 
where do we store it? So it could be lockable? Then we looked at a paper done in [Trust A] and 
they just used lunch boxes. So we went with that idea that it was they were signing in a contract 
to say that they would keep it safe.” – Female diabetes pharmacist, DGH, England (P18) 
“Well, as I say, it's that combination of which locker you buy and what kind of lock you've got it 
on? How do you manage to get over the coding of cards issue.? Erm, and if anyone's cracked it, 
it'll be lovely to know exactly what they've done to see whether that's, you know, duplicatable or 
not…And getting all of the CQC inspectors signed up for that as a collective as well rather than 
just an individual going “Oh, that's fine.” And another one going “No, I don't like that.”” – Male 
clinical pharmacist (managerial), Teaching Hospital, England (P9) 
 
The importance of complete and contemporaneous documentation of insulin self-administration was also 
widely discussed, with reference made to the fact that the requisite documentation is not always 
completed when people are self-administering (e.g. completed risk assessments, consent forms). This also 
had important implications on communication between staff and patients, and the way patients were 
reviewed at ward level: 
“Erm we're also finding interesting that there are sometimes people who are self-admining they 
haven't filled in the separate paperwork. So we need to make sure that it is properly, erm, done 
by policy, really, to make sure it's safely done.” – Female diabetes pharmacist, Teaching 
Hospital, England (P5) 
“But again, the documentation is very vague, because what I find between the self-
administration policy again is a disparity between the electronic system and what is on the BM 
chart and particularly as well, with self-administration you  can imagine how relaxed the nurses 
are about “oh self-administer, ppft, don't even care how much he's given himself’.” – Female 
diabetes pharmacist, DGH, England (P6) 
“And I think because sometimes the medics they may do a ward round and may not know that a 
patient is self-administering, so they’ll just change it on the chart for example, walk asway and 
leave. And then the patient’s still self-administering the units they were always using, and it’s 
not being changed. So, I think it’s important from both angles that both the teams that are 
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prescribing and the patient are having great communication to know, “okay, we're changing this 
so, now start injecting this dose”.” – Male diabetes pharmacist, Teaching Hospital, England (P14) 
 
Designing the documentation to be simple, easy to complete and reducing the number of extra forms was 
also considered an important way to aid completion of the paperwork. This included integration with 
electronic prescribing systems or prescription charts where possible to ease the burden on staff time: 
“So we put the words exactly as they appeared on JBDS at the bottom of our chart and then a 
signature at the bottom that said “is the person self-admining?” get them to sign it, get you to 
sign it, job done. Because it’s obviously a hospital chart its part of patient record so it goes in 
their record so it meant that nothing else had to be written in the notes and it was all great.” – 
Female clinical pharmacist, Teaching Hospital, England (P2) 
“So whereas obviously I've got a lot of paperwork. There's a consent form. There's an 
assessment form, an information form, leaflet form for the patient. And all the other 
documentation, I was thinking, you know, if you can put some of that on, on the EPMA system. 
That could be you know, quite helpful.” – Female MSO, Teaching hospital, England (P13) 
 
An important pattern in the description of designing self-administration policies was the need to be able 
to take the shared learning from other institutions but appreciate that they will need to be carefully 
tailored to the specific needs of the organisation:  
“And then so there's that importance of designing it around, that’s sympathetic to your 
environment. And because I think quite often, we're all for a one-size-fits-all, you know, the 
whole ‘do once’ thing but it's not gonna work.” – Female MSO and diabetes pharmacist, 
Teaching Hospital, England (P11)  
 
The exception to this was participants representing countries that are seeking to achieve a more 
standardised approach. For example, participants from Northern Ireland described the development of 
a Northern Ireland- wide self-administration of insulin protocol: 
“And one of my actual key tasks sitting on the regional inpatient group is within a subgroup of 
that is, is developing a Northern Ireland-wide self-administration of insulin protocol.” - Male 
diabetes pharmacist (managerial), Teaching Hospital, Northern Ireland (P8) 
 
Participants also described the multidisciplinary input required in designing the policy, which involved 
both pharmacists and nurses at the minimum, with others extending this to patients. This was described 
as crucial due to the understanding needed regarding the scope, feasibility, and degree of input from each 
professional group involved in enabling insulin self-administration: 
 “And that’s what we found, so we were really surprised, we did a lot of teaching on the patient 
self-admin at one point. And we kind of just assumed, you know, took it for granted that they 
[nurses] do these kind of capacity assessments all the time. And they basically, they turned round 
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and said “No, we never do them. The OTs do them occasionally, physios sometimes, the medics 
do them, but we don't”. And we went “Oh.”” – Male clinical pharmacist (managerial), Teaching 
Hospital, England (P9) 
“I can’t see any resistance from them I think its key to get nurses on board. For anyone that 
wants to implement it in the hospital you need to get your nursing on board.” - Male diabetes 
pharmacist, Teaching Hospital, England (P14) 
 
The above thematic findings represent a data-driven approach to analysis of the qualitative data by the 
researcher and will be discussed in relation to the survey results below, and also in Chapter 7. The next 
section presents an additional deductive treatment of the data, whereby the findings are mapped to an 
established model of patient safety from a human factors engineering approach.  
 
5.4 A systems approach to insulin prescribing safety 
 
To further present the findings in a theoretically informed but empirically driven way, the thematic analysis was 
re-examined with reference to the components of the Systems Engineering Initiative for Patient Safety (SEIPS) 
work system model (person, organization, tools/technology, tasks, environment). This allowed the researcher to 
be alerted to further systems-related explanatory factors contained in the framework, and brought these to the 
foreground. The findings and inferences from the reflexive thematic were summarised and aligned with 
components of the SEIPS in a deductive process to provide an explanation of the human factors systems issues 
related to insulin prescribing practice in the hospital setting. The presentation of findings in this way is included 
in Table 5.3 along with example quotes.  
 
Table 5.3: Summary of subthemes aligned according to the Systems Engineering Initiative for Patient Safety model. Example quotes 
contain participant numbers but not demographic information for brevity. 








 Education, skills 
and knowledge  
There is a lack of education, 
experience, confidence, 
knowledge, and skills with 
respect to insulin use in 
hospital. 
“Although education is a weak barrier, I think, 
fundamentally it’s a lack of knowledge. They don't 
really know the difference between the different 
insulins and how they work and what the impact is.” 
– P13 
Experienced practitioners may 
also require increased 
knowledge and skills with 
respect to insulin. 
“One of the other I think, it must have been twelve 
units, but it looked like one hundred and twenty. And 
a nurse had actually drawn up one hundred and 
twenty. And this is like an experienced nurse and 
didn't think that was a high dose to be giving.” - P4 
There is a lack of appreciation 
from prescribers about the 
“They'd prescribed Insulatard but actually, they've 





importance of getting insulin 
prescribing right first time. 
but I think  the doctors, I spoke to the doctors about 
it and they weren't really that bothered about it, 
they didn't see the problem.” – P4 
There is a need for 
widespread, accessible insulin 
safety training that is based on 
sound pedagogical principals 
(such as active, experiential 
learning and reflective 
practice) and can translate to 
positive insulin prescribing 
outcomes. 
“I think my biggest thing would be, just people's 
knowledge of insulin to be better” – P5 
 
“So I mean I guess it got people looking in the BNF. 
You know, try and working out in their own heads 
what the differences between the insulin were.” - P3 
Facilitating prescriber 
feedback and reflective 
practice is beneficial and 
motivational. 
“And it's even, for junior doctors to be able to be 
told, and pharmacist prescribers, “You've done a 
good job.” And you can learn as much from that as 
you can from “let's start dissecting this error that you 
had”. So I think that's where we need to be looking 
at how we can get people to start thinking about, 
“would I have done something differently” or “where 
could I have got more information” or “who could 
have helped me with that?”  - P16 
Psychological 
characteristics 
Improvement efforts require 
physical and psychological 
momentum. 
“But it’s having the momentum to keep - you have to 
keep that up all the time, or are the new students, 
the new doctors coming through, the new 
pharmacists coming through, are they going to have 
a better idea now of branding of insulin and, and the 
importance of - I don't know?” P10 
Insulin invites prescriber 
clinical inertia, fear and 
therapeutic misadventure. 
“I tend to find that it's never in the middle - people 
either treat insulin as if it's poison and sometimes 
you have errors of omission because people are so 
worried about it. Or you have the other types of 
errors where people maybe don't treat it with the 
respect that it needs, or the care that it needs and 













Insulin safety teams 
comprising a broad 
membership is important for 
sustainability of interventions. 
“But having that ownership and representation from 
those teams hopefully can be more effective and 
bring about more permanent change.” – P14 
Communication and 
collaboration between 
diabetes teams and usual care 
teams at ward level impacts 
on insulin safety. 
“Maybe the diabetes teams that are there realize 
now that in a way they're a victim of their own 
success, in that because they used to treat or work 
with the people with diabetes, everybody else left 
them alone. And then when you don't have them, 
things go really pear-shaped.” – P8 
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Clear communication between 
primary and secondary care is 
critical for insulin safety in 
hospital. 
“Communication of doses gets lost sometimes or 
misunderstood.” – P2 
Sharing learning between 
organisations can facilitate 
local improvement. 
“So they published that. And I’m thinking oh, that's 
really interesting. That's useful. And they use JAC, the 
same as us for electronic prescribing. And I took that 
to the diabetes team and was like “oh look what they 
do”.” – P13 
Insulin safety is an 
interprofessional issue and a 
sound understanding of each 
other’s roles is necessary to 
devise and implement 
interventions and policies to 
make this safer. 
“And we kind of just assumed, you know, took it for 
granted that they do these kind of capacity 
assessments all the time. And they basically, they 
turned round and said “No, we never do them. The 
OTs do them occasionally, physios sometimes, the 






Hierarchical structure in 
medicine prohibits the 
development of the 
relationships needed to build 
a positive safety culture. 
“… you start to open up a bit more about, you know, 
it's difficult to, you know, find a registrar at three 
o'clock in the morning, and we feel worried that we 
have to ring them or...” – P16 
Reporting prescribing safety 
incidents is time-consuming, 
perceived as unnecessary, and 
rarely occurs unless it impacts 
on administration. 
“But because the DATIXing is so underdone and 
that’s because it’s a, such a long process to DATIX 
something but also you know people just don’t have 
time to sit there and DATIX and sometimes the role 
becomes a bit blurred because as a pharmacist you 
think well actually it is my role to pick up on these 
errors and to resolve them.” - P1 
Work schedules  Organisation size and working 
patterns of staff can impact 
effective communication 
about insulin safety messages. 
“I think the problem is it is in a large organization. 
Lots of docs involved. Getting that messages out to 
all of them.”– P9 
High turnover of staff in 
organisations is prohibitive to 
insulin safety efforts. 
“But in terms of overall reflection, the problem is 
we're set in a workforce that's constantly revolving.” 
– P8 
Enabling a stronger, more 
consistent clinical pharmacy 
presence on the ward would 
aid insulin safety efforts. 
“I think that I personally feel that twenty-four-hour 




pharmacy teams and nursing 
and medical staff are key to 
facilitating their role in insulin 
safety efforts. 
“And when I do get across, because I don't know the 







Senior staff attitudes impact 
on junior doctor confidence 
with insulin. 
“So it’s very much a negative attitude from the top I 
would say as well from seniors. It's a very much like 
‘oh I haven’t done that for years, I don’t know 
























minimises handwritten insulin 
prescribing errors but has a 
limited impact on other 
prescribing errors such as 
wrong product and/or device 
(e.g. mis-selection). 
“I mean, it’s had some impact on some of the errors 
that we would get, particularly around units and 
getting the full details of the prescription specified. 
But what we're getting now is an increased I would 
say error rate from mis-selection from drop down 
menus.” - P3 
Electronic prescribing that 
enables direct transfer of drug 
history records from 
pharmacist medicines 
reconciliation is beneficial. 
“And another good thing about the prescribing 
system is if a pharmacist comes along and does the 
drug history, so puts it on, doctors can, what they 
can do is they can reconcile it, so they just click on 
the electronic prescription what the pharmacist has 
put on and it just transfers it automatically... So, we 
do see less discrepancies from meds rec with 
electronic prescribing compared to the paper one.” - 
P14 
Electronic prescribing systems 
that direct prescriber choice 
based on local insulin 
availability, alerts prescribers 
when they choose 'high 
strength' insulins and prompts 
them to prescribe 
hypoglycaemia order 
sets/protocols is beneficial. 
“So, we also make a distinguish in our electronic 
system of what is formulary with what is not. So, by 
entering basically a symbol on the system then you 
are you able to identify all those insulins that we 
don't keep but we could prescribe. So, there is a 
better, probably is more clear at what is available.” - 
P6 
The restrictive benefits of 
electronic prescribing are 
limited due to the flexibility 
needed to prescribe 
individualised insulin 
regimens. 
“And obviously, we've got electronic prescribing, and 
we've got the ability to put some limits in there. But 
the regimes are so variable, it's very difficult to put 
hard limits on them.” - P3 
Auto labelling and dispensing 
linked to electronic 
prescription reduces human 
error. 
"But once that order’s been picked it flags up things 
like device and all that kind of thing. And then when 
you do the label it auto-labels so you can’t pick the 
wrong label, or the wrong drug from the label, it all 
ties back to the electronic prescription.” - P7 
Insulin charts are particularly 
useful when incorporating 
blood glucose monitoring 
results and prescriber 
support/guidelines, but their 
usefulness may be dependent 
“And that, I think, again, worked in many respects. 
Because, similar to sort of EPMA, it was laid out 
better for you. So I sort of split it into sort of, you 
know, morning, lunch time, teatime, night-time. And 
the units were pre-printed. And there was a lot of 
information as well on that drug chart, although it 
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on the design of other 
prescribing systems in use 
(paper or electronic). 
was only an A4, you know, folded in half, there was a 
lot of information on there to support them.” – P13  
 
“So it’s already an all-encompassing book really. I 
think adding another separate page or a separate 
chart would probably start to overcomplicate 
things.” - P11 
Multiplicity of prescribing 
systems, where insulin is only 
partially prescribed 
electronically (e.g. 
simultaneous use of paper 
chart and electronic system), 
or where an organisation uses 
multiple electronic systems, is 
a risk. 
“So I think that's still our main challenge at the 
moment is the fact that there are two charts, and 
therefore they didn't necessarily tie up. And then so 
you have you have a beautiful prescription on 
electronic because obviously it's electronic. But then 
you still get the handwriting problems on your green 
chart.” - P10 
 
A unified, accessible 
integrated electronic health 
record and prescribing system 
that works across primary and 
secondary care would 
minimise inefficiencies and 
reduce error-prone processes 
currently in place (e.g. at the 
point of care transfer). 
“It probably does need a combined effort, primary, 
secondary care. I mean, ideally, what would be the 
solution, ideally, is you have one patient record that 
has all the information on for each patient in the 
NHS. So it has DN records, it has GP records, has 
hospital – all on one record as opposed to the 
multitude that we have.” - P7 
Medical devices  Data extracted from electronic 
blood glucose monitoring 
records enable easier 
prioritisation and review of 
patients. 
“We also put our glucose monitoring chart 
electronically on our e-noting so our electronic 
noting system so it’s easy to access as a visible 
graph, to see your patient on the ward and see how 
they've been. And it's colour coded.” - P14 
Duplication of blood glucose 
monitoring records (e.g. on a 
paper chart and electronically) 
can introduce risk. 
“So at the moment, we have a separate diabetes 
chart to the main chart…And so there’s that 
potential risk that a blood sugar can be recorded in 
two places.” - P5 
Other 
technologies 
and tools  
Prescriber support cards for 
insulin may be helpful as a 
quick and accessible reference 
but use is unknown. 
“I give them some pocket cards, you know, with the 
common insulins and things like that. Whether they 
use them, look at them, I don't know.” - P13 
Diabetes dashboards may 
enable quick review and 
prioritisation of at-risk 
patients and provide data for 
measuring patient outcomes 
“So, like having a diabetes dashboard electronically 
so each ward can see how many patients on their 
ward are hypo or hyper or within their target range, 
because that’s on the electronic system that were 
currently implementing at the moment.” - P14 
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and tools (e.g. 
usability) 
Highlighting key messages on 
guidelines may aid more 
appropriate prescribing. 
"One of the safety issues we’ve done is pretty much 
on all the guidelines is putting advice, putting in bold 
and you know, quite clear, capital letters “basal must 
not be omitted”.” - P6 
Guidelines need to be 
conspicuous, convenient, 
accessible, clear and succinct. 
“Obviously it is all in our guidelines but then 
guidelines are long and people don’t have time to 
read them, and you know that’s one of the things 
that we come across a lot.” – P1 
Colour-coding of insulin charts 
enables more efficient 
identification and more 
prompt review. 
“So they said that our charts are white. So they're 
not very, like obvious. So they’d quite like them to be 
a brighter colour. Like, the warfarin charts are 
yellow. So, it's like, “look at me” I need to be doing 
something about it. So having a white chart it isn't 
helpful, is what they said.” - P18 
Prescribing systems that 
minimise prescriber input are 
effective at improving the 
quality of insulin prescribing. 
“The reason it was good was because we did most it 
for them. The doctor literally just had to write the 
brand name and the number in the right timed box 
like it’s all they had to do! Takes away all the 
thinking! But as a result of taking away all the 
thinking, so basically, I just assumed they were all 
idiots which is a shame to start with, but what that 
resulted in was great insulin prescribing.”- P2 
Blood glucose monitoring 
records should be accessible 
and proximal to insulin 
prescribing records to enable 
more contemporaneous and 
appropriate prescribing. 
“They like because our charts have the blood glucose 
next to the prescription, and so they can see what 
the blood glucose is doing and then prescribe, 
whereas they don't want a separate blood glucose 
chart to then go and look for that and then prescribe 
and they just said that if it goes on to electronic 
prescribing you don't have that nice view to be able 
to do it straight away.” - P18 
Treatment algorithms (e.g. for 
hyperkalaemia or 
hyperglycaemia) may aid 
prescribing but their use 
without the requisite 
knowledge about insulin may 
confer risk due to lack of a 
'sense-check'. 
“And we actually had one patient who got 
administered one thousand units, because a doctor 
wrote up ten mils of Actrapid, instead of units. And 
they transcribed and you can actually see from the 
initial one, how it could have been mistook from the 
units. And then obviously you’ve got the calcium 
gluconate which is ten mils, so within the treatment 
algorithm your head knows there’s a ten mil there. 
And then there was a, you know, we did the risk 
assessment, and there was a disconnect.” - P5 
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The process and time required 
to undertake incident 
reporting is prohibitive to its 
use, and the system is not 
easy to interrogate, which 
limits it's ability to monitor 
trends in insulin errors. 
“Our incident reporting system is really difficult to 
interrogate. It comes down to individual drugs. And I 
can't pull a report very easily at all even just by 
looking at insulins. So I sort of sometimes have to 
manually trawl it." - P13 
 
“And the staff have got a finite ability to report 
DATIXs because they take so long to do...” - P15 
Ta
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Non-medical prescribers have 
the opportunity to improve 
insulin prescribing safety by 
altering and initiating insulin 
prescriptions rather than 
making recommendations for 
the usual care team to action. 
“I think it’s getting better ‘cause like the diabetes 
nurses push quite well for sort of education, and also 
now they’re both prescribers so when they see 
patients, they can actually make changes 





outreach teams making 
recommendations to usual 
care teams can improve care 
outcomes and empower them 




“So we go and we say “actually Mr Smith is having 
loads of hypos and we’ve had a look and actually we 
think you need to reduce his insulin so we’ve done 
that but we need you to monitor it and if it does this 
then we need you to do this” and that’s all 
documented and we’re feeding that back to the 
consultants and the members of the medical team 
that are with them at that time.” – P1 
Junior doctors are expected to 
independently prescribe 
insulin. 
“Yeah, what do we do with the doctors? Not a lot 
really. I mean, yeah, you see them at induction, I tell 
them a bit about prescribing and the system, we do a 
sort of a teaching session for them. And then then 
they're on their own. And they can ask for, for help, 







Daily prescribing of insulin 
places a higher burden on 
prescribers and nursing staff 
(e.g. when prescriptions aren't 
written on time or the 
prescriber is not available), 
but rolling prescriptions may 
shift the onus onto nursing 
staff to review blood glucose 
results and alert prescribers. 
“But my worry with moving to a rolling prescription 
is that you need buy-in from the nurses because they 
are the ones are going to have to alert the 
prescribers to highs or lows. And does that 
collaboratively work at the minute? No, it doesn't. 
And so actually, you're moving the responsibility 
from prescribers to our nurses. And is that 
appropriate? I'm not entirely sure.” – P18 
 
“You just get a bigger prescribing onus on junior 
staff. And the more times you prescribe things, the 
bigger the risk of even simple transcription errors, 
and omissions and all the rest of it. So that's one 




Increased input from clinical 
pharmacy teams verifying 
prescriptions would require 
significant resource but has 
the potential to significantly 
reduce insulin errors 
“But something along the lines of as soon as it's 
prescribed, it has to be clinically verified by a 
pharmacist before administration. And I know the 
resources that would well, he says, I can have a 
guess at that the amount of resource that would 
take, but I think you put that in then you’re starting 
to get to a point where you would see a fundamental 
decrease in the problems that we experience with 
insulin.” – P12 
Out-of-hours working confers 
particular risk with respect to 
insulin safety 
“We have occasionally missed it at meds rec when 













National safety campaigns can 
help facilitate insulin safety 
efforts, but messages must be 
reflective of ‘real-world’ 
situations. 
“Once it starts to hit the arena, of sort of NPSA alerts 
and things being sort of sent to the Chief Executive 
Office and asking them to be actioned. They tend to 
have then a greater force and a greater drive behind 
them, you know” – P8  
 
“That’s somebody sitting in an ivory tower really who 
has no clue what goes on in the ground.” – P11 
National recommendations 
can facilitate pharmacist 
involvement in insulin safety 
at a directorate and 
organisational level 
“And with GIRFT, the getting it right first time, 
they’re all pushing. You know, [person C] has 
released his “inpatient diabetes teams should have a 
pharmacist” and all stuff like that. All of the words 
now are saying “you need a pharmacist to do this” so 
if you are in that position where you can do it, just 
get on with it.” - P2 
Lack of funding for diabetes 
pharmacists inhibits 
organisations' ability to tackle 
insulin safety 
“And but obviously, at the moment, I'm still only 
doing two days a week until we get some sort of 
funding approved.” - P1 
Hospital performance 
incentivises driving insulin 
safety efforts 
“As part of what we were doing this year as one of 
our quality on the back of obviously CQC one of the 
























Information transfer between 
community and hospital 
settings is suboptimal and 
poses a risk to insulin safety 
“I do quite a lot of teaching with the junior doctors 
and that’s something that they identified as, you 
know, they didn't know how to find what doses 





A culture of resistance to 
change impacts on continuous 
quality improvement efforts 
“The problem with all quality improvement projects, 
from what I can work out in my years of doing it, is 
everyone wants to cling to what they did before or 
the trust has a bit more history.” - P2 
Dedicating time and effort to 
focus on insulin prescribing 
efforts is challenging 
“And, you know, is, is quite high on the on the 
agenda at the hospital, and the medicines safety 
team as well. But it's just obviously dedicating the 
time and focusing really on how best to improve 






















s Job satisfaction 
and other 
attitudes 
Pharmacist involvement in 
diabetes teams is a rewarding 
and fulfilling role with the 
opportunity to positively 
impact on insulin safety 
“So, you know, I think it's, it's quite an exciting 
avenue to go into, because I think in terms of being 
able to elicit change is probably one of the big areas 
to be able to do that in. And yeah so for me, and my 
personal progression, and, you know, professional 
growth, I think, that’s quite good.” – P1 
Prescribing outcomes with 
insulin are felt more acutely 
by junior doctors compared to 
more senior doctors 
“You know, so those are the challenges that they 
have because they haven't done it as many times as 
a, you know, as a consultant whose been a 
consultant for twenty years. So those things just sort 
of brush off them and they go “yeah, I didn't get it 
right that time. Yeah. You know what, in the grand 
scheme of things the patient is well and they haven't 
come to any harm.” Whereas the foundation doctor 
the first time they have the caused a hypo, and they 
see that as a big disaster. Which it is in their life.” - 
P16 
Job stress and 
burnout  
Prescribing outcomes are 
rarely observed by prescribers 
with respect to insulin due to 
time constraints and work 
patterns 
“And I think that's the hard thing for junior doctors, 
they don't get time to go back and check the 













s Patient safety  Insulin prescribing 
improvement efforts are often 
a reactive response to clinical 
incidents affecting patient 
safety in an organisation 
“To be honest, it feels a bit like a knee-jerk reaction 
to an incident.” - P5 
Quality of care Self-administration of insulin 
can improve the shared-
decision making and prevent 
harm from erroneous insulin 
prescribing 
“And we absolutely would agree and support the 
idea that patients need to have a bigger input into 
the decision making. And if they can give it, they 
should be giving it.” - P8 
 
“And actually, when the prescription, when we've 
had incidents where the prescription has been 
wrong, fortunately, on most of those occasions, the 
prescription was wrong, but the patient carried on 
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with their correct insulin. There was no harm to the 
patient for that very reason.”  - P3 
 
The above table highlights important human factors systems components of insulin prescribing practice 
interventions, deduced from the thematic analysis of qualitative semi-structured interviews.  
The next section presents an additional ‘subgroup’ analysis of the qualitative data regarding 3 specific 
interventions: the insulin passport, mandatory insulin training, and insulin self-administration policies. This 
analysis aimed to provide a comparison between hospitals where interventions were in use and those where it 
was not, to give further explanatory power to findings from the cross-sectional survey presented in Chapter 4. 
 
5.5 Perceived effectiveness of interventions 
 
Differences in organisational contexts and implementation strategies, as well as other factors, may explain the 
heterogenicity in the perceived effectiveness of interventions. To explain these results further for interventions 
identified following results of the survey and stakeholder group discussions, an additional analysis was undertaken 
whereby qualitative data pertaining to the use of selected interventions were further categorised according to 
the participant’s current use and/or implementation stage of the intervention, as described by the participant. 
This was to compare between data from hospitals that used the intervention and those that did not, as prioritised 
by the multidisciplinary inpatient group (see Chapter 4, section 4.6). It also facilitated explanations regarding 
whether perceived effectiveness preceded use, or vice versa.  
Data did not undergo re-coding for this analysis, as complete and inductive coding had occurred as part of the 
overall thematic analysis. This additional analysis therefore re-examined the codes presented in Appendix 12, 
along with the associated data in NVivo, considering participants’ self-reported use of the intervention. The results 
presented here complement the 7 major themes identified above and are consistent with the narrative presented 
in section 5.3. 
Interventions selected for further explanation of perceived effectiveness were the insulin passport, mandatory 
training, and insulin self-administration policies. Detailed descriptions of these interventions are included for 
reference in Appendix 13. These interventions were selected due to the differences in their perceived 
effectiveness found in the survey, as well as the specific role of pharmacists in designing, modifying and/or 
implementing these interventions. They were also all discussed in the interviews but were not used unanimously 




5.5.1 Insulin passports 
 
Qualitative data pertaining to experiences and perceptions with the insulin passport were categorised 
and re-examined according to participants’ use of the intervention.  All accounts related to current or 
previous use of the intervention; no participant expressed views about adopting the intervention in the 





There were no significant patterns found that distinguished generative mechanisms for perceived 
intervention effectiveness between participants who used the passports and those who did not. The 
limitations with the use of the passport were the main topic of discussion in both groups, although those 
who did not use them seemed to feel more strongly about their limited effectiveness than those who did. 
All participants who did not use the passports expressed their persuasions against their use, citing a lack 
of intervention coherence, ownership, fidelity, and uptake as reasons for not adopting them locally. 
Participants who did use the insulin passport expressed the limitations and redundancy in their use and 
Figure 5.1: Statements relating to participant's experiences and perceptions of the insulin passport, derived from data categorised 
according to current intervention use. Statements from participants representing organisations currently using the insulin passport are 
presented in green, those representing organisations where it is not used are presented in red. Statements in yellow were identified 
across both categories. 
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described the lack of benefit of the insulin passports over summary care records, mainly due to the lack 
of sufficient information needed for prescribing on the passports. 
 
5.5.2 Mandatory training 
 
Data regarding the use of mandatory training was categorised according to participants’ descriptions of 
its current use at their organisation. Where insulin training was optional, this was regarded as not using 
mandatory training. Example quotes to support the formation of the statements presented in Figure 5.2 
are found in Appendix 14. 
 
 
The categorised data shows that participants who represented trusts that did not include insulin safety 
on their mandatory training felt that this was not a positive outcome, often describing frustrating 
limitations on accessing staff training programmes. Others that delivered optional training expressed the 
benefits of doing so face-to-face, especially when it incorporated regular feedback with prescribers, but 
Figure 5.2: Statements relating to participant's experiences and perceptions of mandatory insulin safety training. Statements are derived from 
data categorised according to current intervention use. Statements from participants representing organisations where insulin safety training 
is mandatory are presented in green, those representing organisations where it is not are presented in red. Statements in yellow were 
identified across both categories. 
181 
 
reach and sustainability was problematic. Those who had mandated training described the requirement 
for it not to be optional to help solve these issues. Of note was the discussion of e-learning as an accessible 
medium for delivering mandatory training, with the ability to monitor completion, which was expressed 
and an important factor across both groups. 
The categorisation also highlighted several sentiments that were consistent across both groups, 
highlighting and reinforcing the overall finding that both the benefits and challenges with delivering 
mandatory insulin training are appreciated across participants, particularly with respect to face-to-face 
training. Most participants also recognised that although training was important to address deficiencies 
in understanding and knowledge, it was described as only a partial solution, and efforts to improve insulin 
safety needed to be accompanied by other system-wide interventions. 
 
5.5.3 Insulin self-administration policies 
 
Qualitative data pertaining to experiences and perceptions with the use and implementation of self-
administration policies were categorised and re-examined according to participants who had no policy in 
place, those who had a policy in place but did not actively use it, and where policies were in place and 




















Impressions from the categorised data suggest that previous negative experience with self-administration 
policy use is the main limiting factor for hospitals re-introducing self-administration policies. This is also 
accompanied by a perception that low numbers would benefit, and nursing burden would increase, 
therefore resulting in a low motivation to pursue the intervention. 
Statements derived from data from participants who have a policy that is not being used include issues 
around implementation, including lack of leadership, low desire from nurses and logistical issues around 
storage and documentation. Most participants in this group, however, described a desire to reinvigorate 
or drive policy use because they related its use to greater quality of care and experience for patients.  
Participants from organisations who had a self-administration policy in use described the need to 
overcome logistical issues, describing ‘workarounds’ and practical solutions to satisfy needs of both 
patients and regulators, and had a positive view of the intervention due to perceived benefits for both 
patients (e.g. empowerment), staff (time and injuries) and the organisation (reduction in errors). Data 
also included the benefits of professional networks for shared learning, perception of the intervention as 
simple and safe, and high regard for the knowledge and abilities of patients to self-care. A few sentiments 
Figure 5.3: Statements relating to participant's experiences and perceptions of insulin self-administration policies. Statements derived from participants 
using the intervention are in green. Statements identified from participants with no policy in place are in red. Those from participants who had a policy 
that was not being actively used are in yellow. 
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were common across all groups, including the need for communication and documentation to be 
complete and accurate and the need to carefully consider and work through logistical issues. 
It is clear from the data that self-administration policy design and implementation was a topic of interest 
to participants, and that the intervention was perhaps the most complex to implement. As such, this 
intervention is explored in greater depth with complexity-sensitive realist methods in the next chapter. 
Self-administration policies are more socially contingent than many other interventions mentioned and 
the data suggest that a greater range of contexts are present that may be explored and theorised further 
for the benefit of improving patient care.  
 
5.6 Discussion of key findings 
 
This is the first qualitative study to focus on subcutaneous insulin prescribing system functionality and safety 
interventions in NHS hospitals. The results describe the opinions and experiences of hospital pharmacists involved 
in insulin prescribing practice intervention design, use and evaluation across UK hospital trusts. Important 
contextual information is given to aid understanding of the survey results presented in Chapter 4, specifically 
around why interventions are perceived to be effective or not, and the circumstances and factors impacting this. 
The successful application of a human factors systems model demonstrated the importance of considering 
intervention use for insulin prescribing practice in relation to the wider systems and ergonomics.  
All participants were able to describe the important roles pharmacists have in the design, implementation or 
evaluation of insulin prescribing error reduction interventions in their respective organisations. For some 
participants, this involved working across multiple organisations, including membership of regional insulin safety 
panels. The consistent presence of pharmacists on the ward was also key to facilitating insulin prescribing safety 
improvement efforts. This helps to explain the survey findings of significant associations between the number of 
interventions used and the employment of specialist diabetes pharmacists at the organisation. This evidence also 
supports the national drive to incorporate pharmacists in the multidisciplinary inpatient diabetes team to help to 
reduce inpatient insulin errors (Joint British Diabetes Societies for inpatient care, 2019; Rayman & Kar, 2020; E. 
Watts & Rayman, 2018). 
Findings regarding the perceived lack of staff knowledge support results from other studies indicating insulin-
related knowledge is lacking amongst healthcare professionals in the hospital setting (Bain, Kavanagh, McCarthy, 
& Babar, 2019; Derr et al., 2007; Lee et al., 2013). The role of complex socio-cultural factors impacting on the 
prescribing process found in this study have also been reported in other studies regarding antibiotic prescribing 
practice in secondary care (Papoutsi et al., 2018). Findings regarding the need for further education and training 
of clinical staff explain the high regard for educational insulin prescribing safety interventions found in the national 
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survey in Chapter 4. This is despite educational interventions more generally being described in the literature as 
having limited effectiveness for improving patient safety (Cafazzo & St-Cyr, 2012; Woods et al., 2008).  
With respect to the design and delivery of educational interventions, results support the systematic review 
findings in Chapter 2 that educational interventions are most effective when they are mandatory rather than 
voluntary.  Findings also indicate that the use of active and experiential pedagogies and incorporating individual 
and peer- reflections on current prescribing practice is more beneficial than tokenistic, brief, tick-box training 
packages received by staff on induction. These results concur with the positive results found with the use of these 
types of pedagogies, and link to well-known pedagogical theories (such as Kolb’s experiential learning theory) that 
explain the benefits of these approaches (Derr et al., 2007; Kolb, 1984; Lee et al., 2013; M. Lloyd, Watmough, 
O’Brien, Furlong, & Hardy, 2018; Stocker et al., 2014). In Northern Ireland, for example, where the national 
‘Making Insulin Treatment Safer’ programme (The Health Foundation, 2019) has been implemented to facilitate 
prescriber situational awareness and reflection around insulin prescribing, participants provided more positive 
descriptions of prescriber skills and knowledge, compared to their English counterparts. Increased exposure of 
undergraduates and trainees to insulin prescribing systems and safety issues (for example in simulated learning) 
is also likely to facilitate improvement efforts by increasing prescriber familiarity with processes (Pichardo-
Lowden, Haidet, & Umpierrez, 2017).  
Findings regarding the insulin passport explain why it is scarcely used and perceived as ineffective by the national 
survey respondents. Participants described incompatibilities with both human and system-level contexts related 
to insulin use and prescribing, which are consistent with previous qualitative studies investigating the use of 
patient handheld tools for information transfer (Waly et al., 2018). These results suggest that the concerns around 
the insulin passport outlined in Chapter 1 are sustained and are raised across multiple organisations. The findings 
of this study go further than previous studies on the use of the insulin passport, however, by suggesting that the 
greater utilisation of existing technology systems (e.g. the summary care record), supported by an appreciable 
national patient safety agenda would enable consideration of wider systems issues impacting on the success of 
the intervention and would likely be more successful in enhancing information transfer at the care interface than 
the passport. 
Around 17% of hospitals using electronic prescribing that did do so for subcutaneous insulin was further explained 
by a lack of system flexibility for the needs of prescribing insulin and the issues with proximity/integration with 
other systems necessary for insulin prescribing (e.g. recorded blood glucose results). Participants in Wales and 
Northern Ireland also explained the national standardised approach to electronic prescribing system introduction 
in their respective countries, which was planned to be implemented after the survey and interviews had been 
conducted (Downey, 2020; Hoeksma, 2020). Findings regarding the limited benefits of electronic prescribing for 
insulin and the introduction of new error types helped to explain the survey results demonstrating that electronic 
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prescribing systems were more highly regarded by trusts yet to implement it, and that it was only modestly 
effective overall.  
The socio-technical issues associated with electronic prescribing systems (e.g. lack of flexibility resulting in 
workarounds, clinical workflow and communication changes) and their impact on medication errors have been 
widely studied in the literature (Z. Ahmed et al., 2016; Brown et al., 2017; Mohsin-Shaikh et al., 2019). This study 
argues that insulin presents unique challenges with respect to electronic prescribing systems with respect for the 
need for flexibility and limited benefits of ‘hard stops’ incorporated into prescribing systems. In order to realise 
the full potential of electronic prescribing systems to reduce insulin errors, consideration of a human factors 
approach to prescribing system design is therefore encouraged. This involves consideration of the proximity of 
blood glucose results to the insulin prescription, as well as targeted, appropriate, accessible prescriber decision 
support tools that are integrated into the prescribing workflow (Bell, Garfield, Khosla, Patel, & Franklin, 2019; 
Nirantharakumar, Chen, Marshall, Webber, & Coleman, 2012). This is particularly important in light of the number 
of hospitals with electronic prescribing systems that currently use paper prescriptions for insulin (as found in the 
national survey) and the lack of prescriber confidence and knowledge with insulin and diabetes management in 
the hospital setting (George et al., 2011). 
This study also explained the survey findings regarding insulin self-administration policies: specifically that insulin 
self-administration policies were perceived to be more effective by organisations that did not have these policies 
in place compared to those that did.  Results elucidated the complexities of designing and implementing these 
policies within organisations in practice, with several hospitals not utilising the policies that they had developed 
as a result. Contextual factors that impacted intervention successes, such as workforce support/collaboration and 
ability to integrate the use of simple policy documentation into existing workflow, were highlighted, along with 
socio-cultural issues, such as ward culture, practice norms, and fear of repercussions if things went wrong.  Some 
of these issues have been described anecdotally in a previous single-centre reports on self-administration (Rowse, 
2018a) but most reports are limited to small-scale audits reporting measurable quantitative outcomes such as 
patient self-administration status and documentation completion (Alabraba, Floyd, Morgan, Kelly, & 
Wallymahmed, 2014; Gangopadhyay et al., 2008; Hodgson & Voigt, 2013; S. Kavanagh & Boparai, 2015). It was 
clear from the study findings that the success of this intervention was socially contingent; Due to the widespread 
problems reported by participants regarding its implementation – despite good intentions – it was decided that 
this would benefit from further investigation using complexity-sensitive realist research methods. 
 
5.7 Stakeholder group discussions 
 
The results of the thematic analysis were presented to the LADDER panel via a group meeting on Microsoft Teams. 
This was the first meeting to be conducted virtually and was a result of new restrictions imposed by the COVID-
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19 pandemic. A lay summary of results was circulated prior to the meeting to allow panel members the 
opportunity to process the results and devise questions in advance of the meeting. During the same meeting, a 
lay proposal of the final study was also presented for comment from the panel. Similar questions were posed to 
the panel in this meeting to the previous meeting and are included in Box 5.1.  
Box 5.1: Questions and discussion points from the patient panel meeting following presentation of the study results. 
 
How do you think the results might impact people with diabetes?  
Are there any results you find particularly interesting or feel should be emphasised? 
Are there any ways you might interpret the results that haven’t been mentioned? 
Are there any other comments you have about the research? 
 
After presenting the results of the thematic analysis virtually, discussions with the panel gravitated towards the 
topic of self-administration interventions and how the results of the qualitative study could be explored in further 
depth. It was clear from discussions with the panel that self-administration interventions remained an important 
and evocative topic, with much of the meeting being given over to answering questions on the results regarding 
this intervention. Circulated feedback from the secretary is included verbatim in Box 5.2.  
Box 5.2: Written feedback from the panel regarding the qualitative results and further exploration with realist synthesis 
The results were interesting as they showed either of two extremes with no middle ground 
Group suggested those capable should be allowed to sign a waiver or disclaimer to self-administer; those 
incapable a set of steps should be put in place to ensure correct administration 
It should be communicated to ward staff should that nothing can go too significantly wrong over a few days 
whilst in hospital 
Some members suggested a strict policy throughout all hospitals 
The policy should be clearly communicated to patients 
Consideration should be given to BAME communities 
Suggested patients should be asked whether they usually receive help with insulin administration 
Suggested that an outcome for the project should be that patients are made aware that each hospital should 
have a policy in place 
The option to self-administer should be discussed throughout the hospital stay, not just on admission 
Suggested a dedicated project manager for each hospital to ensure the policy is put in place 
 
The results of this study were unfortunately not able to be discussed with the multidisciplinary inpatient diabetes 





Insulin prescribing is a complex and difficult task for prescribers in the hospital setting, and is commonly associated 
with medication errors and patient harm. With the use of qualitative interviews, the challenges and solutions with 
facilitating the safe prescribing of insulin were articulated and explored to reveal important mechanisms 
underpinning intervention success or failure. 
 A rich set of qualitative data was obtained and analysed to explain salient results from the survey regarding the 
use of interventions to improve insulin prescribing safety. Findings suggest that current opinion and practice is 
influenced by several contextual factors. These include organisational factors such as staff turnover, 
organisational size, availability and capacity of diabetes and pharmacy teams, as well as socio-cultural factors such 
as hierarchy, fear, and perceived burden of interventions.  
A greater understanding was provided regarding why the insulin passport has a low uptake and perceived 
effectiveness, and why educational interventions are thought to be needed and effective. Interventions that are 
more complex in their design and implementation, such as electronic prescribing and self-administration policies 
were also explored, and contextual factors that impress on their perceived success were articulated. 
The use of the SEIPS model enabled the description of salient human factors systems elements of insulin 
prescribing practice and intervention use in the hospital setting, which increased transferability of the results. The 
categorisation of data based on current intervention use also provided further contextualised results for the 
benefit of readers from various hospital organisations. 
The next chapter builds on these results and focuses on self-administration policies as one of the more widely 
discussed and socially contingent complex interventions. This is also supportive of the priorities of the patient 
stakeholder group. As we have found in this chapter, some interventions work for some people, some of the time, 
to some extent. The next goal of enquiry should therefore be to discover “what works, for whom, under what 




Chapter 6: Realist Synthesis of insulin self-administration policies 
 
 
This chapter presents the in-depth analysis of insulin self-administration policy interventions using realist 
synthesis. This synthesis is presented in its entirety, including the following: 
• Explanation of the initial stages of the synthesis process. 
• Development of preliminary programme theories. 
• Theory refinement with stakeholder consultations and three iterative literature searches. 
• Presentation of the resultant programme theories in the form of context-mechanism-outcome 
configurations, using two established middle range theories as a conceptual framework. 




Insulin errors in the hospital setting are prevalent, costly, and harmful to people with diabetes. Some progress 
has been made to address this in recent years, with the introduction of a range of interventions to improve insulin 
prescribing practice. However, we have found that interventions are used inconsistently and heterogeneously 
across different hospitals, and the success of implementing interventions relies on a complex combination of 
various organisational, personal, technical, and socio-cultural factors, making intervention success difficult to 
measure. We found insulin self-administration policy interventions to be regarded as one of the most complex, 
important and timely interventions used in hospitals to reduce insulin errors, both by interview participants and 
also by our patient stakeholder group.  
Self-administration of medicines (SAM) is considered to be an important aspect of patient self-management, 
which healthcare professionals are encouraged to promote to patients as part of the goal to promote self-care 
(Vanwesemael, Boussery, & Dilles, 2020). During hospitalisation, medication administration is usually the 
responsibility of nurses, which disrupts the continuity of the patient’s usual self-management (Vanwesemael et 
al., 2020). Self-administration of medicines (SAM) is defined as the practice of inpatients administering their own 
medications in hospital, and denotes a significant change to normal practice and shift in responsibility from nurses 
to patients (Richardson et al., 2014). As such, interventions such as policies or guidelines are needed in order to 
facilitate this in the hospital setting (Vanwesemael et al., 2020). 
Self-administration of insulin policies have important distinctions from SAM policies more generally, and are often 
separated in practice. This is due to additional factors that need to be considered with insulin, including the 
disproportionate amount of medication errors associated with the use of insulin in the hospital setting, its 
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association with clinical inertia and the lack of staff knowledge, the relative clinical risks associated with 
maladministration of insulin, and the fear that many people with diabetes feel when insulin is taken away from 
them on admission to hospital. 
The results of the mixed methods study suggest that insulin self-administration policies are often developed by 
hospital teams, but their use is highly variable due to problems with implementation. As the successful 
implementation of insulin self-administration policies is important for people with diabetes across all hospitals, 
as well as hospital teams and the wider NHS, the factors associated with success were chosen as the subject of 
further study (Joint British Diabetes Societies for Inpatient Care Group, 2012; National Institute for Health and 
Care Excellence, 2016; National Patient Safety Agency, 2011; NHS England, 2018; E. Watts & Rayman, 2018). 
The use of theory may help to explain the factors associated with successful implementation. Middle range 
theories (such as Normalisation Process Theory) give conceptual currency to analyse studies involving the use of 
interventions such as self-administration policies. Whilst previous reports have identified barriers and facilitators 
to self-administration policies in the hospital setting (A. Murray, 2011; Richardson et al., 2014; Rowse, 2018a, 
2018b; Vanwesemael et al., 2020), these have not been explicitly underpinned by theory in such a way to facilitate 
translatability across diverse hospital settings. In keeping with one of the objectives of the thesis, this study links 
contextual factors with underlying generative mechanisms to form hypotheses about how these policies work, 
for whom and in what circumstances. 
This ‘reality test’ of the intentions of the intervention can help to form recommendations for hospitals and 
policymakers regarding the implementation and design of insulin self-administration policies.  It can also uncover 
mechanisms to develop more complexity-sensitive measures to use in future effectiveness or implementation 
studies. Unlike in systematic reviews, the goal is not to determine if insulin self-administration policy interventions 
work and to what extent, but to uncover how they work. To achieve this objective, the following research 
questions were asked: 
• What are the ‘mechanisms’ by which self-administration policies are believed to result in their intended 
outcomes? 
• What are the important ‘contexts’ that determine whether or not the identified mechanisms produce 
either positive or negative outcomes? 
• In what circumstances are self-administration policies likely to be effective? 
 
To answer these questions, a realist synthesis was conducted, which enables the production of a series of theories 
about how insulin self-administration policies work, presented as configured context-mechanism-outcome (CMO) 
hypotheses. These theories, known as programme theories, were developed iteratively throughout the synthesis 
by a combination of retroductive theorising, literature searching and stakeholder group consultation. Programme 
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theories were then analysed using two substantive middle-range theories (Normalisation Process Theory (NPT) 
and Kanter’s theory of structural empowerment) as a conceptual framework to aid understanding of the results.  
The protocol for the realist synthesis was published in the PROSPERO register (CRD42020193351) (Bain, Jeffries, 
et al., 2020) prior to reporting. The RAMESES (Realist And MEta-narrative Evidence Syntheses: Evolving Standards) 
training materials were used to guide the synthesis conduct, and the RAMESES publication standards was used to 
guide reporting (G. Wong, Greenhalgh, et al., 2013; G. Wong, Westhorp, et al., 2013) (see Appendix 15). An 
overview of the conduct of the realist synthesis is given in Figure 6.1.  




Although the process of conducting the realist synthesis was iterative and non-linear, it is presented in this 
Chapter in order of the key stages outlined above (see also Chapter 3, Figure 3.4). First, the initial stages of 
clarifying the scope and developing initial theories is presented. This is followed by details of the 3 iterative 
literature searchers, quality appraisal and data extraction processes. Finally, the results of the synthesis are 
presented; the resultant 10 programme theories are outlined in the context-mechanism-outcome configurations 
(CMOCs) and are analysed according to middle range theories. 
 
6.2. Defining and focusing the scope 
 
The initial stages of the synthesis involved informally scoping the literature to identify formal policy documents 
or descriptions of insulin self-administration policies, implementation guides and research or evaluation reports 
regarding the intervention. This was done using electronic databases (Google and PubMed) and a combination of 
the terms ‘self-administration’ ‘insulin’ and ‘hospital’. Only documents relating to insulin self-administration 
policies in UK hospitals were included at this stage, with no date restrictions. These documents were read and 
examined in such a way to attempt to become accustomed to retroductive theorising – the process of uncovering 
the hidden mechanisms of action in the deeper ‘layers’ of reality. This process is shown in Table 6.1 
 
Table 6.1: Documents identified in the initial scoping literature, along with reflective questions asked when reviewing the documents. 
Reflective questions are taken from the RAMESES training materials for realist synthesis (G. Wong, Westhorp, et al., 2013) 
Documents identified in scoping process Questions asked when reading and 
reflecting on the documents  
• Wessex Academic Health Science Network, (2017). Self 
Administration of Insulin in Hospital. 
• Rowse, V. L. (2018a). Implementing self-administration of insulin 
in hospital: a journey of discovery and innovation. Part 1: Culture 
and storage. British Journal of Diabetes, 18(1), 18–21. 
https://doi.org/10.15277/bjd.2018.160 
• Rowse, V. L. (2018b). Implementing self-administration of insulin 
in hospital: a journey of discovery and innovation. Part 2: 
Implementing change. British Journal of Diabetes, 18(2), 66–68. 
https://doi.org/10.15277/bjd.2018.159 
• Alabraba, V., Floyd, E., Morgan, C., Kelly, C., & Wallymahmed, M. 
(2014). “My diabetes, my insulin”: Self-administration of insulin 
in hospital. Journal of Diabetes Nursing, 18(7), 296–299. 
• Gangopadhyay, K. K., Ebinesan, A. D., Mtemererwa, B., Marshall, 
C., McGettigan, A. T., Cope, A., & Narendran, P. (2008). The 
timing of insulin administration to hospital inpatients is unsafe: 
Patient self-administration may make it safer. Practical Diabetes 
International, 25(3), 96–98. https://doi.org/10.1002/pdi.1217 
• Joint British Diabetes Societies for Inpatient Care Group. (2012). 
Self-management of diabetes in hospital. (March) 
• How or why is this outcome 
expected to be achieved? 
• Who is expected to do what 
differently, in order for this outcome 
to be achieved? 
• What different choices or decisions 
would they need to make, in order to 
do that? 
• What will the program do or provide 
to assist them to do that?  
• What is the logic of the intervention?  
• How or why does each link in the 
chain work? 
• What assumptions are built into the 
programme theory? 
• What assumptions am I (the 
reviewer) making? 
• What assumptions are there in the 
data, and which of these do we need 




As a result of this scoping process, a flow diagram was constructed to outline the general architecture of insulin 
self-administration policies (Figure 6.2). Although the scoping process (and results from Chapter 5) revealed that 
details regarding finer sociotechnical elements of the intervention differ between settings, it was concluded that 
all insulin self-administration policies share the same logic. That is, they all aim to empower patients to take 
control of their own insulin injections to improve patient satisfaction and health outcomes, and reduce occurrence 
and adverse consequences of insulin prescribing and administration errors in hospital.  
 
Figure 6.2: Flow diagram outlining the general architecture of inpatient insulin self-administration policies, constructed from reflective 
consideration of the scoping literature and results from Chapter 5. 
 
Following the creation of this logic model, stakeholder groups were recruited and consulted to co-produce a set 
of initial, rough programme theories that could be taken forward for development as part of the synthesis process. 
 
6.2.1 Stakeholder involvement 
 
A diverse stakeholder group was recruited to provide content expertise for the development and 
refinement of insulin self-administration programme theories. This was to drive the focussing process to 
Ongoing assessment and review of the patient’s suitability to self-administer
Complete documentation of the patient’s self-administration status and doses administered
A shift in responsibility for administering insulin from the nurse to the patient
Provision of sharps bins to the patient to dispose of used needles
Agreeing safe and accessible storage of the patient’s insulin whilst on the ward
The completion of a risk assessment and agreement of responsibilities between the patient and healthcare professional
Provision of written information for the patient
A conversation between the healthcare professional regarding the opportunity and suitability for insulin self-administration 
Healthcare professionals aware of policy and patients on their ward who use insulin
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achieve maximal end-user relevance (G. Wong, Westhorp, et al., 2013). Juxtaposing primary data from 
stakeholders alongside the literature enables a more powerful interpretative lens through which to 
explore real-word problems and solutions, and offer authentic data for realist research (Carey et al., 2015; 
in Emmel et al., 2019). This is consistent with the recommendations put forth by Lavis et al. to create a 
‘dialogue that allows the data and research evidence … to inform and be considered alongside the views, 
experiences, and tacit knowledge of those who will be involved in, or affected by, future decisions about 
the health system problem’  (2012). 
Stakeholders were recruited via professional networks and via the charity Diabetes UK. Unlike selection 
for inclusion in qualitative research, there is no formal sampling strategy for involvement in a stakeholder 
group for realist research. This is because the aim is not to achieve proportional representation, but rather 
to have an appropriate variation in the complement of individuals to help achieve the research aims. 
Individuals were considered for inclusion based on their current or previous employment or position as a 
healthcare professional or person with diabetes who had experience in designing, implementing or using 
insulin self-administration policies in the UK hospital setting. People with any type of diabetes were 
considered if they used insulin and had been admitted to hospital for any reason in the past 5 years. The 
stakeholder panel included a variety of healthcare professionals, including diabetes specialists and non-
specialists, from several hospital organisations in the UK, including some of the authors on articles relating 
to insulin self-administration policies in UK hospitals. The group also included people with type 1 and type 
2 diabetes, to represent those who would be most impacted by the implementation of insulin self-
administration policies (see Table 6.2). Selection was checked with a member of the supervisory team in 
order to be critical about the inclusion of individuals involved. 
 
Table 6.2: Stakeholder group for realist synthesis (n=21) 
Role Recruited from (organisation) 
Nurses 
Diabetes inpatient specialist nurse Large teaching hospital in Yorkshire and the 
Humber 
Diabetes inpatient specialist nurse Large teaching hospital in the South of England 
Diabetes nurse consultant CCGs and hospital in London 
Deputy sister – elective orthopaedics Large teaching hospital in the East Midlands 
Medical Doctors 




Consultant diabetes pharmacist and clinical lead for 
diabetes 
Large teaching hospital in the South of England 
Specialist pharmacist Large hospital in the South West of England 
Pharmacist Large teaching hospital in the North West of 
England 
Specialist Diabetes Pharmacist Large teaching hospital in the North of England 
Policymakers and programme managers 
Senior Programme Manager  Academic Health Science Network in the South of 
England 
Policy manager, Getting It Right First Time NHS England, NHS Improvement 
People with diabetes 
Lay member with type 1 diabetes, patient 
representative for ‘making insulin treatment safer’ and 
Antrim hospital self-administration projects, co-lead the 
Diabetes UK Research Network in Northern Ireland 
Diabetes UK 
 
Lay member with type 1 diabetes 
Nurse with type 1 diabetes 
Junior doctor with type 1 diabetes 
Lay member with type 2 diabetes, type 2 clinical 
champion in the London Clinical Network 
Lay member with type 1 diabetes 
4 Lay members with diabetes Sheffield Teaching Hospitals NHS Foundation Trust 
LADDER Panel 
 
Consultations with the stakeholder group took place periodically over the course of the study, via email 
and several group and individual videoconferences. A total of 3 virtual group meetings and 5 individual 
virtual meetings were held, each lasting around 60 minutes. The combination of stakeholders at group 
videoconference meetings varied on each occasion, and two stakeholders were consulted via email 
instead. This non-uniform approach was not originally anticipated, but the researcher soon realised that 
it allowed for increased input of stakeholders throughout the project.  
The first stakeholder group meeting comprised a programme manager, a nurse and 3 people with 
diabetes. Additional individual meetings were had with a diabetes nurse consultant and a lay member 
with diabetes, and a specialist pharmacist. Stakeholders were initially asked about the following areas in 
the first meeting to help generate the initial rough programme theories: 




• Their perceptions about the role of social dynamics and informal influences regarding the 
uptake/use of self-admin policies. 
• The gap between expectations and what happens in practice 
• What do they think the answer is? 
 
Notes were taken from these discussions and used to build the rough programme theories using 
retroductive theorising. Subsequent meetings enabled further refinement of programme theories and 
(see section 6.3). The involvement of stakeholder opinion ensured that the synthesis remained grounded 
in the practical reality experienced by a range of participants, and enhanced the usability of actionable 
findings. 
 
6.2.2 Development of initial programme theories 
 
The process of designing interventions makes use of theories about why certain components to the 
intervention are required in order to achieve the desired outcomes, whether this is done knowingly or 
not (Pawson & Tilley, 1997). For example, the basic theory underlying the introduction of mandatory 
training would be that a lack of knowledge leads to poor prescribing practice and the solution is to educate 
prescribers. The goal of realist synthesis is to identify these theories to explain how self-administration 
policy interventions work and under what circumstances. This process starts with the development of 
rough programme theories.  
Initial rough programme theories attempt to explain and ‘make sense’ of activities involved in self-
administration policies (as described in Figure 6.2) and the responses of individuals to those activities. 
Initial rough programme theories were devised from a mixture of experiential, professional and content 
knowledge, qualitative data from the mixed methods study (see Chapter 5), stakeholder group 
discussions, and insights from reflection on the scoping literature outlined in Table 6.1. This process was 
messy, iterative and complex, whereby the ‘inner workings’ of the intervention were sought to be 
exposed and unpicked. 
First, intervention outcomes relating to insulin safety and patient satisfaction (e.g. insulin errors, 
hypoglycaemic events, number of people wishing to self-administer being able to) were identified and 
selected from the scoping literature. Then, ‘working backwards’ from these outcomes using a process of 
retroductive theorising, insights from stakeholders were incorporated with experiential, professional and 
content knowledge from the research group, as well as relevant qualitative data from Chapter 5 to form 
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a rough theories about how elements of the intervention work to achieve these outcomes (G. Wong, 
Westhorp, et al., 2013).  An illustrative example of this process is given in Figure 6.3. 
Figure 6.3: Initial rough programme theory development. First, key outcomes were identified, then a complex process was used 




In a process of linearizing the complex, three-dimensional and fluid thinking about how these 
interventions work exemplified above, the initial rough programme theories were organised into initial 
sets of contexts, mechanisms, and outcomes. This aimed to capture a broad set of ideas about self-
administration policies (see Table 6.3 for an example).  
 
Table 6.3: Excerpt from initial rough programme theory organised into contexts, mechanisms and outcomes, prior to further refinement 
and development with stakeholders. 
Context Mechanism Outcome 
Inpatients retaining 
possession of their 
insulin as 'the norm' 
Empowerment, greater control and 
confidence felt by patient 
Inpatients are able to accurately administer 
their own correct insulin product(s) on time 
Levelling power relationships Insulin dosing optimised according to insulin 
type and meals 
Greater patient independence 
maintained 
Reduced insulin errors 
Reduced reluctance to change 
nurse-administration norms 
Fewer episodes of hypo/hyperglycaemia 
Reduced risk of harm to the patient 
Greater patient satisfaction 
Greater efficiencies in team processes 
around medicines administration, greater 
productivity 
Correct insulin product and dose 
administered at an appropriate time 
Insulin administration not impacted by staff 
human error 




between patients and 
healthcare team 
Staff acknowledgement of ‘lived 
person’ 
Increased patient awareness of opportunity 
for self-administration  
Motivation to support self-
administration due to greater trust 
and confidence in patient’s expertise 
Patient feels respected and involved 
Recognition and understanding of 
each other’s skills and knowledge 
around insulin 
Patient is empowered to question decisions 
Opportunity for conversation 
prompted by integration of self-
administration into clerking process 
Patient is more in control 
A culture of respect 
and understanding the 
importance of insulin 
being near to the 
patient at all times 
Information and explanations given 
to patients regarding what is 
achievable with respect to insulin 
storage and use whilst in hospital 
Patient is empowered and their opinions are 
respected 
Increased understanding that 
patient partnership and trust is 





6.3 Revised programme theories 
 
Although the scope of the review was clarified and focused, the initial rough programme theories were extensive 
and required refinement and prioritisation for review. The theories were therefore discussed with the stakeholder 
group (via email and videoconferencing) so that theories with particular relevance for influencing practice and 
importance for people with diabetes could be selected for further development.  
Stakeholders were shown the initial programme theories (which they helped to develop previously) and were 
asked to give their perspectives regarding the following: 
• Do the programme theories match their experience and not, and how? 
• Do the programme theories match their ideas about self-administration? 
• Are the identified mechanisms were important and/or relevant? 
• Is the terminology used in the programme theories appropriate? 
Meetings with the stakeholders were engaging and overall, stakeholders agreed that the theories represented 
their experiences and insights with policy use and the important contexts in which they worked. Some important 
areas of development were also elicited through these meetings, including the focus on shared decision-making 
and partnership, as well as the impact of power differentials and consistency of communication. 
The stakeholder group also identified mechanisms with particular salience and value. These included the 
opportunity for open and honest communication, the acknowledgement of the ‘lived person’ with diabetes, 
reducing the perceived burden of the intervention and increasing clarity of governance requirements. These 
revised theories, exemplified in Table 6.4, contained the key mechanisms identified by the stakeholder group, 
which may work to both hinder or facilitate insulin self-administration policy implementation. 
At this point in theory development, mechanisms were separated into resources that the intervention provides 
(e.g. information, opportunities, change in practice) and responses from agents involved in the intervention 
use/implementation (feelings or actions). This disaggregation of mechanisms into its constituent parts helps to 
understand the difference between the resources offered by the intervention and the ways in which this changes 
the reasoning of participants, and helps to distinguish mechanisms from contexts, which is cited as a common 







Table 6.4: Excerpt of revised programme theories following stakeholder discussion, prior to literature searching. 
Context Mechanism (resource) Mechanism (response) Outcome 
Staff unaware of 
patient’s needs or 




Culture of patients 
receiving care as 
‘passengers’ 
Provides opportunity 
for open and honest 
communication 
between patient and 
staff 
Gaining perspective on 
each other’s needs, 
wishes and abilities 




‘lived person’ and 
reassurance 
Highlights potential issues 
  
Improved patient satisfaction 
and service delivery 
 
Maintained patient autonomy, 
independence, and health 
engagement 
 
Increased understanding that 
staff-patient partnership is 
needed to achieve better 
patient care 
Patients are unaware 
of hospital self-
administration policy  
 
Cultural norm of being 







and processes  
 
 
Patient empowered to 
speak up and be 
involved in their own 
care and attenuation 
of fears over lack of 
control and potential 
harm as a result of not 
being able to self-
administer 
Increased numbers of people 
(staff and patients) aware of 
policy 
 
Increased numbers of people 
who wish to/are able to self-
administer doing so 
 
Patient expectations managed  
 
Doctors regarded as 
the ‘expert’ 
 




societal views around 




patient and staff and 





between patient and 
staff  
 








Reduced propensity for 
conflict 
 
The revised theories were then further refined during a process of evidence identification, synthesis, and 
configuration from studies in the literature. This is described further below. 
 
6.4 Evidence searching 
 
In order to develop the programme theories using realist logic of analysis (i.e. the context-mechanism-outcome 
(CMO) heuristic), data from documents need to be gathered, scrutinised and used. This is an interactive and 
interactive process which differs from that of a systematic review. For example, complementary and snowball 
searching, or cluster searching, were used in this synthesis.  
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The first formal literature review was undertaken in September 2020 to locate a relevant body of literature with 
which to refine the programme theories. A broad criterion of studies matching the keywords ‘insulin’ ‘self-
administration’ and ‘hospital’ was used. Terms were tailored and indexed to individual databases (e.g. MEDLINE 
and EMBASE) as well as using free-text searching (see Table 6.5). Searching was undertaken in September and 
October 2020 using the following databases: The Cochrane Library, PubMed, MEDLINE, EMBASE, CINAHL, Google 
Scholar, NICE Evidence, and Google (to identify policy documents, hospital information websites, newspaper 
articles, blogs). Conference abstracts were excluded because they did not contain sufficient extractable detail 
about contexts or mechanisms. Non-English language publications were excluded because there was insufficient 
time and resource to translate them. 
 
Table 6.5: Initial search strategy for the realist synthesis. 
Database Search terms 
Hits 
PubMed Insulin AND hospital AND self-administration 
617 
PubMed Insulin AND hospital AND self-administration AND policy 
16 
MEDLINE exp INSULIN/ AND (hospital).ti,ab AND exp "SELF ADMINISTRATION"/ 
9 
EMBASE exp HOSPITAL/ AND *INSULIN/ AND exp "DRUG SELF ADMINISTRATOIN 
3 
EMCARE exp HOSPITAL/ AND *INSULIN/ AND exp "DRUG SELF ADMINISTRATOIN 
0 
CINAHL 








Scholar Insulin AND self-administration AND hospital 
4420 
NHS 
Evidence “Self-administration of medicines in hospital” 
4161 
Google “Insulin self-administration hospital policy” 
~8,290,000 
 
Citations of relevant articles were also manually searched, as well as relevant grey literature. Inclusion criteria 
remained broad to enable the examination of evidence from studies of all designs that reported on the design, 
implementation, or evaluation of insulin self-administration policies in the inpatient setting, either on patients, 
staff or organisations. All outcome measures focussing on patient satisfaction and safety were included. Studies 
were excluded if they did not concern self-administration policy intervention, or concerned self-administration 
policies in settings other than the acute hospital setting (e.g. care homes, community). Studies were not excluded 
on the basis of date of publication. 
Two additional searches were performed in October 2020 to further illuminate the theorised mechanisms of the 
rough programme theories. This involved searching more specifically for wider literature on the concepts 
identified, due to the dearth of literature to explain this relating to insulin self-administration in the hospital 
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setting. These included “patient empowerment” and “shared decision-making”, thereby reflecting the priority 
areas identified from stakeholder consultations. Inclusion criteria for these searches were widened to include 
studies reporting on self-administration of medicines more generally (i.e. not just insulin-specific) in an inpatient 
setting, to understand and explain the wider socio-cultural context in which insulin self-administration policies 
are implemented.  
It was decided that it was not necessary to search as wide a selection of databases for the purpose of these 
iterations (a general Google search was not performed). Search terms for these were tailored to the database 
searched (see Table 6.6). Only studies from economically developed nations were included due to the particular 
cultural and medico-legal distinctions that exist between this setting and others (e.g. quality of care, liability, roles 
and responsibilities of different professionals).  
 
Table 6.6: Additional iterative search strategies used in the realist synthesis. 
Database Search terms Hits 
Search 2 (patient empowerment) 
PubMed Empowerment AND hospital AND self-administration AND diabetes 17 
PubMed Empowerment AND hospital AND self-administration 152 
MEDLINE (Patient Empowerment). ti, ab AND INPATIENTS/ AND "SELF CARE" 3 
MEDLINE (Patient Empowerment). ti, ab AND INPATIENTS/  21 
MEDLINE (Patient Empowerment). ti, ab AND (hospital). ti, ab AND DIABETES MELLITUS/ 7 
EMBASE EMPOWERMENT/ AND "DRUG SELF ADMINISTRATION"/AND "HOSPITAL PATIENT"/ 0 
EMBASE EMPOWERMENT/ AND "HOSPITAL PATIENT"/ 223 
EMCARE EMPOWERMENT/ AND "DRUG SELF ADMINISTRATION"/AND "HOSPITAL PATIENT"/ 2 
CINAHL EMPOWERMNENT/ AND SELF ADMINISTRATION/ 9 
PsycINFO 
EMPOWERMENT/ AND HOSPITALIZATION/ OR "HOSPITAL ADMISSION"/ AND 
"DRUG SELF ADMINISTRATION"/ 0 
Google 
Scholar Patient empowerment AND self-administration AND hospital 4250 
NHS 
Evidence Empowerment AND self-administration 86 
Search 3 (shared decision-making 
PubMed (shared decision making). ti, ab AND (inpatient). ti, ab AND (diabetes). ti, ab 3 
PubMed (shared decision making). ti, ab AND (inpatient). 208 
MEDLINE "DECISION MAKING, SHARED"/AND INPATIENTS/ 1 
MEDLINE "DECISION MAKING, SHARED"/AND exp" HOSPITAL MEDICINE"/ 0 
MEDLINE "DECISION MAKING, SHARED"/AND "DIABETES MELLITUS"/ 1 
EMBASE "SHARED DECISION MAKING"/ AND exp "HOSPITAL PATIENT"/ 106 
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EMCARE "SHARED DECISION MAKING"/ AND exp "HOSPITAL PATIENT"/ 53 
CINAHL 
("DECISION MAKING, SHARED"/ AND (INPATIENTS/ OR "DIABETIC PATIENTS"/)) AND 
exp "HOSPITAL UNITS"/" 8 
CINAHL "DECISION MAKING, SHARED"/ AND (INPATIENTS/ OR "DIABETIC PATIENTS"/)" 39 
PsycINFO 
(shared decision-making).ti, ab AND HOSPITALIZATION/ OR "HOSPITAL 
ADMISSION"/ AND "DRUG SELF ADMINISTRATION"/ 0 
Google 
Scholar Shared decision-making AND inpatient AND diabetes 69200 
NHS 
Evidence Shared decision making AND diabetes AND hospital 3432 
 
After the initial screening of titles and abstracts, a total of 69 articles were excluded based on irrelevance to the 
review question, not satisfying inclusion criteria, or being irretrievable/conference abstracts. Details of excluded 
articles, along with reasons for exclusion, are listed in Appendix 16. Articles included after the initial full-text 
screen underwent additional in-depth screening to determine their applicability and appropriateness (to 
contribute to theory development) using Pawson’s criteria of relevance and rigor (Pawson, 2006; G. Wong, 
Westhorp, et al., 2013). Details of this process are included in the section below. 
 
6.5 Quality appraisal 
 
As with traditional systematic reviews, realist syntheses require quality appraisal and filtering of evidence based 
on that quality. A quality review process was conducted prior to decision to include evidence in the final synthesis. 
Unlike systematic reviews, however, which are selective based on methodological quality (e.g. based on 
traditional hierarchies of evidence), realist syntheses require a broad range of evidence relating to the 
intervention to illuminate the richer picture. Selecting based on methodological quality would therefore 
impoverish the synthesis and is inappropriate because the study is not the main unit of analysis in realist review. 
Methodological checklists (e.g. the Newcastle Ottowa Scale, QI-MCQS and the Joanna Briggs Institute checklist) 
are therefore also inappropriate because synthesis calls on impact evaluations, documentary analysis, opinion 
pieces, audit results, theses, policy documentation, and all their permutations.  
Both qualitative and quantitative evidence were therefore considered for the development of programme 
theories, in line with realist methodology. Quality of evidence included in studies or documents was judged 
according to its relevance (did it address the theory under test?) and rigor (does the inference have sufficient 
weight to make a methodologically credible contribution to the theory refinement?) relative to the programme 
theory (Pawson et al., 2005; G. Wong, Greenhalgh, et al., 2013). The assessment of relevance was answered as a 
yes/no response with justification, and the assessment of rigour was a brief description of limitations of the 
method used in the article to generate data (either qualitative or quantitative). This meant that elements of 
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evidence could be considered from studies even if the study’s overall quality would not be considered ‘strong’ 
according to traditional quality criteria (e.g. risk of bias assessments).  
The relevance of studies was discussed with members of the supervisory team if necessary, and rigour was 
assessed by judging the plausibility and coherence of the method used to generate data (G. Wong, Westhorp, et 
al., 2013). The relative contribution of each source was weighed using this criteria, and a total of 24 articles were 
excluded across the 3 searches as a result. Evidence from studies that were regarded as not relevant to theory 
development were not included and therefore did not get assessed for rigour. Inclusion of articles often followed 
any uncertainties, as to avoid missing valuable contributions to theory.  Appendix 17 documents the quality 
appraisal for the synthesis, and includes details of excluded articles, along with reasons for exclusion at this stage. 
 
6.6 Data extraction 
 
The revised programme theories were added as individual nodes in NVivo (QSR International Pty Ltd, 2018), using 
shortened subsection names (e.g. “CMOC 1 – empowers patients and highlights problems”). The qualitative data 
from the mixed methods study was imported to NVivo along with the literature passing quality appraisal. The 
included documents were then read in full, and evidence within these interviews and studies were coded to these 
theories as described by Dalkin et. al. (S. Dalkin, Forster, Hodgson, Lhussier, & Carr, 2020). Data were prioritised 
for coding if they were able to elucidate or refute causal claims, or could support/refute programme theories. 
Evidence included results from qualitative and quantitative primary studies, insights from discussion sections, 
information from the introduction sections, and the primary data from the qualitative interviews conducted with 
pharmacists in the mixed methods study.  
Evidence from studies that supported or helped to develop more than one programme theory were coded to 
multiple theories in NVivo. This occurred regularly in the initial stages of coding on account of the interactivity 
between mechanisms contained in the different theories. For example, empowerment and control were often 
discussed together in the literature, and were therefore difficult to untangle for the purposes of developing 
programme theories. Several versions of the programme theories and corresponding supporting or refuting 
evidence was retained on separate dated word documents to demonstrate theory development over time. This 
‘audit trail’ helped to aid transparency in the process. 
 
6.7 Middle-range theories 
 
In order to help to explain how insulin self-administration policies work at a more general, overarching level, 
substantive middle-range theories were sought to be identified from the included literature resulting from the 
iterative literature searches (Jagosh, 2019). Middle range theories, which lie in between the smaller hypotheses 
204 
 
that are required for “day to day research” and the larger “all-inclusive” unifying theories of social behaviour, 
serve to provide a level of abstraction that is specific enough to explain a particular case but general enough to 
apply across a range of cases (Merton, 1968; G. Wong, Westhorp, et al., 2013). 
No complete substantive middle-range theories were identified in the literature, therefore the researcher 
attempted to identify relevant theories from the wider implementation science and healthcare disciplines. 
Although many theories were considered, Normalisation Process theory and Kanter’s Theory of Structural 
Empowerment were selected as middle-range theories that, together, had the most relevance for explaining 
programme theories. Whilst neither of these theories individually explain how insulin self-administration policies 
work through the refined programme theories, they do support specific contexts or mechanisms that predict 
intervention outcomes. The two theories were therefore used together as tools to help frame and explain the 
analysis.  The CMOCs were mapped onto the constructs of the theories to help analyse and explain the results 
and highlight any gaps that may have been missed through the coding process alone. These two theories are 
outlined below: 
 
6.7.1 Normalisation Process Theory  
 
Normalisation Process Theory (NPT) is useful in identifying factors that promote or inhibit the routine 
incorporation of complex interventions (such as self-administration policies) into clinical practice (C. May 
& Finch, 2009; C. R. May et al., 2009). Normalisation Process theory proposes that complex interventions 
become routinely embedded and normalised in their contexts as the result of people working to 
implement them; that this work is operationalised through four dynamic generative mechanisms 
(coherence, cognitive participation, collective action and reflexive monitoring) and that the work of 
integration requires continuous investment by people in ensembles of action that carry forward in time 
and space (E. Murray et al., 2010).  
 
Coherence involves the sense-making work (differentiation, communal and individual specification, and 
internalisation), cognitive participation involves relational work to sustain the community of practice 
around the intervention (initiation, enrolment, legitimation, and activation), collective action involves the 
actual operational work involved in the intervention (interactional workability, relational integration, skill 
set workability and contextual integration), and reflexive monitoring pertains to the appraisal work 
(systemisation, communal and individual appraisal, and reconfiguration). Further definitions and 
examples of these mechanisms and constructs may be found in the work of May, Finch and Murray (C. 





6.7.2 Kanter’s Theory of Structural Empowerment  
 
Kanter describes opportunity and power as two primary empowerment structures in organisations 
(Kanter, 1977). The structure of opportunity to learn and grow relates to job conditions that enable 
employees to advance their knowledge and skills, which enables individuals to take a more proactive 
approach to problem solving and change. The structure of power, where power is defined as the ability 
to “mobilise information, resources and support to get things done” requires access to information, 
support, and resources (Kanter, 1977). These two structures of empowerment are facilitated through 
formal and informal power systems: informal power derives from job activities that allow flexibility and 
discretion in decision-making (such as skill-development and participative management) and formal 
power derives from forming alliances or relationships with others (such as establishing partnerships with 
patients and networking with colleagues). 
The components of Kanter’s theory of structural empowerment are therefore access to information, 
access to support, access to resources, access to opportunity to learn and grow, informal power and 
formal power. Kanter argues that empowered people are more likely to share power with others, which 
in this setting, entails healthcare professionals sharing their power with their patients, resulting in more 
empowered patients, who experience a greater sense of self-determination, self-efficacy and control 




The overall search and screening process resulted in the identification of 49 references for inclusion in the realist 
synthesis (see Figure 6.4). Articles comprised literature reviews (n=5), systematic reviews (n=2), observational 
studies (n= 7), qualitative interview studies (n=12), quality improvement project reports (n=8), surveys (n= 5), 
patient information resources (n=2), implementation guides (n=2), opinion pieces (n=2), conceptual piece (n=1), 
audit (n=1) and best practice guidance (n=2). Studies reporting original data originated in the UK (n=19), USA 






The available data concerning insulin self-administration policies in the UK hospital setting was mostly limited to 
best practice guidance, audit or project reports. Although data presented in these reports was specific to the 
intervention being studied, methodological detail was often lacking. Project reports were often written by those 
responsible for designing/implementing the intervention and included valuable discussion that contributed to 
theory building, however, and were therefore included in the review. Some articles presented duplicate 
information, for example the project described in the insulin self-administration implementation guide (Wessex 
Academic Health Science Network, 2017)  was also presented in an additional article (Rowse, 2018b). Similarly, 
the project included in the article by Dashora et al was also presented as a report by Kavanagh (Umesh Dashora 
et al., 2018; Sallianne Kavanagh et al., 2016).  
Initial search 
Any study meeting broad criteria: insulin, 
self-administration, inpatient, and 
hospital 
n= 9237citations from 9 electronic 
databases: PubMed, MEDLINE, EMBASE,  
EMCARE, CINAHL, PsycINFO, Google 
Scholar, NICE Evidence, Google 
N= 36 citations 
after first screen 
(title/abstract) 








manual search =10 
n=4,770 citations from 8 electronic 
databases: PubMed, MEDLINE, EMBASE, 
EMCARE, CINAHL, PsycINFO, Google 
Scholar, NICE Evidence 
N= 17 citations 











Iterative search 1: Empowerment 
Any study meeting broad criteria: Self-
administration, inpatient, hospital, and 
empowerment  
n= 73,051 citations from 8 electronic 
databases: PubMed, MEDLINE, EMCARE, 
EMBASE, CINAHL, PsycINFO, Google 
Scholar, NICE Evidence 
N= 62 citations 
after first screen 
(title/abstract) 
N= 24 citations 
after full-text 
screen 






Iterative search 2: Shared decision-
making  
Any study meeting broad criteria: self-
administration, inpatient, hospital, and 
shared decision-making,  












manual search = 2 
207 
 
Johnston reported their hospital’s insulin self-administration project in two articles, (Johnston, 2019; Johnston & 
Newland-Jones, 2017), as does  Hendrieckx and Litterbach for their qualitative study (Hendrieckx, Holmes-
Truscott, & Speight, 2020; Litterbach, Holmes-Truscott, Pouwer, Speight, & Hendrieckx, 2020). Articles that 
reported duplicate data were included if they made unique contributions to the development of programme 
theories (i.e. if papers had different emphasis/discussion). This was not thought to be problematic because results 
were not quantified or pooled as in systematic review/meta-analysis, and the aim was to develop theory rather 
than measure effect size. 
Due to the paucity of original data regarding this specific intervention, identified articles that concerned diabetes 
medication self-administration (SAM) in an inpatient setting more generally were included, and judgements were 
made regarding the relevance and applicability to insulin self-administration on a case-by-case basis. In order to 
gather evidence to refine proposed mechanisms, searches were widened further to include more general 
discussions inpatient empowerment and shared decision-making with respect to medicines administration in a 
hospital setting. These searches resulted in the inclusion of articles with a higher methodological quality (e.g. 
qualitative interview studies, cross-sectional surveys), which helped to support theory development. 
 
Refined Programme Theories 
 
The process of theory development, refinement and focus theory resulted in ten overall programme theories (in 
the form of CMO configurations) that help explain how insulin self-administration policies work, for whom, and 
under what circumstances (Table 6.7). These theories expose the mechanisms by which self-administration 
policies are believed to result in their intended outcomes, as well as the contexts that determine whether the 
identified mechanisms produce either positive or negative outcomes. Each theory was examined in light of the 
literature, with data from included publications being used to develop the individual theories.  
The ten theories represent distinct elements of how insulin self-administration policy interventions work for 
different groups of people, namely individual healthcare professionals, teams within the organisation, and 
patients. For individual healthcare professionals, the programme theories identify mechanisms such as clarity of 
responsibility, and increased motivation to challenge norms.  For wider teams within the organisation (e.g. a 
multidisciplinary ward team), collaborative working practices, ward culture and integration with current workflow 
and systems were identified as important explanatory factors. Finally, for patients, important mechanisms were 
identified such as empowerment, control and shared decision-making. A couple of these mechanisms fired in 
more than one context to produce outcomes, and as such appeared in more than one theory, such as altered 
perception of burden on staff and greater appreciation of each other’s contribution to self-administration.  
Prior to writing up, the revised ten theories were presented to the stakeholder group for a final ‘sense check’. 
Stakeholders confirmed the theories encapsulated the key and salient topics with respect to intervention use from 
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their multiple perspectives. Individual videoconference meetings and email exchanges were conducted with three 
of the stakeholders (a nurse with type 1 diabetes, a specialist pharmacist and programme manager) and minor 
changes were made to the wording as a result (e.g. “consistent information given to patient” was changed to 
“consistent information given to patient throughout organisation” in theory 10). 
 
Table 6.7: Summary of programme theories resulting from the realist synthesis 
Subsection Context Mechanism 
(resource) 





Staff awareness of 
patient’s needs or 

























needs, abilities and 
expectations and be 
involved in their own 
care, leading to the care 
team having greater 
awareness and 
understanding of the 
patient’s situation, 
abilities and wishes  
Increased numbers 
of people (staff and 
patients) aware of 
policy, Increased 
numbers of people 
self-administering 
that are willing and 
able to do so. 
Patient expectations 













for patient's ‘lived 
experience’ of 
diabetes 










Patients feel listened to.  
 
More even power 
dynamics. 
 
There is an increased 
appreciation of each 
other’s contribution to 
their care which inspires 





may also be met with a 
feeling from staff as 







Increased  patient 







needed to achieve 











Cultural norm of being 





their own insulin 
administration  
Helps alleviate the 
patient’s fear of harm or 
mismanagement due to 




whilst in hospital, 
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priorities of staff, level 
of trust of healthcare 
professionals' ability 
to manage diabetes 
whilst in hospital 
 availability or 
competence of staff.  
Patients feel more 
empowered and in 
control of their 
diabetes. This can also 
lead to reluctance of 
the nurse to share 
control due to their 





of people who feel 
they can maintain 










Staff familiarity with 
insulin therapy or 
diabetes management 
and presence of 






instead of nurse 
Reduced burden on 
nursing and medical 
staff and patents feel 
reassured that they are 
receiving the right dose 
of the right insulin at 
the right time 










Reduced risk of harm 












norm of nurse 
administration of 
medication. 
Perception of change 










outcomes by staff  
Correcting 
misconceptions, belief 
in value and importance 
of self-administration 
for patient and staff, 


















Staff inertia and fear 
of repercussions or 
















Staff feel protected, 
supported, and 
reassured, leading to an 
increased confidence 
and motivation to 
engage with policy and 
a sense of reassurance 
for the patient 
Improved service 
delivery, 
involvement in policy 
development and 
decision-making and 




















Busyness of ward 
environment 
perception of burden 
resulting from 
intervention 






and systems   
Increased self-assessed 
ability and confidence 



























Altered perception of 
burden required for 
change and reduced 
fear or worry regarding 
patient safety, blame or 
reprimand  












requires the input and 
representation of a 




















of each other’s 
expertise and skills and 
reduced perception of 
extra burden and 
feeling of shared 
responsibility  
 
Power dynamics can 













often taken on as 
additional to day job 
by motivated 
individuals 
The presence of a 
dedicated project 









Reduced burden and 
burnout felt by 
motivated individuals 



















Theory 1: Empowers patients and highlights problems 
 
Publications that specifically described the design, implementation or evaluation of insulin self-administration 
policies in hospital commonly described the intervention as aiming to achieve greater “patient empowerment” 
(Umesh Dashora et al., 2018; Joint British Diabetes Societies for Inpatient Care Group, 2012; Pearce, 2019; Rowse, 
2018a). Patient empowerment is not a well-defined construct but most definitions relate to the process by which 
patients gain more control over their health by participating in their own care as self-determining agents with 
self-efficacy (McAllister, Dunn, Payne, Davies, & Todd, 2012; WHO, 2013).  
This theory hypothesises that insulin self-administration policies work to empower patients by increasing staff 
and patients’ awareness of the ability to self-administer insulin whilst in hospital. This involves the provision of 
timely, accessible, consistent and relevant information about insulin self-administration of insulin (to both 
patients and staff), as well as providing the opportunity for open and honest conversations between patients and 
healthcare professionals about a patient’s individual needs and preferences regarding insulin administration, early 
on in the patient’s hospital admission, and throughout their stay. It is important that patients feel listened to and 
respected during these conversations, and that they feel able to speak up and be involved in their own care: 
“We’d had negative feedback about their sense of disempowerment and feeling uninvolved in their own 
care... In extreme circumstances, some even felt a little bit insulted.” (Pearce, 2019) 
 
“A lot of people don’t know their rights as a patient, like, oh I have to do that, or oh, well I forgot to ask 
the doctor that . . . a lot of times I find myself explaining that you have the right to refuse too, you have 
the right to monitor everything that goes into or out of your body . . . To some people that’s like a 
revelation . . . a lot of people aren’t used to advocating for themselves” (Jerofke-Owen & Bull, 2018) 
Patient preferences need to be established on admission to hospital and where appropriate, mechanisms 
to include patients more effectively and consistently in their own medication management need to be 
identified and implemented. (Bucknall et al., 2019) 
Further, nurses described how they empowered patients by surrendering some of their own power to the 
patients, as they willingly shared information with patients, updating them on plans detailing options. 
(Oxelmark, Ulin, Chaboyer, Bucknall, & Ringdal, 2018) 
 
These conversations between patients and healthcare professionals also had the effect of highlighting pre-
existing problems with insulin self-administration. This also allows healthcare professionals to have an increased 




“So we get a lot more referrals into our diabetes team…and they’re coming and assessing and finding 
problems and fixing them, that actually need fixing…But that’s brilliant because obviously the nurses 
would have been doing it [administering the insulin] assuming the patient would do it when they go 
home, and we would never have found the problem until like the day they’re walking out of hospital or 
something else goes on.” (Interview data, Pharmacist 2) 
More significantly, beyond the primary aim of empowering patients, the SAM program had also enabled 
us to identify the “hidden threat”: a significant number of patients who have entered our program could 
not progress to independent SAM (i.e. SAM 3) during our inpatient assessments, even though they are 
expected to be responsible for self-administration post-discharge. Many of these patients would not 
have been picked up, had they not entered into our program and attempted self-administration, thus 
significantly predisposing them to the risk of medication errors post-discharge, with its myriad of 
potentially serious sequelae. (Meng, Chao, & San San, 2020) 
 
This theory proposes that the above mechanisms fire in the context of variable staff awareness of a patient’s 
needs or wishes, or where there is uncertainty regarding hospital policy or procedure regarding self-
administration, to result in an increase in awareness and number of willing and able patients self-administering 
their insulin: 
“Our project suggests that raising healthcare professionals’ awareness of self-administration can greatly 
increase the proportion of patients who wish to self-administer who are actually able to do so…Many 
healthcare professionals, particularly doctors, junior nurses and therapists, indicated that they knew very 
little of the policy and that increasing training and making the key components more accessible would be 
helpful.” (Garfield et al., 2018) 
 
Box 6.1 
Context Mechanism (resource) Mechanism (response) Outcome Evidence 
Staff awareness of 
patient’s needs or 
wishes with 











Patient and care team 
informed about self-
administration policies 









needs, abilities and 
expectations and be 
involved in their own 
care, leading to the 
care team having 
greater awareness and 
understanding of the 
patient’s situation, 
abilities and wishes  
Increased 
numbers of 
people (staff and 





are willing and 






(S. H. Ahmed, Chiran, & 
Chattington, 2013; 
Bucknall et al., 2019; 
Umesh Dashora et al., 
2018; Garfield et al., 
2018; Hendrieckx et al., 
2020; Jerofke-Owen & 
Bull, 2018; Joint British 
Diabetes Societies for 
Inpatient Care Group, 
2012; Manias, Beanland, 
Riley, & Baker, 2004; 
Meng et al., 2020; 





These identified mechanisms may also be explained by Kanter’s Theory of Structural Empowerment, both for 
patients and for staff. Kanter proposes that access to information, support and resources are empowering for 
employees, which in turn, results in individuals that motivate and empower others by sharing the sources of 
power (Kanter, 1977).  
Access to information about the ability to self-administer insulin and what that entails, in the form of timely 
provision of written and/or verbal information and communication, empowers both patients and staff to act on 
the information and engage with the policy. Access to support for patients may be achieved by maintaining open 
communication with staff regarding their abilities, feelings, needs and wishes regarding insulin self-administration 
throughout their hospital stay. Staff may also give patients access to support by encouraging their autonomy; this 
may come as a result of greater understanding of their individual circumstances. The conversation that occurs 
between the healthcare staff and the patient maps well to the construct of informal power, where relationships 
are built in order to facilitate empowerment; in this instance, the relationship between the patient and healthcare 
professional (e.g. nurse).  
 
Theory 2: Facilitates shared decision-making 
 
Shared decision-making between patients and healthcare professionals is a hallmark of patient-centred care, and 
involves the open communication and information-sharing activities described above (Charles, Gafni, & Whelan, 
1997; Waldron et al., 2020). Shared decision-making requires a balanced relationship between healthcare 
professionals and patients whereby information exchange and discussion results in a mutually agreed decision 
regarding elements of their care, and promotes greater patient involvement. In this respect, shared decision-
making as a mechanism is an extension of the empowerment mechanism outlined in the previous theory.  
The process of making decisions about insulin use in the acute inpatient setting is traditionally practitioner-led 
(Griscti, Aston, Warner, Martin-Misener, & McLeod, 2017; Munt & Hutton, 2012). This theory hypothesises that 
insulin self-administration policies work to improve patient satisfaction and staff-patient relationships by 
providing the means for greater shared decision-making, which inspires trust, respect and aids mutual 
understanding: 
The choice to continue to self-manage during admission, if well enough to do so, should be that of the 
patient… Whenever possible, the patient should be involved in decisions and, as with all other aspects of 
their care, should be allowed to make the final decision about self-management -(Joint British Diabetes 
Societies for Inpatient Care Group, 2012) 
 
Their subjective experiences of being respected, encouraged and enabled (or not) were important 





Having a better understanding of the person’s perspective facilitates shared decision-making, and will 
very likely impact the person’s motivation to engage with the agreed action plan. This affects the 
therapeutic relationship, to the satisfaction of both parties. (Hendrieckx et al., 2020) 
 
For this to work, the policy must provide opportunities for ongoing dialogue and connectedness between patients 
and the healthcare team, which, like in theory 1, involves the provision of information. Information exchange and 
dialogue between healthcare professionals and patients should be continuous, and seek to promote mutual 
understanding, respect and connectivity in the relationship: 
 
Other observational data related to power and control were that nurses sometimes limited patients’ 
choices. For example, nurses did not involve patients in decision-making, and when asked about this at 
interview, most of the evidence related to nurses considering that patients had enough 
information…Some patients also noticed that they were not involved in decision-making. (Crispin, Bugge, 
& Stoddart, 2017) 
 
It is crucial to recognise that some degree of responsiveness to and accommodation of patient 
perspectives is essential if involvement is to be more than ‘lip service’ and also to see that responsiveness 
to patients’ lifeworlds can  - just as with patient education – serve intrinsic and not merely instrumental 
purposes (Cribb & Donetto, 2013) 
 
It is vital for providers to identify patient preferences regarding engagement early on and educate the 
patients on the benefits of being active in healthcare decisions. Patients reported that their engagement 
in health care changed over time based on their situations, highlighting the need for repeated 
assessments of patient preferences for engagement throughout the continuum of care. (Jerofke-Owen & 
Dahlman, 2019) 
 
I think this (discussion about self-management of medication) opens more possibilities for improving the 
connection between the patient and the team, not patient and doctor but patient and care team. - 
Physician 2 (Vanwesemael, Boussery, Manias, et al., 2018) 
 
 
A ‘space of trust’ in which patients and the care team could exchange perspectives openly with one another is 
needed. This may sometimes present challenges to the ingrown notions of the roles of patients and professionals, 
which can sometimes serve to hinder the relationship between patients and healthcare professionals (Cribb & 
Donetto, 2013). This is particularly when the patient is considered to be an ‘expert’ in the management of their 
own condition: 
 
Both patients and professionals have incentives to fall back upon transitional scripts sometimes, with 
patients sometimes not wanting to assume responsibility and professionals sometimes being more 
familiar with ‘prescription’ (even when it is ineffective), than with the ‘messy’ and potentially 
compromising process of negotiation and support. (Cribb & Donetto, 2013) 
 
Nurses found those wanting to have discussion to be a hindrance to their relationship with the expert 
patient… and their professional confidence and years of experience were questioned and diminished by 
215 
 
the expert patient’s knowledge, further hindering their relationship with the expert patient (Wilson et al., 
2006 in Munt & Hutton, 2012). 
 
The contexts relating to these mechanisms relate to the ideological model and culture of healthcare delivery, 
which has an impact on the value that healthcare professionals place on the contribution of experiential 
knowledge that people with diabetes can bring to the decision-making process. This, in turn, impacts the extent 
of the collaborative approach taken with respect to decision-making (Schultz, Maaegaard, Hamid, & Qvist, 
2019): 
The findings under this study revealed that hospitals are still embedded in a patriarchal system, which 
privileges expert knowledge over patient’s wisdom about the management of their condition. (Griscti et 
al., 2017) 
 
Participants’ narratives confirmed the importance that patients attach to practitioners eliciting, listening 
empathetically to and taking seriously the patient’s own view of their symptoms, of how their diabetes 
affected their life (and not just how their life affected their diabetes) and of their current treatment 
regime… Third, and most frequently, involvement was associated with practitioners recommending 
rather than  ordering particular treatments, phrasing treatment proposals as suggestions, asking 
patients for their opinions and in some sense giving them an option. (Entwistle et al., 2008) 
 
Variation among services remained very influential after adjusting for team and patient characteristics, 
which suggests that “climate” or service culture should be targeted by an intervention, rather than 
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(S. H. Ahmed et al., 2013; 
Asimakopoulou, Newton, Sinclair, 
& Scambler, 2012; Baysari, 
Westbrook, & Day, 2011; 
Blankenburg et al., 2018; Cribb & 
Donetto, 2013; Crispin et al., 2017; 
Umesh Dashora et al., 2018; 
Entwistle et al., 2008; Griscti et al., 
2017; Health Foundation, 2012; 
Hendrieckx et al., 2020; Hughes et 
al., 2018; Joint British Diabetes 
Societies for Inpatient Care Group, 
2012; Joseph-Williams, Elwyn, & 
Edwards, 2014; Köberich, 
Feuchtinger, & Farin, 2016; 
Litterbach et al., 2020; Milky & 
Thomas, 2020; Munt & Hutton, 
2012; Ommen, Thuem, Pfaff, & 
Janssen, 2011; Oxelmark et al., 
2018; Pearce, 2019; Scholl, 
LaRussa, Hahlweg, Kobrin, & Elwyn, 
2018; Schultz et al., 2019; 
Vanwesemael, Boussery, Manias, 
et al., 2018; Weingart et al., 2011) 
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This theory may be explained by constructs of both Kanter’s Theory of Structural Empowerment (access to 
support, informal power) and Normalisation Process theory, as there is work to be done, both individually and 
collectively, to normalise the change in practice required to embed shared decision-making processes into 
practice. Specifically, coherence, or the sense-making work necessary to implement the intervention, requires a 
shared and individual understanding of the benefits of the intervention component, that is, the opportunity for 
shared decision-making. It also requires staff understanding on how the practice of shared decision-making is 
different, if at all, to current practice.  
 
Theory 3: Allows patients to maintain control 
 
Another mechanism identified in the process of the synthesis that is related to patient empowerment and shared 
decision-making, is the concept of patient control over elements of their care in the inpatient setting. In an 
inpatient setting, many activities that would usually be within the patient’s control (e.g. washing, eating) are now 
dependent on the care team or hospital services’ schedule. Allowing patients to be responsible to self-administer 
their insulin allows them to maintain control of this important activity, which is particularly important due to the 
consequences of not being able to have timely access to their insulin (Johnston & Newland-Jones, 2017): 
 
Twenty-one of 25 patients in Group 1 returned the questionnaire of whom 15 patients preferred to self-
inject their insulin whilst in hospital, and, of these, the vast majority (13 patients) felt that they had a 
lack of control over their diabetes while in hospital because they were not allowed to self-inject 
(Gangopadhyay et al., 2008) 
 
Also, because I have more control. Which they (nurses) give me, because as I have a lot of medication, it 
causes a lot of difficulties for the nurses, with, what is that now and what is that now. They have trouble 
understanding it while I know all about it… if I am in charge I know that I have taken them correctly and 
yes, that gives me peace of mind. - Patient 5 (Vanwesemael, Boussery, Manias, et al., 2018) 
 
They [patients] felt that they could be sure that they took the right medication at the right time and felt 
more in control about their health... the big advantage is that what people could do before, you hand 
back to them. In fact, this is about independence and autonomy, and respect for that autonomy - Nurse 
6 (Vanwesemael, Boussery, Manias, et al., 2018) 
 
By allowing the patient to self-administer, the ‘skill’ of self-administration is maintained, which may otherwise be 
lost (Rowse, 2018a). In addition, allowing patients to self-administer facilitates diabetes management in a context 
where this may not be of immediate or primary importance to the healthcare team (e.g. if the admission is elective 
or not diabetes-related) and where healthcare professionals’ knowledge of diabetes is lacking (Cohen et al 2007 




Because at the end of the day, a patient should be self-administering where they can. They've got to go 
home and do that. And we, you know, we de-skill them, we take that away whilst they're in hospital. 
(Interview data, P13) 
 
“In my experience and that of some of my colleagues, with select patients, usually type 1’s, patient self-
management (with physician oversight) yields better glycemic results (and less patient and physician 
anxiety) than if insulin dosing is left to the vagaries of the busy floor staff…In past years, as surgeons and 
cardiologists tended to their more immediate tasks, my diabetes was often relegated to a secondary and 
sometimes seemingly non-existent concern. I was frustrated and angered by substitution of the sliding-
scale for my normal insulin regimen, especially as my blood glucose spiralled out of control…(Weiss, 
2006) 
 
“In that sense, the patient often knows all his (self-managed) medication better than the nurses or the 
treating physician, because it often involves something completely different to the disease for which he is 
being treated” - Hospital pharmacist 1 (Vanwesemael, Boussery, Manias, et al., 2018) 
 
The transference of responsibility and control from the care team to the patient represents a shift in role and 
potentially professional identity, which may take time to change and be met with resistance, particularly from 
members of the care team who did not initially train under a patient empowerment participant ideology, with 
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(Alabraba et al., 2014; 
Booth, n.d.; 
Gangopadhyay et al., 
2008; Houlind et al., 2018; 
Johnston & Newland-
Jones, 2017; Pearce, 2019; 
Schultz et al., 2019; 
Vanwesemael, Boussery, 
Manias, et al., 2018; 
Vanwesemael, Boussery, 
van den Bemt, & Dilles, 
2018; Weiss, 2006) 
Interviews (P13,15) 
 
In Kanter’s Theory of Structural Empowerment, formal power systems that lead to empowerment are linked to 
greater feelings of trust and respect between the individual agents (which here would be patients and healthcare 
professionals). The relationship between the patient and healthcare professional can be viewed as a formal power 
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structure; where healthcare professionals are empowered, they are more likely to share power with their patients 
(Spence Laschinger et al., 2010). Furthermore, as per Kanter’s theory, where patients are given access to support 
to self-administer, they are empowered to maintain control of their health. 
The mechanism relating to professional roles and identity can be explained by the cognitive participation and 
collective action constructs of Normalisation Process Theory, namely the process of legitimisation, whereby 
healthcare professionals need to believe that they should be involved in the intervention (allowing patients to 
control their insulin administration), and skill set workability, where there is a division of labour that is required 
to operationalise the work of the intervention (transference of the act of injecting from the nurse to the patient). 
 
Theory 4: Reduces insulin errors and improves efficiency 
 
One of the key drivers for self-administration policies in the inpatient setting are the numbers of avoidable and 
harmful errors that occur as a result of insulin prescribing and administration errors. Allowing patients to self-
administer insulin shifts the work of administering insulin from nurses to patients. This reduces the need to rely 
on staff who are less familiar with insulin and diabetes treatment, and can safeguard patients against the 
consequences of insulin errors, such as hypoglycaemia, hyperglycaemia or diabetic ketoacidosis (Johnston, 2019). 
For patients, this provides reassurance of insulin safety whilst staying in hospital, and is linked to being able to 
maintain control as outlined in Theory 3: 
Thorne and Paterson (2001, p. 87) found their participants experienced terror at delegating their T1DM 
management to health professionals in hospital and therefore suggested the patients need to be their 
own advocate during hospitalisation to ensure errors aren’t made (Munt & Hutton, 2012) 
 
It was thought that 40% of incidents could have been prevented if the patient had been self-
administering whereas 12% (6) incidents occurred in patients who were self-injecting…A patient focus 
group identified some of the concerns patients had when coming to hospital, including not having access 
to their insulin and doses not being given at the correct time in relation to meals with resulting 
hypoglycaemia.  (Umesh Dashora et al., 2018) 
 
When the insulin was self-administered by the patient, it was appropriately timed in 78% of cases. 
Though not perfect, this is significantly better than when administered by hospital staff (p<0.0001)… 
Though some self-administration was still inappropriate, many of these instances appeared to be due to 
factors beyond the patient’s control. Aside from patients’ failure to bring their own insulin pen, these 
included waiting for hospital staff to check insulin doses, retrieving insulin from the fridge, and the food 
trolley arriving without warning. (Gangopadhyay et al., 2008) 
 
“If you look at your many numbers of administration errors by being given the wrong insulin, or the 
wrong dose, or been using the wrong needle, for example, whichever it is. If your patient is able to 
manage their own insulin at home usually, there's no reason for them not to then in hospital, then I 
guarantee I’m quite sure that that number of administration errors will come down, if they’re self-




And actually, when the prescription, when we've had incidents where the prescription has been wrong, 
fortunately, on most of those occasions, the prescription was wrong, but the patient carried on with their 
correct insulin. There was no harm to the patient for that very reason. – P3 
Patients also suggested that self-administration would result in an increased compliance after their 
discharge (68%) and it would even increase their own safety while in hospital (65.4%). A smaller 
percentage of the patients indicated that, self-administration would make them more satisfied about 
their hospital stay (62.4%). Over half of the patients were convinced self-administration would lead to 
patients taking their medication more correctly compared with administration of medication by nurses 
(56.7%). (Vanwesemael, Boussery, van den Bemt, et al., 2018) 
 
By allowing patients to administer their own insulin, nursing time is also released, which provides benefits for 
workload and efficiency. One observational study showed that an average of 12 minutes of nursing time per 
patient per hospitalisation was saved with self-administration compared to nurse administration (Houlind et al., 
2018): 
 
“Once the new process was implemented they were happy with electronic documentation at each drug 
round and bedside storage of the insulin as it reduced the time they had to spend walking around the 
ward, releasing their time to care…The early outcomes are timely insulin injections; safer, happier 
patients; and nurses’ time released to care.” - (Rowse, 2018a)  
 
It takes a long time to administer drugs and I can see the interruptions on the ward during the drug 
administration period…People get called away to handle something that’s cropped up in the middle of it, 
and they have to leave…If you were given control of the thing, the problem…of mistakes would be small. 
(P3) (Manias et al., 2004) 
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(Umesh Dashora et al., 2018; 
Gangopadhyay et al., 2008; Houlind et 
al., 2018; Johnston, 2019; Joint British 
Diabetes Societies for Inpatient Care 
Group, 2012; Manias et al., 2004; Munt 
& Hutton, 2012; Pearce, 2019; Rowse, 
2018a; Schultz et al., 2019; 
Vanwesemael, Boussery, Manias, et al., 
2018; Vanwesemael, Boussery, van den 
Bemt, et al., 2018; Weingart et al., 
2011) 
 
Interviews (P1, 11, 14, 3, 9) 
 
Skill set workability as a quality of collective action in Normalisation Process Theory describes the distribution and 
conduct of work that distributes a practice in a division of labour (May et al., 2009). Insulin self-administration 
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policies affect the ways that the work of injecting insulin is allocated, and the way skills are defined. For patients 
injecting insulin appropriately prior to admission, the task of self-injecting whilst in hospital may be more 
appropriate for their skills than for some staff (providing no clinical deterioration impacting this skill is present). 
 
Theory 5: Changes culture and beliefs 
 
The shift in practice away from traditional nurse administration and control of medicines in hospital described 
above is not a straightforward or insignificant one. Such a change to job responsibilities and roles requires a 
change in the wider culture surrounding administration of medicines in the hospital setting. The culture of a ward 
environment has been described in the form of values, beliefs and norms which influence the behaviour of people 
as members of an organisation. This is also linked to how a team is managed (Schneider & Barbera, 2014). The 
pervading culture on many ward teams is that of nurse control of the medication administration process, which 
has assumptions about medication safety and ‘right practices’ underpinning them: 
There is what Watson (2006, p. 935) describes as a ‘ritual confiscation’ of medication, where the nursing 
staff remove an individual’s medication and store it in a locked medicine cupboard or trolley...Risk 
adverse practices prevail, with severe reluctance to relinquish control to the patient in areas such as 
medicines management. Fears for the  maintenance of personal safety within the assessment unit 
continue to be the factors that perpetuate the lack of patient autonomy, decision-making or self-
determination (A. Murray, 2011) 
 
This theory suggests that insulin self-administration policies work to challenge this culture (and underlying 
assumptions), and indeed, this shift in culture is needed in order for them to work on many ward settings: 
And I think in the past, the sort of de facto position was, we look after everything for you. Whereas, we 
nearly need to flip that. We really need to say that we expect you to be giving your own insulin unless 
you can’t, providing you do it at home and providing it’s safe to do so… the traditional feeling or sort of 
understanding that we look after patients in hospital. You know, if you're a nurse you’ll be giving their 
insulin because you’re giving them their medicine and insulin is a medicine. (Interview data P8) 
The theory-based construct most frequently associated with intention was subjective norm…This 
conclusion is consistent with a recent study that showed that intention to engage in SDM behaviours is 
most effectively changed by  implementations that target subjective norm and perceived behavioural 
control. (Thompson-Leduc, Clayman, Turcotte, & Légaré, 2015) 
 
This change in culture also needs to be supported by leaders that impact culture, including professional and 
regulatory bodies and senior leaders, to provide reassurance to staff and facilitate change (Johnston, 2019; 
Pearce, 2019; Rowse, 2018a; Wessex Academic Health Science Network, 2017).  
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The beliefs and practice norms of staff that contribute to ward culture are important elements that are 
hypothesised to impact how the intervention works. In a context where staff are sceptical or wary of the change 
and implications of insulin self-administration (e.g. on workload or patient safety), it is important that concerns 
are addressed and promptly resolved, and the intervention is appraised (e.g. with outcome data). This will help 
to ensure sustainability and buy-in from the many staff members across the organisation required for success 
(Pearce, 2019; Rowse, 2018a). 
And I think that's, that's probably a challenge for, you know, a busy ward. When the nurses are thinking, 
“oh, god, and I’m going to have to take that patient off self-administration”, or “I have to try and put 
them on it”. And sometimes maybe they just think you know what, it's just easier to just do it all yourself. 
(Interview data P16) 
There was also a perceivable, but not quantified, ambivalence among the staff on this policy. A major 
limitation quoted as a hindrance to the execution of the policy was time constraint, as risk assessment 
for self-administration in the acute setting can be time consuming. It must also be reviewed regularly as 
the clinical condition of any patient can change over time. (S. H. Ahmed et al., 2013) 
Teams that routinely monitored new SDM practices could demonstrate impact, which increased 
motivation for sustained implementation. (A. Lloyd, Joseph-Williams, Edwards, Rix, & Elwyn, 2013) 
The main challenge was overcoming the preconceptions of the governance teams about the potential 
risk of a patient or visitor misappropriating insulin and causing harm to themself or another patient. This 
was overcome by analysing the incident reporting system and communication with the national 
medicines safety officers. The confirmation that their concerns had not been a reality appeased this 
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This theory can be further understood with Normalisation Process Theory, which proposes that “the production 
and reproduction of a practice requires that actors collectively invest effort in its understanding.” This involves 
formal and informal appraisal and evaluative work (both collectively and individually), known as reflexive 
monitoring, that is required for an intervention to be embedded in practice. This may also result in 
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reconfiguration, whereby ideas about the use and utility of the policy are modified in a way that promotes further 
coherence and meaningfulness of the practice associated with the intervention. The active involvement of staff 
and the importance of receiving and acting on feedback (which may result in iterations of the policy) are therefore 
important elements for the success of insulin self-administration policies. 
 
Theory 6:  Alleviates fears and clarifies roles 
 
Following on from the contexts and mechanisms exposed in Theory 5, it is also hypothesised that successful 
implementation of insulin self-administration polices relies on staff feeling supported and being empowered by 
being given information about individual responsibilities, accountability and repercussions for specific situations 
relating to insulin self-administration (Johnston & Newland-Jones, 2017; Rowse, 2018a; Vanwesemael, Boussery, 
Manias, et al., 2018). The actions required to alleviate any fears associated with the change in practice required 
(e.g. information giving and appropriate documentation/processes to support staff) are thought to result in staff 
clarity around how to apply the policy, and subsequent reassurance and confidence, which impacts the outcomes 
that the policy can have: 
Following the training, the staff in the diabetes and endocrinology ward felt confident to take on the role 
of assessing the patients’ ability to administer their insulin. (Alabraba et al., 2014) 
 
“And yes, sort of staff worry, staff resistance is one of the main ones. ‘Cause I know I’ve had a look at 
various patients and stuff. And I know staff can worry if the patient takes the wrong dosage they’ll be 
held responsible for it and all of that.  So yeah, I think we need to make sure that within the policy we 
think of doing the capacity assessments daily and actually if something goes wrong staff will be 
supported about it.” (Interview data, P5) 
 
A much-debated obstacle during the interviews, and one about which all healthcare providers were 
unanimous about, was the absence of a clearly defined legal context in which responsibilities were 
determined (Vanwesemael, Boussery, Manias, et al., 2018) 
The other barrier that has been faced was concern from nurses about ‘what if the patient gives the 
wrong dose’, this is covered in the policy which details the action to be taken, and states that the 
responsibility does not lie with the nurse if the correct procedures for ensuring competence had been 
followed. – Rowan Hillson Insulin Safety Award 
Information for nurses about accountability and what their regulatory body says is vital in changing the 
beliefs of nurses that they can’t support patients to self-administer, as is endorsement from matrons and 
chief nurses. Commonly, nurses believe they will be disciplined if a patient makes a mistake under their 
care…nursing teams were made aware of the Nursing and Midwifery Council (NMC) Standards for 
Medicines Management and their responsibilities… as lead for both quality and patient experience, she 
was able to support the change of thinking on the wards and provide access to senior nursing forums to 
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In the same way that Kanter’s theory helps to further explain the patient empowerment mechanisms in Theory 
1, here we see that the idea of access to information regarding application of the policy, support to encourage 
autonomy and provide protection (if things do go wrong), and resources (e.g. signed disclaimer) through formal 
power structures can help empower nurses to use the policy. In Normalisation process theory, cognitive 
participation is the relational work required to sustain a community of practice around the intervention, and 
involves legitimation, whereby staff ‘buy in’ to the practice in relation to institutionally shared beliefs (e.g. about 
repercussions of the policy and its propriety). This leads to activation, whereby the materials and means are 
brought forth to effectively operationalise the policy in a clinical setting – here this would involve any 
documentation and support structures for staff to feel reassured and able to use the policy. 
 
Theory 7: Integrates with work processes and systems 
 
An important mechanism identified in the theory building and refinement process was relating to perceived 
ability, confidence and effort required to undertake the risk assessment component of the self-administration 
policy. This was particularly pertinent in the context of a busy ward environment, where any tasks that are 
allocated on top of existing workloads may be perceived as burdensome. 
The process whereby staff assess the individual risk and appropriateness (sometimes termed competence) of a 
patient to undertake insulin self-administration is an extra task in many settings, and therefore requires careful 
consideration with respect to how it should be integrated into existing processes and systems. 
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Where changes are made to existing processes, that require documentation and ‘extra steps’ to processes, these 
should be made in such a way that causes the least disruption to existing processes, and integrates with current 
systems as much as possible (Garfield et al., 2018; Rowse, 2018a): 
We suspect that if the assessment could be better integrated into current electronic prescribing workflow 
in a more user friendly way, completion may increase and we are working on this within our organisation. 
Healthcare professionals were of the view that they did not have the time for an additional process but 
that most of the information required would be gathered as part of their current workflow and that it was 
a question of prompting them at the correct times to consider self-administration. Ideally, an automated 
process could be created where the electronic system draws together information from different records 
and identifies patients who may be suitable for self-administration. (Garfield et al., 2018) 
So whereas obviously I've got a lot of paperwork. There's a consent form. There's an assessment form, an 
information form, leaflet form for the patient. And all the other documentation, I was thinking, you 
know, if you can put some of that on, on the EPMA system. That could be you know, quite helpful – 
(Interview data, P13) 
 
But what happened is that the chart didn’t look any different. It was always there to be used but we just 
force anyone to use it. And what we did is put the assessment, we followed the JBDS guidelines exactly 
which was we assumed competence, and then temporary exclusion and definite exclusion. So we put the 
words exactly as they appeared on JBDS at the bottom of our chart and then a signature at the bottom 
that said “is the person self-admining?” get them to sign it, get you to sign it, job done. Because it’s 
obviously a hospital chart its part of patient record so it goes in their record so it meant that nothing else 
had to be written in the notes and it was all great. (Interview data, P2) 
 
Risk assessments should be accessible and easily retrievable (Garfield et al., 2018) and simple and quick enough 
that any appropriate staff member can complete them (e.g. RGN, pharmacist, pharmacy technician). Risk 
assessment processes should be designed in such a way that they prioritise safety over the need to evidence 
perfection in a patient’s injection technique (Johnston, 2019; Pearce, 2019): 
Previous policies on self-administering medications were rigid, with patients needing to prove they knew 
what they were taking, and nurses observing them counting out doses. ‘My feeling, as a patient and a 
professional, was that it was never done, because it made everyone’s lives so miserable and was far too 
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Normalisation Process Theory helps us to understand the above theory with its concept of collective action, which 
addresses how the intervention affects the work of healthcare professionals, division of labour, resources and 
responsibilities, and how compatible it is with existing work practices. Work is required to define and 
operationalise a practice, which may involve reshaping behaviours or actions and employing objects, which in this 
case would involve the additional practice of conducting a risk assessment and documenting this in the medical 
notes. Integrating and streamlining these actions as much as possible within existing structures aids the activation 
of this practice to help operationalise it in the clinical setting. 
 
Theory 8: Satisfies governance requirements 
 
Similar to the mechanisms involving perception of burden and reprimand presented above, this theory exposes 
how the policy works in relation to insulin storage requirement adherence in order to alleviate fears of breaching 
regulatory standards. 
Typically, insulin needs to be locked away in a safe, secure locker, either by the patient’s bedside or on a ward 
medication storage unit. Although this seeks to ensure patient safety in one respect, it can lead to problems with 
insulin accessibility for patients, who must rely on nurses being available to retrieve their insulin to receive a 
timely dose. This can disrupt the correct administration schedule in relation to meals and may result in 
hypo/hyperglycaemia (thereby risking safety). The perceived effort and cost needed to solve this problem by 
providing secure but accessible storage is commonly reported as a barrier to insulin self-administration: 
 
And the other side of it, we’re never quite sure what the CQC would make of it because their stance is, 
everything needs to be secured and locked away… So practically, I'm not sure that the technology for 
self-administration is that good. If the CQC have a patient with their insulin sitting on the side, they 
won't like it. So you then have to go down a locker for the insulin. If you do that, you might as well do it 
for the rest of the medicines. And you can’t do it for the locker because it's the sort of technical issues in 
getting specific patient access to their medicine locker… And getting all of the CQC inspectors signed up 
for that as a collective as well rather than just an individual going “Oh, that's fine.” And another one 
going “No, I don't like that.” (Interview data, P9). 
 
Self-administration policies that apply clear and consistent information from external regulators (such as the Care 
Quality Commission) regarding workable, suitable, safe and affordable bedside storage solutions are therefore 
needed in order to alleviate fears from staff regarding the misappropriation of insulin on the ward and the need 
to satisfy regulatory requirements (Garfield et al., 2018; Johnston, 2019; Johnston & Newland-Jones, 2017; Joint 
British Diabetes Societies for Inpatient Care Group, 2012; Rowse, 2018a): 
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So [pharmacist A] did all the work with the CQC to prove you didn’t have to lock insulin away so I took 
that part of it and [pharmacist B] did the risk assessment that the CQC asked for so I took her one and 
then just [trust A]’d it, submitted it to our medicines governance and they were happy to agree to it not 
being locked away because we had approval from the CQC so they were happy with that. – P2 
The CQC supports SAFE patient self care. We asked the pharmacy advisor who said: Key is being able to 
demonstrate that the organisation has identified the risks and put in place systems to mitigate the risks 
whilst promoting independence and better care. Where it is being done well we have seen clear risk 
assessments, policies, SOPs, care plans, and there is secure patient access storage. - (Wessex Academic 




Here, the theory of structural empowerment helps to explain how organisations more generally may be 
empowered by the provision of information and resources needed to apply the regulatory and governance 
requirements to the context of insulin self-administration in a hospital setting. Clear, consistent information from 
the CQC that is disseminated and appropriately interpreted and applied in inpatient settings can empower teams 
who would otherwise regard insulin self-administration to be incompatible with insulin storage requirements. 
Similarly, readily accessible storage (resources) for insulin for patients can empower teams to implement the 
policy. As has been shown from the literature,  this may be cost-effective, with creative and inexpensive solutions 
being shown to satisfy regulatory requirements (Umesh Dashora et al., 2018; Johnston, 2019). 
 
Theory 9: Encourages collaborative working 
 
Insulin self-administration policy implementation requires multidisciplinary input in order to work. An 
understanding of project management, insulin governance, nursing work and diabetes is required for the policy 
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And that’s what we found, so we were really surprised, we did a lot of teaching on the patient self-admin 
at one point. And we kind of just assumed, you know, took it for granted that they do these kind of 
capacity assessments all the time. And they basically, they turned round and said “No, we never do 
them. The OTs do them occasionally, physios sometimes, the medics do them, but we don't”. And we 
went “Oh.”  - (interview data, P9) 
 
By providing the opportunity for collaborative working, it is hypothesised that an increase of role appreciation, 
innovation and collegiality will follow:  
Collaboration between pharmacy and nursing in the management of this project enabled innovative 
thinking. (Rowse, 2018a) 
‘We have shared goals and passion and that’s important…But we come at it from different angles. As a 
project, it means it’s more holistic because we’re doing different aspects – and it usually means we’ve 
covered everything between us.’ (Pearce, 2019) 
 
Where individual responsibilities amongst a multidisciplinary team are indicated in the policy, it will reduce 
burden on a single professional group (Johnston, 2019; Rowse, 2018a): 
Our findings suggested that rather than self-administration assessment being solely nurses’ responsibility, 
it should be multi-disciplinary. The majority of healthcare professionals interviewed were of the view that 
their profession could contribute to advising on patients’ suitability for Increasing self-administration but 




Both Kanter’s theory and Normalisation Process Theory help explain the above programme theories. In Kanter’s 
Theory of Structural Empowerment, informal power is derived from alliances or relationships with people at 
different levels in the organisation (e.g. interdisciplinary networking and collegiality), which enable staff to get the 
required co-operation to achieve their goal (which here would be the successful use of the policy). The collective 
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action construct of NPT also explains how relational integration is required for successful intervention 
implementation. Here, a practice affects the ways that people understand the actions of others around them, 
which in this case, explains how the work that people do to build accountability and maintain confidence in each 
other leads to a greater appreciation of each other’s roles as they relate to the practice of insulin self-
administration. This may however, conversely result in loss of confidence in each other, particularly where there 
are uneven interprofessional power dynamics and unresolved problems in workload allocation, which has been 
reflected in the above theory. 
 
Theory 10: Reduces burnout and ensures consistency 
 
Following on from Theory 9 which exposes mechanisms around multidisciplinary interactions, this theory 
hypothesises that the allocation of a project leader, who has protected time to dedicate to policy design and 
implementation, will further reduce the perception of burden on individuals and burnout experienced by the 
individuals driving the policy implementation on top of their regular clinical duties.  
The complexity and scale of implementing the policy consistently across large organisations requires engagement 
of leaders and staff at various levels. This is, however, unlikely to be achieved without dedicated time. There is a 
risk of burnout individuals are attempting to achieve organisation-wide change in addition to usual job tasks 
(Garfield et al., 2018; Rowse, 2018a): 
Initially, we thought we could do it within our team, alongside our day jobs. But it quickly became 
apparent that it would take dedicated time to achieve. I was seconded to work on the project three days 
a week, funded by pharmacy. It took 18-24 months to implement at our trust and we are rolling it out to 
the remaining final areas.  (Johnston, 2019) 
 
And sometimes it's a bit like, even in our own work, sometimes other things take priority and some days 
you might be focused on thinking, “actually, I'm going to try and get the patients on this ward, anybody 
who can, to self-administer and we'll try and adopt that for this week”. You know, that will be this 
week.’. But then other things get in the way. (Interview data, P16) 
 
The presence of a dedicated project manager to lead the project can also help ensure that the policy is 
implemented consistently and successfully across the organisation and that issues are highlighted and resolved 
(Sorensen et al., 2020; Wessex Academic Health Science Network, 2017): 
The lack of progress made initially with the diabetes team trying to fit the project in with their day job 
made us decide that a dedicated project manager with time, the right skills and connections/relationships 
in the trust was vital to the success of the project… Implementation of self-administration of insulin is 






This theory may be further explained by the NPT construct of cognitive participation, specifically the initiation 
component, where key participants are working to drive the new set of practices forward. Commonly, 
implementation strategies (e.g. communication, education) are curtailed by time and resource constraints, and 




The aim of the realist synthesis was to generate evidence-informed theory that explains how insulin self-
administration interventions works, for whom, and in what circumstances. This was achieved by an analytic 
process that involved iterative testing and refinement of theoretically based explanations using empirical findings 
in data obtained from literature (G. Wong, Greenhalgh, et al., 2013). Contexts, mechanisms, and outcomes 
pertaining to intervention use were configured in explanatory sequences (CMOCs) to produce realist programme 
theories.  
Theory development, which involved amending wording, reviewing the proposed relationships between contexts 
and mechanisms, and how the evidence supports this, was discussed with stakeholders and with the research 
team throughout the synthesis. This was an iterative process that was not always straightforward, particularly 
where concepts were inter-related in the literature and were not clearly discrete. Designations of concepts 
between theories were therefore made according to how best to describe what the policy does with respect to 
the responses described. A wider set of studies were drawn on to comprehensively explain the professional, socio-
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cultural, and organisational dynamics in which inpatient insulin self-administration policy intervention use by 
healthcare professionals is situated. 
Findings confirm that insulin self-administration policy interventions are complex and socially contingent, with 
their success depending on many personal, socio-cultural, organisational, and technical factors. For example, key 
contextual factors included staff awareness and appreciation of diabetes and the importance of shared decision-
making, cultural norms of the organisation (e.g. nurse administration and control of medicines), staff familiarity 
with insulin therapy, and the presence of motivated individuals to oversee and lead policy implementation. These 
contexts, amongst others, were thought to lead to outcomes that included patient satisfaction, increased self-
management and collaborative behaviours, reduced insulin errors and consequential harm to patients and 
increased consistency of information given to patients.  
These outcomes consider a wider variety of measures compared to previously published studies, which tend to 
focus on more easily quantifiable outcomes such as percentage of documents completed or patients self-
administering insulin (Alabraba et al., 2014; Johnston & Newland-Jones, 2017; S. Kavanagh & Boparai, 2015). 
Findings encourage the consideration of these wider outcome measures in future studies seeking to examine the 
impact and effectiveness of insulin self-administration policies in the hospital setting.  
Of particular interest is the mechanisms that were identified during the course of the realist synthesis, which gives 
contextually sensitive explanatory power to how insulin self-administration policy interventions work. These 
included how particular resources offered by the policies facilitate patient empowerment, shared decision-
making, mutual respect and understanding, alleviation of fear, confidence and motivation and altered perception 
of burden required for change.  
These results both echo and extend the findings from the qualitative study in Chapter 5 regarding self-
administration. For example, the qualitative study results indicated that insulin errors would be reduced by the 
implementation of self-administration policies. The findings of the synthesis enable this to be supported with 
other evidence and explain that this is achieved by reducing the burden on nursing staff and increasing patient 
reassurance. The description of self-administration interventions being empowering in the qualitative study was 
also explained further with the realist synthesis findings; policies inform patients and prompt them to 
communicate their abilities, needs and expectations with staff, and staff gain awareness and understanding of 
the patient’s situation as a result. Also, the paternalistic perspective described by interview participants was 
delineated further in the synthesis to expose related mechanisms including patients feeling listened to, power 
differentials, appreciation, respect and understanding and correcting misconceptions. 
The use of a combination of Normalisation Process Theory (NPT) and Kanter’s theory of structural empowerment 
was useful in helping to further explain the programme theories generated in the realist synthesis. All four 
constructs of NPT were identified in the analysis of the 10 CMOCs. Taken together, the 10 CMOCs demonstrated 
that self-administration polices focus more on the constructs of collective action and cognitive participation than 
231 
 
coherence and reflexive monitoring. This means that when operationalised in complex interventions such as 
hospital environments, insulin self-administration policies need to lead to normative and relational restructuring, 
and the legitimation of new working practices through experience. 
All but one construct of Kanter’s theory was identified in being able to help interpret the results of the synthesis. 
The construct of ‘access to opportunities to learn’ was not identified as one that had relevance for helping to 
explain how insulin self-administration policies worked in the inpatient setting. It may be presumed, however, 
that to empower people with diabetes to self-administer their insulin on initiation of therapy, access to 
opportunities to learn and grow in skills such as injection technique and self-management of diabetes more 
generally should be offered (e.g. by the diabetes nurse specialist in the community). Arguably this may not be so 
relevant for acute inpatient settings that this theory pertains to.  Similarly, providing opportunities for staff to 
access training on self-administration and inpatient diabetes care, and giving them new challenges (e.g. acting as 
a diabetes link nurse between the ward and the specialist diabetes team), would also help empower them through 
formal power structures. This theory focuses on policy implementation, which although requires staff training (on 
use of the policy), did not quite fit as an empowerment construct for staff in and of itself. 
The findings of the realist synthesis highlight important circumstances that impact on the success of policy use in 
organisations. These include the extent to which patients are (and feel) listened to, shared decision-making is 
practiced, and the powerful cultural norms of nurse control and expected passivity of inpatients. Findings also 
suggest that when staff feel adequately informed, protected, and supported regarding self-administration, these 
are more likely to result in successful use of the policy. This also links to the absence of a blame culture, which 
remains a wider problem in the NHS despite efforts to promote a more ‘just’ culture (Stretton, 2020). Considering 
these complex and multiple factors that contribute to the success of policy interventions, it is likely that a 
combination of multifaceted intrinsic (bottom-up) and extrinsic (top-down) solutions would be required to 
support implementation across NHS hospitals. 
As realist synthesis places primary emphasis on actionable findings that can lead to context-sensitive change, a 
number of high-level principals that can be tailored to different environments to suit different needs are outlined: 
• All hospitals should devise policies that facilitate the self-administration of insulin for people with diabetes 
staying in hospital. This requires multidisciplinary collaboration between nurses, pharmacists, doctors, 
and patients. 
• All staff should be aware of the policy and know how to access the relevant information and 
documentation. Staff should inform people who use insulin about self-administration on admission to 
hospital (or before, in the case of elective admissions). 
• Healthcare staff (e.g. nurses, pharmacists) caring for patients using insulin should listen to the patients to 
help understand their individual needs, expectations and abilities regarding insulin administration. 
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• Healthcare staff should offer patients a fully informed choice to self-administer their insulin and 
participate in shared decision-making. 
• Healthcare staff should be educated (e.g. by diabetes teams) regarding the importance of timely insulin 
administration and the benefits of allowing patients to control their own insulin administration. Outcomes 
of policy implementation should be shared with staff and any questions/concerns should be addressed. 
• Healthcare staff should be given clear and consistent information regarding their responsibilities and 
positions from their regulatory/professional bodies regarding insulin administration, storage, and 
associated regulations.  
• Healthcare staff should feel supported and protected by senior leadership teams with respect to 
facilitating self-administration. Completion of associated documentation (e.g. risk assessments, 
disclaimers) should be accessible, simple and integrated into normal workflows. 
• A dedicated project manager should be appointed to oversee the design and implementation of the policy 
across the whole organisation. 
 
Overall, the use of realist synthesis was appropriate to uncover the underlying mechanisms that cause the 
intervention to work in different ways in different settings. This enabled a rich description of how the self-





Insulin self-administration policies to promote insulin safety in the inpatient setting are a complex intervention 
that requires careful implementation to successfully achieve their intended outcomes. Existing literature on 
insulin self-administration policy interventions in the UK hospital setting is limited to short audit reports or 
implementation commentaries. Although these are useful to understand elements of policy implementation in 
given settings, a theory-driven approach to uncover generative mechanisms that can lead to intervention success 
was needed given the timeliness and importance of this intervention. This realist synthesis exposes the underlying 
logic behind self-administration policy interventions, as well as identifying the mechanisms by which these 
interventions result in their intended outcomes. The important contexts that determine whether or not the 
identified mechanisms produce either positive or negative outcomes were also identified, and as such, the 
circumstances where insulin self-administration policies are likely to be effective are explained.   
These contexts, mechanisms and outcomes were configured to produce programme theories that were refined 
with a combination of expert, professional and content knowledge, stakeholder input, re-examination of 
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qualitative interview data and a series of iterative literature searches. The analysis of the theories was aided with 
the use of existing, substantive middle-range theories as conceptual frameworks. 
The function of insulin self-administration policies in the hospital setting was found to include patient 
empowerment, diagnosis of existing/potential administration problems, shared decision-making, patient 
autonomy and independence, as well as insulin error reduction. It was found that consideration of the necessary 
governance issues was essential, as was a significant shift in organisational culture and perception of the staff-
patient relationship. Certain features of intervention implementation and change management, such as the 
designation of a dedicated project lead and the collaboration of professionals, as well as work to clarify roles and 
alleviate staff fears, were also highlighted as important elements of making insulin self-administration successful. 
The next chapter discusses quality of the realist synthesis along with the quality of the overall research 
programme. The extent to which the overarching aims and objectives of the research were met with the methods 




Chapter 7: General Discussion 
 
This chapter discusses the overall research programme in terms of its outcomes, process, quality, and implications 
for policy and practice, and is presented according to the stated objectives and research questions presented in 
Chapter 1. The discussion presented here complements the discussions presented in each chapter on how the 
key findings relate to the literature and triangulate each other. Sections include: 
• Discussion of the outcomes of the research 
• Discussion of stakeholder groups at each stage of the project 
• Strengths, limitations, and quality assessment 
• Implications for practice 
• Future research 
• Impact of the research on the researcher  
 
7.1 Discussion of study outcomes 
 
The overall aim of this thesis was to investigate the current use of interventions designed to prevent insulin 
prescription errors in UK hospitals.  This research fulfilled this aim by describing the current use of interventions 
in hospitals across the UK, determining the perceived effectiveness of those interventions on reducing insulin 
prescribing errors and exploring the opinions and insights of hospital pharmacists involved in the design, 
implementation and/or evaluation of these interventions in practice. The identification of insulin self-
administration policy interventions as a particularly complex and salient intervention to explore further – both 
through reflection on the results of the mixed methods study discussions with the PPI stakeholder groups – led to 
the generation of evidence-informed testable theory of how this intervention works to achieve various outcomes 
in different contexts.  
 
Summary of key findings 
 
The systematic review identified the published interventions used to improve insulin prescribing in the inpatient 
setting, both in the UK and further afield. The mixed methods study allowed quantification of issues relating to 
the use of interventions to improve inpatient insulin prescribing practice followed by in-depth exploration of key 
issues with the survey participants. The cross-sectional survey stage identified that most insulin is prescribed for 
inpatients with diabetes using paper charts, or a combination of paper and electronic prescribing systems in 
hospital, with important safety implications. Only 30% of respondents considered the insulin passport to be 
effective at improving insulin prescribing safety, whereas around 80% respondents considered guidelines and self-
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administration policies to be effective. The highest scoring interventions in terms of perceived efficacy were 
outreach team review and mandatory insulin safety education for clinical staff. The only organisational 
characteristic that was associated with increased number of interventions used was the presence of a specialist 
diabetes pharmacist at the trust.  
On exploring the use and perceived effectiveness of interventions with survey respondents during qualitative 
interviews, key themes were identified that included: insulin prescribing safety being an important but ‘wicked’ 
problem, fear and complexity of the prescribing process, the battle to educate staff on insulin safety, the need to 
broaden responsibility for insulin prescribing safety, the difficulty of evaluating interventions, the need to find a 
balance between prescribing system control and flexibility and insulin self-administration in the inpatient setting 
being a problem worth solving. 
The realist synthesis exposed the explanatory mechanisms of insulin self-administration interventions further, 
and presented evidence-informed theory about how the intervention leads to outcomes in different contexts. The 
theories addressed how insulin self-administration policies work to empower patients and highlight problems, 
facilitate shared decision-making, allow patients to maintain control, reduce insulin errors and improve efficiency, 
change attitudes and culture, alleviate fears and clarify roles, integrate with work processes and systems, satisfy 
governance requirements, encourage collaborative working, reduce burnout and ensure consistency across the 
organisation. 
How the research objectives were achieved throughout the thesis are discussed below, including how key findings 
contribute to the existing literature in this field. 
 
Objective 1: Systematically review evidence regarding the impact of interventions on insulin prescription 
errors in the hospital setting. 
 
The systematic review enabled the comprehensive identification of published interventions designed to reduce 
inpatient insulin prescribing errors using a proven methodology that was well-suited to this aim. The types of 
interventions designed to improve inpatient insulin prescribing practice were documented, and the impact on 
insulin prescription error reduction, completeness or accuracy of prescription, or adherence to prescribing 
guidelines was analysed to reveal the types of interventions that were associated with positive outcomes. Aspects 
of intervention implementation that were associated with more favourable outcomes in the studies were also 
described.  
Despite this, it is appreciated that systematic reviews are, by nature, summative, and judge interventions in terms 
of change in outcome measures to give a generalised view. In this sense they are limited in their ability to more 
fully explain the context in which an intervention is successful in one setting and a failure in another. The use of 
the Quality Intervention Minimum Quality Criteria Set (QI-MQCS) tool as part of the quality assessment process 
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in the systematic review was helpful to give an overview of the general reporting quality of the included studies, 
and to encourage future original studies in this area to include sufficient contextual information when reporting 
on intervention use. 
Although the heterogenicity of study design, reporting standards and definition and measurement of insulin 
prescribing error limited the ability to draw quantifiable conclusions, the research questions were answered using 
systematic review methodology, and results highlighted opportunities for research and provided a helpful 




Following discussions with the LADDER panel regarding the systematic review results and implications for 
research (see Chapter 2), it was clear that the investigation of insulin prescribing practice was important 
to people with diabetes to reduce insulin errors and harm. It was also evident that the panel prioritised 
investigation of interventions that were perceived has having a high impact on people with diabetes, for 
example self-administration policies. As these policies were not reported in the studies identified in the 
systematic review, but featured in various UK national guidance recommendations, it was decided that 
these interventions should be included in the questionnaire tool. This decision was an example of shared-
decision-making and co-production, directed by the priorities of patients, as the researcher’s personal 
thought was that self-administration policies are more targeted at the impact of insulin prescription errors 
(as well as other aims, such as patient empowerment), rather than preventing the prescription error itself.  
Discussing the research with a variety of stakeholders at this early stage helped to achieve a greater 
understanding and appreciation of the issues from the patient’s perspective. This is of particular value 
when studying interventions to improve patient safety with insulin, and especially interventions to enable 
insulin self-administration in hospital (Wilson et al., 2015).  
 
Objective 2: Investigate the current use and perceived effectiveness of insulin prescribing interventions. 
 
Investigating current intervention use and perceived effectiveness across UK hospitals at an organisational level 
involved answering the following questions: 
1. What systems are currently used to prescribe subcutaneous insulin for inpatients in UK hospitals? 
2. What interventions are currently being used in UK hospitals to improve insulin prescribing practice? 
3. Is there an association between hospital characteristics and intervention use? 
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4. What interventions are perceived to be most effective for improving insulin prescribing practice by those 
who have a role in implementing and evaluating them? 
5. Is there an association between hospital characteristics and perceived effectiveness of interventions? 
 
To answer these questions, a questionnaire tool was developed, validated and used in a national cross-sectional 
survey of UK hospitals. The self-administered questionnaire tool was designed to capture information about 
hospital characteristics, prescribing system use, intervention use and perceived effectiveness of interventions. 
Results from the systematic review were incorporated into the tool design, including the list of documented 
interventions, and some of the contextual information identified from the studies (e.g. local prescribing practice, 
prescribing systems used, organisation size, presence of diabetes pharmacist, type of hospital). The tool was 
developed according to good practice guidance and piloted with content experts and those representing the 
target population of survey respondents, namely hospital pharmacists who are responsible for designing, 
implementing, and evaluating insulin prescribing practice interventions in UK hospitals. 
The survey was conducted as the first phase of the mixed methods study, and was the first of its kind to capture 
information on the functionality of systems used to prescribe subcutaneous insulin and the use of interventions 
to prevent insulin prescription errors, both in the UK and worldwide. The current use of a range of interventions 
to improve insulin prescribing safety in hospitals was described, and potential opportunities for safety features to 
be incorporated in both electronic and non-electronic prescribing systems were highlighted.  
How the research questions above were answered with the use of the research method are discussed below. 
 
Prescribing system and intervention use  
 
Research questions 1-3 pertain to the description of insulin prescribing system and intervention use, and 
the existence of any association between hospital characteristics and intervention use.  
Prescribing systems were able to be described with the use of the survey, as a range of functionalities 
were included as items that were informed by both the systematic review results and co-design with 
content experts and representative respondents. The tool was limited in that it may not have been 
sensitive enough to capture the breadth of information for organisations that used multiple electronic 
systems (each with different functionalities), although the tool could describe the use of concomitant 
paper and electronic systems.  
Comparing the results of the survey with the most recently published NaDIA data, which was collected a 
few months after the survey was administered, confirmed that the tool was able to capture accurate 
information about prescribing system use. For example, the results of the survey indicated that around 
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48% hospitals are using electronic prescribing systems, but just under 17% hospitals are prescribing insulin 
using electronic prescribing systems alone (i.e. not in combination with paper charts). The NaDIA found 
that result that a total of 55.8% of sites are at least partially using electronic prescribing is similar to our 
finding of 48%. The difference may be explained by the NaDIA only including hospitals in England, whereas 
this survey included hospitals in other parts of the UK, none of which were using electronic prescribing 
systems at the time of data collection. There are also no accompanying definitions of what ‘partial’ or 
‘full’ utilisation means in the NaDIA audit results, and the NaDIA did not measure what proportion of sites 
using electronic prescribing used it for insulin.  
The survey built on the results of the systematic review by enabling the capture of all currently used 
interventions by enabling respondents to document bespoke interventions in use in their hospital. This 
facilitates the shared learning of organisations and also provides a broader picture of the interventions in 
use compared to what the NaDIA used to report in terms of care improvement initiative use (NHS England 
and Wales, 2018), for example use of mandatory training and the insulin passport and self-administration 
policy use. Although the bespoke interventions self-reported by survey respondents could not undergo 
statistical analyses, some may be incorporated into future versions of the survey. 
Results show that despite the recommendation by NICE and JBDS (2012) for trusts to implement systems 
to allow insulin self-administration of insulin by inpatients, only 63% stated they had policies to enable 
insulin self-administration and only 31% had a policy to enable self-management. This is roughly similar 
to the reported figures from the NaDIA, where 65.2% sites stated they allowed self-administration of 
diabetes medication, and 45.9% had a policy to enable self-management of diabetes (NHS Digital, 2020). 
The difference in the self-management figure may be due to some hospitals allowing self-administration 
of oral medicines, but not insulin, as the wording in the NaDIA was not specific to insulin. 
The usefulness of the survey for reporting pharmacist input into diabetes care was limited by the variation 
of job titles self-reported by respondents, as well as difficulties in interpreting this. For example, 
pharmacists may be covering diabetes wards but not have the title of specialist diabetes pharmacist, and 
these roles and titles may depend on organisational practices and norms. Nevertheless, the data retrieved 
was able to be analysed to find associations between the number of interventions used and the presence 
of a specialist diabetes pharmacist, as well as other characteristics such as hospital type, size and location. 
The anonymous nature of the survey at the point of data input meant that it was not possible to externally 
verify self-reported descriptive information about the organisation. Although no unclear responses were 
received, non-anonymity may have been useful to clarify responses that were classed as ‘unknown’ 
responses and to enable purposive sampling of respondents based on maximum variation for the follow-
up interviews. It would also enable characteristics of non-respondents to be described so that any 
differences between respondents and non-respondents could be further analysed. However, a wide 
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variety of hospitals from across the UK responded, which provided a broad and generalisable insight into 
current opinion at an organisational level. The survey response rate was reasonable, and comparable to 
other similar surveys of healthcare professionals (Cook, Dickinson, & Eccles, 2009).  
 
Perceived Effectiveness of interventions 
 
Research questions 4 and 5 pertain to the measurement of perceived effectiveness of listed interventions 
and the identification of any associations between hospital characteristics and these perceptions. The 
questionnaire used as part of the survey was developed and validated to describe the perceived 
effectiveness of a range of insulin prescribing interventions with good reliability.  
The survey enabled the reporting of clear distinctions between interventions that were perceived to be 
highly effective, and those that were not. Results indicated that there was support for certain national 
recommendations, such as mandatory insulin training for clinical staff and self-administration, but not 
others, including the insulin passport.  
Whilst the intervention list included in the tool was obtained from the systematic review results in 
Chapter 2, as well as input from frontline staff from multiple hospitals, the open question responses show 
that it was not completely exhaustive. Other interventions, such as insulin safety campaigns, prescriber 
feedback, insulin safety huddles and other bespoke strategies described by respondents were not 
included in the item list and were therefore unable to be represented in the statistical data analysis.  
Despite the benefits of using perceived effectiveness of insulin prescribing interventions as a concept to 
measure for the purposes of a national survey, it also has its limitations. For example, the effectiveness 
of an intervention may be perceived differently between two members of the same organisation, neither 
of which may be identical to a quantitative measure indicating functional effect of the intervention (e.g. 
percentage reduction in insulin prescription errors at the trust). Perceived effectiveness may be 
influenced by experience, context, cognition and perceptual biases filtering individual observations 
(Ohrens, Santiago-Ávila, & Treves, 2019; Slovic, 1987; Starr, 1969) and may not be static. Sekhon et al 
comment that use and experience of an intervention may change one’s perception of its effectiveness, 
which the analysis of survey results would support (Sekhon et al., 2017). It is also acknowledged that 
perceived effectiveness is just one element of the overall acceptability of an intervention. Other elements, 
or constructs, include affective attitude, burden, ethicality, intervention coherence, opportunity costs, 
and self-efficacy (Sekhon et al., 2017). These constructs may be also be important when considering the 






The discussions with the patient panel following the results presentation was useful in appreciating the 
patient’s concerns over the safety of people with diabetes in hospital. The participants used words like 
‘frightening’ and ‘shocking’ to describe their reaction to the results. These wouldn’t have been terms I 
would have identified with as a person who does not have diabetes, and a healthcare professional used 
to viewing data regarding prescribing errors.  
The meeting enabled me to be critically reflective and examine my assumptions about the research 
results; for example being able to view the results through the lens of someone who would be on the 
receiving end of such a statistic, with all the implications that may have on their wellbeing and safety 
helped me to appreciate the impact of the results.  
The panel clearly identified the variation in self-administration and self-management policies as 
something that required further investigation due to the perceived benefits from them that this 
intervention can bring to their experience in hospital.  These insights gave further support for the need to 
include discussion of this intervention in the interviews, and as such, it was included in the interview 
guide. The survey results regarding this intervention would benefit from further explanation, so it was 
easy to agree to include discussion of self-administration policies in the next study. The decision to retain 
questions on wider topics in the interview guide (i.e. to not make the qualitative interview study 
exclusively about self-administration policies) was made to balance the interests of the panel with that of 
the research team. 
The prioritisation of quantitative data from the multidisciplinary inpatient group was an interesting 
difference in perspective to that of the patient group. Although this could not be achieved within the 
study design, exploring ‘actual’ intervention effectiveness further between a limited number of 
organisations with complexity-sensitive methods may be worthwhile. 
 
Objective 3: Analyse the experiences and opinions of hospital pharmacists involved in insulin prescribing 
intervention design, implementation, and evaluation. 
 
Analysing the experience and opinions of hospital pharmacists involved in the design, implementation and/or 
evaluation of insulin prescribing interventions involved answering the following research questions: 
1. What are the current challenges and solutions with respect to improving insulin prescribing practice in 
the UK hospital setting? 
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2. What are the contextual factors that may influence the success of insulin prescribing practice 
interventions in the UK hospital setting? 
This was achieved by in-depth, collective examination of insulin safety issues across multiple UK hospitals using 
thematic analysis of qualitative interview data collected from survey participants. The survey respondents were 
well positioned to discuss insulin prescribing practice interventions in their hospital setting, and results were able 
to further our understanding of contextual factors that threaten insulin safety and influence the success of 
interventions designed to reduce insulin prescribing errors in the hospital setting.  
This was the first study of its kind to analyse the collective experiences and opinions of pharmacists (or any 
healthcare professional) involved in insulin prescribing safety in the hospital setting across multiple organisations 
both in the UK and worldwide. It was also the first study to collect qualitative data in this field in the UK, with the 
use of a well-known and thoughtfully considered approach to data analysis (Braun and Clarke’s reflexive thematic 
analysis). Studies conducted prior to this were limited to single site studies and did not report qualitative analyses 
methods in requisite detail to critically appraise. It was also the first study to interpret findings relating to insulin 
prescribing safety using a human factors systems approach using the SEIPS model, with previous literature 
focusing on the outcomes of a small number of interventions being implemented at single sites.  
It is also recognised that although coding was done inductively, there was also some level of deduction on account 
of the identification of topics to discuss in the interview guide. For example, insulin self-administration policy use 
was chosen as a topic for discussion prior to the interviews and consequently appeared as the topic of one of the 
themes. 
 
Current challenges and solutions for improving insulin prescribing practice  
 
The use of semi-structured interviews allowed participants to freely discuss a range of the challenges and 
solutions regarding current insulin prescribing practice in the hospital setting. The generation of deep 
contextual data was valuable in generating descriptions of the various organisational, personal, 
technological, environmental and socio-cultural factors that contribute to insulin prescribing errors.  
Existing theoretical frameworks were not used to design the interview guide or code the transcribed data. 
This decision was to help widen the lens through which insulin prescribing problems and interventions 
were viewed during the interview and coding process. Although this enabled the identification of 
important mechanisms that lie outside of ‘off the shelf’ theoretical frameworks, it may have been 
beneficial to include more prompts in the interview guide that were based on elements contained in the 
SEIPS framework or consideration of Normalisation Process Theory (NPT) or the Theoretical Framework 
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of Acceptability (TFA) constructs to stimulate discussion further, or to enable additional deductive 
analyses to be undertaken using the dataset in the future.  
Although interview data were not mapped to Reason’s error theory categories in the same way as the 
SEIPS, consideration of the results suggests that both latent and active failures contribute to insulin 
prescription errors in current practice, including organisational processes (e.g. lack of training), error-
provoking conditions (e.g. look-alike-sound-alike products), slips (prescriber writes 80 instead of 8), lapses 
(prescriber writes ‘units’ on a chart with pre-printed ‘units’ on), mistakes (lack of knowledge of long-acting 
vs short-acting) and violations (adjusting insulin prescription not prioritized by doctor). 
The complex and widespread problems with insulin prescribing processes in hospitals are not bound by a 
single organisational setting; wider issues regarding staff retention and rotation, insulin branding, primary 
care systems and communication across settings, as well as undergraduate and postgraduate education 
all impact on the ability of prescribers to generate safe and appropriate insulin prescriptions for people 
with diabetes in the hospital setting. Solutions, therefore, need to be able to consider these wider systems 
issues. Evidence of this include recent calls from the UK Clinical Pharmacists Association Diabetes and 
Endocrinology group for manufacturers to change the name of biosimilar insulins coming onto the market 
to avoid mis-selection (Jelley, 2019). 
 
Contextual factors that influence intervention success 
 
The integration of the qualitative data with the quantitative data from the survey enabled further 
explanation of the salient survey results regarding perceived effectiveness of interventions. Many factors 
align closely with human factors associated with prescribing errors more generally outlined in the 
literature, such as reduction of prescriber cognitive ‘work’ required to generate prescriptions, proximity 
to other tools (e.g. prescription chart and blood glucose results), and conspicuousness (Coombes, 
Stowasser, Coombes, & Mitchell, 2008; Sutherland et al., 2019; M. P. Tully et al., 2009). The application 
of the findings to the SEIPS model alerted the researcher further to a range of components at multiple 
levels of social reality that should be accounted for when designing and evaluating interventions (Kislov 
et al., 2019). This enabled the more evaluative findings to be further translatable, to increase the 
relevance and significance of results. This also provided further clarity with respect to uncovering 
generative mechanisms behind why and in what contexts, interventions were perceived to work by 
participants.  
All components of the model were able to be populated, often with multiple inferences made from the 
thematic analysis. These inferences mapped to specific domains aids the development of interventions 
that are likely to be more effective than those developed without reference to theory. Consideration of 
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the results with reference to NPT would be difficult due to the disparate categories of interventions 
discussed. However, all four constructs of NPT (coherence, cognitive participation, collective action and 
reflexive monitoring) can help further explain findings in general. For example, reference was made to 
“aligning priorities” (coherence - communal specification), individuals driving interventions (cognitive 
participation – initiation), the division of labour required for self-administration policies (collective action 
– skill set workability) and collecting feedback on prescription charts from prescribers (reflexive 
monitoring – communal appraisal).  
This collection of feedback on interventions and being inclusive in their design in particular may enable a 
more proactive approach to safety management (Braithwaite, Wears, & Hollnagel, 2015; Sujan, 2015). 
Overall, results suggest that a chiefly reactive method of strategy implementation which prioritises 
consideration of local safety trends is taken, which may be problematic (Carson-Stevens, Donaldson, & 
Sheikh, 2018; Macrae, 2016).  
The additional ‘subgroup’ analyses undertaken to categorise the data according to intervention use may 
be limited as the study was not designed to include equal numbers of representatives from organisations 
with those characteristics. Results should therefore be taken with caution. Despite this, the presentation 
of data in this way was thought to have utility for inpatient diabetes and pharmacy teams, as it 
communicated ‘lessons learned’ from those who had implemented interventions. Future studies designed 
for the purpose of comparing between organisations may benefit from careful purposive selection of 
participants and more structured questioning. 
Although electronic prescribing was of particular interest to the multidisciplinary stakeholder team, this 
was not chosen for subgroup analysis due to the complexity of the intervention. For example, participants 
described many variations of system use (as outlined in the survey) which would obfuscate the 
categorisation process. The important human factors systems elements of electronic prescribing use for 
subcutaneous insulin were, however, contained in the SEIPS model to help hospitals implementing 




The discussion with the patient panel following the presentation of the results was conducted virtually 
due to the COVID-19 restrictions on in-person meetings. This did not seem to impact discussions but there 
were noticeably less panel members in attendance compared to usual (4 compared to the usual 6-8). In 
contrast to previous meetings, the questions posed were not answered straightforwardly as the panel 
quickly entered into a lively discussion about self-administration of insulin in hospital. As this had been a 
theme throughout the panel discussions this was unsurprising, but it was difficult on this occasion to direct 
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discussions towards how the research may uncover how the interventions work. Participants vivaciously 
gave their different opinions about how interventions should be designed and delivered to patients in 
hospital (see Box 2 in Chapter 5) but it was difficult to conduct the deeper discussions around potential 
mechanisms that generate outcomes. Despite this, the meeting did confirm that researching self-
administration interventions in more depth with realist methods was an appropriate way to conclude the 
body of work. 
 
Objective 4: Generate evidence-informed theory to explain how an intervention works, for whom, and 
in what circumstances. 
 
Following the identification and exploration of self-administration policies as a salient and complex intervention 
from the mixed methods study and patient/multidisciplinary team consultation, a realist synthesis was chosen to 
examine “what works, for who, in what circumstances and why?” with respect to intervention design, 
implementation and use.  Realist synthesis exposes and links contextual factors with underlying generative 
mechanisms to form hypotheses about how organisations can successfully implement insulin self-administration 
policies. The paucity of published literature evaluating insulin self-administration interventions and providing a 
theoretical grounding to implementation and design confirmed the need for such a study to contribute to 
improvement efforts. The realist synthesis answered the following research questions: 
1. What are the ‘mechanisms’ by which self-administration policies are believed to result in their 
intended outcomes? 
2. What are the important ‘contexts’ that determine whether or not the identified mechanisms 
produce either positive or negative outcomes? 
3. What are the circumstances in which self-administration policies are most likely to be effective? 
This is the first study that studies self-administration intervention implementation in a hospital context using 
realist review methods. Prior to this study, implementation designers had written commentary pieces on their 
experience and used audit methods to report outcomes of policy use (Johnston, 2019; Johnston & Newland-Jones, 
2017; Pearce, 2019; Rowse, 2018b, 2018a). Although there has been qualitative research investigating inpatient 
self-administration of medicines more generally, often this concerns oral medication use in the hospital setting 
and excludes the self-administration of injectable medicines with additional governance considerations such as 
insulin (Schultz et al., 2019). This study adds to the literature by using evidence-informed theory to uncover the 
generative intervention mechanisms that lead to outcomes of insulin self-administration policies (both positive 
and negative). 
The decision to use realist research methods for this final study was prompted by careful reflection on the 
qualitative analysis and the importance of context in contributing to intervention effectiveness highlighted by the 
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studies conducted so far (perceived or real). It was also important to continue the theme of including patients in 
the research, and as insulin self-administration in hospital was such an important topic to the panel, it was felt 
that working with a wider stakeholder group to co-produce a theory of how they work was an appropriate way to 
finish the current programme of research.  
All three research questions were answered by the collaborative, iterative and evidence-informed generation of 
10 context-mechanism-outcome configurations (CMOCs) that explained how insulin self-administration policies 
worked in what circumstances, and why. Insulin self-administration interventions are inherently complex and 
socially contingent, meaning that this intervention was particularly well-suited to realist research methods. 
The process of undertaking the realist synthesis was, however, very challenging, and required familiarisation and 
understanding of the underpinning realist logic as well as the use of more specialist terminology. For example, 
the cognitive task required to linearise the messy, ‘three-dimensional’ and fluid thinking process, and distinguish 
between realist-defined contexts and mechanisms was complex, and has been cited as a criticism of the method 
by some (Porter, 2015). For example, some of the outcomes included in the theories (e.g. patient empowerment 
and control) may become new contexts over time as the policy becomes embedded, in what has been described 
as a ‘ripple effect’ (Jagosh et al., 2015). The iterative process with which the realist synthesis was conducted 
differed markedly to other research methods used in this thesis, for example the systematic review and cross-
sectional survey. However, spending sufficient time to develop rough programme theories early on helped to 
identify the type of data needed at context, mechanism or outcome level in the later stages. 
It is recognised that the synthesis relies on available evidence, which is limited in the specific area of inpatient 
insulin self-administration policies in the UK hospital setting. A key strength of the synthesis was the additional 
literature searches conducted once key influencing factors were identified (empowerment and shared decision-
making). These searches were not limited to inpatient insulin self-administration policies in the UK hospital 
setting, which increased the validity and plausibility of the findings. For example, more literature was available 
regarding general self-administration of medicines and in non-UK settings, which could be used to help further 
develop theories for transferable learning. 
The co-creation of theories with stakeholder groups also presented an increased commitment to participatory 
health research approaches; the administrative task of conducting, documenting, processing, and synthesising 
stakeholder input was considerable. The stakeholder involvement was significant and useful throughout the 
review, however, both in theory creation early in the review, and later in confirming and refining programme 
theories. Although the literature searching was undertaken solely by the researcher, the in-depth, reflective 
discussions with various stakeholders throughout the project added to the validity of findings. Keeping records of 
meetings, notes and versions of programme theories as they developed added to the transparency of the process, 
along with following a systematic approach as outlined in the publicly available study protocol. 
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The creation of ‘non-academic’ actionable findings from the realist review should also help hospital teams 
improve the design and implementation of insulin self-administration policies. These findings are planned to be 
disseminated along with the per-reviewed publication of the review, via professional networks and national 
diabetes fora (e.g. Diabetes UK). 
The CMOs are not exhaustive, that is, there were more candidate CMOs than were prioritised for refinement with 
the literature. Realist programme theory is not designed to be exhaustive, however, unlike other theory-based 
approaches like certain types of grounded theory (Pawson et al., 2005). As such, there is scope for further work 
to generate other theories focusing on different intervention outcomes (such as reduction in medicines wastage 
and increase cost saving). Realist theories are also tentative, designed to be testable, and not absolute, so results 
should be interpreted with caution (Blamey & Mackenzie, 2007). Further refinement of theories is expected, for 
example through realist evaluation methods (see section 7.5, below).  
The application of both NPT and Kanter’s theory in the healthcare setting is well documented, and have been used 
in previous studies that were multi-perspectival with involvement of healthcare professionals and patients (C. 
May et al., 2011; McEvoy et al., 2014; Spence Laschinger et al., 2010). By framing the analysis with substantive 
middle-range theories, the resulting product of the realist synthesis can be applied across different settings and 




The additional stakeholder group recruited for the realist synthesis provided valuable ‘insider knowledge’ 
with respect to advice and insight into the use of self-administration policies from a range of perspectives 
at different points throughout the study. There was much interest in being part of the realist synthesis 
stakeholder group at the early stages, and it was not a struggle to recruit an appropriate variation of 
stakeholders that could add legitimate voices to the development of the theory from both patient and 
multidisciplinary healthcare professional angles. This also confirmed the salience of the topic for a wider 
range of healthcare professionals and patients than previously consulted. 
The decision to facilitate both synchronous and asynchronous discussions with stakeholders throughout 
the project was taken to accommodate the diverse availabilities of the group, many of whom were 
working in hospitals as front-line clinicians during the COVID-19 pandemic. Individual meetings were 
arranged where stakeholders could not attend group meetings, and email conversations were had with 
others.  This also helped individuals’ voices to be heard, which can be difficult when conducting group 
discussions that tend towards producing consensus opinion, especially in diverse groups such as this 
where professionals and patients – each with their own preconceptions, values and understanding of each 
other (Somekh & Lewin, 2005, p43). 
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The composition of members attending the group discussions varied, with a combination of healthcare 
professionals and patients attending the first group meeting, and with patients being the majority in the 
second meeting. The third meeting comprised mainly healthcare professionals. This may have impacted 
the theory development by disproportionately including patients’ input in the early ‘formative’ stages of 
theory refinement. The consideration of the interview data from the qualitative phase early on helped to 
redress what may have been an imbalance, as well as multiple healthcare professionals inputting into 
theory refinement during the later stages. The purpose of stakeholder involvement in realist research is 
not to get a proportionate sample of representative voices, however, but to add relevance and value to 
the theory development.  
Group meetings comprised between 4-6 individuals, which was an ideal size for group discussions 
(Liamputtong, 2011).  Although power differentials between group participants was anticipated due to 
the heterogeneous nature of the groups (patients, nurses, pharmacists, programme managers), there 
were no conflicts or apparent difficulties resulting from differences in participant characteristics. The 
group dynamics resulted in productive and positive discussions, and all members contributed unique 
insights. This may have been due to group members being motivated and educated enough to feel 
confident to volunteer for participation, and united in their desire to contribute to the research agenda 
on account of it being an important topic to them personally. Future studies may benefit from efforts to 
recruit ‘harder to reach’ representatives or those that could provide additional insights from a different 
perspective (i.e. those opposed to or wary of inpatient insulin self-administration). 
 
In summary, the research objectives were able to be met with the use of mixed methods and realist synthesis, 
although results should be interpreted with caution. The next section discusses the quality of the overall research, 
starting with general strengths and limitations of the thesis, followed by quality assessment of the individual 
studies. 
 
7.2 Strengths and limitations of the research 
  
The mixed methods study followed by the realist synthesis allowed quantification of issues relating to insulin 
prescribing practice interventions followed by in-depth exploration of key issues and interventions. Overall, this 
body of work extends our knowledge and understanding of current practice and experience with respect to insulin 
prescribing practice in the hospital setting, which is important to aid much-needed improvement efforts both in 
the UK and worldwide.  
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A mixed methods approach is utilized to provide a rich and contextualised dataset for the purposes of answering 
the research questions. In doing so, a more comprehensive understanding of the research problem is gained 
compared to the use of qualitative or quantitative methods alone. The sequential order of the studies aided the 
explanation of salient issues pertaining to insulin prescribing safety in the hospital setting as they were identified 
and discussed with stakeholders throughout the work. The list of identified interventions generated from the 
systematic review was further developed by cross-sectional survey results, generating a comprehensive 
documentation of current strategies for the benefit of shared learning and improvement of care across hospitals. 
The qualitative study results were able to explain the variation in the use and perceived effectiveness of 
interventions by discovering that these are influenced by the success of current implementation, individual 
organisational contexts, and respondents’ experiences. The use of reflexive thematic analysis to identify patterns 
of shared meaning across the dataset, as well as the application of a theoretical human factors framework, aids 
transferability of the findings. The scientific realist position and pragmatic approach to the research was congruent 
with the methodologies chosen. Although the studies produced somewhat different ‘types’ of knowledge, these 
were complementary, allowing tentative conclusions to be drawn relative to research questions that had arisen 
from the need to solve a common practice-based problem. 
Dissemination of results that identify salient interventions to improve insulin prescribing practice has further 
facilitated improvement efforts across NHS hospitals since publication, which is increasingly important where 
resources and capacity are increasingly limited (The Health Foundation, 2013). For example, results from the 
mixed methods study were discussed in person to policy makers at the NHS Getting It Right First Time (GIRFT) 
programme for diabetes ahead of the publication of the national report, particularly those relating to the 
association between specialist diabetes pharmacists and the greater use of insulin prescribing safety interventions 
(Rayman & Kar, 2020).  
Results from Chapters 2 and 3 have so far been disseminated via peer-reviewed publications, conference 
abstracts, professional networks and locally via hospital patient and professional forums. Following publication, 
individual clinicians, pharmacists, and medicines safety officers from trusts across the UK, including national 
speciality advisors, and clinical directors, have contacted the researcher to discuss local improvement efforts 
further. Survey participants have received copies of the peer-reviewed publications for more targeted 
dissemination of the findings (in their respective organisations), and it is intended that results will be shared with 
national patient groups via the charity Diabetes UK, specifically to help empower patients who are admitted to 
hospital to ask about insulin self-administration policies. This will also help to bring about one of the desired 
contextual factors impacting intervention success from the realist synthesis (i.e. patient empowerment by 
provision of information) on a national level. 
Although sometimes challenging, there have been many benefits to using a participatory health research 
approach throughout this thesis, including a sense of ‘closing the gap’ between research, policy, and practice. 
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Such approaches should be therefore considered for research that seeks to describe and investigate healthcare 
professional practices that impact on patient care and safety. Although the need to include patient public 
involvement in much research that is funded, it is appreciated that this may sometimes be ‘tokenistic’ and not 
always be in the spirit of participatory health research. If the researcher had not adopted a participatory approach 
in this work, it would likely have been to the detriment of themselves, their colleagues, and the stakeholders with 
whom they were working throughout the project. 
In summarising the evidence for interventions, along with reporting their current implementation status and 
perceived effectiveness, policymakers and practitioners can critically reflect on the suitability of initiatives being 
used locally and driven nationally. The use of human factors systems theory in exposing the contextual factors 
impacting on insulin prescribing practice in the hospital setting also enables policymakers and practitioners to 
take more of an evidence-informed and theoretically grounded approach to intervention use. The evidence-
informed theory generated from the realist synthesis will also facilitate the successful implementation of self-
administration interventions for the benefit of patients and practitioners. The product of the synthesis can also 
function as a set of contextually-sensitive measures for future evaluation studies. 
 
7.2.1 Limitations  
 
Despite this, it is recognised that the work has some limitations and therefore results should be 
interpreted cautiously. Data retrieved in the mixed methods study was limited to the views and 
experiences of pharmacist intervention designers and implementors in NHS hospital organisations. 
Although the project has benefitted from multidisciplinary input throughout, including medical 
prescribers, nurses and patients as participants in future studies would enable the consideration of 
alternative viewpoints and thus add value to results. As in all self-reported surveys, it was not possible to 
validate the data.  
Surveys were anonymised which limited the ability to do an in-depth analysis on individual cases (as 
interviewees were also survey respondents). This could have enabled additional analyses to be conducted 
on the overall mixed methods dataset, where a focus is on cases rather than themes (e.g. comparing a 
respondent’s interview data with survey data). 
Interventions were also not associated directly with reported organisational insulin error rates to 
generate results on ‘actual effectiveness’ of interventions. This was due to the diversity and complexity 
of organisations, systems and error measurement that would present significant confounders threatening 
the ability to draw any meaningful conclusions for investigations being conducted at a multi-
organisational level.  The product of this research does, however, aid the design of future evaluation 
studies by outlining contextual factors that influence intervention success, as well as relevant human 
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factors measures that extend past insulin error measurement (such as extent of integration with current 
prescribing systems, pedagogic design of educational interventions, and patient empowerment). 
 
7.3 Quality Assessment 
 
To assess the quality of the work produced one must apply quality criteria that is coherent with the overall 
philosophical and methodological approach to the research. This research was conducted under a pragmatic view, 
such that the most appropriate methodology was used to answer the research questions. A combination of mixed 
methods and realist research was used, which, within a critical realist ontology and relativist epistemology, calls 
for the application of different quality criteria to assess each study, rather than one general criteria.  For example, 
in this research, it would be inappropriate to assess the quality of the qualitative research with quantitative 
criteria (reliability, validity, generalisability, objectivity), as a relativist-informed reflexive thematic analysis was 
conducted from a non-positivist epistemology that did not seek to quantify qualitative data. Quality criteria 
therefore emerge from the specifics of a study, and are discussed below in order of the studies presented in the 
thesis. 
 
7.3.1 Systematic review 
 
The systematic review aims to conduct a literature review with the same rigour that should be used when 
conducting original research. As the aim is to minimise bias and random error in systematic review, the 
use of transparent and objective methods is required to allow the review to be reproducible. The 
systematic review was conducted according to the PRISMA guidelines, which enabled the generation and 
peer-reviewed publication of a high-quality review. A protocol that was externally peer-assessed and 
published on the PROSPERO database increased the quality and transparency of the review. 
The literature search was comprehensive, with a wide range of electronic databases being used to search 
the literature, including grey literature and hand searches of reference lists and journals. This enables a 
greater proportion of the literature to be captured, although it is possible that some papers may be 
missed. Selection criteria were discussed with the supervisory team (including a topic expert) and applied 
consistently to all papers. The studies were assessed independently by two researchers using a 
combination of three verified quality assessment tools appropriate to the study type, which strengthened 
the rigour of the review. Data extraction forms were developed based on those provided by the Cochrane 
Handbook and piloted to ensure that no relevant data were missed (J. Higgins, 2011) 
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Although publication bias was minimised by including grey literature searches, it was not formally 
assessed (e.g. with a funnel plot) as it was deemed unnecessary in the absence of meta-analysis. As meta-
analysis was not possible due to the diverse methodologies, methods, and definitions of prescription error 
in the studies, a narrative synthesis of findings was conducted. 
 
7.3.2 Mixed methods study 
 
Currently there is a lack of consensus in the description of quality for mixed methods studies, as well as a 
lack of consensus guidelines on how to evaluate mixed methods research designs (Ramzan, Hadi, & Babar, 
2019). Some of the current frameworks for conducting mixed methods research recommend justifying 
the use of mixed methods, describing the design, methods and integration, as well as identifying 
limitations, insights and discussing how disagreements between components will be dealt with (Creswell 
& Clark, 2017; Hadi, Alldred, Closs, & Briggs, 2014; NIH Office of Behavioral and Social Sciences, 2018; 
O’Cathain, Murphy, & Nicholl, 2008). These considerations have been discussed in Chapter 3 (section 
3.1.1). Due to the differences in mixed methods designs, approaches and typologies (Teddlie & 
Tashakkori, 2009), the application of individual quality criteria appropriate to the individual components 
of the studies was also undertaken. This will be discussed for the quantitative and qualitative phases 
below. 
 
Quantitative phase: cross-sectional survey 
 
Quality of quantitative research is considered in terms of validity and reliability, replicability, and 
generalisability. Although replicability and generalisability are understandably important in clinical studies 
quantifying effectiveness of treatments, they are considered less relevant for social research, with criteria 
such as explicitness and transparency being more valued (Alan Bryman, Becker, & Sempik, 2008). The 
range of quantitative study designs and purposes calls for the application of specific quality criteria 
relevant to the research being conducted.  The cross-sectional survey was conducted and reported 
according to the STROBE guidelines for reporting observational studies (see Appendix 9), which was 
deemed the most appropriate criteria to apply for this cross-sectional survey according to the EQATOR 
network (EQUATOR network, 2016). The use of these guidelines facilitated the transparent and explicit 
reporting of the survey, and included consideration of generalisability. The measures taken to address 





   
In survey research, validity refers to the extent that the measure used accurately reflects the 
concept we are interested in (Cowles & Nelson, 2019). Although there is debate about what 
constitutes instrument validation, the minimum requirement of tool validation is thought to be 
face validity (Burns et al., 2008; Menold, Bluemke, & Hubley, 2018). For the questionnaire tool 
used in this survey, face validity and content validity are the most relevant. Construct and criterion 
validity are important to consider when developing psychometric scales but were not applicable 
to this survey, which aimed to describe the use of systems and interventions across multiple 
organisations (a fact-based measurement) and report on respondent’s perceptions of 
effectiveness of multiple interventions, rather than generate constructs of perceived 
effectiveness of a single intervention (see also Chapter 3, section 3.3.1). 
Face validity assesses the presentation and relevance of the questionnaire such that the goals of 
the survey are met; that is, questions can be interpreted by participants, who are then willing and 
able to respond accurately (Dillman et al., 2014). To this end, due consideration was given to 
ensure item wording was specific, clear and of appropriate length and complexity (Cowles & 
Nelson, 2019). The use of an external expert panel allowed for the face validity to be assessed 
and the content and wording to enable the collection of relevant information. All expert panel 
reviewers were female diabetes pharmacists from larger teaching hospitals in England with 
involvement in diabetes research and healthcare professional education on a national level. It is 
therefore recognised that although they represented the target population, face validity may 
have been further improved by consulting additional target respondents from Wales, Scotland 
and Northern Ireland who represented other pharmacist respondents such as chief pharmacists 
or clinical pharmacy service managers. 
Content validity refers to the extent to which the items in the questionnaire are fairly 
representative of the entire domain it seeks to measure (Salkind, 2012). To address this, items 
were initially derived from the systematic review conducted in Chapter 2 as well as the literature 
identified in Chapter 1, the expert content knowledge from the supervisory team, external face 
validators and personal professional knowledge of interventions used in practice. Inter-rater 
reliability of judgements made on the usefulness of each item was also calculated as 
recommended by Wynd et al. (Wynd et al., 2003). This increased the chances of any important 
intervention items being omitted from the questionnaire tool design. The panel consisted of four 
target respondents who were also considered experts in the area; if a larger number of panellists 
was able to be recruited, additional quantitative validity testing may have been performed, such 
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as content validity index or content validity ratio, which is widely reported in tool development 
studies (Lawshe, 1975; Rubio et al., 2003; Zamanzadeh et al., 2015). 
 Although questions were limited in scope (i.e. use, functions and perceived effectiveness of 
interventions), this was on account of due consideration being given to minimising the burden on 
respondents. Future iterations on the survey may benefit from limiting the number of 
interventions being investigated, and using the results of the qualitative study to inform 
development of more detailed questions regarding respondents’ understanding of intervention 
effectiveness. 
Although the survey was reviewed by a multidisciplinary diabetes team, and involved mainly fact-
based questions that could be answered with reference to protocols or colleagues in the 
organisation, the possibility that some responses may have been different if answered by another 
individual at the hospital cannot be ruled out. As respondents were asked to describe current 
practice, recall bias is unlikely to impact results, although non-response bias could have affected 
the results. This was not formally assessed, however, due to the lack of readily available relevant 
demographic information for non-responding hospital organisations (e.g. type, size of hospital, 
presence of diabetes service and diabetes pharmacist). Sample size estimates were not 
conducted on account of the whole population of NHS hospitals being surveyed. It is recognised 
that those with an interest in insulin prescribing safety may have been more inclined to respond 




In surveys, reliability refers to the consistency in responses across different respondents in the 
same situations. Perceptions on the individual questions asked in may impact reliability of the 
questionnaire; this is minimised by asking questions that are likely to have a shared meaning. In 
this tool, the individual items have a high probability of being understood by the respondents, all 
being hospital pharmacists who are familiar with prescribing practice intervention design, use and 
evaluation and associated terminology. Most questions in the tool were fact-based and were 
therefore likely to be reliable. Different individuals’ understanding of the concept of perceived 
effectiveness may vary, however this is a common concern with self-administered questionnaires.  
Test-retest reliability was not undertaken in this study, due to time and resource constraints, as 
well as the unfavourable ethical and financial implications of requesting front-line healthcare 
professionals’ time to complete additional surveys, when the likelihood that response rate for re-
tests would be low. Split half reliability was not undertaken due to the absence of factor analyses, 
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however internal consistency reliability was undertaken using Cronbach’s Alpha. This test showed 
that the items were highly correlated across both the overall tool and the Likert scale section. It 
is understood, however, that alpha is also sensitive to the number of items in a test, with larger 
number of items resulting in a larger alpha.  
 
Qualitative phase: semi-structured interviews 
 
There is no absolute criteria for judging whether a piece of qualitative research is good (Braun & Clarke, 
2013), and different types of qualitative research employ varying theoretical approaches stemming from 
with diverse philosophical assumptions. The quality criteria described above (namely reliability and 
validity) stem from more positivist approaches that seek to minimise error and bias in research studies 
originating from the researcher. Some qualitative research that is conducted within this paradigm may 
employ techniques such as inter-rater reliability for data coding that researchers seek to quantify, but 
these are based on the assumptions that coding can and should be objective (Braun & Clarke, 2013).  
This study is underpinned by the researcher’s assumption that truth is context-bound, and that data are 
thus produced (rather than passively collected) by the researcher who inevitably influences the research 
process. Techniques such as inter-rater reliability assessments were therefore not considered for this 
research as they are not consistent with the approach taken.  The qualitative phase was conducted with 
reference to the criteria for reporting qualitative research (COREQ) checklist, which facilitates quality 
assessment of how elements of reflexivity, methods, context, findings, analysis, and interpretations are 
reported (Tong et al., 2007). It is recognised, however, that checklists such as this do not ensure quality 
in a qualitative project (Amin et al., 2020; Braun & Clarke, 2013) and are not always completely relevant 
for the type of qualitative research undertaken. For example, although most of the items on the COREQ 
checklist were relevant to the qualitative phase of the mixed methods study, the requirement for data 
saturation included in the checklist was not compatible with the methodological approach used (Braun 
and Clarke’s reflexive thematic analysis). Braun and Clarke argue that data saturation is a concept that is 
not compatible with reflexive thematic analysis where codes (and coding) are context-dependent, and 
the meaning of themes derive from the interpretative process of data analysis, which is an ongoing and 
organic process (Braun & Clarke, 2019). This supports Richer’s position that it might not be possible to 
develop a single set of guidelines that apply to all forms of qualitative research, and that each study should 
be judged on its own terms (Braun & Clarke, 2013; Reicher, 2000). 
Therefore, in addition to the COREQ checklist, a 15-point checklist for a good thematic analysis produced 
Braun and Clarke (the authors of the approach used in this study) was also considered (Braun & Clarke, 
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2006, 2013). This checklist covers the different processes involved in thematic analysis, including 
transcription, coding, analysis and writing. 
To reflect on the overall rigour of the qualitative phase is described below, the general quality criteria of 
trustworthiness and authenticity are discussed briefly below. These criteria are the original and widely 
accepted  criteria outlined by Lincoln and Guba (Lincoln & Guba, 1985, 1986) recently developed for 




Trustworthiness involves establishing the credibility, transferability, dependability, and 
confirmability of the research. My background as a hospital pharmacist and previous research 
into inpatient insulin prescribing quality (prior to and during the PhD) enabled prolonged 
engagement with the research topic and the ‘culture’ that I was researching, as well as 
development of trust with the research participants, who are from the same pharmacy profession 
and sector and had expressed interest to participate following their completion of the cross-
sectional survey.  
The sequential nature of this study following analysis of the survey, as well as discussions with 
stakeholder teams and keeping a reflective diary after each telephone interview, facilitated 
persistent observation, and a more critical reflection on contextual factors, salient issues and my 
own presumptions, ideas, doubts and thoughts throughout the study. The combination of 
prolonged engagement and persistent observation serve for a thick description to be presented 
in the analysis, to advance our knowledge of the topic and enhance transferability (Amin et al., 
2020)  
Member checking, where participants are given their transcripts, data interpretations or codes to 
review and confirm, is recommended by Lincoln and Guba to enhance the confirmability of the 
research (Lincoln & Guba, 1985). This was not undertaken due to the resource and time 
constraints of both the researcher and the pharmacist participants, as well as potential problems 
over non-response, or the impact of partial response and how to manage the analysis if accounts 
were changed or redacted. 
Triangulation is another technique recommended by Amin to enhance trustworthiness of the 
data by establishing its credibility. This qualitative study benefits from methodological 
triangulation with the cross-sectional survey and investigator triangulation by the involvement of 
2 undergraduate student researchers to ensure the analysis is rich, comprehensive, and inclusive 
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of others’ insights and interpretations. Theoretical triangulation was also achieved with the use 
of both reflexive thematic analysis and the application of human factors theory to the data. 
Peer debriefing was also undertaken with a fellow pharmacy practice PhD researcher studying 
diabetes medication use, whereby questions were asked about the research process, question 
formation, study design, analysis and data interpretation that enabled reflection on biases that 
may remain implicit. Negative case analysis, where elements in the data that deviated from the 
‘norm’ was also conducted to a limited degree. For example, one participant described how 
insulin prescribing charts were not helpful in their organisation during the interview, which was 
contrary to the majority opinion. This was explored further in order  to amplify the 
understanding of the data, for example why the predicted response did not occur, and strengthen 
trustworthiness (Amin et al., 2020).  
Finally, although not included in the thesis, an audit trail was kept throughout the study, in which 
records of the raw data, recordings, interview notes, iterations of data analysis on serial dated 
NVivo file versions, pilot forms of interview guides and dated reflective diary entries were kept. 
Lincoln and Guba promote this practice as the examination of the research process can 
corroborate its dependability (Lincoln & Guba, 1985). The inclusion of reflective diary accounts 
also demonstrate reflexivity as a mark of trustworthiness, as preconceptions and biases are 
accounted for during the conduct of the research as well as in the choosing of topic and research 




Authenticity refers to the fair and faithful presentation of a range of the different realities 
expressed by the participants, and involves an assessment of the meaningfulness, usefulness and 
impact of interactive inquiry processes (Shannon & Hambacher, 2014). The concept of 
authenticity stems from a more constructivist positionality, which recognises the existence of 
multiple ‘truths’ or ‘realities’ and seeks to ensure these are represented in the work produced. As 
this is not congruent with the scientific realist position, which claims the existence of one 
universal truth that cannot be completely known, this criteria may have limited applicability here. 
However, the concept of fairness is applicable due to the recognition of value-pluralism. The use 
of fully informed consent processes, member checks, thick description, audit trails, a reflective 
diary, and peer-debriefing helped to avoid a situation where some participants’ values were 
suppressed or enhanced depending on their agreement with my own. Also, excerpts were chosen 
that were felt to best represent the participants’ views, rather than serve the purpose of 
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confirming/refuting my assumptions. The same semi-structured interview guide was used with 
each participant, which gave each participant the opportunity to make their opinion heard on 
different aspects of the issue. It was also flexible enough to allow discussion of issues that 
participants felt were important to the topic area.  
Taken altogether, the above considerations should provide the reader with greater confidence in 
the qualitative study results. It is recognised, however, that this confidence is not guaranteed and 
complete evidence to inspire confidence is not possible to demonstrate, therefore the results 
should be interpreted with caution.  
 
7.3.3 Realist synthesis 
 
Unlike the mixed methods study, the assessment of quality of the realist synthesis benefits from the 
publication of a universally accepted quality criteria outlined by the Realist And Meta‐narrative Evidence 
Syntheses: Evolving Standards (RAMESES) group (G. Wong, Greenhalgh, Westhorp, & Pawson, 2014a). 
The RAMESES quality criteria involve 8 core components, with associated sub-criteria that enable 
researchers to appraise elements of the work as either inadequate, adequate, good, or excellent. These 
components include due consideration of the appropriateness of the research problem for realist 
synthesis, demonstration of understanding and application of the underpinning principals of a realist 
philosophy of science, along with elements of how the synthesis was undertaken (programme theory 
development, search strategy, document appraisal, data extraction). These quality standards were 
considered in addition to the publication standards referred to in Chapter 6, and enabled the 
enhancement of methodological rigour by aiming to achieve the ‘excellent’ standard for each criterion. A 
brief discussion of how these criteria were met is provided below: 
 
 The research problem 
 
The study of insulin self-administration policies was identified as suitable for realist research methods as 
it is a complex intervention that involves human decisions and actions. This was confirmed with 
consultation with a realist methodology specialist during attendance at a training conference prior to the 
start of the study. The results from the mixed methods study prompted further explanation of the ‘why’ 
question, which is paramount concern of realist synthesis. The research question was structured to reflect 
the elements of realist explanation, and was simple and focused enough to be achieved with realist 




Understanding and applying the underpinning principals 
 
To apply the underpinning principals of realist synthesis, I took time to wrestle with and understand the 
realist philosophy and logic of enquiry. This included familiarising myself with the work of social science 
methodologists Pawson and Tilley (Pawson, 2006; Pawson & Tilley, 1997), as well as their forerunners 
(Bhaskar and Sayer) and others advancing (and criticising) the use of the method (S. Dalkin et al., 2020; S. 
M. Dalkin et al., 2015; Emmel et al., 2019; Luetsch, Twigg, Rowett, & Wong, 2019; Porter, 2015), as well 
as participating in a specialist realist methodology training course.  
The realist synthesis presented in Chapter 6 demonstrates the iterative testing and refinement of 
theoretically-based explanations of how and why self-administration interventions work, which is the key 
analytic process in realist synthesis. 
 
Focussing the review 
 
The initial stages of the synthesis generated many potential avenues for exploration and explanation, on 
account of the complexity of the intervention and the diversity of stakeholders included. The process of 
focusing the breadth and depth was considered from the start on account of resource and time limitations 
to undertake the synthesis. The second round of stakeholder meetings were dedicated to prioritising 
issues to focus the review, which achieved maximal end-user relevance. This was documented as part of 
the review. 
 
Constructing and refining a realist programme theory 
 
The initial programme theories were elicited according to the structure recommended in the RAMESES 
training materials, by starting with outcomes of interest, and ‘working back’ to uncover why the 
intervention was thought to work to generate these outcomes. This was then iteratively recast in realist 
terms as the synthesis progressed, first using the CMO heuristic outlined by Pawson (Pawson & Tilley, 
1997) and later as multiple CM(response + reasoning)O configurations, as per Dalkin (S. M. Dalkin et al., 
2015). The relationship between programme theories and substantive theory (NPT and Kanter’s theory 





Developing a search strategy 
 
The search strategy was guided by the objectives and focus of the review and was directed at retrieving 
evidence from documents from a wide range of sources in order to refine the programme theory. No 
restrictions were placed on the study or documentation type, and further searchers were undertaken to 
seek out data from situations related to the intervention under study (general inpatient self-
administration policies) to find additional data to enable further theory refinement (e.g. search 2 and 3 
described in Chapter 6).  
 
Selection and appraisal of documents 
 
All documents were appraised and selected based on their relevance (their contribution to theory 
development), and rigour (the credibility of the method used to generate the piece of data). The 
limitations of the methods used to generate data were identified, considered, and documented in 
Appendix 17. This ran in parallel with the analysis stage and was based on explanations of this process 




Data were extracted from documents in such a way that prioritised theory refinement. Unlike in the 
systematic review presented in Chapter 2, data concerned contexts, mechanisms, outcomes, demi-
regularities and theories. This was facilitated by the use of NVIVO, which allowed elements of papers to 
be coded. The extraction process was refined to progress from coding data to individual contexts, 
mechanisms and outcomes, to overall CMO configurations. This improved the clarity of theory 
development and refinement. 
 
Reporting 
   
The final component of quality assessment pertains to reporting the synthesis, where adherence to the 
items listed in the RAMESES Reporting standards for realist synthesis is prioritised along with the 
availability of additional materials for external readers to investigate aspects of the review in further 
detail. The reporting standards were followed and additional material pertaining to the theory 




7.4 Implications for policy and practice 
 
The importance of the implementation of evidence-based policy cannot be underestimated. In the context of a 
national health system with scarce resource, one may argue that there is an ethical imperative to only commit 
resources to interventions where there is sound reason to believe that they will bring about effective change 
(Hawe, 2015). Resources should be targeted towards interventions that target mechanisms that have the most 
leverage, and away from those which are minimal in their effects. In investigating the interventions that are 
perceived to be the most (and least) effective for improving insulin prescribing safety nationally, this research 
provides policymakers with evidence with which to direct efforts. For example, our results would support a move 
away from the national recommendation and resources directed towards the insulin passport in the UK, in favour 
of interventions such as pedagogically sound and meaningful insulin safety training for healthcare professionals. 
The use and development of theory allows the deeper influences that impact on intervention use and outcomes 
to be uncovered, rather than focusing on surface-level barriers and facilitators to insulin prescription error 
reduction in the hospital setting. The wider contextual and human factors are considered to allow policymakers 
and practitioners to consider the sustainability issues around how interventions work within the wider system 
prior to implementation and during formal or informal evaluation. 
The annual national diabetes inpatient audit (NaDIA) in England and Wales has been used to benchmark and 
measure improvements in insulin prescribing practice both nationally and locally. Although this study did not 
include the NaDIA as an intervention per se, the use of the NaDIA data for promoting improvements in insulin 
prescribing may be improved by reports separating insulin errors into insulin prescription errors and insulin 
administration errors. At present they are reported together, either as insulin errors – incorporating insulin 
prescription and management errors, or prescription errors – incorporating other types of diabetes medication. 
Also, as our results show that not all trusts using electronic prescribing do so for subcutaneous insulin, the routine 
collection of more detailed data on how insulin is prescribed may help to interpret associations between 
electronic prescribing systems and prescription errors reported in their results. 
Our results suggest that the intrinsic motivations of frontline staff to improve insulin prescribing practice are 
substantial, but limited to what is enabled and prioritised by leadership, both in the trust and wider. This leads to 
the persuasion that, in keeping with the Health Foundation’s position, a combination of both top-down ‘extrinsic’ 
and bottom-up ‘intrinsic’ approaches lead to more sustainable improvements in inpatient insulin prescribing. This 
needs to involve and engage all members of the healthcare team, not just diabetes specialists in the hospital 
setting.  
With respect to the implications for the use of individual interventions in organisations, recommendations for 
trusts following consideration of the research results are presented in Table 7.1. 
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All trusts should have a dedicated insulin safety team that comprise a broad membership to facilitate 
sustainability and spread of interventions. Inclusion of primary care representation would further 
promote insulin safety efforts and continuity of safe care across the interface. 
All inpatient care teams (with or without specialist diabetes inpatient services) should benefit from 
the input of a pharmacist to help design, implement and evaluate interventions to improve inpatient 
insulin prescribing practice.  
The implementation of insulin prescribing safety interventions requires dedicated time and a 
systems approach across all hospital teams to be effective. These should be designed with generalist 
staff in mind, to empower non-diabetes specialist staff to make safe decisions with respect to insulin 
prescribing. This may help relieve the burden of responsibility for insulin safety falling onto specialist 













Well-designed prescribing systems (paper or electronic) can help to reduce insulin errors. These 
should reduce the ‘work’ of prescribing (e.g. electronic insulin order sets linked to trust formularies, 
pre-printed paper insulin prescribing charts) and be easily identifiable (coloured paper 
charts/inclusion of the word ‘insulin’ next to the product name on the electronic system/avoidance 
of device/product selection errors).  
Insulin prescriptions should be proximal to readily accessible blood glucose results. Design of 
electronic systems need to be flexible enough to be able to prescribe insulin appropriately, 
particularly as safety features (restrictive functions/limits) are not easily applicable to insulin. 
Local guidance regarding insulin prescribing, particularly in special situations (e.g. peri-
operative/dose titrations/hyperglycaemia etc.) needs to be up-to-date, brief, easy to follow, and 









Availability of current and complete insulin information at the point of care transfer is a problem. 
The insulin passport has incompatibilities with wider systems and mechanistic flaws in its design and 
is not supported as an effective intervention.   
Current systems/technology that span the care interface (e.g. the summary care record) should be 
utilised to include current insulin prescribing information (including doses). Inclusion of a well-
staffed pharmacy team at the front door would facilitate the timeliness and accuracy of insulin 
















Although mandatory insulin safety training is recommended, brief sessions or training packages 
completed on induction are unlikely to be effective. Active learning strategies utilising simulated and 
experiential pedagogies, and individual/group reflection on practise is likely to be more effective. 
Well-designed, mandatory, repeated e-learning packages that incorporate individual reflection and 





















Most hospitals have the intention of creating and using insulin self-administration policies, but 
multiple problems arise in the implementation phase, often due to complex socio-cultural issues. A 
supportive culture is needed to reassure staff that they will not be ‘blamed’ or ‘chastised’ if things 
go wrong. Open and honest communication, a culture of listening to patient’s concerns and 
opinions, and shared decision-making between the nurse and the patient is needed.  
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Risk assessments for insulin self-administration need to be simple and quick to complete, prioritising 
safety over perfection of technique. These should be integrated into existing review processes and 
documentation to ease the perceived burden on nursing staff time. 
Within-organisation communication and documentation needs to be consistent and reliable, so that 
patients are empowered to ask about self-administration and get a unified response irrespective of 
ward/directorate. 
Staff should have a forum to discuss and contribute to policy development/implementation with 
dedicated project leads to respond quickly to challenges and concerns. Strong supportive 
professional relationships are needed between diabetes specialists and non-specialists in order to 
facilitate shared ownership and responsibility for self-administration. 
 
7.5 Future research 
 
Following the consideration and discussion of the key outcomes of this research, as well as the strengths and 
limitations of the work, research areas that may be proposed for future work could include: 
1. Analysis of the experiences and perceptions of foundation doctors and nurses regarding the perceived 
effectiveness of inpatient insulin prescribing practice interventions in UK hospitals. This could be done 
nationally (like the present study) or in a bounded case study to triangulate with other data sources (such 
as local incident reporting analysis and prescribing error data) 
2. Assessment of the effectiveness of individual interventions to improve inpatient insulin prescribing 
practice in a UK hospital setting. This may be achieved using a multi-site bounded case study approach to 
allow for cross-comparisons. 
3. Investigating the overall acceptability of individual insulin prescribing practice interventions using other 
constructs included in the theoretical framework of acceptability (e.g. burden, intervention coherence). 
This could be conducted using similar methodology to the present study but incorporating psychometric 
scale development for these constructs. 
4. Investigating the implementation outcomes of individual insulin prescribing practice interventions 
amongst a larger number of healthcare professionals in a single organisation (e.g. acceptability, adoption, 
feasibility, sustainability).  This may be done using a mixed methods approach. 
5. Investigating the challenges and solutions to inpatient insulin prescribing practice and use of interventions 
in low-and-middle-income countries (LMICs). This could be conducted using similar methodology to the 
present study, following examination of the individual care systems and context of inpatient diabetes care 
in the countries of interest. 
6. Investigating the perceptions of patients on insulin self-administration using qualitative interview studies 
and incorporating a diverse sample of patients from different backgrounds. This may allow for the 
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identification and exploration of patient-factors that may impact the use of insulin self-administration 
interventions. 
7. Further testing and refinement of the insulin self-administration policy programme theories using primary 
data collection methods within a realist approach. This could be done with realist evaluation using a single 
or multi-site, mixed methods, bounded case study approach. 
 
7.6 Impact of the research on the researcher 
 
Prior to this research project I had not thought critically or in-depth about the design and implementation of 
interventions that are used to improve insulin prescribing practice in hospital, despite having been a pharmacist, 
whose role it is to ensure safe prescribing in this setting for many years. I have grown in my understanding of the 
various ways that pharmacists work with specialist inpatient diabetes teams to improve patient safety and care 
for people with diabetes. I have also been encouraged by the increased visibility that pharmacists have in this area 
amongst the multidisciplinary team, which has been reflected in national guidance and reports that have been 
published during the conduct of this PhD (Joint British Diabetes Societies for inpatient care, 2019; Rayman & Kar, 
2020). I feel more confident and responsible to take a proactive approach to assist in the design, implementation 
and evaluation of prescribing interventions more generally in the trust. I have also gained valuable experience 
with using human factors and implementation theories to help approach problem identification and solving for 
issues wider than insulin prescribing in practice. 
Throughout conducting the research it has become increasingly apparent that the work many pharmacists do in 
hospital goes unpublished. I also feel a responsibility to share my learning in this area to support the conduct and 
dissemination of good quality practice-based research, both locally in my new trust and working with colleagues 
further afield. This will help to demonstrate the positive impact pharmacists have on patient care for the ongoing 
health, growth and standing of our profession. I feel the skills I have learnt during the course of the PhD will benefit 
me as a pharmacist going forward, and are very relevant to my practice as a hospital pharmacist. 
By co-producing work with patients and other members of the inpatient care team, particularly in the realist 
synthesis, I have also grown in my awareness of the need to be patient-centred, both in research and in practice. 
Key skills of communication, partnership, shared decision-making and empathy have been developed during the 
course of this work. Being able to incorporate different viewpoints and value positions into the research agenda 





7.7 Conclusion  
 
Insulin prescribing is a common but risky process that has the potential to cause unintentional harm to people 
with diabetes in the hospital setting. The use of effective interventions to improve insulin prescribing quality are 
needed to reduce harmful and costly insulin errors for people with diabetes in hospital. Prompted by the lack of 
large-scale quantitative and qualitative research conducted in the UK in this area, this research aimed to 
investigate inpatient insulin prescribing practice and the current use of interventions designed to prevent insulin 
prescription errors in UK hospitals.  
The research findings indicate that inpatient electronic prescribing use is increasing, but there are significant 
differences in the functionality of systems to optimise insulin prescribing safety, which may limit the abilities of 
these systems to prevent errors. Both electronic and paper prescribing systems that reduce prescriber cognitive 
work and input during the prescribing process are likely to be more effective, such as the use of electronic insulin 
order sets or pre-printed ‘units’ and associations of doses with mealtimes. Restrictive functions may also be useful 
but these are limited for insulin due to the variability in doses and regimens required. Socio-technical factors that 
should be considered in system design include simple, obvious, accessible prescriber support for insulin 
prescribing in close proximity to the prescription (e.g. blood glucose results, local hypo/hyperglycaemia 
management guidelines). 
There is a wide variation in the use of recommended strategies to help improve insulin prescribing quality 
including prescriber education, decision-support tools, and policies. The implementation of nationally 
recommended strategies varies across hospitals, with only 46% using mandatory training, 31% using the insulin 
passport and 63% using self-administration policies. Interventions that were desirable and perceived to be 
effective included mandatory training, outreach team review and self-administration policies. The insulin passport 
was not perceived to be effective on account of flaws in its design and reliability; results suggest that efforts 
should be directed away from the passport and towards the optimisation of other systems such as summary care 
records to improve information transfer on admission to hospital. 
The implementation of interventions relies on a combination of personal, organisational and socio-cultural 
factors, such as staff turnover, availability and capacity of diabetes and pharmacy teams, hierarchy, fear, and 
perceived burden of interventions. This suggests that a multifactorial strategy is needed to prevent insulin 
prescription errors, including both bottom-up and top-down approaches. With respect to insulin self-
administration policies, the creation of programme theories enabled the circumstances in which these are likely 
to succeed was unearthed. These included promoting shared decision-making and more even power dynamics, 
simple documentation and integration with current workflow and systems, and the presence of a dedicated 
project lead to ensure consistent implementation and messages given to patients across the organisation. 
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With the use of systematic review, mixed methods and realist synthesis methods, this body of work extends our 
knowledge and understanding of current insulin prescribing practice and intervention use across NHS hospitals in 
the UK. The research has resulted in a comprehensive review of the evidence for such interventions, determined 
current intervention use and perceived effectiveness in UK hospitals, highlighted the current challenges and 
solutions to insulin prescribing practice improvement and has produced programme theories regarding how 
insulin self-administration policy interventions work, for whom and in what circumstances. The application of 
middle-range theories and a human factors systems model will enable practitioners and policymakers to design, 
implement and evaluate interventions in a more evidence-informed and contextually sensitive way, which is 
especially important in the climate of restricted resources and capacity. The use of a participatory health research 
approach enabled the research to be designed and interpreted with its end-users throughout; this resulted in 
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2002 0 1 1 1 1 1 1 1 1 1 0 0 0 0 0 1 
Al-Yassin 
2013 0 1 1 0 1 1 0 1 1 1 1 0 1 0 1 1 
Courtneay 
2007 0 1 1 1 1 1 1 1 1 0 0 0 0 1 0 1 
Donihi 2006 
1 0 1 1 0 1 1 1 1 1 1 0 0 0 0 0 
Dooley 2011 
1 1 1 1 1 1 0 1 1 1 0 1 1 1 1 1 
Donsa 2016 
1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 0 
Doyle 2014 
0 1 1 0 1 1 1 1 1 1 1 0 0 0 0 1 
Ena 2009 
1 0 1 1 1 1 1 1 1 0 1 0 1 0 0 1 
Gomez-
Huelgas 2014 0 1 1 1 1 1 1 1 1 0 1 0 1 0 1 1 
Guerra 2010 
0 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 
Hamilton 
2013 1 1 1 0 1 1 1 1 1 1 0 0 1 1 0 0 
Harbin 2015 
0 1 1 0 0 1 1 1 1 1 1 0 0 0 1 1 
Helmle 2017 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Horton 2015 
0 0 0 0 0 1 0 1 1 0 1 0 0 0 0 1 
Kowiatek 
2001 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 0 
Lehnbom 
2009 1 0 1 1 1 1 0 1 1 0 1 0 1 0 1 1 
Mamillapalli 
2012 1 0 1 0 1 1 0 1 1 0 1 0 1 1 1 0 
Maynard 
2009 0 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 
McIver 2009 
0 1 1 0 1 1 0 1 1 0 1 0 1 1 1 1 
Mulla 2015 
0 1 0 0 1 0 0 1 1 0 1 1 1 0 1 0 
Newsom 
2018 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Noschese 
2008 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 
Rushmer 




2009 0 1 1 1 1 1 0 1 1 0 1 0 0 0 0 1 
Schnipper 
2010 0 1 1 0 1 1 1 1 1 1 1 0 0 1 1 1 
Taylor 2012 
0 1 1 0 1 1 0 1 1 1 1 0 0 0 1 0 
Thompson 
2009 1 0 1 1 1 1 0 1 1 0 1 0 0 0 0 1 
Trujillo 2008 
0 1 1 1 1 1 0 1 1 1 1 0 1 1 1 1 
Tully 2018 
1 1 1 1 1 1 1 1 1 1 1 1 0 1 0 1 
Vaidya 2012 
0 0 1 0 1 1 0 1 1 1 1 0 1 0 0 1 
Valgardson 
2015 1 0 1 1 0 1 0 1 1 1 1 1 1 0 0 1 
Wesorick 
2010 0 1 1 0 1 1 1 1 1 1 1 0 0 0 0 1 
Wexler 2010 
0 1 1 0 1 1 1 1 1 0 1 0 0 0 0 0 
Wong 2016 
1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
Yeung 2018 
1 1 1 0 0 1 1 1 1 0 1 1 1 1 0 1 
 
 




































intervention"  Unclear risk High risk High risk Low risk Low risk 
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* NA * * * NA * * * 
Al-Yassin 2013 
* NA * * NA NA * * * 
Courtneay 2007 
* * * * NA NA * * * 
Donihi 2006 
* * * * NA NA * * * 
Dooley 2011 
* NA * *     * * * 
Donsa 2016 
  NA * *   NA * * * 
Doyle 2014 
* NA * * NA   * * * 
Ena 2009 
  NA * *   NA * * * 
Gomez-Huelgas 
2014 
* NA * * * * * * * 
Guerra 2010 
* NA * * * * * * * 
Hamilton 2013 
*  * * *     * * * 
Harbin 2015 
* * * * * * * * * 
Helmle 2017 
* * * * * * * * * 
Horton 2015 
* *   *     * * * 
Kowiatek 2001 
* *   *       * * 
Lehnbom 2009 
* * * * * * * * * 
Mamillapalli 
2012 
    * *     * * * 
Maynard 2009 




* * * *     * * * 
Mulla 2015 
* * * *    * * * 
Newsom 2018 
*   * * *   * * * 
Noschese 2008 
* * * * * * *   * 
Rushmer 2008 
    * *     * * * 
Schnipper 2009 
    * * * * * * * 
Taylor 2012 
* * * *     * * * 
Thompson 2009 
* * * *     *   * 
Trujillo 2008 
    * *     * * * 
Tully 2018 
* * * *     *   * 
Vaidya 2012 
* * * *     *   * 
Valgardson 
2015 
    * *     * * * 
Wesorick 2010 
* * * *     * * * 
Wong 2016 
* * * *     * * * 
Yeung 2018 






Appendix 4: Cross-sectional survey tool 
National survey of insulin prescribing in UK 
NHS hospitals 
 
We are conducting a cross-sectional survey that aims to describe how insulin is currently prescribed 
for inpatients in National Health Service hospitals throughout the United Kingdom. 
 
Despite various measures to help improve insulin safety, medication errors involving insulin remain 
a problem. Your valuable responses will help us to understand how to focus efforts to improve insulin 
prescribing safety and reduce insulin errors. 
 
Please answer the following questions to the best of your ability and as fully as possible. Feel free to 
ask colleagues for help as appropriate. Any information you provide will remain strictly confidential. 
 
If you are answering on behalf of a Hospital Trust in England, please answer according to the main 
acute hospital in the Trust. The survey should take approximately 15 minutes to complete. Please 
send your completed survey back to us using the pre-paid envelope provided by Thursday 31st 
January 2019. 
 
Once the survey is complete, a copy of the results will be sent to you as a token of our appreciation.  
 
If you have any questions about this survey, or require any help, please do not hesitate to contact 
the research team lead, Amie Bain, at a.bain@hud.ac.uk 
 
 
   THANK YOU for your time and for contributing to this valuable piece of work  
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  Section  A    About your hospital 
 
Please answer the following questions about your hospital. 
1. Where in the UK is your hospital situated? (please circle one) 
England  Wales  Scotland Northern Ireland 
2. How would you best describe the hospital you work in? (please circle one) 
Teaching Hospital District General Hospital Community Hospital  
Other (please state): __________________________________________________________ 
 
3. How many inpatient beds does your hospital have? (please circle one) 
<200  200-500  501-1000  >1000 
 
             YES  NO     Unsure 
4. Does your hospital provide specialist diabetes services?      
5. Is there currently a specialist diabetes pharmacist in post? 
6. Please describe the grade/role and full-time equivalent (FTE) of the pharmacist(s) overseeing diabetes care 
 (e.g. 1 band 8a diabetes specialist pharmacist 0.5FTE, 2 band 7 medicine pharmacists both 1 FTE) 
 
_________________________________________________________________________________ 
   
7. Are there current, local hypoglycaemia guidelines in use?   
8. Are there current, local hyperglycaemia guidelines in use? 
9. Is inpatient electronic prescribing used at your hospital?  
10. Is subcutaneous insulin prescribed electronically for inpatients?   
If you answered YES to question 10, please go to Section B  
If you answered NO to question 10, please go to Section C 
If your hospital currently has both electronic AND non-electronic prescribing of insulin, please complete 








  Section B      Electronic prescribing of subcutaneous insulin 
 
11. How long has subcutaneous insulin been prescribed electronically at the hospital? (please circle one) 
 
<1 year   1-2 years  3-5 years  >5 years  not sure 
Please indicate if any of the following are currently used in the electronic prescribing of subcutaneous insulin 
at your hospital (please tick one box per question) 
      YES        NO    
Unsure 




13. Electronic prescribing system integrated with electronic medical record 
14. Electronic prescribing system linked to electronic blood glucose results 
15. Electronic prescribing system linked to the pharmacy dispensing software 
16. Electronic prescribing system linked to the discharge/transfer summary 
 
17. Mandatory selection of ‘units’ (as opposed to u, iu, mg, ml) 
 
18. Function to check that the insulin dose is in a ‘normal’ range 
19. Alerts for when insulin is prescribed at particularly high doses 
20. Alerts to notify prescriber when a concentrated insulin product is selected 
21. Dropdown or auto fill menu selection for insulin product(s) 
22. Ability to specify insulin device (e.g. vial, pen-fill, disposable pen) 
 
23. ‘Free-typing’ insulin product names for insulin prescribing 
24. Ability to select mealtimes instead of clock times for dosing 
25. Insulin order sets* 
26. Function to automatically calculate correctional insulin doses for 
hyperglycaemia 
 
27. Ability to prescribe variable doses/dose range(s) (e.g. for patients who dose-
adjust according to carbohydrate intake) 
 
28. Ability to signpost for self-administration and/or self-management with insulin 
 
29. Electronic prescribing of insulin pumps (continuous subcutaneous insulin 
infusions) 
 
30. Electronic system linked to results from remote blood glucose testing 
  




   Section C      Non-electronic prescribing of subcutaneous insulin 
 
Please indicate if any of the following are currently used in the non-electronic prescribing of subcutaneous 
insulin at your hospital (please tick one box per question) 
    YES     NO  
Unsure 
31. Dedicated subcutaneous insulin prescription chart 
32. Dedicated subcutaneous insulin prescription chart incorporating a blood 
glucose monitoring section 
33. Dedicated subcutaneous insulin prescription chart incorporating a blood 
glucose monitoring section AND management guidelines? 
34. Pre-written ‘units’ to minimise the use of alternatives (e.g. u, iu, mg, ml) 
        
        YES       NO      
Unsure 
35. Mealtimes specified rather than clock-times         
36. Device specified (e.g. prescribers may select from pre-printed devices) 
37. Dedicated subcutaneous insulin prescription chart incorporating a section for 
STAT doses of insulin 
38. Ability to prescribe variable doses/dose range(s) (e.g. for patients who dose-
adjust according to carbohydrate intake) 
 
 
39. Dedicated chart for prescription of insulin pumps (continuous subcutaneous 
insulin infusions)  
40. Electronic system linked to results from remote blood glucose testing  
41. Does the hospital intend to prescribe subcutaneous insulin electronically in the 
near future? 











    Section D     Other insulin prescribing interventions 
 
     Please indicate if any of the following are used in your hospital (please tick one box per question) 
             
                                                   YES        NO Unsure 
42. Additional requirements for medicines reconciliation of insulin on 
admission* 
43. Insulin passport 
44. Use of patient's own insulin on admission to hospital 
45. Insulin self-administration policy 
46. Insulin self-management policy 
47. Formulary limitations on numbers of insulins able to be prescribed 
48. Limitations on number of insulins/devices available to order as ward stock 
49. Dedicated insulin order form (i.e. if transcription required to dispense insulin) 
 
50. Restrictions on ordering of concentrated (200-500 units/ml) insulin (e.g. 
restricted policy/extra checks required before dispensing) 
 
51. Additional validation of 'high doses' of prescribed insulin before dispensing 
(e.g. over 50 units) 
 
52. Tallman lettering on insulin prescriptions (electronic or paper) 
53. Specific requirements for medicines reconciliation of insulin on discharge*  
54. Nursing double-check of insulin prescriptions on discharge 
55. Insulin discharge checklists 
Pocket-sized guideline cards       
56. Algorithm for calculating correctional insulin doses for hyperglycaemia             
57. Mandatory insulin safety education for clinical staff on induction        
58. Mandatory repeat/booster insulin safety education for clinical staff 
           
59. Outreach team review of patients with hypo/hyperglycaemia (e.g. in conjunction 
with remote blood glucose monitoring)  
 
60. Local policies/recommendations addressing the use of biosimilar insulins 
 
 





61. If your hospital currently uses other interventions or strategies (not listed above) to improve insulin 







Please continue on to Section E
  
 
   Section E      Effectiveness of insulin prescribing interventions 
 
How effective do you think the following interventions are (or could be) for promoting insulin safety at your 
hospital?  Please give your answer on a scale of 1 to 5, with 1 being not effective and 5 being very effective. 
 
                           Not effective            Very effective 
                          1             2            3            4       5 
62. Electronic prescribing of subcutaneous insulin 
63. Dedicated subcutaneous insulin prescription chart 
64. Local hypoglycaemia guidelines 
65. local hyperglycaemia guidelines 
66. Specific requirements for medicines reconciliation of insulin on 
admission* 
67. Insulin passport 
68. Use of patient's own insulin on admission to hospital 
69. Insulin self-administration policy 
70. Insulin self-management policy 
*Such as pre-admission insulin administration and monitoring arrangements, management plans, recent dose/device changes, details of last dose given 
etc. 
                Not effective                                         Very effective
                   1           2             3            4     5 
71. Formulary limitations on numbers of insulins able to be prescribed  
72. Limitations on number of insulins/devices available to order as ward 
stock          
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73. Dedicated insulin order form (i.e. if transcription required to 
dispense insulin)                                          
74. Restrictions on ordering of concentrated (200-500 units/ml) insulin                                       
75. Additional validation of 'high doses' of prescribed insulin before 
dispensing (e.g. over 50 units) 
76. Tallman lettering on insulin prescriptions 
77. Specific requirements for medicines reconciliation of insulin on 
discharge* 
78. Nursing double-check of insulin prescriptions on discharge 
79. Insulin discharge checklists 
80. Pocket-sized guideline cards 
81. Algorithm for calculating correctional insulin doses for hyperglycaemia 
82. Mandatory insulin safety education for clinical staff  
83. Outreach team review of patients with hypo/hyperglycaemia 
(e.g. who have been flagged by an electronic system linked to 
remote blood glucose monitoring)  
*Such as post-discharge insulin administration and monitoring arrangements, recent dose or device changes, diabetes management care plans. 
 
 
84. If you described any other insulin safety measures at your hospital in Q62, please comment on their 
effectiveness below 
 
               Not effective                     Very effective 






End of Questions 
 
 
You are welcome to enclose anonymised copies of your hospital’s insulin prescribing charts or educational 
materials should you wish to. These may be included in the published report as appendices. 
 






This page will be removed by the administration team prior to data analysis.  
Providing your details will not compromise the anonymity of your responses. Your expression of 
interest information will be transferred to the research team once the survey has been completed. If 
you wish to withdraw your interest at any point, please let us know via email (a.bain@hud.ac.uk).  
Thank you. 
 
Thank you for completing this survey 
 
Your valuable responses will help inform evidence-based strategies to improve insulin safety in 
hospital.  
If you are interested in being involved in the next stage of our research, which will seek to further 
















Thank you again for your participation in this survey. 
Please return your completed survey to the research team using the 




Appendix 5: Accompanying letter to cross-sectional survey 
Mrs Amie Bain 
School of Applied Sciences 
University of Huddersfield 
HD1 3DH 
Email: a.bain@hud.ac.uk 
Tel: 01484 471476 
 
  10th January 2019 
 
Dear 
You are invited to participate in a national survey regarding the prescribing of subcutaneous insulin in hospital. 
The study is being conducted by a team of researchers at the University of Huddersfield, which includes 
undergraduate MPharm students, and has been approved by the University’s Research Ethics Committee (REF: 
SAS-SREIC 4.1.19-3). 
The purpose of the study is to describe how insulin is currently prescribed in hospitals across the United Kingdom, 
along with any measures taken to improve insulin prescribing safety. Your participation in the survey will help us 
to better understand how to focus efforts to improve insulin prescribing for inpatients with diabetes. This is 
particularly pertinent following both the 2017 WHO Global Patient Safety Challenge on Medication Safety and 
National Inpatient Diabetes Audit (NaDIA) report, which urges hospitals to take measures to considerably reduce 
insulin errors.  
We have contacted you as either the chief pharmacist, pharmacy manager or specialist diabetes pharmacist for 
your hospital. If you feel there is a more suitable member of the team to complete this survey on behalf of your 
hospital please feel free to redirect accordingly. We estimate that it will take about 15 minutes of your time to 
complete the survey.  
Your participation in the survey is voluntary. You may decline to answer any question you wish and you have the 
right to withdraw from participation at any time. Please feel free to contact us at the above address if you would 
like to discuss the survey further. 
Responses given in this survey are anonymous and will remain confidential. Identification codes included on the 
self-addressed envelopes will be kept by a member of the university administration team during the data 
collection phase for tracking and follow-up purposes only.  
If you agree to participate please complete the attached survey and post it back to us using the included pre-paid 
envelope by Thursday 31st January 2019.  
Thank you for your valuable time in helping us with this important work. 
Yours sincerely 
Amie Bain 
Academic Practitioner, University of Huddersfield/Sheffield Teaching Hospitals NHS Foundation Trust 
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Appendix 6: Email invitation to participate in telephone interviews 
 
Dear __________ 
Thank you for expressing interest in our research, which aims to explore insulin prescribing safety in hospitals 
across the UK. Your participation in the National Insulin Prescribing Survey earlier this year was very much 
appreciated; the report is currently undergoing peer-review and we will send you a copy as soon as it is published.  
We would like to invite you to participate in a short, semi-structured telephone interview in order to further 
explore some of the results from the survey. More information is included in the attached information sheet, but 
briefly, we would like to talk about the following topics: 
• Your experiences and opinions regarding insulin prescribing safety strategies at your hospital. 
• The impact of any strategies on insulin errors and patient experience. 
• Challenges and possible solutions to the safe prescribing of insulin in hospital. 
If, after reading the attached information sheet, you would like to participate, please reply to this email and we 
can arrange a suitable time to call. We would love to hear from you – your responses are really valuable in helping 
to shape future strategies and interventions to help achieve safer use of insulin in hospital. If you have any 
questions, please do not hesitate to get in contact. 






Appendix 7: Participant information sheet for telephone interviews 
 
Improving the safety of insulin prescribing in hospital 
Information sheet for participants 
 
Introduction 
We would like to invite you to participate in this project, which is concerned with the safe prescribing of insulin 
for people with diabetes in hospital. We are interested in exploring the challenges and solutions with respect to 
safe insulin prescribing at different hospitals throughout the United Kingdom. Please read the following 
information before deciding to participate in this study. 
 
Why am I doing this project? 
Despite various interventions to help improve insulin prescribing safety, insulin errors persist. The 2017 National 
Diabetes Inpatient Audit showed that 4 in 10 patients using insulin experience an insulin error, and urged 
pharmacy teams to work with diabetes teams to support the safe use of insulin in hospital. 
As part of this project, people who responded to the National Insulin Prescribing Survey earlier on this year will 
be invited to participate in a telephone interview with the lead researcher and pharmacist, Amie Bain. These 
interviews aim to explore some of the results of the survey, and will be audio-recorded and the information will 
be transcribed and analysed and the results published for wider dissemination. This study forms part of a PhD 
project at the University of Huddersfield and Sheffield Teaching Hospitals NHS Foundation Trust and has had 
ethical approval from the university (ref: SAS-SREIC 12.7.19-1). 
 
What will you have to do if you agree to take part? 
Your consent to take part will mean the following will happen: 
We will arrange a time when we can talk over the phone about your experience of insulin prescribing at your 
hospital. This should take around 30 minutes and will be at a time that is convenient to you.  
The interview will be semi-structured with open questions designed to facilitate an in-depth discussion. I am 
particularly interested in discussing the following, although we can talk through any related topics that are 
important to you: 
• Your experiences and opinions regarding insulin prescribing safety strategies at your hospital. 
• The impact of any strategies on insulin errors and patient experience. 
• Challenges and possible solutions to the safe prescribing of insulin in hospital. 
 
Will your participation in this project remain confidential? 
All identifiable information about yourself or your organisation will not be transcribed or disclosed to third parties. 
Your responses will remain anonymous and used for the purposes of this project only. Transcribed information 
will remain secure on a password-protected networked computer at the university, accessible only to myself. 
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What are the advantages of taking part? 
This interview will help explore the current challenges and solutions to the safe use of insulin in hospital. The 
results from this study could inform strategies to improve insulin prescribing in hospitals across the country. The 
interview process may also help facilitate reflection on related issues affecting your organisation locally. 
 
Are there any disadvantages to taking part? 
You may not feel comfortable talking about current practices or your experiences at your hospital, but you can be 
assured that any data will remain fully anonymised.  
 
Do you have to take part in the study? 
Participation in this study is completely voluntary, and you can withdraw at any point should you wish to do so.  
 
What happens now? 
If you are interested in being interviewed, please reply to the email from Amie Bain (a.bain@hud.ac.uk) and we 
can arrange a phone call at a time convenient for you - my intention is to not impede on your working day so I can 
be as flexible as possible. Feel free to ask any questions you may have. You can contact me (Amie) or another 
member of the research team as detailed below. 
Thank you once again for your help with this important work. 
Contact details: 
Lead Researcher:    Research team member:  
Amie Bain     Dr Shahzad Hasan 
School of Applied Sciences   School of Applied Sciences 
University of Huddersfield   University of Huddersfield 
Queensgate     Queensgate 
Huddersfield     Huddersfield 
HD1 3DH    HD1 3DH 
01484 471 476    01484 471 594 
A.bain@hud.ac.uk     s.hasan@hud.ac.uk 
amie.bain@nhs.net   
 
Supervisory Team:  
Professor Zaheer-Ud-Din Babar  Dr Neil Hamilton 
School of Applied Sciences   Sheffield Teaching Hospitals NHS Foundation Trust 
University of Huddersfield   Royal Hallamshire Hospital   
Queensgate    Glossop Road 
Huddersfield    Sheffield  
HD1 3DH    S10 2JF 
01484471471    0114 213259 
z.babar@hud.ac.uk    neil.hamilton@sth.nhs.uk  
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Appendix 8: Transcription Notation system 
 
Feature Notation and explanation of use 
The identity of the 
speaker 
The speaker’s pseudonym or role, followed by a colon, or with their 
speech on the following line. E.g: 
 
Interviewer 




Interviewer: how are you? 
 
Where one person is mid-way through a phrase and the other verbally 
signals agreement or similar, this is included in parenthesis and italics 
with a colon after the speaker’s name in the text. E.g.: 
 
P1 
Don’t you think, yeah (interviewer: yeah) that it happens this way 
because  
 
Laughing (laughs) signals a speaker laughing during their turn of talk 
Reported speech Where the interviewer or participant is quoting themselves or someone 
else in their phrase, this is indicated with speech marks. E.g.: 
 
she said “why not, it’s only a biscuit?” 
when I started in the role I said “do we use these?” 
Pausing (pauses) signals a significant pause (a few seconds or longer). 
Spoken abbreviations Abbreviations are included as given (e.g. DKA) but abbreviations will not 
be included unless a participant does so. 
Inaudible (inaudible) used where speech and sounds are inaudible on the audio. 
Where the phrase is uncertain, use a question mark before it is written 
in parenthesis (e.g. (?abasaglar)) 
Non-verbal utterances Common non-verbal sounds such as ‘erm’ ‘mm’ ‘uhuh’ will not be 
included unless it is deemed critical to interpret the phrase. 
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Spoken numbers All spoken numbers are spelled out rather than using numerals. The 
exception to this is when referring to job titles e.g. FY1 doctor, years e.g. 
in 2012, or paper sizes e.g. on an A4 sheet of paper. 
Emphasis on particular 
words 
Emphasis is indicated by italicising words in the transcript (e.g. I think it 
really is a waste of time)  
Expression Where phrases are said in an expressive way, this is indicated by the use 
of exclamation marks as would be in written text. E.g. 
 
Interviewer 




Where information has been redacted or replaced due to anonymity this 
is presented in brackets (e.g. I worked at [Hospital A] for 5 years with 




Participants’ speech will be as closely represented as possible and not 
‘corrected’ in the transcript to correct pronunciation or ‘standard 
English’. 
Cut-off sounds The phonetic sounds heard will be transcribed followed by a dash (e.g. I 
went to eat my breakf- oh, I forgot to mention) 
Non-transcription of 
sections of data 












Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the 
abstract 
(b) Provide in the abstract an informative and balanced summary of what was 
done and what was found 
Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation being 
reported 
Objectives 3 State specific objectives, including any prespecified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of 
participants 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, 
and effect modifiers. Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods 
if there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative 
variables 
11 Explain how quantitative variables were handled in the analyses. If 
applicable, describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for 
confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) If applicable, describe analytical methods taking account of sampling 
strategy 
(e) Describe any sensitivity analyses 
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers 
potentially eligible, examined for eligibility, confirmed eligible, included in the 
study, completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
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Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) 
and information on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of 
interest 
Outcome data 15* Report numbers of outcome events or summary measures 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted 
estimates and their precision (eg, 95% confidence interval). Make clear which 
confounders were adjusted for and why they were included 
(b) Report category boundaries when continuous variables were categorized 
(c) If relevant, consider translating estimates of relative risk into absolute risk 
for a meaningful time period 
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and 
sensitivity analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias 
or imprecision. Discuss both direction and magnitude of any potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, 
limitations, multiplicity of analyses, results from similar studies, and other 
relevant evidence 
Generalisability 21 Discuss the generalisability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present study 
and, if applicable, for the original study on which the present article is based 
 





Appendix 10: Semi-structured telephone interview guide 
 
Improving the safety of insulin prescribing in hospital 
 
Semi-structured telephone interview 
 
Start of interview 
• Introduce yourself and thank for participation 
• Explain reason for interview – to explore your opinions and experiences with respect to challenges and 
solutions of [the design, implementation and use of] insulin prescribing improvement strategies and their 
impact. 
• Agree time limits 
• Inform conditions of confidentiality- as stated in participant information sheet 
• Ask for consent to use tape recorder 
 
Examples of questions to be asked: 
• Can I start by asking what your role is? 
• How long have you been in your current role? 
• What kind of organisation do you work for? 
• As part of your role, are you involved with helping the trust to safely prescribe insulin? 
o If not, is there anyone within pharmacy with this responsibility? 
• What does your/their role involve with respect to insulin prescribing safety? 
o Prompts – some of the things we asked about in the survey were around medicines 
reconciliation/ prescribing systems/guidance/education 
• What do you feel the main challenges are at the moment in your hospital with respect to insulin 
prescribing safety? 
• What strategies are currently in place to try and optimise the quality of insulin prescribing at your trust? 
o Why have these specifically been used? 
• What do you feel has been the most impactful strategy that has been put into place in this area? 
o Why is that? 
• How do you go about reflecting on [this strategy]? 
• Have any strategies not worked particularly well?  
o What factors do you feel contributed to this? 
• When we discussed the results of the survey with our patient panel, one of the main issues raised was 
around self-management and self-administration of insulin in hospital.  
o Could you describe what happens in your hospital with respect to this? 
o What are your reflections on this? 
▪ Ideas and assumptions about how it works 
▪ What is necessary to support success? 
• One of the main things we looked at in the survey was electronic prescribing. Does your trust use 
electronic prescribing? 




• Is there any advice you would give someone who is wanting to improve insulin prescribing safety at 
their hospital? 




• Any other factors that you think might be important that we haven’t covered? 
• Is there anything you would like to add, or ask me? 
You can choose to stay updated about the project in which case I will add you to a regular mailing list and inform 
you regarding the progress of the study. Alternatively, you can opt out of any further communication too 




Appendix 11: COREQ (COnsolidated criteria for REporting Qualitative research) Checklist  
 
Topic  Item 
No.  
Guide Questions/Description  
Domain 1: Research team and reflexivity  
Personal characteristics  
Interviewer/facilitator  1  Which author/s conducted the interview or focus group?  
Credentials  2  What were the researcher’s credentials? E.g. PhD, MD  
Occupation  3  What was their occupation at the time of the study?  
Gender  4  Was the researcher male or female?  
Experience and training  5  What experience or training did the researcher have?  
Relationship with participants  
Relationship established  6  Was a relationship established prior to study commencement?  
Participant knowledge of the 
interviewer  
7  What did the participants know about the researcher? e.g. personal goals, 
reasons for doing the research  
Interviewer characteristics  8  What characteristics were reported about the inter viewer/facilitator? e.g. Bias, 
assumptions, reasons and interests in the research topic  
Domain 2: Study design  
Theoretical framework  
Methodological orientation and 
Theory  
9  What methodological orientation was stated to underpin the study? e.g. 
grounded theory, discourse analysis, ethnography, phenomenology, content 
analysis  
Participant selection  
Sampling  10  How were participants selected? e.g. purposive, convenience, consecutive, 
snowball  
Method of approach  11  How were participants approached? e.g. face-to-face, telephone, mail, email  
Sample size  12  How many participants were in the study?  
Non-participation  13  How many people refused to participate or dropped out? Reasons?  
Setting  
Setting of data collection  14  Where was the data collected? e.g. home, clinic, workplace  
Presence of non-participants  15  Was anyone else present besides the participants and researchers?  
Description of sample  16  What are the important characteristics of the sample? e.g. demographic data, 
date  
Data collection  
Interview guide  17  Were questions, prompts, guides provided by the authors? Was it pilot tested?  
Repeat interviews  18  Were repeat inter views carried out? If yes, how many?  
Audio/visual recording  19  Did the research use audio or visual recording to collect the data?  
Field notes  20  Were field notes made during and/or after the inter view or focus group?  
Duration  21  What was the duration of the inter views or focus group?  
Data saturation  22  Was data saturation discussed?  




Appendix 12: Explanations of codes and example quotes 
 
The codes provided below are exported from NVivo and appear in alphabetical order, which may differ slightly 
from the logical order presented in Chapter 5. 
 
1. Improving insulin prescribing practice is an important but ‘wicked’ problem 
The perceived need for insulin prescribing quality improvement interventions, organisational and personal drivers 
for the improvement of insulin prescribing quality locally, and the challenges to making desired changes amongst 
individuals, teams and organisations. 






Drivers for improvement 
 
 
Organisational and personal 
drivers exist for the 
improvement of insulin 
prescribing quality locally. 
Factors that facilitate the 
desire to improve insulin 
prescribing quality. 
 
“The reason was I suppose on 
the back of a CQC where we 
had quite a negative report 
around diabetes.” P10 
“And then, and then, of 
course, the alerts came out 
saying you need to do you 
know, this, this and this. And 
on the back of that, well, I'd 
come from a trust with a 
separate insulin drug chart, so 
I devised an insulin drug 
chart.” P13 
“I think the driver was at the 
time it was set up we had a 
consultant nurse for diabetes 
that was very keen on 
progressing those sort of 
things, and linked in with 
pharmacy – it was in response 
to, you know, the number of 




Data as a driver 8 12 
Interventions as designed around causes of 
error 
2 3 
Research as a tool for improvement 3 3 
Experience as a driver 6 19 
Independent prescribing as positive 6 10 
Individuals driving insulin safety 2 3 
Action as dependant on individuals in power 2 4 
Engaging senior staff as important to 
improvement 
6 11 
Diabetes team infrastructure as longstanding 1 1 
Enthusiasm as important for success 1 1 
Relationships as dependent on individuals 1 1 
Regulation and recommendations as a driver 8 16 
Care Quality Commission as a driver for 
improvement 
1 2 
Never event as just avoided 1 1 
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NPSA as removed from practice  2 3 
Quality markers as a facilitator 1 1 
Improvement is challenging 
 
 
The challenges and barriers 
to making desired changes 
amongst individuals, teams, 
and organisations. Factors 
that make the process and 
sustainment of improvement 
difficult. 
“Absolutely, it’s the number 
one drug in our hospital for 
harm-related incidents". – P11 
“And, you know, is, is quite 
high on the on the agenda at 
the hospital, and the 
medicines safety team as well. 
But it's just obviously 
dedicating the time and 
focusing really on how best to 
improve what is going 
wrong.” P1 
“Although we, you know, 
they've tried. And they will 
have, they will have, you 
know, bursts of intervention, if 
I can call it that where there is 
increased training, but then it 
lapses until something else 
bad happens.” – P12 
“Yeah. I don’t know. I mean, 
you know, there is no one fix. 
Otherwise we’d have done 
it.” – P13 
17 70 
Funding as needed 2 3 
Insulin errors as common 9 15 
Insulin errors as recurrent 3 4 
Insulin errors as widespread 2 3 
Insulin improvement as ongoing 1 1 
Intervention design as contextual 3 4 
Intervention efforts as needing reviving after time 1 1 
Lack of staff as a barrier to improvement 1 1 
Lack of time or capacity as a challenge 5 9 
Problem as difficult to fix 8 17 
Risk reduction as territorial 1 2 
Staff turnover as a barrier to improvement 6 10 
Insulin safety is important 
 
 
The perceived need for 
insulin prescribing quality 
improvement 
“I think there's such a lot of 
improvements to be made in 
every hospital, because of 
these errors and issues that 
happen everywhere.” P1 
“All trusts care about insulin 
safety” P2 
12 24 
Implementation of interventions as important 5 11 
Insulin prescribing as poor 3 3 
Insulin prescribing improvements as necessary 2 4 
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“Yeah, so I think there was a 
large focus on insulin safety, 
they realized they recognize 
that there's a lot of work to be 
done.” P5 
Pharmacists as a safety net 
 
 
The role of pharmacists in the 
area of insulin prescribing 
safety 
 
“I’m employed to pick up on 
that error, so I am the safety 
net” P1 
“What we do when we're 
doing it well, in pharmacy, I 
think is we, in terms of having 
an organizational 
responsibility for insulin is we 
try and shoulder as much of 
the risk as we can.” P12 
“And that's where 
pharmacists can make things 
better because we're on the 
ward every day. We're 
consistently there.” P16  
14 43 
Diabetes pharmacy teams as desirable 10 26 
Diabetes pharmacists as improving insulin 
prescribing 
8 20 
Diabetes pharmacists as reviewers of 
medicines safety incidents 
4 7 
Diabetes pharmacists running insulin 
clinics 
2 3 
Diabetes pharmacy as a positive role 1 3 
Specialist diabetes pharmacists as 
recently accepted 
1 1 
Increased pharmacy ward cover as necessary 2 4 
Medicines safety officer as a point of contact 1 1 
Pharmacy team awareness of insulin errors as 
important 
1 2 
The importance of team 
 
 
The role of the wider team, 
and how is this composed, 





“So what we’ve just started 
now is we've got support from 
our trust directors to 
implement a trust-wide 
diabetes group. And that has 
representation from each 
directorate.” P14 
15 46 
Discussion forum as important 2 3 
Governance board as a forum for improvement 8 13 
Insulin group as beneficial 6 10 
Insulin safety as multidisciplinary 11 14 











“We also have as an offshoot 
of our medicines safety team 
we have an insulin safety 
group as well.” P7 
 
2. Prescribing insulin is regarded as scary and complex 
The nature of insulin errors in hospital, and the various drug-related and socio-cultural factors that precipitate 
them. Particular issues and risks around prescribing at the point of care transfer, including access to information, 
and the perception of interventions that can facilitate this. 




Errors are there to be made 
 
 
The nature and types of insulin 
prescribing errors in hospital. 
 
“And with insulin, it's probably, 
it's never one thing. It's never 
it's never just the knowledge. 
Sometimes it's the environment 
or the circumstance at the time. 
And also sometimes it's, it's 
because there are competing 
demands maybe, which, which is 
a little bit different. So not 
necessarily the physical 
environment.” P12 
“All it takes is one three AM 
night shift and an inexperienced 
F1 and an inexperienced nurse 




Causes of insulin error as complex 4 5 
Errors as inadvertent 1 1 
Errors resulting from environment as common 1 2 
Failure as inevitable 2 3 
Insulin errors as happening with experienced 
nurses 
1 1 
Lapses as main error types 1 1 
Mistakes as there to be made 1 1 
Not thinking as a risk 2 2 
Out of hours working as a risk 4 7 
Insulin prescribing is not easy 
 
 
The range of factors that make 
insulin prescribing errors likely 
in hospital. 
 
“Once you take a decision to 
make a prescription for insulin 
there are a lot of external 
factors that will impact on the 
8 23 
Complexity of insulins as a risk 2 3 
High-strength insulins as a risk 6 9 
Insulin terminology as confusing 1 3 
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Variability of dose as a risk outcome of your prescription” 
P16 
“I think there’s a lot of problems 
in terms of so many different 
brand names there’s so many 
different insulin types as well 
and when you, when ordinarily 
we encourage prescribing by 
drug name, but then with 
insulins say actually “no, it has 
to be brand name” and then 





Variety of insulins as a risk 7 16 
Consequences of prescribing as difficult to know 1 2 
Hospital food as a risk 5 11 
Impact of errors as more consequential to junior 
doctors 
1 2 
Insulin as a unique risk 2 3 
Prescribers as alone 1 1 
Prescribing as complex 1 1 
Socio-cultural issues with prescribing 
 
 
The social and cultural issues 
around the prescribing process 
in hospital. 
 
“And the really frustrating thing 
is that if that foundation doctor 
doesn't do the job right, then 
everyone feels that they can 
tear strips off them because you 
know, “what do you mean you 
caused a hypo there? Do you 
not know what you're doing?” 
It's not like it “actually I don't 
know what you were doing 
either. But I’m senior enough to 
be able to not have to ask you, 
tell me, you know ask me that 
question”. P16 
“So it’s very much a negative 
attitude from the top I would 
say as well (interviewer, okay. 
Yeah.) from seniors. It's a very 
much like ‘oh I haven’t done 
that for years, I don’t know 
anything about it’”P18 
5 19 
Being a junior doctor as hard 1 1 
Challenging prescribing as rejected 1 1 
Hierarchy as a barrier 2 5 
Prescribing as a FY1 job 1 1 
Seniority as a veil 2 4 
Vulnerability and humility 1 2 
Ward culture as a barrier 4 5 
Prescribers are scared of insulin 
 
 
The fear that doctors 
sometimes experience when 
prescribing insulin for 








Clinical inertia as a risk  
“They’re coming back to me 
and saying, “I don't want to be 
involved in that because I don't 
know anything about insulin. 
And that's too, that's too 
dangerous for me”.” P16 
“In terms of prescribing it but 
they're scared of it. It’s two-
pronged, they’re scared of it 
because they don’t know what 
to do with it. But then they don't 
do anything about it.” – P18 
3 4 
A ‘shot in the dark’ on admission Issues and risks around 
prescribing at the point of care 
transfer, including access to 
information and interventions 
designed to improve this. 
 
“And you know even the insulin 
passport doesn’t even have the 
doses on it because they 
change. Like it’s so silly.” P5 
“So obviously we all cheer when 
a patient knows exactly what 
they're doing and tells us exactly 
how many units etcetera, 
etcetera. But that doesn't 
always happen.” P10 
“I think the difficulty there is 
that they don't know what the 
patient takes.” P13 
“So just the sort of thing of, 
what dose is the patient on? 
Primary care sometimes know 
but are a bit vague depends 
whose giving the dose and who 
is writing it down, secondary 
care only knows what primary 
care know or the patient could 
tell them” P2 
“I guess, just generally, with 
doctors clerking patients in and I 
think there's a bit of a lack of 
13 132 
Prescriber support on admission 11 37 
Algorithm for admission doses as useful 1 3 
Insulin passport 8 27 
Insulin passport as undesirable 7 16 
Insulin passports as dead 2 3 
Insulin passports as feasible 1 1 
Mobile apps as problematic 1 1 
Patient handheld app as new 1 1 
Patient handheld information as 
dependent on patient's engagement 
3 5 
Medicines reconciliation as beneficial 4 7 
Patients as a source of information 2 3 
Transfer of care issues 13 95 
Access to shared database as important 5 12 
Role of primary care as important 3 12 
Insulin dose changes as misunderstood 2 5 
Primary care mentality as irrational 1 2 
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Transfer of care as a risk awareness about how to take a 
good drug history. They maybe 
just look at the maybe the GP 
record, or ask patients, they 
might do both, but they didn't 




Accessing information on admission as 
difficult 
10 34 
Care home transfers as not bad 2 2 
Discharge letters as a risk 2 2 
Maintaining clarity on insulin as 
difficult 
1 1 
Medical clerking as poor 3 15 
Miscommunication of doses changes as 
risky 
2 3 




3. Insulin prescribing safety should be everyone's responsibility 
Diabetes teams make a positive contribution, but this may result in an over-reliance on them to manage people 
with diabetes. The need for an increased collective responsibility for insulin prescribing safety and the perception 
of interventions that can facilitate this. 










Diabetes teams make a 
positive contribution, but this 
may result in an over-reliance 
on them to manage people 
with diabetes. The need for a 
collective and increased 
responsibility for insulin 
prescribing safety from all 
staff involved in patient care, 
including pharmacists. 
 
“So we have we obviously 
have a DSN team we have an 
in-reach team etcetera. but 
they can't see every single 
patient.” P10 
13 52 
Diabetes teams as positive 4 13 
Diabetes link as important 1 3 
DSN presence as strong 1 1 
Lack of specialist support as a risk 1 1 
Outreach teams as a safety net 1 5 











Outreach teams as interacting with 
care teams 
“And I think part of that is 
because for so long when the 
diabetes team has been 
embedded as “they’re the 
experts” and so a lot of staff 
on the ward don't take 
responsibility because they 
think, “oh, well, you get the 
diabetes nurse to sort it out”, 
or refer to them.” – P5 
“I think empowering non-
diabetes specialists to have an 
understanding of what to do 
with their insulin and how to 




Passing the buck 12 38 
DSNs as overloaded 3 4 
Generalist staff as over-reliant on DSNs 3 3 
Involving and empowering non-specialist 
staff as key 
3 9 
Lack of responsibility as a risk 5 9 
Responsibility for insulin as needed 8 11 




The benefits and risks with 
the use of guidelines as a tool 
to help empower staff to 
make more appropriate 
decisions with respect to 
prescribing insulin in 
hospital. 
 
“Obviously it is all in our 
guidelines but then guidelines 
are long and people don’t 
have time to read them, and 
you know that’s one of the 
things that we come across a 
lot.” P1 
“Then obviously, we have all 
the other guidelines that are 
out there and then trying to 
sort of put them together in 
one place around our, you 
know, our trust SharePoint 
and stuff in our own intranet. 
So there’s far more 
information out there for you. 
Better concise sort of 
guidelines and documentation 
is designed with error 
reduction in mind. They’ve all 
sort of helped.” P8 
9 27 
Algorithms as a risk 1 1 
Guidance as de-skilling 1 1 
Guidance on high-strength insulins as effective 1 2 
Guideline length as a barrier 1 1 
Guidelines as available 4 10 
Guidelines as instruction 2 2 
Guidelines as new 2 3 
Insulin cards as prescriber support 3 3 
Pharmacists as guideline producers 3 3 




4. It is an important but uphill battle to educate staff on insulin prescribing safety 
The perceived need for educational interventions, and the importance of how these are designed and delivered, 
as well as the factors that make educating the workforce on insulin use difficult, including organisational, 
employment and political issues. 






Challenges with educating the workforce 
 
 
The factors that make 
educating the workforce on 
insulin use difficult, including 
organisational, employment 
and political issues. 
 
“So the idea of providing, like, 
training, and making sure 
everybody's up to speed with 
that is a very, very difficult 
thing to do. And when you line 
it up with all the other 
training that sits for a trust to 
have to undertake, unless, 
unless you can get these sorts 
of things into the mandatory 
category, you generally don't 
have much success with 
them.” – P8 
“For our staff nurses when 
they come in and you know, 
and they leave and start and 
doctors leave and start. And 
so it's trying to keep on top 
really, people being aware of 
the incidents that we've had, 
and how we're trying to 
overcome these.” P1 
11 47 
Access to staff for training as difficult 2 3 
Communicating with nurses as difficult 1 3 
Competing agendas for essential training as a 
barrier 
5 7 
Complexity of care as difficult to teach 1 1 
Education as a challenge 5 13 
Information sharing as ineffective 1 2 
Keeping momentum as a challenge 1 1 
Nurse turnover as recent 1 1 
Size of organisation as a challenge 3 5 
Staff turnover as a barrier to training 4 5 
Time for training as difficult 2 2 
Variety of staff as a barrier to education 2 4 
Education alone as insufficient 
 
 
Education in its current form 
and delivery as insufficient to 
tackle the issues around 
insulin prescribing in 
hospitals. 
 
“I think our education and 
training needs improving” 
P17 
“So yes, we often do do some 
teaching. But it's obviously. 
What, you know, what can 
7 14 
Education as requiring improvement 1 1 
Repeated training as important 3 5 
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you get across in forty-five 
minutes to an hour to a small 
number of junior doctors once 
a year or whatever it may 
be?” P13 
“But it’s also about having 
that repeated training. I don’t 
think its repeated. I think 
you’d need to have it every 
three years, like refreshers, for 
example.” P14 
Education is desirable 
 
 
The desire and benefits for 
educating staff on insulin 
prescribing safety. 
 
“I just think education. 
Making them more confident. 
I think if we had confident 
prescribers, then there 
wouldn't be problems 
because they would be 
confident to prescribe the 
insulin which would be 
available for the patient.” P18 
“I don't see that it can be 
occupying the place that it 
should do in all 
undergraduate courses for 
people to be coming out with 
a level of knowledge that they 
seem to.” P12 
11 28 
Education as inspiring confidence 2 3 
Educational packages as desirable 1 1 
Standardised education as desirable 2 2 
Raised awareness campaign as needed 2 4 
Undergraduate insulin education as necessary 5 7 
Staff as peer-educators 
 
 
The various members of staff 
who have a role in educating 
the workforce about insulin. 
 
“I know the diabetic nurses as 
well do some teaching to, to 
the nurses and the 
consultants do and teaching 
to the junior doctors” P1 
“I do quite a lot of teaching 
with the junior doctors and 
that’s something that they 
identified as, you know, they 
12 22 
Diabetes pharmacist as a teacher 7 10 
Diabetologists as teachers 1 1 
DSNs as teachers 3 5 
Outreach teams as teachers 1 2 
Pharmacists as teachers 4 4 
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didn't know how to find what 
doses people were on.” P11 
The trouble with mandatory training 
 
 
The use and issues around 
mandating insulin training in 
hospital, and how this is 
delivered, for clinical staff. 
 
“So for example, I know that 
insulin safety is not 
mandatory training for people 
who prescribe, administer or 
supply insulin when it’s our 
number one high risk drug as 
well.” P14 
“So when there was a CQUIN 
linked to it, it was funded for - 
everyone had to do a bit of e-
learning. But that got pulled 
the moment the CQUIN 
went.” P5 
“And when you line it up with 
all the other training that sits 
for a trust to have to 
undertake, unless, unless you 
can get these sorts of things 
into the mandatory category, 
you generally don't have 
much success with them.” P8 
11 33 
Induction training as not optimal 2 3 
Induction training as patchy 2 2 
Mandatory training as desirable 5 11 
Mandatory training as important 3 6 
Mandatory training as inadequate 1 1 
Mandatory training as lamented 3 3 
Mandatory training as not supported 1 2 
Restrictions on mandatory training as negative 3 4 
Too much information on induction as a barrier 1 1 
Pedagogy is important The way in which insulin 
education is designed and 
delivered is important. 
 
“And I think the doctors – 
they can either do face to face 
or they can do e-learning, the 
doctors. And they definitely 
benefit from face to face.” 
P10 
“So it's about how do you 
develop the skill of prescribing 
insulin well, and it's not about 
having the knowledge on its 
own, it's about having the 
10 38 
Active learning as beneficial 3 4 
Assessment as a tool 2 2 
Errors as not the focus 1 1 
Experiential learning as beneficial 1 1 
Face-to-face education as desirable 3 3 
Feedback with foundation doctors as a tool for 
improvement 
4 8 
New junior doctors as more exposed to insulin 1 2 
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Pedagogy as important knowledge and being able to 
put that into practice in a safe 
way and a secure way, you 
know, you're, you're sort of 
supported to put that into 
practice and given the space 
to, to reflect.” P16 
“So I mean I guess it got 
people looking in the BNF. You 
know, try and working out in 
their own heads what the 
differences between the 
insulin were.” P3 
1 3 
Reflective practice as beneficial 4 13 
Opportunity for reflection as challenging 1 1 
Reflecting as informal 1 1 
Reflection perceived as unimportant 1 1 
Reflective motivation as necessary 1 1 




The lack of knowledge, 
experience and familiarity 
with insulin and the need for 
educational interventions. 
 
“To be honest, just because 
we had an open and honest 
forum with the twenty-ish or 
so F1s that we have. And to be 
honest, the lack of knowledge 
and education is a massive 
gap for them.” – P18 
“I just get the feeling that 
they’re coming out of med 
school with less pharmacology 
knowledge than ever used 
to.” P9 
“But I think obviously my 
biggest concern is certainly no 
awareness of what insulin, not 
necessarily about what Insulin 
does. But it is why patients 
shouldn’t miss it.” P6 
“I think my biggest thing 
would be, just people's 
knowledge of insulin to be 
better. So I just find it really 
frustrating. The fact that the 
wrong insulin is still prescribed 
at the wrong time of day. It’s 
literally that basis of which is 
16 111 
Attitudes towards insulin as polarised 1 1 
Basics as going wrong 3 5 
Consequences of errors as unappreciated 4 8 
Consultants as non-specialists in diabetes 2 3 
Control of BG as an aim of education 1 1 
Diabetes knowledge as lacking 2 2 
Education as patchy 3 3 
Fundamental knowledge as lacking 1 2 
Importance of insulin safety as unappreciated 1 1 
Increased awareness of risk as important 3 3 
Insulin prescribing risks as understood 2 2 
Lack of confidence as a risk 1 3 
Lack of education as a risk 6 8 
Lack of experience as a risk 7 10 
333 
 






Experience with insulin as beneficial long-acting, which is a short-
acting, and therefore, you 
know, what would be a rough 






Lack of knowledge about insulin as a risk 9 17 
Lack of knowledge as embarrassing 1 1 
Lack of knowledge as frustrating 1 1 
Lack of understanding as a risk 5 11 
Medical clerking process as a target 3 15 
Staff unaware of historical events as a risk 2 4 
Undergraduate education as inadequate 2 6 
Understanding clinical picture as important 2 3 
  
5. A balance must be found between prescribing system control and flexibility to prescribe 
insulin 
Perceptions regarding the way in which insulin is prescribed in hospital and how this may promote or risk insulin 
safety in hospital are varied. Restricting prescribing behaviour/actions as beneficial for the sake of insulin 
prescribing quality on both paper and electronic systems, however flexibility is needed. 










The importance of being able 
to access and review BGs 
when prescribing insulin, and 
the risks of multiplicity of 
systems for monitoring BGs. 
 
“obviously with our glucose 
monitors, it all goes 
electronic, so we get a report 
for high INRs, sorry blood 
glucose levels and low blood 
glucose levels, so if we can see 
that someone is having hypos 
or hypers, then we go and 
assess those patients as part 
of the ward round in the 
morning and feed back to the 
medical team looking after 
them as well.” P1 
3 4 
Monitoring technology as less risky 2 2 
Diabetes dashboard as helpful 2 2 
Integrated prescribing and monitoring notes 
system as hopeful 
2 2 
Monitoring technology as a risk 2 3 
Review of BG as prescribers' role 1 1 
Reviewing BG as nurse responsibility 1 1 
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Prescribing processes vary 
 
 
The process of prescribing 
insulin and how this may 
promote or risk insulin safety 
in hospital, including what is 
required on prescriptions and 
daily prescribing. 
 
“I think that's definitely a 
challenge as well. Even 
though we encourage 
everybody to prescribe by 
brand, that's in all our 
guidelines. But it doesn’t 
happen both in primary and 
secondary care.” P11 
“I mean, we do daily 
prescribing of it. So our 
prescriptions are not like a 
rolling prescription, they are a 
daily prescription so they have 
to prescribe insulin each day. 
Well, when I say that they 
have to prescribe it each day, 
they don't have to, they can 
prescribe in advance for 
patients that are stable, but 
for unstable patients, they 
may change, they would 
prescribe each day. So it's not, 
in our trust, it's not a rolling 
prescription.” P18 
14 52 
Biosimilars as a challenge 1 6 
Brand vs Generic 10 19 
Brand and generic as useful 2 4 
Brand name prescribing as beneficial 1 1 
Brand naming as a risk 5 9 
Generic prescribing as a risk 4 5 
Considering prescribing options as risk 
management 
1 1 
Daily prescribing 3 11 
Daily prescribing as a risk 2 3 
Ineffective handover as a risk 1 2 
Daily prescribing of insulin as a challenge 3 7 
Daily prescribing of insulin as positive 1 1 
Devices on prescriptions 2 3 
Insulin pumps as a challenge 2 3 
Strength of insulin on prescription 3 9 




The benefits and risks with 
using current paper-based or 
electronic systems to 
prescribe insulin, including 
explanations around 
functionality and 
opportunities for improving 
insulin prescribing quality. 
 
17 145 
Electronic Prescribing 13 49 
Alerts 1 2 
Electronic prescribing as a challenge 5 8 
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Electronic prescribing advances as 
dependant on regional plans 
“I mean, it’s had some impact 
on some of the errors that we 
would get, particularly around 
units and getting the full 
details of the prescription 
specified. But what we're 
getting now is an increased I 
would say error rate from mis-
selection from drop down 
menus.” P3 
“Electronic prescribing, I think 
has helped overall. Because 
yeah, you might have seen 
some of those terrible 
prescriptions where they had 
no idea the names, the doses, 
the timings were awful. Yeah, 
I think it’s marginally better.” 
P13 
“So I think that's still our main 
challenge at the moment is 
the fact that there are two 
charts, and therefore they 
didn't necessarily tie up. And 
then so you have you have a 
beautiful prescription on 
electronic because obviously 
it's electronic. But then you 
still get the handwriting 
problems on your green 
chart.” P10 
“But saying that, you know, 
we still managed to have two 
weeks ago, a doctor write 
‘units’ on an insulin chart 
where the word ‘units’ was 
pre-printed which resulted in a 
you know, a not unserious 
overdose.” P12 
 
“And obviously, we've got 
electronic prescribing, and 
we've got the ability to put 
some limits in there. But the 
regimes are so variable, it's 
very difficult to put hard limits 
on them.” P3 
1 1 
Influencing technology companies as 
challenging 
1 1 
Understanding drugs when designing 
electronic prescribing systems as 
necessary 
1 2 
Electronic prescribing as desirable 10 23 
Default fields as desirable 1 2 
Electronic prescribing alerts as 
desirable 
2 3 
Protocol prescribing as effective 1 1 
Electronic prescribing of insulin as 
undesirable 
2 6 
Benefits of electronic prescribing as 
limited 
3 3 
Electronic prescribing as a risk 6 12 
Electronic prescribing as 
impacting the type of errors 
5 8 
Flexibility as needed 4 10 
Prescribing insulin as rule-based 3 4 
Paper charts 16 77 
Carb counting chart as absent 1 1 
Handwritten prescriptions as a risk 5 8 
Insulin Charts 16 65 
Colour-coding as helpful 3 3 
Documentation as improved 1 1 
Insulin chart as effective 5 8 
Charts as sustainable 1 1 
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Insulin charts for prescriber 
support 
5 5 
Insulin charts as a risk 2 5 
Insulin charts as not necessary 1 1 
Insulin charts as requiring 
improvement 
2 3 
Insulin prescribed on normal 
prescription chart 
1 1 
Insulin prescribing chart and BG chart 
together 
9 11 
Multiplicity of prescribing systems as a 
risk 
5 16 
Pre-printed prescribing charts as a 
safety net 
3 4 
Removing prescribing steps as effective 2 3 
Uniformity in prescribing charts as 
needed 
3 10 
Standard prescription charts 2 4 
Use of charts as outdated 1 2 
Visual markers on charts as effective 1 1 
Medication charts as limited 1 3 
Restrictive measures as beneficial 4 19 
Electronic prescribing as a restrictive 
measure 
2 5 
Safety measures as circumvented 1 1 




6. Interventions to improve insulin prescribing are hard to evaluate in practice 
The desire to measure the effectiveness of interventions is not met with the ability to reliably do so using audit or 
error reporting systems, and the use of feedback and anecdotes to evaluate interventions is common. 









The use of feedback and 
anecdotes to evaluate the 
efficacy of interventions. 
 
“I guess the diabetes nurses 
have probably got quite a 
good idea from when they go 
around and see patients. It's 
like a town that we're in. So 
they know a lot of the patients 
that come in and out of 
hospital anyway, they're 
probably like  ‘oh I know that 
patient. I see them in clinic’.” 
P4  
3 5 
Evaluating effectiveness as anecdotal 2 2 
Feedback on interventions as important 1 1 
Feedback as unreliable measure 1 1 
High dose rule as contentious 1 2 
Audit as a measure for improvement 
 
 
The use of audit to collect 
data on intervention efficacy, 
and the issues with this. 
“so I think its difficult, you 
want to be able to audit, but 
I’m not sure you’re ever going 
to be able to audit to see if it 
has improved and that’s the 
problem really.” – P10 
9 18 
Audit as difficult 1 1 
Paper-based systems as difficult to 
interrogate 
1 2 
Recording of insulin doses as unreliable 2 3 




The use of error reporting 
systems in order to evaluate 
intervention efficacy and the 
problems associated with 
this. 
 
“I think that prescribing is 
under-reported generally. So I 
think what tends to happen 
with prescribing is that unless 
it ends up being administered, 
nothing gets reported. If it's 
11 50 
Error reporting as a challenge 4 4 
Error reporting as a feedback tool 6 10 
Error reporting as a tool for measuring 
effectiveness of interventions 
5 5 
Error reporting as an unreliable measure 6 18 
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Interventions implemented as a response to 
incident types 
just picked up as an error, it 
just gets sorted. And we don't 




Insulin safety achievements as varied 
 
 
The variability in insulin 
prescribing intervention 
effectiveness in different 
hospitals. 
 
“So whatever we've done, it's 
definitely improved.” P10 
“So, my colleague, who works 
next to me is, has a greater 
role within medicine safety, 
whereas I kind of focus on 
service. But we spend a lot of 
time talking about incidents. 
And the thing that she says 
about insulin safety is that 
“we've tried everything and 
nothing seems to work”. That 
that was her take.” P12 
4 5 
Interventions as effective 1 1 
Progress as gradual 3 4 
Interventions as unsuccessful 2 3 
Measuring intervention success is desirable but 
difficult 
The desire to measure the 
effectiveness of interventions 
in hospital but the lack of 
ability to do this reliably. 
“Now can I turn round and 
tell you that they definitely 
reduced our error rates? Well I 
actually couldn't. Because it's 
very difficult to measure your 
error rates.” – P8 
“so I think its difficult, you 
want to be able to audit, but 
I’m not sure you’re ever going 
to be able to audit to see if it 
has improved and that’s the 





7. Inpatient insulin self-administration is a problem worth solving 
Self-administration policies to promote the independence of people with diabetes in hospital are laudable and 
encouraged but are often difficult to implement. 






Assessment processes The process and oversight of 
assessing patients as 
‘competent’ or ‘safe’ to self-
administer their insulin during 
their hospital stay. 
 
“We will try for pharmacy and 
technicians to also support 
that role if we, if we have the 
availability. So yes, they need 
to know about it as well. But 
predominantly, it would be, 
also because the nurses are 
more likely to be on the ward 
twenty-four seven.” P10 
“So yeah, I think we need to 
make sure that within the 
policy we think of doing the 
capacity assessments daily and 
actually if something goes 
wrong staff will be supported 
about it.” P5 
“I think I suppose the hard 
part about that is getting 
someone to assess the patient 
to make sure that they are 
safe to self-administer.” P16 
14 42 
Administration technique assessment as not a 
DSN job 
1 1 
Assessment as needing to be simple and easy 2 5 
General self-administration assessment 5 6 
Self-administration assessment as a nurse job 7 8 
Self-administration assessment as cautious 2 2 
Self-administration assessment as formal 1 2 
Self-administration assessment as necessary 10 14 
Self-administration process as stratified 4 4 
Attitudes to self-administration Staff perceptions, attitudes 
and beliefs around the 
processes, policy and 
consequences of insulin self-
administration in the 
inpatient setting. 
 
“Number one is the traditional 
feeling or sort of 
understanding that we look 
after patients in hospital. You 
know, if you're a nurse you’ll 
be giving their insulin because 
you’re giving them their 
8 20 
Change as psychological 1 3 
Fear from nurses 1 1 
Nurse familiarity as an enabler to self-
administration 
1 1 
Nurses as not conscious of self-administration 
consequences 
1 1 
Nurses as relaxed about self-administration 1 1 
Past approaches as flipped 1 2 
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Perceived consequences of self-administration as 
a barrier 
1 1 
Self-administration policy as not desired 1 2 
Staff as wary of self-administration 2 4 
Staff resistance as a barrier 1 1 
Traditional understanding as paternalistic 1 1 
Burden of self-administration The burden of work and 
change processes associated 
with implementing insulin 
self-administration policies. 
 
“So, you know, you've got to 
consider obviously, the security 
arrangements and disposal 
arrangements. The 
monitoring, the 
documentation, the consent. 
And the assessment of the 
patient. You know there’s an 
awful lot to consider.” P13 
“And I think that's, that's 
probably a challenge for, you 
know, a busy ward. When the 
nurses are thinking, “oh, god, 
and I’m going to have to take 
that patient off self-
administration”, or “I have to 
try and put them on it”. And 
sometimes maybe they just 
think you know what, it's just 
easier to just do it all 
yourself.” P16 
6 23 
Burden of work for self-administration as a 
challenge 
1 1 
Nurse administration as easier than self-
administration 
3 5 
Self-administration as requiring nurse oversight 3 6 
Self-administration is time-consuming 2 5 
Self-administration policy as complex 3 6 
Communication  Issues around how 
communication between 
healthcare professionals and 
patients, and between ward 
teams impacts self-
administration policy 











“The issue with that, though, 
is that if any medical team 
changes the patient’s dose its 
key that they let patient know 
so they are able to change 





The systems and processes 
involved in documenting 




“It didn’t really feel 
appropriate for patients to be 
using our insulin charts 
because all they wanted to do 
is tell you what their blood 
sugar was and how much they 
gave themselves.” P18 
“Erm we're also finding 
interesting that there are 
sometimes people who are 
self-admin-ing they haven't 
filled in the separate 
paperwork. So we need to 
make sure that it is properly, 
erm, done by policy, really, to 
make sure it's safely done.” P5 
9 23 
Electronic prescribing impacts self-administration 5 7 
Patients documenting BG on charts as 
inappropriate 
1 1 
Recording BG as patient job 1 1 
Self-administration document as a safety net 1 1 
Self-administration documentation as accessible 3 4 




Issues around the 
implementation of self-
administration policies in 
practice, including how this 
process is overseen and its 
integration into normal 
workflows. 
 
“But we haven't managed to 
roll it out as successfully as 
we’ve wanted to. And I think, 
again, that's probably on the 
back of staffing really?” P10 
 
13 31 
Adherence to intervention 6 11 
Oversight of self-administration intervention 5 12 
Competing priorities as a barrier to self-
administration 
1 1 
Lack of staff as a barrier to self-
administration 
1 2 
Self-administration as a pharmacy job 1 4 
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Self-administration policy as not a pharmacy 
job 
“And I really didn't want to 
lead on it. It’s like ‘this is not 
for me to do’ this is, I've 
provided you with the 
framework because you know, 
I'm happy to put something 
down on paper. But you know, 
this is for you.” P13 
“So it's not just having the 
policy and the staff being 
aware (interviewer: exactly), 
it's who's pushing, who's 
driving it? (interviewer: yes) is 
probably also the thing.” P16 
1 1 
Who is driving self-administration as 
important 
4 4 
Self-administration as difficult to implement 2 2 
Self-administration as ingrained in workflow 1 1 
Self-administration as established 3 3 
Supporting staff 2 2 
Self-administration provider education as 
pre-requisite 
1 1 




Issues around how the 
success of insulin self-
administration policy 
interventions are measured 
and evaluated. 
 
“We looked at a variety of 
things then and we did find 
actually most patients who 
wanted to self-administer 
were self-administering 
following that proforma being 
filled in.” P17  
“So its difficult to see uptake 
but there was definitely a need 
for it there and its now there 
so helping patients to self-
administer so it’s a valid 
process that they can go 
through to be able to do that.” 
P1 
9 25 
Patient feedback on interventions as important 1 2 
Self-administration as not perfect 1 2 
Self-administration as successful 4 9 
Self-administration as unsuccessful 6 10 
Self-administration interventions being 
pulled 
2 2 
Uptake of self-administration policy as difficult to 
measure 
2 2 
Self-administration as a risk 
 
 




“I think the problem is that as 










suppose in the fact that 
patients refuse to give up their 
insulin. And we then found 
that they were probably more 
confused than they thought 
they were and they've had 
crashing hypos because 
they’ve given themselves too 
much insulin. So what’s really 
difficult here, I think, is the fact 
that people are wary.” P10 
“But Yeah. I also think that 
there have been cases where 
people have self-admined and 
it's gone wrong.” P5 




“One of the key benefits of 
self-administration would be 
to actually get it at the right 
time.” P11 
“Because at the end of the 
day, a patient should be self-
administering where they can. 
They've got to go home and do 
that. And we, you know, we 
de-skill them, we take that 
away whilst they're in 
hospital.” P13 
“So, within the mental health 
service, we don't see a lot of it 
and where we do see it, we 
very much encourage patients 
to self-administer.” P15 
“And we absolutely would 
agree and support the idea 
that patients need to have a 
bigger input into the decision 
making. And if they can give it, 
they should be giving it.” P8 
15 63 
Patients as being empowered 5 6 
People with diabetes as knowledgeable about 
diabetes 
2 2 
Self-administration as a safety net 11 20 
Administration errors as common 1 1 
Nurse administration as a risk 3 3 
Nurse unavailability as a risk 1 1 
Nurse workload as a risk 2 2 
Self-administration as a vested interest 2 2 
Self-administration as beneficial to patients 3 4 
Self-administration as important 6 10 
Self-administration as patient prerogative 2 6 
Self-administration as satisfactory for patients 1 1 
Self-administration policy as a respite for nurses 4 4 
Self-management 3 9 
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Self-administration as different to self-
management 
The discussion of insulin self-
management in hospital, 
where people with diabetes 
measure their blood glucose 
levels and self-adjust their 
insulin dose. 
 
“It was to say that we are only 
able to do self-administration. 
We can’t do self-management, 
because our point of care team 
insists that we use our meters” 
P5 
2 3 
Self-management as a safety net 1 2 
Self-management as restricted by policy 1 2 
Self-monitoring as deemed insufficient 1 2 
Storage and disposal of sharps 
 
 
Practical issues around how 
insulin paraphernalia is stored 
and disposed of safely at 
ward level and the impact this 
has on policy use. 
 
“But we, I think we, I think we 
struggle with the 
infrastructure to allow it in 
terms of around the keys, 
you’ve got to give the patient 
the keys to the locker in order 
that they can they can have 
access as well.” P12 
“So, just about the self-
administration the key thing 
that we kind of had a hiccup 
was around sharps bins in that 
you can overlook but it’s quite 
key that if they are going to be 
self-administering and wards 
they will need access to sharps 
bins.” P14 
13 30 
CQC approval for storage as required 1 1 
Safety needles as problematic in self-
administration 
1 2 
Sharps bins as an issue 3 4 
Storage for self-administration as necessary 12 13 
Storage of insulin as a problem 7 10 
Suitability of patients for self-administration 
 
 
The factors impacting how 
suitable self-administration 
policies are for different 
groups of patients in the 
hospital setting, and the 
impact this has on policy use. 
15 31 
Criteria for self-administration as strict 1 1 
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Patient capacity and competence as needed  
“So obviously if someone 
comes in acutely confused or 
they’ve got some sort of 
cognitive impairment then we 
would take over control of 
doing the insulin as we 
wouldn’t want them to be at 
risk of administering it 
incorrectly.” P1 
“And we sort of piloted it for a 
little while, but it didn't really 
sort of come off. The numbers 
were really small. And the sort 
of feedback that we had was 
the “Oh, the criteria, perhaps 
was a bit too strict”. Because 
we say obviously, we don't 
want anybody that’s comatose 
or going for surgery, x, y, z. So 
the numbers were small.” P13 
10 22 
Uptake of self-administration as varied 6 8 
Writing the policy 
 
 
The nature and processes 
involved in designing and 
formulating insulin self-
administration policies for use 
in the inpatient setting. 
“So as I say I'm in the next 
couple of weeks I've already 
talked to the sort of nurse, 
lead nurse in our assessment 
unit. And the DSN and myself 
and some of the pharmacists 
and some of the technicians 
are going to sit down and work 
through a sort of a quality 
improvement sort of model to 
try and get the whole sound 
piece tied up a little bit, you 
know.” P8 
“And because I think quite 
often, we're all for a one-size-
fits-all, you know, the whole 
‘do once’ thing but it's not 
gonna work.” P11 
8 13 
Assumptions about HCP role as problematic 1 1 
Insulin as unique for self-administration 1 1 
Self-administration policy as collaborative 6 7 
Self-administration policy as standardised 1 1 
General self-administration policy as useless 1 1 




Appendix 13: Descriptions of the insulin passport, mandatory insulin training and insulin self-
administration policies  
 
Interventions are described using the Template for Intervention Description and Replication (TIDieR) checklist 
(Hoffmann et al., 2014). Descriptions are provided by the researcher with reference to relevant supporting 
literature as outlined in Chapter 1. As this study is looking at an organisational level across a range of hospital 
settings, descriptions provided are more generic compared to those pertaining to individual specific system or 
modification of an intervention.  
Brief name Insulin passport Mandatory insulin training Insulin self-administration 
policy 
Why? Designed to minimise insulin 
errors by providing readily 
available information on each 
patient’s insulin product(s) to 
help ensure that the insulin 
products that patients use are 
correct, that the dose is right 
and that patients self-
administer insulin in hospital 
whenever appropriate. 
Enables patients and 
healthcare professionals to 
check the accuracy of 
prescribing, dispensing and 
administering of insulin as well 
as providing a mechanism for 
transferring patient safety 
information across all 
healthcare interfaces. 
Healthcare professionals lack 
knowledge and confidence 
with diabetes management 
and insulin. Inpatient 
perception of staff 
awareness of diabetes is 
declining. Pre-registration 
training doesn't always 
support a sound knowledge 
in diabetes and post-
registration training is 
challenging due to ward 
pressures and high staff 
turnover. Basic mandatory 
training on the safe use of 
insulin and the main 
diabetes harms and how 
they can be prevented 
should be provided for all 
healthcare professionals 
caring for people with 
diabetes. 
Self-administration 
empowers patients to take 
more control of their care 
whilst in hospital, and can 
avoid nurse administration 
errors (such as untimely, 
erroneous or omitted doses, 




The Insulin Passport is a single, 
double-sided sheet that folds 
up to credit-card size with 
cardboard covers. It contains 
the necessary information for 
emergencies and safe use of 
insulin as patients transfer 
across healthcare providers. 
Accompanied by a patient 
information booklet designed 
for adults who are 18 years or 
older. Insulin passports are 
obtained via telephone or 
Insulin safety training is 
aimed at a wide range of 
healthcare professionals and 
to varying degrees. Training 
may take many forms, for 
example at induction only, or 
repeated, linked to staff 
personal development plans. 
It may involve manipulation 
of placebo insulin devices, 
gamification, and/or hard 
copies of training material. A 
range of insulin safety 
Patient information about 
self-administration may be 
given to patients on 
admission to hospital. Self-
administration training 
materials may be provided to 
hospital staff (nurses, 
pharmacists, doctors). 
Materials required include 
bedside insulin storage 
facility (e.g. locker), self-
administration assessment 





appendix is available to 
support healthcare 
professionals in advising 
patients about the Insulin 
Passport 
training packages exist and 
are available nationally or 
created locally. An example 
of an open-access package is 


















Adult patients on insulin 
therapy receive a patient 
information booklet and an 
Insulin Passport from their 
prescriber. Healthcare 
professionals and patients are 
informed how the Insulin 
Passport and associated 
patient information can be 
used to improve safety. When 
prescriptions of insulin are 
prescribed, dispensed or 
administered, healthcare 
professionals cross-reference 
available information to 
confirm the correct identity of 
insulin products. 
Activities may include 
completing an online e-
learning package, or 
attending a face-to-face 
session. Topics may include 
understanding the action of 
insulin, risks involved, 
common errors, range of 
insulin profiles and devices, 
understanding insulin 
regimens, safeguarding 
patients, quality of 
prescribing and 
administration 
Provision of written 
information to explain 
responsibilities of self-
administration to people 
with diabetes and hospital 
staff. Nurse and patient to 
agree if and when self-
administration is 
appropriate. 
Agreement/consent form to 
be signed. The patient has 
free access to their own 
insulin whilst in hospital and 
self-injects their usual insulin 
when required. 
Documentation outlining the 
patient's self-administration 
status and recorded doses 
should be completed. The 
patient's ability to self-
administer should be 
assessed on a regular basis. 
Safe storage and disposal 
facilities should be suitably 
available. Support activities 
for staff should be provided. 
Who 
provided? 
The NPSA designed and 
provided the insulin passports 
to organisations from 2011, 
accompanied by a national 
'Patient Safety Alert' 
(NPSA/2011/PSA003).  
"Healthcare professionals who 
prescribe insulin" are 
responsible for issuing 
patients with a patient 
information booklet and an 
Insulin Passport, and their 
Providers may include local 
diabetes teams: nurses, 
pharmacists, doctors. 
National providers include 
TREND UK, the Primary Care 
Diabetes Society and Health 
Education England. The 
University of Southampton 
and the University of 
Leicester (EDEN) also offer 
The nurse, pharmacist or 
pharmacy technician working 
on the ward prompts and 
completes the self-
administration assessment 
and consent forms with the 
patient. All staff involved in 
self-administration should be 
supported and trained 
accordingly in its aims, risks, 




professionals must be 
available to assist patients in 
completing the Insulin 
Passport, and specifically in 
how to describe their insulin 
products so that there is no 
ambiguity in what they are 
using. 
insulin online/distance 
learning education packages. 
How? Face-to-face provision of a 
hard copy of the insulin 
passport by healthcare 
professionals to patients. 
Depending on the training 
provided, this may be face-
to-face or online, either 
individually (e.g. e-learning) 
or group (e.g. face-to-face). 
face-to-face discussion about 
self-administration and 
completion of 
documentation (electronic or 
hard copy depending on local 
systems used). Intervention 
provided individually to 
patients at ward level.  
Where? Although not specified 
directly, presumably both 
primary and secondary care 
(GP surgeries, diabetes 
outpatient clinics, hospital 
wards). The organisation must 
themselves order, store and 
ensure an adequate supply of 
the passports for 
dissemination.  
The main anticipated site 
would be at the hospital, 
either in a dedicated training 
space or at ward level. E-
learning would be completed 
at any appropriate, available 
workspace. 
Inpatient ward facility. 
Depending on 'level' of self-
administration and type of 
inpatient facility, individual 
lockers or containers may be 
provided at the patient's 
bedside, or insulin may be 
stored centrally for patients 




Since March 2011 when the 
NPSA alert was disseminated, 
the intervention was intended 
for initial use for every patient 
using insulin currently and 
henceforth any patient newly 
prescribed insulin. Thereafter, 
the passport was updated 
anytime there was a change in 
patients’ circumstances, their 
insulin products, other drug 
therapy (if recorded) and 
information that needed to be 
communicated. Anytime 
insulin was prescribed, 
dispensed and administered 
across any care setting the 
intervention was intended for 
use. 
Mandatory training may 
involve induction training 
only (when new staff 
members commence 
employment at the trust), or 
may be required to be 
repeated every 1-5 years. 
Initial assessment to be 
conducted at the point of 
admission or transfer to 
inpatient ward area. 
Subsequent assessment to b 
e completed periodically (e.g. 
daily). Patient self-
administers according to 
their individualised insulin 
regimen. Nurse to record 
that patient has self-
administered their dose each 
time it is due. The 
intervention may cease if 
patient clinical status 
declines throughout patient 
stay, or on request. 
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Tailoring The NPSA permitted providers 
of diabetes services to tailor 
the insulin passport, in 
conjunction with patients, but 
stipulated that the result must 
facilitate patients receiving 
the correct insulin products 
and allow for details of 
concurrent medications. The 
developer then takes full 
responsibility for the amended 
version of the intervention 
Training is often tailored to 
include insulin prescribing 
information that is most 
relevant to the organisation 
(e.g. particular prescribing 
charts/electronic systems). 
Training may also be tailored 
to the professional group 
(e.g. HCAs would receive a 
different type and level of 
training than junior doctors) 
according to their role and 
requirement for information. 
Local errors and incident 
trends may also be 
incorporated into training. 
Self-administration policies 
are usually locally created by 
the hospital trust to tailor to 
their 
prescribing/administration 
systems, ward set-up, staff 
capacity and governance 
arrangements. Regional 
policies may be created if 
similarities in 
systems/procedures allow, 
and any national policy 
created must take into 
account any differences in 
organisation facilities, staff 
and structures. Any tailoring 
must take into account the 
requirements for safe 
medicines storage and 
disposal by the relevant 
governance agencies, 
professional regulations and 
standards (e.g. medicines 
code, CQC, NMC). 
Modificati
ons 
Modifications to the insulin 
passport have been described, 
including electronic versions 
and addition of doses and 
diabetes team contact details. 
Regional medicines 
management teams and CCGs 
have developed clearer 
guidance for the use of insulin 
passports more locally. 
Modifications may be made 
to locally designed and 
delivered training may be 
expected based on changes 
to policy, procedures and 
systems, as well as local 
evaluation and 
organisational requirements. 
Modifications may be made 
in light of staff and patient 
feedback or more formal 
evaluation, as well as any 
changes made at an 
organisational level to 




Use of the Insulin Passport is 
recommended but is not 
mandated. Local protocols and 
policies should describe clear 
processes and audit 
benchmarks for cross-checking 
information in the Insulin 
Passport during the 
prescribing and dispensing 
processes, and to identify and 
document if patients decide 
not to follow the 
Staff adherence to e-learning 
and face-to-face training 
may be measured by register 
keeping and electronic e-
learning completion records. 
Impact of training on staff 
knowledge/confidence/satisf
action may be measured and 
evaluated with feedback and 
test scores. Impact of staff 
training on patients may be 
tracked by question 
Intervention uptake, 
appropriateness and 
compliance with policy (e.g. 
completion of requisite 
documentation) may be 
audited locally by 
prospective or retrospective 
interrogation of medical 
documentation. Feedback 
from staff and patients may 




recommendations in this 
Patient Safety Alert. 
response to the National 
Diabetes Inpatient Audit. 
How well 
(actual)? 
Local audits have 
demonstrated varying degrees 
of acceptability and adherence 
to the insulin passport from 
both staff and patients. The 
National Diabetes Inpatient 
Audit monitors trust-wide use 
of the insulin passport (%) 
each year. 
Previous local evaluations 
have included self-reported 
changes in confidence and 
knowledge and/or impact on 
insulin prescribing quality. 
The National Diabetes 
Inpatient Audit monitors the 
proportion of hospital trusts 
who provide insulin safety 
training (%) each year. 
Previous local audits have 
demonstrated varying 
degrees of adherence to self-
administration policies and 
disparate uptake of the 
intervention. The National 
Diabetes Inpatient Audit 
monitors the proportion of 
hospital trusts who use self-










Example quotes Inferences -
respondents 














I mean, I’m personally not diabetic, but 
carrying round an insulin passport 
doesn’t, I would defiantly, and I’m not 
young but I’m of the era where I would 
have my phone with me all the time and 
it would be on there – if I’m a diabetic it 
would be on there. But then is that 
because I’m a diabetes pharmacist and 
therefore I know how important it is? 











low use of 
the insulin 
passport. 
So the passport would never work 
and everyone kind of made a sort of 
sighing effort towards having 
something available and then chose 
to ignore it because it was never 










And probably when they first come, they 
may get sort of an insulin passport, but 
that doesn't really give any doses. It’s 
never given the doses anyway. All it ever 
did is tell you hopefully the actual 
insulin that they’re on. But there's never 
been anything which says, “this is the 






to aid with 
complete 
prescribing 
And you know even the insulin 
passport doesn’t even have the 
doses on it because they change. 

















is absent or 
outdated 
Yeah, the insulin passport seems to have 
died a death. In fact, I tried to order 
some more recently and the details on 
the original alert to get more supplies, 
that route of ordering them doesn't 
even exist anymore. And I've been 
asking another trust, you know, where 
are you getting them? And no one 
seems to be able to give me an answer. 
So we’re actually at the point where we 
can't get any more of the product, 
although we could obviously start 











it’s been, you know, a stone around 
everyone’s foot and we’ve all 
drowning because no one updates it, 
it can’t be updated and the only 
people who use it well are the 
people who don’t need them i.e. the 







But to be honest, now we've got the 
summary care records and they're in 
fairly routine use. I think that's 
becoming utilized a lot more frequently 
than the insulin passport as a source of 
information (interviewer: yeah) because 
obviously, when you do meds 
reconciliation you’ve got other drugs as 





their care are 





likely to use 
them. 
The problem with the passport is 
that it relies on the patients being 
engaged and the engaged patients 











And even if they had an insulin passport, 
they would probably come without it. 
Yeah. And then we end up going to 




due to lack of 
intervention 
coherence 
and use by 
patients 
We don’t use them because a, 
people forget to bring them in or the 
insulin changes so much or the doses 
change so much that they don’t 







with their use 
and 
recommenda
tion for use is 
significant. 
It doesn’t help anyone it just creates 
a lot of work. And everyone keeps 
chasing it everyone keeps saying 
“we should do more about those 
passports, do we use those 
passports? We should definitely use 
those passports” and everyone else 
is going “We don’t need passports. 
The passports aren’t helpful. Ignore 












its lack of 
adoption. 
Insulin passport isn’t the answer. I 
know locally it's not been adopted. 
You’re relying on people updating it 
and it actually being a 
contemporaneous record, which, 
unless somebody takes ownership it 







Yeah, so we’ve not gone down that 
route. Which is, which is irritating 
because you know, it's such a big a big 
clinical area. - P1 
Motivation 
from trust to 
include 
insulin safety 
in training is 
often a 
response to a 
clinical 
incident 
I think we rely on, what happens is 
we get a potentially serious error 
and everyone says ‘you must put it 
in the junior doctor’s training’.  But 
we have to keep bumping things 
down. You know, you can't do 
everything in twenty minutes on 










I haven't made it part of the Essential 
Training because there's so many 
different things that are on the 
hospital’s agenda that people want as 
part of the essential training so I think 
one of our consultants asked a couple of 
years ago and they were declined to 
have it as part of the essential training. 
Yeah, so we’ve not gone down that 






as issues are 
still occurring 
So even though they have these 
mandatory training days - some of 
the issues still don't seem to get 









on the agenda 
I know that for medics, when they start 
new, on induction it’s very difficult to 
get within five minutes on their 
induction timetable, it’s basically an 
overload. But there’s nothing that I 
know specific in regard to insulins. - P14 
SAME Um, but I think at that point, they're 
getting absolutely bombarded with 
everything on their first day. They’re 









And then we've also had – at the 
moment there’s not a lot of support for 
mandatory training. So when there was 
a CQUIN linked to it, it was funded for - 
everyone had to do a bit of e-learning. 
But that got pulled the moment the 





is a challenge 
and requires 
momentum 
And, and you know, when you are 
teaching, if you get ten junior 
doctors turn up, then that's probably 
quite a good number out of the total 
of them, but I mean, ten, in the 
scheme of things is a drop in the 





the trust (e.g. 
CQUIN) 
trouble within the trust because there 
are so many competing things which are 
important. Erm, and because it's not 
actually linked to any money. We were 
finding more often bumped.- P5 
 
on the part of 
the trainer 
and teach them is just an ongoing 
battle. You'd have to be doing it all 










safety but is 
not logistically 
feasible due to 
volume and 
inaccessibility 
of staff, and 
high 
turnaround 
it would be great to have some 
mandatory training for every staff nurse 
which isn’t necessarily logistically 
feasible but that would be one of the 
ways,  you know like a half-day training 
event or something like that that was 
set up for staff nurses and doctors to go 
on to learn about the correct prescribing 
of insulin, the risks with insulin, so they 
do it a little bit more in-depth than 
perhaps they’d do with other medicines. 
That, I think, would overcome a lot of 
the issues but again it’s the logistics of 
trying to get that arranged to get 
people to come to it and as I said with 
staff coming and going you’d 
continually have to be giving that 
training to people so its not necessarily 
going to fix everything but trying to get 
the message out there is the big thing.  - 
P1 
 
SAME And you know, even if it's the case of 
nurses moving on to other things, 
and you get another batch of nurses 
in and it used to feel it in work that 
the sort of the nurse contingent was 
the steady thing, as well as 
pharmacists on wards, and now 
that’s not the case anymore. They 
nearly turn over as quickly as the 
docs. So it's a real sort of nightmare 
when it comes what you're trying to 
do, and instil sort of good practice 
and get keeping people up to speed. 
So the idea of providing, like, 
training, and making sure 
everybody's up to speed with that is 








its ability to be 
evaluated 
And that’s then got to be agreed with 
your line manager that's specific to your 
role, and there’s no real follow up to see 
whether you've done it or not. So even if 
we go down the e-learning the 
assurance on whether people do it is 











But that’s again something else we 








And if its, that's one aspect of the 
training, the mandatory training. Then I 
think another aspect is going to be still 
face to face training does help and then 
implementing ‘train the trainer’. - P14 
SAME And I think the doctors – they can 
either do face to face or they can do 
e-learning, the doctors. And they 














I mean, not even the teaching trust, but 
trying to teach all of those staff 
members who will be involved in 
diabetic care, which is pretty much 
everybody on every ward, about how 
important it is a really difficult 
challenge. You know, and we spoke 
about, “do we get it as part of the 
central training?”, but then actually, you 
know, half an hour of a video isn't 
enough to teach somebody all the skills 
that they're gonna need to look after 
diabetic patients. - P1 
 
SAME So, yeah, I did a number of things. 
One of which was the drug chart 
and, and, and some teaching, but I 
mean, teaching is a very weak 
barrier really...That’s because 
people, you know, can only 
remember two or three things, and 
then might only remember that for 
that week. Then they’re not always 
going to take that with them 
(interviewer: yes, yeah) throughout. 
And, and you know, when you are 
teaching, if you get ten junior 
doctors turn up, then that's probably 
quite a good number out of the total 
of them, but I mean, ten, in the 
scheme of things is a drop in the 
ocean. So yes, we often do do some 
teaching. But it's obviously. What, 
you know, what can you get across 
in forty-five minutes to an hour to a 
small number of junior doctors once 
a year or whatever it may be? - P13 
Mandatory 
training needs 
to be repeated 
Yeah, so, yeah nursing wise, everyone 
who's a new nurse to the trust, they 
have an induction with our diabetic 
specialist nurses and that does cover 
some form of diabetes as a whole 
training. But it’s also about having that 
repeated training. I don’t think its 
repeated. I think you’d need to have it 
every three years, like refreshers, for 
example. - P14 
SAME I mean, I guess probably you’ve got 
to come back to it, at some point 











And then I do regular sessions with the 
F1 and the F2 doctors. In terms of just 
twenty minutes a month, just at the 
beginning of their sessions of learning 
from common prescribing errors. And, 
and it's really helpful because they feed 








And when you line it up with all the 
other training that sits for a trust to 
have to undertake, unless, unless 
you can get these sorts of things into 
the mandatory category, you 
generally don't have much success 






Some people might share the answers, 
but at least it will put it on the agenda 
that insulin is important, especially for 
people who are actually going to come 






Although nurses do manage to carve 
out time for training, which we 
struggle with in pharmacy, because 
of the availability of bank or locum 








always come across a fire where you 
work but yet you do the annual fire 
safety training. For insulin its regularly 











say “these six people are not going 
to work on that day, because they're 
going to have their mandatory day’s 
training”, which they do do here, I 
don’t know if they do it elsewhere, 
and they will fill the ward then with 
bank or locum staff. Whereas we 
simply do not have that within 








I know mandatory training doesn’t 
always work if you think of things like 
hand washing or fire training. It’s a tick-
box exercise, everyone does it. - P14 
SAME But you can see that their attending, 
thinking, “I've read that policy, I 
know that policy. I've got twenty 
scripts to do when I go back to the 
ward”, or you know, and they're on 
their phones. They're not looking at 
the screen. They're not interacting in 
the teaching. Yeah, they're not 
[engaged]. They're just there 
because they sign their name and 
they get their lunch. But if you ask 













Example quotes Inferences - 
respondents 




















that the chart 





its part of 
patient record 
so it goes in 
their record so 
it meant that 
nothing else 
had to be 
written in the 
notes and it 
Pharmacy-led 
implementatio
n is desirable 





“There really isn’t 
much time and I 
know and other 
hospitals their 
MMTs, their techs do 
some of that. And we 
just haven't got the 
staff to do that 
unfortunately. But 
yeah. So in my 
inpatient  safety 
group they say well 
can’t pharmacy do, 
and I say we'd love 
to, but we just 
haven't got the 
technicians base to 



















medicines policy that 
I think the midwives 




So quite often, it 
wouldn't necessarily 
be prescribed timely 
or correctly because 
they just assumed 
the patients are self-
administering. We've 
now stopped that. So 
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was all great. - 
P2 
 
their time to be able 
to do to do that, 
unfortunately.” – 
P10 










So its difficult 
to see uptake 
but there was 
definitely a 
need for it 
there and its 




so it’s a valid 
process that 
they can go 
through to be 
able to do 
that. And it 
gives our 
nurses some 
respite as well 
from having to 
give medicines 
as well. Some 
time respite. - 
P1 
Lack of use of 











Because at the end 
of the day, a patient 
should be self-
administering where 
they can. They've got 
to go home and do 
that. And we, you 
know, we de-skill 
them, we take that 
away whilst they're 











But I think the 
problem that we've 
got … is that a lot of 
it is down to the 
assessment of the 
patient’s ability to 
self-administer. And 
the group of patients 
that you've got, 
presumably as your 
kind of advisory 
group or whatever 
are presumably fit 
and healthy people 
(interviewer: Yes. 
Yes, exactly) who 
would be absolutely 
mortified to think 
that somebody else 
could do their 
medicines better 
than them. Whereas 
actually, the kind of 
people that we've 
got acutely ill in our 
hospital (interviewer: 
yeah,) are generally 















Okay. So, I 
have a 
personal 
interest in this 
area, in self-
administration
. So I 
personally do 
feel that most 
of our errors 
would be 
reduced if the 
patient is 
competent 
and able to 
self-
administer. A 
lot of the 
errors I think 
would come 












I think the problem is 
that as a trust we 
have been burnt I 
suppose in the fact 
that patients refuse 
to give up their 
insulin. And we then 
found that they were 
probably more 
confused than they 
thought they were 
and they've had 
crashing hypos 
because they’ve 
given themselves too 
much insulin. So 
what’s really difficult 
here, I think, is the 
fact that people are 
















I think the difficulty 
with self-
administration in 
general, is that there 
isn’t a one-size-fits-
all. And if you could 
write the policy that, 
you know, sensible 
people can self-
administer, and 
we're going to give 
them the keys to 
their lockers, and 
you know, anybody 
who's dependent 
isn't going to be. But 
actually, for all of us, 
that can change. And 
so I think, for me, I 
think that’s the 
challenge and the 
difficulty. 
Unfortunately, I've 
been around for too 
long than I care to 
remember, and so 
having done a self-
administration 
policy, you know, 
twenty years ago in 
a previous hospital. 
Things are 
completely different 
now than what they 
used to be. Patients 
are far sicker, 
because actually if 
they’re not very sick, 
actually we need the 
bed for the person 
who is very sick and 
waiting in A and E, 
so you have less well 
patients who could 
self-administer if you 
















are best at 
managing 
their own 









giving at what 
times and 
when we start 
to get involved 
in it there is 
always a risk 
we will get it 
wrong. So I 
think that’s 
why it works 
well. I think 
the other thing 




















insulin at ward 





The thing that makes 
us, erm, twitchy, if 
that's a word, about 
self-administration 
of insulin is 
potentially around 
how you have to 
store it to make it 
available. Actually 
saying it out loud, it 
sounds pathetic. But 
we, I think we, I think 
we struggle with the 
infrastructure to 
allow it in terms of 
around the keys, 
you’ve got to give 
the patient the keys 
to the locker in order 
that they can they 
can have access as 
well. And I, I'm not 
sure we’re there yet 
with that. Which is a 
shame, because 
what I perceive to be 
the vast majority of 
patients who would 
be able to self-











The nurses haven’t 
got time to do it. 
One of the key 
benefits of self-
administration 
would be to actually 
get it at the right 
time. Dinners are all 
put out and if the 
nurse has got like 
five patients on 
insulin to do. 
Someone's not 
gonna get it at the 
right time invariably. 
So if you’ve got 
someone that can 
self-administer it 
pre-meal, and you 
know, that would be 










in hospital can 
And I just think that a lot of 
people might not even know 
that they are able to offer that 
so were currently also putting 
together a leaflet for diabetes 
patients when they come into 
hospital and within that leaflet 
Staff competence 
and confidence to 
complete capacity 
assessments is a 
barrier to allowing 
self-administration 
And they do implement the self-
administration policy. But I still don't 
think its clear cut in regards to okay 
who's appropriate who's not because 
I don't know necessarily that the 
nurses are really conscious of the 
consequences of you know, using 





it talks about self-
administration. P14 









Certainly on our community 
wards that’s true. On the 
mental health wards that’s true 
as well. On the rare occasions 
we have people that are either 
confused and not knowing what 
dose to dial up or potentially at 
risk of harming themselves with 
the insulin then that takes a 
little bit more supervision. - P15 
Absence of engaged 
leadership driving 
implementation as a 
barrier to uptake 
 
And then when I was on mat leave it 
just got stopped because nobody 













The only problem with it though 
is it, sorry (interviewer: no, go 
ahead) is that to self-administer 
at level three you need to have 
a key to your locker, on most 
wards what you’ll find what you 
find is it's the same key for every 
single locker on the ward. It’s 
the same code because no one’s 
going to purchase thirty 
different keys. Sometimes it 
won't be level three it will be 
level two. So, it will just be 
supervised self-administration 
because they can’t actually give 
you a key, not to say that a 
patient going to go to another 
person locker in the night and 
steal their medicines, but it’s 
just that risk. - P14 




Because I think that the people that 
would probably really want it, are 
nurses because it would decrease 
administration time for them, which, 
bearing in mind the rest of the stuff 
that they've got going on. They 
could, where it was safe, offload it, 
but I don't feel a support for it. But 
then I might not be in the position to 





as a motivator 
So what I then I did was write 
the hospital policy, and again 
we came up against a problem, 
because they had, every 
hospital has a self-admin policy 
and they all vary in degrees of 
utterly useless, basically. - P2 
Low numbers of 
patients using policy 
due to strict criteria 
in pilot phase as a 
barrier to uptake. 
And we sort of piloted it for a little 
while, but it didn't really sort of come 
off. The numbers were really small. 
And the sort of feedback that we had 
was the “Oh, the criteria, perhaps 
was a bit too strict”. Because we say 
obviously, we don't want anybody 
that’s comatose or going for surgery, 
x, y, z. So the numbers were small. So 
it’s like okay, well, we'll, we'll adjust 
it, and we came back to it. And I 
don't know, for one reason or 
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another, it didn't really sort of take 
off. - P13 
Self-
administration 







key to success 
But patients basically have to do 
some kind of NVQ in giving 
themselves a drug before 
they’re allowed to have a key, 
you know, it’s incredibly 
complex, incredibly 











So it's like they’re shocking figures. 
And I think it seems like that which 
was hopefully going to help get 
people on board and improving the 
self-admin. Because Yeah, we we 
definitely have issues with it being 







so [pharmacist A] did all the 
work with the CQC to prove you 
didn’t have to lock insulin away 
so I took that part of it and 
[pharmacist B] did the risk 
assessment that the CQC asked 
for so I took her one and then 
just [trust A]’d it, submitted it to 
our medicines governance and 
they were happy to agree to it 
not being locked away because 
we had approval from the CQC 
so they were happy with that. - 
P2 
Perception of time 
and cognitive burden 
and competing 
interests in an 
already busy 
environment as a 
barrier to uptake 
Not that much, no. But and I think it 
is, even with the self-administration 
under supervision, there has to be, 
there's still some, still some, you 
know, tick-boxes that are needed. 
And I think sometimes it's easier for 
nursing staff just to do it themselves 









And so what we did, we piloted 
it in like cardiology and renal 
were all your diabetics are, and 
it worked a treat and then we 
took it to the admissions unit 
and obviously I was admissions 
pharmacist so that made it a 
little bit easier as well and they 
were like “yeah no that’s cool” 
and so what we’re doing, and so 
the nurses were just kind of like 
“yeah cool” and obviously what 
we say to them is “go and do 
this and the patient gets on with 
it”. So we’ve had it where the 
nurses are just doing it, they’re 
happy to sign it off, the patient 
signs it and off they go. - P2 
Implementation 
perceived as difficult 
So you they had a, you know, a 
whole booklet really on how to do it. 
And I just lifted it from that. The 
consent and stuff like that. So again, 
the sort of templates were there. It 
wasn't difficult to do, it was really a 
matter of the sort of implementation 
by the nursing staff. And I just think, 
oh, it was it was, I guess it was too 
difficult for whatever reason to 









than letting it 
be a barrier 
Now, we had this thing were 
they had to put everything into 
boxes and no one ever did, but I 
was like “look, just make sure 
it’s in the locker out of the way, 
you know, like in their bedside 
locker out the way, off the table 
and you’re fine” and they kind 




as a factor in timing 
and design of policy 
But again, it goes hand in hand with 
maybe devising a new chart and 
maybe putting it on EP because 
we’re moving to a whole new EPMA 
system. - P18 
The aim of 
assessment is 
to ensure they 
are safe, not 
strive for 
perfection 
So we’ve lots of conversations 
about it. It’s the classic thing, 
they fall into this trap of trying 
to prove perfect diabetes-ness 
and I keep trying to say to them 
“patients weren’t perfect before 
they came in but they were safe, 
and that’s all were doing with 
self-admin”. And as long as that 
patient doesn’t give themselves 
a hypo or DKA, I don’t actually 
care what they are doing. And 
they don’t like it. They don’t like 
it at all. And I’m like “it’s up to 
the primary care team to look 
after this patient and their 
ability to inject. Not you.  You’re 
here to keep everyone safe.”  - 
P2 




Erm we're also finding interesting 
that there are sometimes people 
who are self-admin-ing they haven't 
filled in the separate paperwork. So 
we need to make sure that it is 
properly, erm, done by policy, really, 







high, uptake is 





And we've got, we've got quite 
a good self-administration 
policy that's been in use for a 
number of years and because 
we've got a number of long-
term patients, I guess, who are 
returning to us. We've got, 
we've got a vested interest in 
encouraging them to manage 
their own conditions. - P3 
 
Staff resistance to 
uptake out of fear of 
blame if mistakes are 
made 
 
Another bit is that the nurses are 
sort of a little bit tentative in the 
context of “well if I let the patient do 
this and they forget to do it or 
they're not as competent as they 
originally thought and they miss 
their insulin doses and the sugars are 
sky high. And something happens 
they’ll come back to me on it”. You 
know “why did you let that patient 
do that?” you know? So there's a 
little bit of, I would assume, fear. 
And sort of wanting to protect 
yourself. So the best way to protect 
yourself is just to blast on and you 















use of policy  
 
It’s quite formal that. The 
diabetes nurses pick up on if 
patients haven’t got the forms 
filled in and they’re self-meding, 
self-administering they will 
actually do that as an incident. 
We have some robust kind of 
systems to ensure that patients 
who are self-administering that 
the appropriate documents and 
assessments have been done. - 
P7 
 
Lack of culture and 
familiarity of self-
administration 
depends on ward 
type and patient 
demographic 
So I think it's very hit and miss as to 
where they are doing it well. So I 
know the CF unit. They are using self-
admin quite a lot. But then yeah, 
they self admin all their meds. That's 
the sort of part of the culture of the 
ward. And again on maternity they 
can self-admin, which isn't - they're 
not doing it as per policy, but 
because actually the vast majority of 
women there are healthy they’re just 
in because they’ve had a baby. - P5 
  Multidisciplinary 
team working 
required to plan and 
implement 
intervention that is 
workable 
 
And that’s what we found, so we 
were really surprised, we did a lot of 
teaching on the patient self-admin at 
one point. And we kind of just 
assumed, you know, took it for 
granted that they do these kind of 
capacity assessments all the time. 
And they basically, they turned 
round and said “No, we never do 
them. The OTs do them occasionally, 
physios sometimes, the medics do 
them, but we don't”. And we went 
“Oh.” - P9 
 
  Paternalistic 
mentality to 
overcome in order to 
use self-
administration policy 
A couple of different things with it. 
Number one is the traditional feeling 
or sort of understanding that we look 
after patients in hospital. You know, 
if you're a nurse you’ll be giving their 
insulin because you’re giving them 
their medicine and insulin is a 
medicine. So they need to let go of 
that a little bit.  - P8 




prohibitive to uptake 
of policy 
And getting all of the CQC inspectors 
signed up for that as a collective as 
well rather than just an individual 
going “Oh, that's fine.” And another 
one going “No, I don't like that.” - P9 
363 
 
Appendix 15: RAMESES Checklist: List of items to be included when reporting a realist synthesis 
 
TITLE 
1 In the title, identify the document as a realist synthesis or review 
ABSTRACT 
2 While acknowledging publication requirements and house style, abstracts should 
ideally contain brief details of: the study’s background, review question or objectives; 
search strategy; methods of selection, appraisal, analysis and synthesis of sources; main 
results; and implications for practice. 
INTRODUCTION 
  
3. Rationale for review Explain why the review is needed and what it is likely to contribute to existing 
understanding of the topic area. 
4. Objectives and focus 
of review 
State the objective(s) of the review and/or the review question(s). Define and provide a 
rationale for the focus of the review. 
METHODS 
5. Changes in the review 
process 
Any changes made to the review process that was initially planned should be briefly 
described and justified. 
6. Rationale for using 
realist synthesis  
Explain why realist synthesis was considered the most appropriate method to use. 
7. Scoping the literature Describe and justify the initial process of exploratory scoping of the literature. 
8. Searching processes While considering specific requirements of the journal or other publication outlet, state 
and provide a rationale for how the iterative searching was done. Provide details on all 
the sources accessed for information in the review. Where searching in electronic 
databases has taken place, the details should include, for example, name of database, 
search terms, dates of coverage and date last searched. If individuals familiar with the 
relevant literature and/or topic area were contacted, indicate how they were identified 
and selected. 
9. Selection and 
appraisal of documents 
Explain how judgements were made about including and excluding data from 
documents, and justify these 
10. Data extraction Describe and explain which data or information were extracted from the included 
documents and justify this selection. 
11 Analysis and 
synthesis processes 
Describe the analysis and synthesis processes in detail. This section should include 
information on the constructs analyzed and describe the analytic process 
RESULTS 
12 Document flow 
diagram 
Provide details on the number of documents assessed for eligibility and included in the 
review with reasons for exclusion at each stage as well as an indication of their source 
of origin (for example, from searching databases, reference lists and so on). You may 
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consider using the example templates (which are likely to need modification to suit the 
data) that are provided. 
13 Document 
characteristics 
Provide information on the characteristics of the documents included in the review. 
14 Main findings Present the key findings with a specific focus on theory building and testing. 
DISCUSSION  
15 Summary of findings Summarize the main findings, taking into account the review’s objective(s), research 
question(s), focus and intended audience(s). 
16 Strengths, limitations 
and future research 
directions 
Discuss both the strengths of the review and its limitations. These should include (but 
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